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ABSTRACT OF THE DISSERTATION
Structural Insights into Host-Pathogen Interactions of Alphaviruses
by
Katherine Basore
Doctor of Philosophy in Biology and Biomedical Sciences
Biochemistry, Biophysics, and Structural Biology
Washington University in St. Louis, 2021
Professor Daved H. Fremont, Chair

Alphaviruses are arthropod-borne, single-stranded positive-sense RNA viruses of the
Togaviridae family that infect various vertebrates worldwide in tropical and temperate areas,
causing emerging and reemerging diseases in humans. Mature virions are 70 nm in diameter and
contain a ~11-kilobase genome encapsidated within a nucleocapsid core, a host-derived lipid
bilayer, and an envelope comprised of heterodimers of the glycoproteins E1 and E2 arranged into
trimeric spikes with T=4 icosahedral symmetry. Alphaviruses are categorized into two groups
based on their clinical symptoms: the arthritogenic alphaviruses, such as chikungunya (CHIKV),
Mayaro (MAYV), Ross River (RRV), Semliki Forest (SFV), and O’nyong-nyong (ONNV)
viruses, which induce arthritis, polyarthralgia, and musculoskeletal-associated diseases, and the
encephalitic alphaviruses, including Venezuelan (VEEV), Eastern (EEEV), and Western (WEEV)
equine encephalitic viruses, which lead to meningitis, encephalitis, and long-term neurological
sequelae in survivors. The global distribution of alphaviruses has increased in recent decades due
to international travel, expansion of mosquito vectors, deforestation, and urbanization. Currently,
there are no approved vaccines or treatments available to mitigate alphavirus infection and disease.
xiv

Further understanding of host-alphavirus interactions may inform the development of such
therapies for multiple members of this family. The studies encompassed in this dissertation
describe how alphaviruses engage two different entry receptors and how a panel neutralizing antiMAYV monoclonal antibodies protect against infection.
Mxra8 is a receptor for multiple arthritogenic alphaviruses such as CHIKV, MAYV, RRV,
and ONNV. We determined a 2.2 Å resolution X-ray crystal structure of Mxra8 and 4 to 5 Å
resolution cryo-electron microscopy reconstructions of Mxra8 bound to CHIKV virus-like
particles (VLPs) and infectious virus. Our structures revealed that the Mxra8 ectodomain contains
two strand-swapped Ig-like domains oriented in a unique disulfide-linked head-to-head
arrangement, and that Mxra8 binds CHIKV by wedging into a cleft created by two adjacent E2E1 heterodimers in one trimeric spike while also engaging a neighboring spike. Furthermore, we
observed two binding modes with the fully mature VLP, with one Mxra8 binding with unique
additional contacts. This high- and low- binding-site model was supported by our surface plasmon
resonance measurements. Lastly, we found that the low-affinity binding sites were sterically
obscured by the retention of the E3 glycoprotein on infectious CHIKV, suggesting that viral
maturation and E3 occupancy influences receptor binding-site usage.
In later studies, we also determined near-atomic resolution cryo-electron microscopy
reconstructions of VEEV VLPs alone and complexed with its entry receptor, LDLRAD3. We
showed that domain 1 (D1) of LDLRAD3, a low-density lipoprotein receptor type-A (LA) module,
binds VEEV by wedging into a cleft created by two adjacent E2-E1 heterodimers in one trimeric
spike, specifically engaging domains A and B of E2 and the fusion loop in E1. Our atomic
modeling of this interface was supported by mutagenesis and anti-VEEV antibody binding
competition assays. These studies demonstrated that VEEV engages LDLRAD3 in a manner that
xv

is remarkably similar to CHIKV with the Mxra8 receptor, but with an exceptionally smaller
interface. We speculate that the common positioning of these receptors near the fusion loop might
serve to modulate viral fusion during endocytosis. Our studies are among the first to structurally
characterize alphavirus-receptor complexes.
Additionally, we generated a panel of neutralizing monoclonal antibodies (mAbs) against
MAYV, over half of which had “elite” activity that inhibited infection with EC50 values of <10
ng/ml. We demonstrated that antibodies with the greatest inhibitory capacity in vitro mapped to
epitopes near the fusion peptide of E1 and in domain B of E2. Unexpectedly, many of the elite
neutralizing mAbs failed to prevent MAYV infection and disease in vivo. Instead, protection
required fragment crystallizable (Fc) effector functions, as isotype-switched or aglycosyl variants
with less or no capacity to interact with the complement component C1q or activating Fc-γ
receptors lost protective activity in vivo. These results demonstrated that an optimally protective
antibody response to MAYV and possibly other alphaviruses may require tandem optimization of
virus neutralization by the Fab moiety and effector functions of the Fc region. Altogether, these
studies establish how alphaviruses interact with the entry receptors and humoral responses of their
hosts, which may inform the basis of future therapies and improved vaccine designs.

xvi

Chapter 1:
Introduction to Alphaviruses

1

1.1 Overview of Alphaviruses
Alphaviruses are a diverse group of small, spherical, enveloped, positive-strand RNA
viruses responsible for numerous emerging and reemerging diseases. They are transmitted by
blood-sucking arthropods, primarily mosquitoes, infecting various vertebrates worldwide in
tropical and temperate areas1. The sole genus in the Togaviridae family, Alphavirus species are
categorized into two groups based on their clinical symptoms: the arthritogenic alphaviruses, such
as chikungunya (CHIKV), Mayaro (MAYV) Ross River (RRV), Semliki Forest (SFV), and
O’nyong-nyong (ONNV) viruses, which cause arthritis, polyarthralgia, and musculoskeletalassociated diseases, and the encephalitic alphaviruses, including Venezuelan (VEEV), Eastern
(EEEV), and Western (WEEV) equine encephalitic viruses, which cause meningitis, encephalitis,
and long-term neurological sequelae in survivors (Figure 1.1). The global distribution of

Figure 1.1: Phylogenetic tree of alphaviruses. The tree was constructed from e a full-length genome alignment. Light and dark
shading indicates encephalitic and arthritogenic alphaviruses, respectively. Abbreviations: EVEV, Everglades; VEEV, Venezuelan
equine encephalitis; PIXV, Pixuna; TONV, Tonate; CABV, Cabassou; RNV, Rio Negro; EEEV, Eastern equine encephalitis;
WEEV, Western equine encephalitis; SINV, Sindbis; WHAV, Whataroa; AURAV, Aura; TROV, Trocara; BFV, Barmah Forest;
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NDUV, Ndumu; MIDV, Middelburg; GETV, Getah; SAGV, Sagiyama; RRV, Ross River; SFV, Semliki Forest; BEBV, Bebaru;
MAYV, Mayaro; UNAV, Una; CHIKV, Chikungunya; ONNV, O’nyong-nyong; SESV, Southern elephant seal; SPDV, Salmon
pancreatic disease. Adapted from Forrester et al., 20112.

alphaviruses has increased in recent decades due to international travel, expansion of mosquito
vectors, deforestation, and urbanization3. Currently, there are no approved vaccines or treatments
available to mitigate alphavirus infection and disease.
1.2 Alphavirus virology and structure
Despite their differences in disease outcomes, arthritogenic and encephalitic alphaviruses
are very similar in their genome organization, replication, assembly pathway, and virion structure.
Alphaviruses enter a host cell via receptor-mediated endocytosis4 (Figure 1.2). Within a low pH

Figure 1.2: The alphavirus lifecycle. Figure created with BioRender.com.

endosomal compartment, the virion envelope rearranges to allow membrane fusion and
nucleocapsid penetration into the cytoplasm5. The approximately 11-kilobase alphavirus genome
is released after capsid disassembly and translated from two open reading frames (Figure 1.3).
The non-structural proteins (nsP1-4) mediate viral translation, viral replication, and host
subversion and evasion6, and the structural proteins (capsid (C)-envelope (E)3-E2-6K-E1) undergo
3

Figure 1.3: The alphavirus genome. The genome comprises of a single-stranded, positive-sense RNA molecule of approximately
11 kilobases and encodes 4 nonstructural proteins (nsP1–4) and 5 structural proteins (capsid (CP), E3, E2, 6K, and E1). The RNA
is capped at the 5’ end and polyadenylated at the 3’ end. Figure created with BioRender.com.

processing and modification in the ER-Golgi network (Figure 1.4). The E1 envelope
glycoprotein drives membrane fusion during viral entry7, whereas the E2 envelope
glycoprotein binds to entry factors8,9. E1 and E2 are both type I membrane proteins and
interact to form a heterodimer. The carboxyl terminus of E2 interacts with the capsid core,
which stabilizes the virion10,11. The E3 protein is essential for the proper folding of p62
(precursor to E2) and the formation of the p62-E1 heterodimer12,13 but is cleaved by furin-like
proteases during maturation14. It remains associated with E2 at acidic pH to stabilize the
heterodimer and prevent premature fusion within secretory vesicles15. The 6K protein is thought
to promote virus release from inside the host cell and act as a viroporin16.

Figure 1.4: Processing of alphavirus structural proteins. Topology schematic for organization and processing of the envelope
glycoproteins during folding in the ER membrane of an infected cell. Modified from Voss et al., 201025. Figure created with
BioRender.com.

Mature E2-E1 heterodimers assemble into trimeric spikes at the plasma membrane
before budding and release of the virion from the host cell17. The approximately 70 nm
diameter alphavirus virion is comprised of the viral genome encapsidated within a
4

nucleocapsid core, a host-derived lipid bilayer, and an envelope made of 240 E2-E1
heterodimers arranged into 80 trimeric spikes with T=4 icosahedral symmetry18,19,20 (Figure
1.5). Twenty of these trimeric spikes sit on the icosahedral three-fold (i3) symmetry axes, and
the other 60 spikes sit on the quasi-three-fold (q3) axes. The three E2-E1 heterodimers that
comprise an i3 spike are in identical chemical environments, whereas the three heterodimers that

Figure 1.5: Structure of alphavirus virion. Surface-shaded figure of ectodomain (left) and cross-section of the particle (right),
colored according to radial distance from the center. The white triangle indicates one icosahedral asymmetric unit, and the
numbers indicate the position and type of symmetry axis. Adapted from Sun et al., 201326.

make up a q3 spike are in non-identical, but similar chemical environments. An asymmetric unit
contains four E2-E1 heterodimers, one from an i3 spike and three from a q3 spike21,22 (Figure 1.6).
1.3 Alphavirus E1/E2 structure
Previous crystallographic studies of the precursor p62-E1, the mature E2-E1 glycoprotein
complex, and the E1 protein have elucidated the glycoprotein structures7,23,24,25 (Figure 1.7). p62E1 has the shape of a twisted plate, with E3 sticking out at one side and only contacting E2. The
E1 ectodomain consists of three b-barrel domains termed Domain I (DI), DII, and DIII. The fusion
loop is located at the distal end of DII. E1 monomers lie at the base of the surface spikes and form
trimers surrounding the icosahedral axes. E2 localizes to a long, thin, leaf-like structure on the top
of the spike. The mature E2 protein contains three domains with immunoglobulin (Ig)-like folds:
5

Figure 1.6: Alphavirus q3 and i3 spikes. Cartoon representation of q3 and i3 spikes according to T=4 icosahedral symmetry. The
areas a-g enclosed with a dotted line represent seven asymmetric units. The white numbers indicate the four chemically distinct
positions of the E2 (blue)-E1 (green) heterodimer in an asymmetric unit. The icosahedral and quasi axes of symmetry are shown
as red filled or unfilled shapes, respectively. Adapted from Long et al., 201522.

the N-terminal domain A, located at the center; domain B at the lateral tip; and the C-terminal
domain C, located close to E1 and the viral membrane. A long b-ribbon connector (termed the blinker) lies between domain B and domains A and C, making most of the contacts with E3. The
fusion loop of E1 is in the groove formed between domains A and B of E2 and is stabilized by
several E2 histidine side chains25.
1.4 Cryo-Electron Microscopy Studies of Alphaviruses
Over the last two decades, numerous cryo-electron microscopy (cryo-EM) reconstructions
of alphaviruses have been generated, along with subsequently built atomic models of the structural
proteins. Structures of CHIKV26,27,28, MAYV29,30, SFV31, BFV19, WEEV32, SINV33,34,35,
EEEV36,37, and VEEV38,39 as infectious virions or virus-like particles (VLPs) have been deposited
into the Electron Microscopy Data Bank (EMDB) and the Protein Data Bank (PDB) (Table 1.1).
Chapters 2 and 3 of this dissertation contain my contributions to this collection of structures28,39.
6

Even at near-atomic resolution, alphavirus reconstructions are indistinguishable from one
another, revealing significant structural homology within this diverse family of viruses. Notably,
electron density of E3 has been reported in a number of infectious alphavirus reconstructions28,35,38.
For reasons unknown, the cleavage and dissociation event can vary depending on the specific virus
and cell-type14,40.

Figure 1.7: Structure of p62-E1. Ribbon diagram of CHIKV p62-E1 (PDB 3N42)25, colored and labeled by domains. E1: DI, light
grey; DII, medium grey; DIII, dark grey; fusion loop, orange. E2: A domain, light cyan; b-linker, medium cyan; domain B, dark
cyan; domain C, medium blue. A portion of the E1 stem region, which connected DIII to the transmembrane segment, is in black.
N-linked glycans are shown as balls and sticks and colored by heteroatom.

7

Table 1.1: Summary of deposited cryo-EM structures of alphaviruses

Antigenic complex

Alphavirus

Resolution (Å)

EMDB

PDB

Citation

SFV complex

CHIKV

5.3

5577

3J2W

Sun et al., 201326

6.80

8734

5VU2

Yap et al., 201727

4.16

9393

6NK5

Basore et al., 201928

4.80

21532

6W2U

Powell et al., 202029

4.4

22961

7KO8

Ribeiro-Filho et al., 202130

SFV

9

1015

N/A

Mancini et al., 200031

BFV

6

1886

2YEW

Kostyuchenko et al., 201119

WEEV

12

5210

N/A

Sherman et al., 201032

SINV

9

1121

1Z8Y

Mukhopadhyay et al., 200633

7

5251

3J0F

Tang et al., 201134

3.5

9693

6IMM

Chen et al., 201835

4.4

9280

6MX4

Hasan et al., 201836

4.2

22276

6XO4

Williamson et al., 202037

4.4

5275

3J0C

Zhang et al, 201138

4.23

24117

7N1I

Basore et al., 202139

MAYV

WEEV complex

EEEV complex
VEEV complex

EEEV
VEEV

Citations in bold are studies encompassed in the body of this dissertation.

1.5 Alphavirus attachment and entry
To initiate infection, alphaviruses must attach to target cells and engage an entry receptor.
Attachment factors allow the virus to make initial contact with the target cell whereas entry
receptors facilitate internalization of the virus prior to endosomal fusion. Over the past several
decades, many groups have investigated the cell surface molecules involved in alphavirus
attachment and entry (Figure 1.8)41.
Alphaviruses utilize several cell surface molecules including heparan sulfate (HS), C-type
lectins, and phosphatidylserine receptors to carry out an initial attachment to target cells. HS is a
negatively charged glycosaminoglycan (GAG) that has been shown to increase the infectivity of
SINV42, SFV43, CHIKV4445, RRV46, and EEEV47. Mutational and structural studies have identified
various basic amino acids in E2 as key residues at the HS binding interface depending on the
8

specific alphavirus and type of HS used41. C-type lectins, which function as adhesion molecules
and pattern recognition receptors (PRRs) by binding high-mannose N-glycans on the surfaces of
pathogens, can also act as attachment factors for alphaviruses; dendritic cell-specific intercellular
adhesion molecule-3-grabbing non-integrin (DC-SIGN) and liver-specific SIGN (L-SIGN) can
increase the infectivity of SINV48 and SFV49. Additionally, the C-type lectin dendritic cell
immunoreceptor (DCIR) limits CHIKV disease, an effect which may require direct binding of
CHIKV50. Phosphatidylserine receptors such as TIM-1, which are involved in apoptosis signaling
pathways, have been shown to be attachment factors for SINV, CHIKV, RRV, and EEEV51,52.
Many questions remain about how these specific attachment factors interact with alphaviruses to
enhance viral entry and infection.

Figure 1.8: Alphavirus attachment factors and entry receptors. Figure modified from Holmes et al., 202041. Figure created with
BioRender.com.

Although a consensus of what constitutes a virus receptor has not been established, a recent
suggestion proposed the following: a protein is a bona fide virus receptor if (1) it binds directly
and specifically to a virus; (2) the receptor directly mediates and/or facilitates internalization of
the virus; (3) virus infection is blocked by antibodies against the receptor, by soluble receptor
decoy molecules, or through mutagenesis of the virus receptor binding domain; and (4)
susceptibility of a permissive cell type correlates with receptor expression level41. The
identification of alphavirus receptors has been historically difficult due to a lack of discernable
interactions between putative receptors and purified E2 proteins and the lingering susceptibility of
9

permissive cells lacking the proposed receptors53. In recent years, new molecules have been
identified that meet most if not all the criteria for a bona fide virus receptor. Natural resistanceassociated macrophage protein 2 (NRAMP2) is a divalent metal ion transporter that is a proposed
receptor for SINV as direct binding to virus was demonstrated, and infection was reduced in
NRAMP2-deleted permissive cells54. Another possible receptor for SINV is laminin receptor
based on antibody blocking studies55. Prohibitin1 (PHB1), a membrane- and mitochondriaassociated protein involved in regulating cell proliferation and mitochondrial integrity, is a
proposed receptor for CHIKV based on co-localization, co-immunoprecipitation, antibody
blocking, and siRNA mediated infection inhibition studies56. Although there is currently not
enough evidence to classify NRAMP2, laminin receptor, or PHB1 as bona vide receptors for
alphaviruses, two other receptors met all four classification criteria and will be discussed in the
following two sections.
1.5.1 Mxra8
Using a genome-wide CRISPR/Cas9-based screen, Matrix remodeling associate protein 8
(Mxra8) was identified as an entry receptor for multiple arthritogenic alphaviruses such as CHIKV,
MAYV, RRV, and ONNV, but not for any of the encephalitic alphaviruses (see Appendix 1)57.
Mxra8 is a cell adhesion molecule containing two Ig-like domains that is expressed on epithelial,
myeloid, and mesenchymal cells of mammals, birds, and amphibians. Previous studies suggest that
Mxra8 functions in mesenchymal cell differentiation58, blood-brain barrier homeostasis59,
osteoclast development60, cell adhesion61, and angiogenesis62. Notably, mice lacking Mxra8 are
viable and fertile63,64, indicating a non-essential role.
Mxra8 binds directly to CHIKV particles, resulting in enhanced attachment and
internalization in vitro. Mice administered anti-Mxra8 antibodies or Mxra8-Fc fusion protein
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showed lower titers and reduced foot sweeting following infection with CHIKV or ONNV57.
Similar results were seen in mice with mutant Mxra8 alleles. Furthermore, ectopic Mxra8
expression was sufficient to enhance CHIKV infection and lethality in transgenic flies64. Low
levels of residual infections were observed in the absence of receptor expression in in vitro and in
vivo studies57,64. Also, mosquitoes lack apparent orthologues of Mxra8. This signifies the existence
of Mxra8-independent pathways for cell binding and entry. Remarkably, Bovinae Mxra8, which
contains a 15-amino acid insertion in the ectodomain, does not enable alphavirus binding and
infection. Removal of the insertion restored alphavirus infection in vitro, and introduction of the
insertion into Mxra8 of mice prevented CHIKV-induced pathogenesis (see Appendix 2)65.
Residues in domains A and B of the E2 glycoprotein were identified by alanine screening
to play a role in Mxra8 binding. Also, several human anti-CHIKV monoclonal antibodies with
epitopes on E2 were shown to block Mxra8-Fc binding to CHIKV57. To further define how
arthritogenic alphaviruses engage the Mxra8 receptor, structural studies were pursued, and the
published findings28 are described in Chapter 2 of this dissertation. Pharmacologically targeting
this interaction may make a good strategy for mitigating infection and disease of arthritogenic
alphaviruses.
1.5.2 LDLRAD3
Recently, low-density lipoprotein receptor class A domain-containing 3 (LDLRAD3) was
identified as a receptor for VEEV via a genome-wide CRISPR-Cas9-based screen (see Appendix
3)66. LDLRAD3 is a conserved yet poorly characterized plasma membrane protein of the LDL
scavenger-receptor family that is expressed in neurons and in epithelial cells of the gastrointestinal
tract, myeloid cells, and muscle tissue of mammals, birds, reptiles, amphibians, and fish. Like
Mxra8, little is known about the endogenous functions of LDLRAD3; previous studies suggest a
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role in modulating amyloid precursor protein function in neurons67 and promoting E3 ubiquitin
ligase activity68.
Domain 1 (D1) of LDLRAD3 binds directly to VEEV and enhances virus attachment and
internalization into host cells66. Both anti-LDLRAD3 antibodies and a LDLRAD3(D1)-Fc fusion
protein block VEEV infection in cell culture, and the deletion of the Ldlrad3 gene or prophylactic
administration of LDLRAD3(D1)-Fc prevented morbidity and mortality in mice by pathogenic
VEEV strains. Analogous to CHIKV and the Mxra8 receptor, low levels of residual infections
were detected in cells lacking LDLRAD3. Furthermore, mosquito vectors do not have an ortholog.
This indicates that there are alternative LDLRAD3-independent pathways for VEEV to bind to
and enter host cells.
Like the studies conducted with Mxra828, we structurally characterized the VEEVLDLRAD3 interaction. This published body of work39, described in Chapter 3 of this dissertation,
may provide further insight into encephalitic alphavirus-receptor interactions and aid in the
development of treatment strategies to circumvent VEEV infection and disease.
1.6 Monoclonal antibodies against alphaviruses
There are currently no FDA-approved vaccines or antiviral therapies for alphaviruses. In
the past few decades, several mouse and human monoclonal antibodies (mAbs) against various
arthritogenic and encephalitic alphaviruses have been shown to protect against infection in vitro
and in vivo (Table 1.2). Chapter 3 of this dissertation characterizes a panel of neutralizing mAbs
against MAYV69. For most of mAbs against alphaviruses, protection correlates with neutralizing
activity70. The most potently neutralizing mAbs typically bind epitopes on E2 and block different
steps in the virus replication cycle from attachment to egress77,86,81,118. Notably, a number of
neutralizing human anti-CHIKV and anti-RRV mAbs with epitopes in domains A and B of E2
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have been shown to block Mxra8 binding to arthritogenic alphaviruses57,78,81,99. Many studies have
described non- or poorly-neutralizing mAbs that can still protect against alphavirus infection in
vivo82,84,89,91,103,105,107,113,122. These mAbs primarily bind epitopes on E1 and protect by blocking
viral egress or via Fc-effector functions (see Appendix 4)82,89,120.
Table 1.2: Summary of studies on monoclonal antibodies against alphaviruses

Antigenic complex

Alphavirus

Species

Antigenic Sites

Citation

SFV complex

CHIKV

human

E2

Lee et al., 201171
Warter et al., 201172
Selvarajah et al., 201373
Sun et al., 201326
Fong et al., 201474
Porta et al., 201475
Jin et al., 201576, 201877
Long et al., 201522
Smith et al., 201578
Broeckel et al., 201779
Quiroz et al., 201980
Powell et al., 202081
Quiroz et al., 201980
Kim et al., 202182
Kose et al., 201983
Lee et al., 201171
Warter et al., 201172
Pal et al., 201384
Sun et al., 201326
Chua et al., 201485
Porta et al., 201475
Fox et al., 201586, 201987
Lee et al., 201171
Warter et al., 201172
Pal et al., 201384
Masrinoul et al., 201488
Porta et al., 201475
Fox et al., 201586, 201987
Earnest et al., 201969, 202189
Earnest et al., 201969
Boere et al., 198390, 198491, 198592
Kielian et al., 199093
Amor et al., 199694
Hammar et al., 200395
Fragkoudis 2008?
Boere et al., 198491
Kielian et al., 199096
Ahn et al., 199997
Hammar et al., 200398
Powell et al., 202081, 2020a99

E1
mouse

unknown
E2

mouse

E1

MAYV

mouse

SFV

mouse

E2
E1
E2

E1

RRV

human

E2
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WEEV complex

WEEV
SINV

human
macaques
mouse

unknown
unknown
E2

E1

EEEV complex

VEEV complex

EEEV

VEEV

mouse

E2

avian
human

E2
E2
E1
E2

mouse

E1
human

E2

Burke et al., 2018100
Hülseweh et al., 2014101
Roehrig et al., 1982102
Schmaljohn et al., 1982103, 1983104
Stanley et al., 1985105, 1986106
Mendoza et al., 1988107
Levine et al., 1991108
Despres et al., 1995109, 1995a110
Byrnes et al., 2000111
Chanas et al., 1982112
Roehrig et al., 1982102
Schmaljohn et al., 1982103, 1983104
Hunt & Roehrig, 1985113
Stanley et al., 1985105, 1986106
Mendoza et al., 1988107
Pereboev et al., 1996114
Zhao et al., 2012115
EnCheng et al., 2013116
Hasan et al., 2018117
Kim et al., 2019118
Sun et al., 2013a119
Williamson et al., 202037
Williamson et al., 2021120
Roehrig et al., 1982a121
Mathews et al., 1985122
Roehrig & Mathews, 1985123
Hunt et al., 1991124
Agapov et al., 1994125
Phillpotts et al., 2002126
Phillpotts, 2006127
Porta et al., 201475
Burke et al., 2019128
Mathews et al., 1985122
Agapov et al., 1994125
Burke et al., 2019128
Hunt et al., 2010129, 2011130
Hunt et al., 2006131

Citations in italics are studies with humanized mAbs. Citations in bold are studies encompassed in the body of this dissertation.

One goal of vaccine and therapeutic efforts is the development of protective antibodies that
recognize conserved sites on the envelope glycoproteins of various alphaviruses. Multiple
arthritogenic alphaviruses contain a conserved epitope in domain B of E2 that is recognized by
broadly neutralizing antibodies that protect against infection and disease by CHIKV, MAYV,
RRV, and ONNV81,86. Cross-protective mAbs have also been reported between VEEV and
WEEV132 and even between several arthritogenic and encephalitic alphaviruses82.
14

1.7 Summary
Alphaviruses are a family of arthropod-borne pathogens distributed worldwide in tropical
and temperate areas, causing emerging and reemerging diseases in humans with symptoms ranging
from chronic arthritis to lethal encephalitis. Currently, there are no approved vaccines or treatments
available to mitigate infection and disease against any member of this family. Defining how
alphaviruses interact with the entry receptors and humoral responses of their hosts may inform the
development of such therapies. The studies encompassed in this dissertation establish how
alphaviruses engage two different entry receptors—Mxra8 and LDLRAD3—and how a panel of
neutralizing anti-MAYV mAbs protect against infection.
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Chapter 2:
Cryo-EM Structure of Chikungunya Virus in Complex with the
Mxra8 Receptor
This chapter is adapted from a manuscript published in Cell:
Basore, K., Kim, A. S., Nelson, C. A., Zhang, R., Smith, B. K., Uranga, C., Vang, L., Cheng, M.,
Gross, M. L., Smith, J., Diamond, M. S., & Fremont, D. H. Cryo-EM Structure of
Chikungunya Virus in Complex with the Mxra8 Receptor. Cell 177, 1725-1737.e16
(2019).
Author contributions: K.B. undertook the cryo-EM reconstructions and asymmetric unit atomic
modeling with support from C.A.N. and D.H.F. A.S.K. engineered and purified the Mxra8 proteins
and developed crystallization conditions. C.A.N., A.S.K., and D.H.F. solved the Mxra8 structure.
B.S. aided in Mxra8 model building. K.B. performed and analyzed the SPR and BLI data. R.Z.
performed the CHIKV infection experiments and provided key virus reagents. C.U. and L.V.
produced and purified the CHIKV VLPs. J.S. provided key resources for CHIKV VLP generation.
M.C. and M.L.G. performed and analyzed the HDX epitope mapping. K.B. and A.S.K. performed
data analysis. M.S.D., K.B., and D.H.F. wrote the initial manuscript draft, with the other authors
providing editorial comments.
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2.1 Summary
Mxra8 is a receptor for multiple arthritogenic alphaviruses that cause debilitating acute and
chronic musculoskeletal disease in humans. Herein, we present a 2.2 Å resolution X-ray crystal
structure of Mxra8 and 4 to 5 Å resolution cryo-electron microscopy reconstructions of Mxra8
bound to chikungunya (CHIKV) virus-like particles and infectious virus (Figure 2.1). The Mxra8
ectodomain contains two strand-swapped Ig-like domains oriented in a unique disulfide-linked
head-to-head arrangement. Mxra8 binds by wedging into a cleft created by two adjacent CHIKV
E2-E1 heterodimers in one trimeric spike and engaging a neighboring spike. Two binding modes
are observed with the fully mature VLP, with one Mxra8 binding with unique contacts. Only the
high-affinity binding mode was observed in the complex with infectious CHIKV, as viral
maturation and E3 occupancy appear to influence receptor binding-site usage. Our studies provide
insight into how Mxra8 binds CHIKV and creates a path for developing alphavirus entry inhibitors.

Figure 2.1: Graphical summary of Chapter 2.
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2.2 Introduction
Alphaviruses are positive-sense, single-stranded, enveloped RNA viruses and are among
the most important arthropod-borne viruses causing disease in humans1. This genus includes
chikungunya (CHIKV), Mayaro (MAYV), O’nyong’nyong (ONNV), and Ross River (RRV)
viruses, which are emerging beyond their historical boundaries and now cause debilitating acute
and chronic polyarthritis affecting millions of people in Africa, Asia, Europe, and the Americas.
Despite their epidemic potential, there are no specific therapies or licensed vaccines for any
alphavirus infection.
Alphavirus genomes encode four non-structural and five structural proteins. The nonstructural proteins are required for virus replication, protein modification, and immune evasion.
The structural proteins (capsid (C)-envelope (E)3-E2–6K-E1) are synthesized from a subgenomic
promoter and cleaved co- and post-translationally. The E1 envelope glycoprotein participates in
cell fusion2, whereas the E2 envelope glycoprotein binds to entry factors3,4 and initiates clathrindependent endocytosis5,6,7. The E3 protein is essential for the proper folding of p62 (precursor to
E2) and the formation of the p62-E1 heterodimer8,9 but is cleaved by furin-like proteases during
the maturation process in the trans-Golgi network10. Mature alphaviruses are ~700 Å diameter
icosahedral particles that assemble at the plasma membrane and contain a lipid bilayer with 240
embedded E2-E1 heterodimers assembled into 80 trimeric spikes with T=4 icosahedral
symmetry11,12,13, and a nucleocapsid containing a single copy of genomic RNA.
Crystallographic studies of the precursor p62-E1, the mature E2-E1 glycoprotein complex,
and the E1 protein2,14,15,16 have elucidated the glycoprotein structures. Several alphavirus virions
structures also were described by cryo-electron microscopy (cryo-EM) 11,12,14,17,18,19,20,21,22. The E1
ectodomain consists of three β-barrel domains termed Domain I (DI), DII, and DIII. The fusion
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peptide is located at the distal end of DII. E1 monomers lie at the base of the surface spikes and
form trimers surrounding the icosahedral axes. E2 localizes to a long, thin, leaf-like structure on
the top of the spike. The mature E2 protein contains three domains with immunoglobulin (Ig)-like
folds: the N-terminal domain A, located at the center; domain B at the lateral tip; and the Cterminal domain C, located close to E1 and the viral membrane.
We recently used a genome-wide CRISPR/Cas9-based screen to identify mouse Mxra8, a
two immunoglobulin (Ig)-like domain containing cell adhesion molecule, as a receptor for multiple
arthritogenic alphaviruses including CHIKV, RRV, MAYV, and ONNV (see Appendix 1)23.
Importantly, the human ortholog, MXRA8, also bound to CHIKV and other alphaviruses, and its
cell surface expression was required for efficient infection of primary human target cells including
fibroblasts, skeletal muscle cells, and chondrocytes. Mxra8 bound directly to CHIKV particles and
enhanced attachment and internalization into cells, and Mxra8-Fc fusion protein or anti-Mxra8
monoclonal antibodies (mAbs) blocked CHIKV infection of several cell types. Administration of
Mxr8a-Fc protein or anti-Mxra8 blocking mAbs to mice reduced CHIKV or ONNV infection and
associated joint swelling. Despite defining several biological characteristics of CHIKV interaction
with this receptor, structural insight as to how Mxra8 engages the alphavirus spike proteins on the
virion is lacking.
To date, there has been limited structural information of the binding of receptors to
icosahedral enveloped viruses. Here, we describe the X-ray crystal structure of the Mxra8
ectodomain and cryo-EM reconstructions of CHIKV virus-like particles (VLPs, produced as
capsid-E3-E2–6K-E1 but lacking viral RNA) and fully infectious CHIKV in complex with Mxra8.
Mxra8 has an unusual architecture, as its two Ig-like domains are oriented in a disulfide-linked
head-to-head arrangement, with domain 1 inserted into a loop of domain 2. Mxra8 binds into a
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cleft formed between two CHIKV E2-E1 heterodimers within a trimeric spike and also extends to
engage an adjacent trimeric spike. Two binding modes for Mxra8 were observed with mature
CHIKV VLPs, which is consistent with a high and low affinity binding site model supported by
surface plasmon resonance measurements. The low affinity binding sites, however, were sterically
obscured by the retention of E3 on infectious CHIKV. Overall, our structural analysis defines how
CHIKV engages its receptor Mxra8 to facilitate attachment and infection of cells. This information
may inform the basis of therapies and improved vaccine designs that mitigate disease of multiple
emerging alphaviruses.
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2.3 Results
2.3.1 Mxra8 protein and CHIKV VLPs
The soluble ectodomain of murine Mxra8 (amino acids 23 through 296) was produced as
E. coli inclusion bodies that were oxidatively refolded (Figure 2.2A). Size exclusion
chromatography coupled with multi-angle light scattering (SEC-MALS) analysis reveals that
refolded Mxra8 is monomeric with a molecular weight of 31 kDa (Figure 2.2B). Each Mxra8
monomer contains three disulfide linkages as indicated by a monoisotopic molecular weight of

Figure 2.2: Biochemical characterization of soluble Mxra8 proteins and CHIKV VLPs. A-D. Mxra8 characterization. A-B.
Bacterially-derived Mxra8 ectodomain was expressed in BL21 cells, oxidatively refolded, and purified by size exclusion
chromatography. A. Coomassie-stained SDS-PAGE of refolded Mxra8 under non-reducing and reducing conditions. B. SEC-MALS
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of refolded Mxra8 showing a monomeric form at ~31 kDa. C-D. Mxra8-Fc was produced in Expi-293 cells, purified by protein A
affinity chromatography, and digested with HRV protease to release the monomeric form of Mxra8 from the Fc region. C.
Coomassie-stained SDS-PAGE under non-reducing and reducing conditions of 5 μg of undigested (left panel) and HRV-digested
(right panel) Mxra8. One representative experiment of three is shown. D. SEC-MALS of soluble Mxra8 showing a monomeric form
at ~38 kDa. E-G. VLP characterization. After transfection of HEK-293 cells with plasmid DNA encoding CHIKV C-E3-E2–6K-E1
(strain 37997), VLPs were harvested from the supernatant and purified by anion exchange chromatography. E. Coomassie-stained
4–12% SDS-PAGE of 2 μg of purified VLPs. E2 and E1 co-migrate at ~52–53 kDa. Capsid migrates at ~35 kDa. One representative
experiment of two is shown. F. Immunoblotting of 0.25 μg of VLPs with a rabbit anti-CHIKV polyclonal antibody. One
representative experiment of two is shown. G. Dynamic light scattering analysis of CHIKV VLPs. A single homogeneous peak of
68 ± 5.3 nm is shown. Data are representative of six experiments from two different VLP preparations. See Figures 2.4 and 2.6.

31,092.45 determined by electrospray mass spectrometry. This value corresponds to the predicted
weight of the native expression construct, minus the first methionine removed by aminopeptidase
and six hydrogens lost during formation of the three disulfide bonds. We also produced a
mammalian-expressed soluble form of Mxra8 by engineering a Mxra8-Fc fusion protein23 with a
human rhinovirus 3C (HRV) protease site between the C-terminus of Mxra8 and the Fc domain.
After production of Mxra8-Fc fusion protein in HEK-293F cells and purification by protein A
affinity chromatography, we cleaved the Fc domain with HRV, and isolated Mxra8 in the flowthrough of a second round of protein A agarose affinity chromatography (Figure 2.2C). SECMALS analysis revealed that cleaved mammalian cell-generated Mxra8 is monomeric with a
molecular weight of 38 kDa (Figure 2.2D), and N-terminal sequencing using Edman degradation
showed that the mature N-terminus of the protein begins at position 23 (Figure 2.3). These
preparations of Mxra8 were used for the crystallographic and cryo-EM studies described below.
Previous studies have obtained high-resolution structural information about how
neutralizing antibodies engage CHIKV using VLPs, which contain the structural proteins but lack
infectious viral RNA and can be imaged under lower biosafety conditions24,25. To begin to define
the structural basis for interaction between Mxra8 and arthritogenic alphaviruses23, we produced
CHIKV VLPs (strain 37997) after transient transfection of HEK-293 cells with a plasmid encoding
C-E3-E2–6K-E126; equivalent preparation of VLPs were used in phase 1 and 2 human clinical
trials for vaccine protection against CHIKV disease (NCT02562482 and NCT03483961)27.
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Soluble VLPs were collected, buffer exchanged, and monitored for purity by SDS-PAGE and
antigenicity by Western blotting with anti-capsid and anti-E2/E1 antibodies (Figure 2.2E and F).
Dynamic light scattering experiments revealed a particle diameter of ~680 Å (Figure 2.2G), which
is close to the expected external diameter of 700 Å for a CHIKV virion11.

Figure 2.3: Sequence alignment of mouse and human Mxra8 orthologs. Alignment was performed between mouse (NP_077225)
and human (NP_001269514) Mxra8 using PROMALS3D28 with mouse Mxra8 numbering. The Figure was prepared using ESPript
3.029. Domains 1 (light magenta) and 2 (dark magenta) are indicated above the sequence, along with the labeled secondary
structures. Triangles indicate the N- and C- termini of the crystal structure (black) and the cryo-EM model at sites 2, 3, and 4 (red).
Red boxes signify conserved residues; white boxes and black letters, non-conserved residues. Numbers under the alignment indicate
contacts between Mxra8 and individual E2-E1 heterodimers, given as percentage buried surface area calculated by PDBePISA
(http://www.ebi.ac.uk/pdbe/pisa/): 1 represents 10% buried surface area, 2 represents 20% buried surface area, and so on.
“Wrapped” denotes contacts to the wrapped E2-E1 heterodimer making the primary contacts to Mxra8. “Intraspike” refers to the
intraspike heterodimer, which is adjacent to the wrapped heterodimer but within the same trimeric spike. “Interspike” refers to
the interspike heterodimer, which is in the neighboring spike. Red numbers indicate contacts to CHIKV E3. See Figures 2.4, 2.8
and 2.12

2.3.2 X-ray crystallographic structure of Mxra8
Diffraction quality crystals of bacterially produced murine Mxra8 (ectodomain residues 23
to 296) were obtained in space group I222 with cell dimensions a = 72.59 Å, b = 142.85 Å, and c
= 195.59 Å. There are two copies of Mxra8 in the asymmetric unit. The structure was solved by
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molecular replacement using junctional adhesion molecule-like protein (JAML; PDB code
3MJ630) as a model. There was visible density for all but the first nine and last two residues of
chain A, and all but the first seven and last two residues of chain B. The final statistics for the
Mxra8 model, refined to a resolution of 2.2 Å, are provided in Table 2.1. Mxra8 consists of two
Ig-V-like domains arranged in a head to-head orientation with the CDR-like loops pointing
Table 2.1: Crystallographic data collection and refinement statistics for mouse Mxra8

PDB ID code
6NK3
a
Resolution range
46.22 - 2.20 (2.28 - 2.20)
Space group
I222
Unit cell (Å) a, b, c
72.55, 142.70 195.38
Total number of reflections
1,360,821 (89,722)
Unique reflections
51,479 (4856)
Multiplicity
26.4 (17.7)
Completeness (%)
99.42 (95.83)
Mean I/sigma(I)
23.63 (1.44)
Wilson B-factor
51.15
CC1/2
0.999 (0.666)
Reflections used in refinement
51,265 (4851)
Reflections used for R-free
1,577 (150)
R-work
0.1988 (0.3523)
R-free
0.2258 (0.3667)
Number of non-hydrogen atoms
4,524
protein
4,258
solvent
266
Protein residues
528
RMS(bonds) (Å)
0.002
RMS(angles) (˚)
0.54
Ramachandran favored (%)
96.18
Ramachandran allowed (%)
3.63
Ramachandran outliers (%)
0.19
Rotamer outliers (%)
0.44
Clashscore
3.49
2
Average B-factor(Å )
70.05
protein
69.89
solvent
72.62
a
Values in parentheses refer to the highest resolution shell. Data
collection at ALS BL4.2.2 using an RDI CMOS_8M detector.
Data processing carried out in XDS52 and refinement in Phenix53.
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towards one another. The two FG-loops (CDR3-like) are connected by a disulfide bond (Figure
2.4A–C). Unexpectedly, the first two β-strands of each domain are swapped such that the full
domain 1 is seen as an insertion into the BC-loop (CDR1-like) of domain 2. Domains 1 and 2 are
similar in sequence (Figure 2.3) and nearly identical in fold, with an average root-mean-square
deviation (RMSD) of 0.90 Å over 68 Cα positions for chain A and 1.13 Å over 67 positions for
chain B in the crystal structure. In comparison, the two domain 1 structures in the asymmetric unit

Figure 2.4: Mxra8 crystal structure and topology diagram. A. Ribbon model of the mouse Mxra8 protein structure. The β-strands
are labeled following standard convention. The two Ig-like domains are colored from the N- to C-terminus in a rainbow spectrum
of blue to red with the disulfides shown as yellow ball and stick bonds. The positions of the cysteines forming the interdomain
disulfide bond are indicated. The N- and C-termini are labeled in lowercase. B. Secondary structure diagram of Mxra8, numbered
by sequence positions in the X-ray structure. Colored arrows indicate the β-strands as in panel A. Yellow lines connect the cysteine
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positions forming disulfide bonds. The AB strand swaps anchor the connections between the D1 and D2 domains. C. Cartoon
schematic of Mxra8, with labeled D1 and D2 domains, N- and C-termini, BC linkers, and cysteine residues forming the interdomain
disulfide bond. Mxra8 is bowed. A rotation of ~155˚ around the hinge region is required for alignment of the two domains. See
Figures 2.2, 2.2, 2.5 and Table 2.1.

align with a RMSD of 0.4 Å over 110 residues, whereas the two domain 2 structures align with an
RMSD of 1.0 Å over 104 residues. The hinge connecting the two domains is flexible, and
comparison of the two independent Mxra8 structures indicates that domain 1 can move by at least
~43° relative to D2 (Figure 2.5)31.

Figure 2.5: Domain rotation in Mxra8. (Upper left) Ribbon drawings of the Mxra8 structural models obtained from cryo-EM
refinement shown superposed on the basis of the membrane proximal domain 2 (D2). These structures correspond to the four
different binding sites (sites 1–4) on the CHIKV VLP. Analysis of the domain movements using DynDom31 suggest that all four
domains are essentially identical in conformation. (Upper right) In contrast, comparison of the two Mxra8 models from the
asymmetric unit of the X-ray crystal structure (chains A and B) show a difference in domain orientation, yielding a rotation of ~
43˚ around the axis shown in black. Furthermore, the conformations of both chains A and B vary from that seen in the cryo-EM
structure of Mxra8 bound to VLP (Lower panels). To facilitate comparison, the position of domain 2 was held constant throughout
all four panels. The rotation axes pass through the hinge region near the interdomain disulfide. The domain movements include
both bending and twisting motions, as indicated by differences in the relative orientations of the rotation axes. Depiction of helical
twists have been removed for clarity. See Figures 2.4 and 2.8.
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2.3.3 Cryo-EM reconstruction of Mxra8 bound to CHIKV VLPs
Electron micrographs of CHIKV VLPs with or without bound mammalian cell-derived
Mxra8 were recorded using a 300 kV Titan Krios cryo-electron microscope with Gatan K2 detector
at the Washington University Center for Cellular Imaging (WUCCI) (Figure 2.6A and Table 2.2).

Figure 2.6: Two-dimensional cisTEM analysis of CHIKV particles with or without Mxra8 bound. A. Raw electron micrographs
of CHIKV VLPs. B. Two-dimensional classification scheme for binning of CHIKV VLPs. C-D. Two-dimensional equatorial slices
of CHIKV VLP alone (C) or CHIKV VLP in complex with Mxra8 (D). Dimensions: the outer radius of the nucleocapsid shell (~180
Å), lipid bilayer (~240 Å), E1 protein glycoprotein shell (~280 Å), E2 protein spike (~340 Å), and bound Mxra8 (~350 Å) from the
viral center. E-F. Fourier shell correlation (FSC) plot versus resolution for CHIKV VLP alone (E) or CHIKV VLP with bound
Mxra8 (F). See Figure 2.2 and Table 2.2.
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The images were corrected for beam-induced motion using MotionCor232. Particles were autopicked from the micrographs and subjected to two-dimensional classification to remove ice
contamination and debris (Figure 2.6B). The remaining particles underwent ab initio threedimensional reconstruction and refinement in cisTEM33. The reconstructions of CHIKV VLP
alone and with Mxra8 were determined at overall resolutions of 4.16 Å and 4.06 Å (Figure 2.6C
and D), respectively, based on Fourier Shell Correlation (FCS) analysis (Figure 2.6E and F).
Table 2.2: Summary of Cryo-EM data collection. See Figures 2 and 3.

Sample
# of Micrographs
# of particles picked
# of particles after 2D classification
ResolutionFSC=0.5 (Å)
ResolutionFCS=0.143 (Å)

VLP alone
(EMDB 9393)
1332
8888
8113
4.48
4.16

VLP + Mxra8
(EMDB 9394)
7294
26790
22486
4.32
4.06

CHIKV + Mxra8
(EMDB 9395)
5318
9547
8357
5.27
4.99

The microscope settings for image collection were: Dose: 50 e-/Å2; Magnification: 18,000x; Pixel size: 1.4 Å; and Voltage: 300
keV. Micrographs were corrected for the contrast transfer function using CTFFIND456 in the program cisTEM33.

The three-dimensional reconstructions showed no large conformational changes in the
structure of the CHIKV VLP when Mxra8 is bound (Figure 2.7A and B). Despite the different
chemical environments of the structural glycoproteins within the asymmetric unit of the particle,
Mxra8 binds E2-E1 heterodimers in a 1:1 ratio, with 240 Mxra8 molecules bound per virion. The
local resolution of the reconstruction of CHIKV VLP-Mxra8 complex indicates that the membrane
proximal regions of the E2-E1 heterodimers were the best resolved, with an estimated resolution
of 3.9–5.4 Å for E1 ectodomains. In comparison, the radially distant trimeric spikes and Mxra8
were resolved less well, with an estimated resolution of 4.2–8.0 Å for Mxra8 chains (Figure 2.7C
and F). Mxra8 binds to the CHIKV VLP with a complex quaternary epitope, wedging into a cleft
created by two E2-E1 heterodimers in one trimeric spike, effectively wrapping around the distal
end of one E2-E1 heterodimer (herein referred to as “wrapped”), and contacting an adjacent
heterodimer within the same trimeric spike (the “intraspike” heterodimer). Mxra8 also engages
another heterodimer on a neighboring spike (the “interspike” heterodimer”) (Figure 2.7D and E).
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Figure 2.7: Cryo-EM reconstruction of CHIKV particles with or without Mxra8 binding. A-C. Paired, colored surface
representations (top panel) and equatorial cross-sections (bottom panel) of CHIKV VLP (A), CHIKV VLP + Mxra8 (B), and local
resolution of CHIKV VLP + Mxra8 (C). The white triangle indicates one icosahedral asymmetric unit. The 5-fold (i5), 3-fold (i3),
and 2-fold (i2) icosahedral axes of symmetry are indicated with a pentagon, triangles, and oval, respectively. Trimeric spikes are
labeled “i3” if coincident with the i3 axes, and “q3” if on a quasi 3-fold axes. Black arrows: directions of icosahedral symmetry
axes (i2, i3, q3, and i5). (A-B) Radial distance color scheme: red, electron dense core and RNA; yellow, capsid; green, membrane
lipid; dark blue, E1; cyan, E2 spike; and magenta, Mxra8. D. Zoomed-in view of the q3 spike, highlighting the three E2-E1
heterodimers that interact with Mxra8 at site 3: the wrapped (light grey), the intraspike (medium grey), and the interspike (dark
grey) heterodimers. The i5 and i2 axes of symmetry are labeled with a pentagon and oval, respectively. Mxra8 is colored by domain
(D2, dark magenta; D1, light magenta). E-F. Side views of Mxra8 at site 3. (E) Mxra8 and the wrapped, intraspike, and interspike
heterodimers are colored to match panel D. (F) Mxra8 and the wrapped, intraspike, and interspike heterodimers are colored by
local resolution, as reported in panel C: red, 4 Å; yellow, 6 Å; and green, 8 Å; See Tables 2.2 and 2.3.
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2.3.4 Building and refinement of cryo-EM structural models
We iteratively built an atomic model of the CHIKV VLP structural proteins and Mxra8
using a combination of published CHIKV crystal structures and de novo modelling. As a starting
point, we used the structures of the CHIKV capsid (PDB: 5H2358), CHIKV p62-E1 (PDB: 3N4216),
modeled transmembrane domains of E1 and E2 from Venezuelan equine encephalitis virus
(VEEV) (PDB: 3J0C21), and our structure of Mxra8 (Figure 2.2) to build one assembly into the
map of CHIKV VLP bound to Mxra8. Neither chain A nor B of the crystallographic model of
Mxra8 initially docked well as one rigid body into the cryo-EM density map (Figure 2.5); instead,
chain A D1 and D2 were docked as two separate rigid bodies and the hinge regions connecting
them were re-built manually using COOT34. To ensure accurate modeling of all interaction
interfaces, these coordinates were used to build the T=4 asymmetric unit plus surrounding adjacent
subunits in neighboring asymmetric units. This model underwent manual and computational realspace refinement employing COOT and PHENIX35 (Figure 2.8A and B, Table 2.3).
Our model details the domains and residues of the CHIKV E2-E1 heterodimers at the
Mxra8 binding interface. At the wrapped heterodimer in all four unique environments, Mxra8
engages the A and B domains of E2 (residues 18, 26–29, 71–72, 74–76 119–121, 123, 178–182,
189, 191, 193, 212–214, 221–223), the fusion loop in E1 (83, 85, 87, 88–91), and domain II of E1
(223, 226–227). On the intraspike heterodimer, Mxra8 interacts with domain A and the 𝛽-linker
of E2 (residues 5–6, 62, 64, 144, 150, 157–160, 263–265, 267). Mxra8 at site 1 also makes unique
contacts to domains I and II of E1 (residues 37, 130, 132, 142–143, 145–147, 152, 154, 156–157,
263–265, 267); these interactions were not observed at sites 2, 3, and 4. In contrast, at all binding
positions except at site 1, Mxra8 makes additional contacts with domain II of E1 (residues 71–74,
112, 115, 206–207, 209–212) of the interspike heterodimer (Figures 2.8C, 2.9, 2.10, and 2.11,
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Table 2.4). The average overall binding interface at each of the four sites in an asymmetric unit is
~2,100 Å2. The largest contributing interface is between Mxra8 and the wrapped heterodimer
(~1,200 Å2), followed by the intraspike (~600 Å2), and interspike (~300 Å2) heterodimers.

Figure 2.8: Atomic model of Mxra8 interaction with CHIKV. A. The refined model of Mxra8 and CHIKV structural proteins (E1,
E2, transmembrane (TM) helices, and Capsid) in the electron density map of the CHIKV VLP with Mxra8 reconstruction at
threshold σ=1, viewed from the side (left panel) and top (right panel) of the asymmetric unit. B. Cartoon of the asymmetric unit
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viewed from the side (left panel) and top (right panel) with all domains labeled. “q3” and “i3” refer to the icosahedral and quasi
3-fold axes, respectively. C. Individual E2-E1 subunits at the binding interface, specifically site 1 Mxra8 and its wrapped
heterodimer (left panel), site 1 Mxra8 with its intraspike heterodimer (middle panel), and site 3 Mxra8 with its interspike
heterodimer (right panel). Mxra8 and structural proteins are colored by domain. Mxra8: dark magenta, D2; light magenta, D1.
E1: DI, light grey; DII, medium grey; DIII, dark grey; fusion loop, orange; TM region, black. E2: A domain, light cyan; β-linker,
medium cyan; domain B, dark cyan; domain C, medium blue; TM region, dark blue. Capsid, forest green. Domain labels are boxed
if the domain is at the binding interface. Disulfide bonds are shown as yellow balls and sticks. D. Ribbon model of the refined site
1 Mxra8 in its electron density map, with the N- to C-terminus in a rainbow spectrum of blue to red and the disulfide bonds shown
as yellow balls and sticks. The N- and C-termini are labeled in lowercase, and the β-strands are labeled in uppercase. The density
map is viewed at contour level =1.7. E. Zoomed-in view of the protrusion density and atomic structure of the N-linked glycan at
residue 118, viewed at contour level =1.4. The value is the standard deviation of density values above the mean in the map. See
Figures 2.3, 2.5, 2.11 and Table. 2.4.
Table 2.3: Refinement and model statistics. See Figure 3.

Asymmetric Unit Model
CHIKV strain
# of chains
# of residues
# of carbohydrates
Resolution (Å)
MolProbity score
All-atom clash score
Rotamer outliers (%)
C𝜷 outliers (%)
Ramachandran Plot Favored (%)
values
Allowed (%)
Outliers (%)
R.M.S. Deviations
Bond lengths (Å)
Bond angles
Correlation
E1
Coefficient by
E2
protein
E3
(mean ± std)
Capsid
Mxra8

VLP alone
(PDB 6NK5)
CHIKV-37997
12
4036
8
4.2
2.18
11.54
1.05
0.00
88.70
11.15
0.15
0.007
1.087
0.801±0.006
0.787±0.012
N/A
0.756±0.005
N/A

VLP + Mxra8
(PDB 6NK6)
CHIKV-37997
16
5104
12
4.1
1.98
9.37
0.85
0.00
92.15
7.57
0.28
0.006
1.277
0.789±0.009
0.775±0.013
N/A
0.735±0.010
0.583±0.033

CHIKV + Mxra8
(PDB 6NK7)
CHIKV-181/25
17
4537
5
5.0
2.31
16.29
0.69
0.00
88.34
11.57
0.09
0.006
1.122
0.842±0.024
0.840±0.019
0.891±0.006
0.818±0.014
0.339

Our model details the domains and residues of the CHIKV E2-E1 heterodimers at the
Mxra8 binding interface. At the wrapped heterodimer in all four unique environments, Mxra8
engages the A and B domains of E2 (residues 18, 26–29, 71–72, 74–76 119–121, 123, 178–182,
189, 191, 193, 212–214, 221–223), the fusion loop in E1 (83, 85, 87, 88–91), and domain II of E1
(223, 226–227). On the intraspike heterodimer, Mxra8 interacts with domain A and the 𝛽-linker
of E2 (residues 5–6, 62, 64, 144, 150, 157–160, 263–265, 267). Mxra8 at site 1 also makes unique
contacts to domains I and II of E1 (residues 37, 130, 132, 142–143, 145–147, 152, 154, 156–157,
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263–265, 267); these interactions were not observed at sites 2, 3, and 4. In contrast, at all binding
positions except at site 1, Mxra8 makes additional contacts with domain II of E1 (residues 71–74,
112, 115, 206–207, 209–212) of the interspike heterodimer (Figures 2.8C, 2.9, 2.10, and 2.11,
Table 2.4). The average overall binding interface at each of the four sites in an asymmetric unit is
~2,100 Å2. The largest contributing interface is between Mxra8 and the wrapped heterodimer
(~1,200 Å2), followed by the intraspike (~600 Å2), and interspike (~300 Å2) heterodimers.
Mxra8 residues at the binding interface also were identified in our model. Both D1 and the
hinge region contribute to the binding of the wrapped heterodimer (residues 56–57, 63–66, 71, 73,
82–86, 89, 91–99, 104, 137, 139, 141, 144, 146, 148, 247, 250–251). To the intraspike
heterodimer, E2 is contacted by amino acids in D1 and the hinge region of Mxra8 at all binding
sites (residues 60, 62–63, 112, 114–115, 190, 193–196, 198, 200, 227–229), and E1 is contacted
by only D2 residues of Mxra8 at binding site 1 (46, 230–232, 236–237, 239–240, 260, 262). To
the interspike heterodimer, only D2 amino acids of Mxra8 at binding sites 2, 3, and 4 are at the
binding interface (residues 45, 208, 210–213, 217, 219, 235–237, 241, 262–264, 266, 290–291)
(Figures 2.8C and 2.3, and Table 2.4).
To evaluate our docking and modeling of Mxra8, we first assessed the general fit of the
atomic coordinates and searched for key features in the electron density map. The additional βstrand (termed “H” strand) and its adjacent A strand uniquely fill the “flap” density of D1 (Figure
2.8D). There is a predicted N-linked glycosylation site in the ectodomain of Mxra8 at residue 118.
At this position in our model, a clear density protrudes (Figure 2.8E). The relative size and shape
of this density is similar at each of the four sites in the asymmetric unit. Additional weak density
is seen at the C-terminus of Mxra8 at sites 2, 3, and 4; this allowed us to model 10 additional
residues at these sites past the G strand of D2 that is beyond the register of the crystal structure.
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Figure 2.9: Sequence alignment of E1 proteins of arthritogenic and encephalitic alphaviruses. Amino acid sequence alignment
of E1 proteins of arthritogenic (CHIKV, ABX40011; MAYV, AAY45742; RRV, ACV67002; ONNV, AOS52786; SFV, AAM64227;
and SINV, AUV65223) and encephalitic alphaviruses (WEEV, AAF60166; EEEV, AAF04796; and VEEV, AAB02517). Structure
based sequence alignments were performed between alphaviruses that do (group 1, left margin) or do not (group 2, left margin)
require Mxra8 for infection using PROMALS3D28 with CHIKV numbering. The Figure was prepared using ESPript 3.029. Domains
I (light grey), II (medium grey), III (dark grey), the fusion loop (orange), and the E1 stem, TM segment, and cytoplasmic tail (black)
are indicated above the sequence, along with the secondary structure features and nomenclature (PDB 3N4216). Red boxes, 100%
conserved; White boxes and red letters; homologous residues; White boxes and black letters, non-conserved residues. Numbers
under the alignment indicate contacts between Mxra8 and individual E2-E1 heterodimers, given as percentage buried surface area
calculated by PDBePISA: 1 represents 10% buried surface area, 2 represents 20% buried surface area, and so on. “Wrapped”
denotes contacts to the wrapped E2-E1 heterodimer making the primary contacts to Mxra8. “Intraspike” refers to the intraspike
heterodimer, which is adjacent to the wrapped heterodimer but within the same trimeric spike. “Interspike” refers to the interspike
heterodimer, which is in the neighboring spike. See Figure 2.12.
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Figure 2.10: Sequence alignment of p62 (E3-E2) proteins of arthritogenic and encephalitic alphaviruses. Amino acid sequence
alignment of p62 (E3 and E2) proteins of arthritogenic (CHIKV, ABX40011; MAYV, AAY45742; RRV, ACV67002; ONNV,
AOS52786; SFV, AAM64227; and SINV, AUV65223) and encephalitic alphaviruses (WEEV, AAF60166; EEEV, AAF04796; and
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VEEV, AAB02517). Structure based sequence alignments were performed between alphaviruses that do (group 1, left margin) or
do not (group 2, left margin) require Mxra8 for infection using PROMALS28 with CHIKV numbering. The Figure was prepared
using ESPript 3.029. E3 (yellow), and E2 domains A (light cyan), B (medium cyan), C (blue), the 𝛽-linker (medium cyan), and the
stem, TM segment, and cytoplasmic tail (dark blue) are indicated above the sequence, along with the secondary structure features
and nomenclature (PDB 3N4216). Red boxes, 100% conserved; White boxes and red letters; homologous residues; White boxes
and black letters, non-conserved residues. Numbers under the alignment indicate contacts between Mxra8 and individual E2-E1
heterodimers, given as percentage buried surface area calculated by PDBePISA: 1 represents 10% buried surface area, 2
represents 20% buried surface area, and so on. “Wrapped” denotes contacts to the wrapped E2-E1 heterodimer making the
primary contacts to Mxra8. “Intraspike” refers to the intraspike heterodimer, which is adjacent to the wrapped heterodimer but
within the same trimeric spike. “Interspike” refers to the interspike heterodimer in the neighboring spike. See Figure 2.12.
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Figure 2.11: Unique E1 contacts by Mxra8 at site 1. A. Top view of the asymmetric unit of CHIKV VLP with labeled Mxra8
binding sites. Site 1 is the Mxra8 (magenta) site that makes additional contacts to domains I and II of E1 directly beneath it (grey).
E2, cyan; capsid, green. B-C. Side views (top panels) and zoomed-in views (bottom panels) of site 1 (B) and site 2 (C), highlighting
the unique residues of E1 (orange) that contact site 1 of Mxra8 binding. Contacts were identified from the atomic model using
PDBePISA (http://www.ebi.ac.uk/pdbe/pisa/). See Figure 2.8.

In support of our model, biolayer interferometry (BLI) competition binding experiments
revealed that Mxra8 cannot bind to CHIKV VLPs in the presence of a subset of previously
described anti-Mxra8 mAbs that inhibit infection23 (Figure 2.12A). Epitope mapping via
hydrogen-deuterium exchange mass spectrometry analysis shows that competing mAbs bind to
Mxra8 at its interface with CHIKV, whereas non-competing mAbs bind at other sites (Figures
2.12B and 2.13A–B). We observed competitive inhibition with mAbs 4E7.D10 and 8F7.E1, which
map to an epitope in D1 of Mxra8 in residues adjacent to the E2 A domain of the wrapped
heterodimer, and mAb 1G11.E6, whose epitope in D2 residues is adjacent to the E1 fusion loop of
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the wrapped heterodimer. In contrast, mAbs 1H1.F5 and 3G2.F5, which do not compete in the BLI
assay, map to predominantly solvent-exposed peptides in D1 near the interspike heterodimer. If
the orientation of the Mxra8 Ig-like domains were inverted, the epitope of mAbs 1H1.F5 and
3G2.F5 would be inaccessible due to wrapped heterodimer contacts with E2 domain B and the E1
fusion loop. The alternate domain-flipped model also is not consistent with the observed ability of
mAb 1G11.E6 to compete for virus binding (Figure 2.13C–D).
Table 2.4. List of contact residues of CHIKV E2-E1 at Mxra8 binding interface. See Figures 4 and 5.

E2-E1
heterodimer
Wrapped

E2-E1
domain
Domain A of
E2
Domain B of
E2
Fusion loop
of E1

Intraspike

Interspike

E2-E1 residues

Mxra8 residues

H18, H26, S27, C28, H29,
D71, S72, T74, P75, A76,
R119, K120, I121, H123
R178, T179, L180, M181,
T182, K189, T191, N193,
T212, T213, D214, K221,
I222, D223
G83, Y85, F87, M88, W89,
G90, G91

V71, H73, S82, Q83, R84,
R85, R86, D89, Y91, S92,
A93, G94, E95, Q96, R97,
V98, Y99, R104, N137, H139,
H141, H144, D146, S148

Domain II of
E1

R223, A226, G227

Domain A of
E2

N5, F6, H62, W64

β-linker of
E2

R144, E150, V157, Q158,
S159, T160, N263, V264,
T265, R267

Domain I of
E1

I142, T143, A145, A146,
Y147, H152, V154, V156,
K157

Domain II of
E1

T37, S130, K132, T263,
N264, P265, R267

Domain II of
E1

K71, S72, L73, P74, E112,
K115, R206, T207, E209,
S210, K211, D212

Mxra8
domain
D1

P56, R57, D63, R64, L65,
H66

hinge

N247, A250, R251

D2

S112, F114, H115, S227,
G228, E229

D1

G46, R230, R231, A232,
P236, F237, R239, D240,
E260, E262

D2

W60, Q62, D63, H190, T193,
D194, R195, H196, E198,
A200

hinge

A45, R208, L210, P211,
G212, V213, R217, D219,
P235, P236, F237, R241,
E262, R263, A264, E266,
V290, T291

D2

Contact residues were identified using PDBePISA (www.ebi.ac.uk/pdbe/pisa/). Mxra8 is numbered according to NCBI reference
sequence NP_077225.4. In bold are contacts unique to Mxra8 at binding site 1, and in italics are contacts at each Mxra8 position
except binding site 1.
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Figure 2.12: Binding competition, epitope mapping, and mutagenesis supporting the Mxra8-CHIKV cryo-EM model. A.
Competition BLI assay traces. CHIKV VLP was captured on the biosensor with an anti-CHIKV mAb and then dipped into wells
containing Mxra8 ectodomain alone or with an anti-Mxra8 mAb or isotype control mAb. One experiment of three is shown. B.
Surface and ribbon diagrams of Mxra8 at site 3 and the E2-E1 domains at its binding interface. Structural proteins are colored by
domain. E1: DI, light grey; DII, medium grey; fusion loop, orange. E2: A domain, light cyan; β-linker, medium cyan; domain B,
dark cyan. ‘ denotes domains within the intraspike heterodimer, and “ for the interspike heterodimer; the wrapped heterodimer is
labelled without symbols. Surface representation of Mxra8 models are colored with the HDX-mapped epitopes of anti-Mxra8
mAbs, where shades of violet correspond to mAb 1G11.E6, green for mAbs 1H1.F5 and 3G2.F5, and yellow for mAbs 4E7.D10
and 8F7.E1. C. Trans-complementation of 293T cells (which lack endogenous MXRA8) with charge-reversal mutated Mxra8.
(Top) CHIKV infection was determined flow cytometric analysis of intracellular E2 protein. (Bottom) Relative surface expression
of Mxra8 by flow cytometry using anti-Mxra8 mAbs. Data are pooled from three experiments performed in triplicate, normalized
to the WT controls, and the mean values are shown (one-way ANOVA with Dunnett’s post-test: *, P < 0.05; ****, P < 0.0001).
D. Ribbon diagram of Mxra8 model at site 1 with side chains of mutated residues shown as balls and sticks. Mutations that result
in statistically significant decreases in CHIKV infection are colored. Inset, zoomed-in view of the surface representation of Mxra8
at the interface. Side chains of residues of E2 (cyan ribbon) at this interface are displayed as balls and sticks. E. Surface
representation of all CHIKV structural protein domains at the interface of Mxra8 at site 3 (shown as ribbon diagram), colored by
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E2-E1 heterodimer: wrapped, light grey; intraspike, medium grey; interspike, dark grey. CHIKV protein residues are colored
magenta if they lose over 30% solvent surface area upon Mxra8 binding as calculated by PDBePISA
(http://www.ebi.ac.uk/pdbe/pisa/). F-G. Zoomed-in view of D1 of Mxra8. (F) CHIKV E2 residues identified as epitopes for
neutralizing human anti-CHIKV mAbs24,36 that also block binding to Mxra823 are labeled and colored blue. (G) Four CHIKV E2
residues at the CHIKV-Mxra8 interface as defined by previous alanine scanning mutagenesis data23 are labeled and colored green.
See Figures 2.3, 2.9, 2.10, 2.13, and Table 2.4.

As another test of the model, charge-reversal point mutations were introduced in Mxra8 at
wrapped heterodimer interface residues with high percentages of buried surface area as well as
other control residues not predicted to be part of the binding interface (Figure 2.3). WT and mutant
Mxra8 cDNAs were transfected into 293T cells, which lack expression of endogenous human
MXRA823, and tested for their surface expression and ability to support CHIKV infection. Several
mutations (e.g., A49R, V88R, A93R, G117R, and F119R) in Mxra8 affected surface expression
and were not analyzed further. For mutations with wild-type levels of Mxra8 surface expression,
three substitutions (D89R, G94R, and R97E) resulted in marked reductions in CHIKV infection
and two other residues (V98R and Y99R) showed smaller yet reproducible decreases (Figure
2.12C). All five of these residues are at the interface of domain A of E2 of the wrapped site (Figure
2.12D). Thus, the binding competition and mapping results support the identified residues at the
Mxra8 interface, as well as the positioning of D1 and D2 in our electron density map.
For the interface on CHIKV (Figure 2.12E), many of the identified E2 contact residues
are supported by coincident antibody mapping and mutagenesis data (Figure 2.10, Table 2.4).
Several neutralizing human mAbs against CHIKV that disrupt Mxra8 binding23 map to epitopes
in the A domain of E224,36 that are shared with the Mxra8 binding site (Figure 2.12F). Previous
alanine scanning mutagenesis mapping data identified four solvent-exposed residues in domain A
of E2 as important for optimal Mxra8 binding23; Mxra8 residues D71, T116, and I121 are at the
wrapped interface whereas W64 contacts Mxra8 at the intraspike interface in our model (Figure
2.12G). In the original study, mutations in E1 were not evaluated for binding to Mxra8 because it
was expected that E2 and not E1 contributed to receptor engagement37,38.
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Figure 2.13: Epitope mapping of hamster anti-Mxra8 mAbs by hydrogen-deuterium exchange and mass spectrometry. A.
Representative HDX kinetic plots of peptides from mAbs of each of the 3 classified groups, both in the presence (black lines) and
absence (red lines) of Mxra8. Regions are considered to contain the binding epitopes if they show reduced rates or extents of
hydrogen-deuterium exchange. All experiments were performed in duplicate, and data are representative of two experiments. B.
Heat map depicting the average difference of deuterium incorporation between the mAb alone and with Mxra8 present across all
seven time points (∆D%). Coloring of the peptides correspond to the mAb classification. Yellow: mAbs 4E7.D10, 8F7.E1; violet:
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mAbs 1G11.E6, 7F1.D8; green: mAbs 1H1.F5, 3G2.F5, 9G2.D6. Consensus peptides for epitope designation and depiction: 4151, light violet; 91-107, yellow; 162-173, light green; 185-202, green; 241-256, violet. C-D. Surface and ribbon diagrams of Mxra8
at site 3 and the E2-E1 domains at its binding interface. CHIKV structural proteins are colored by domain. E1: DI, light grey; DII,
medium grey; fusion loop, orange. E2: A domain, light cyan; β-linker, medium cyan; domain B, dark cyan. ' denotes domains
within the intraspike heterodimer, and '' for the interspike heterodimer; labels with no punctuation indicate domains within the
wrapped heterodimer. Surface representation of Mxra8 models are colored with the HDX-mapped epitopes of anti-Mxra8 mAbs,
where shades of violet correlate to mAbs 1G11.E6 and 7F1.D8, shades of green for 1H1.F5, 3G2.F5, and 9G2.D6, and yellow for
4E7.D10 and 8F7.E1. (C) Mxra8 model shown is of the properly docked model, with D2 proximal to the virion. (D) Alternative
Mxra8 model where the Mxra8 docking was flipped (D1 proximal to the virion). This model underwent an identical building and
refinement process as described in the Methods and resulted in a poorer fit into its density map (as evident by visual inspection
and a lower correlation coefficient). See Figure 2.12.

2.3.5 Modes of Mxra8 binding to CHIKV VLPs and infectious virus
We also generated a 4.99 Å cryo-EM reconstruction of CHIKV infectious particles with Mxra8
and built an atomic model (Figure 2.14A, Tables 2.2 and 2.3). In contrast to the CHIKV VLP,
strong electron density was seen for the E3 protein in all four chemical environments of the
infectious CHIKV (Figure 2.14B-C), which similarly was observed in other infectious and noninfectious alphavirus particle preparations21,39,40. In the CHIKV infectious particles, weaker
electron density was seen for Mxra8 compared to the CHIKV VLP reconstruction. Only one of the
four potential binding sites in the asymmetric unit showed interpretable Mxra8 density (Figure
2.14B). This suggested there might be a lower occupancy of Mxra8 binding on the infectious
particle compared to on the fully mature VLP, potentially due to steric hindrance by the residual
E3 protein in three of four chemical environments. To test this hypothesis, we docked in the
difference map of Mxra8 from the mature Mxra8-VLP complex onto our Mxra8-bound CHIKV
infectious virus reconstruction and assessed for clashes. E3 appears to sterically obstruct Mxra8
binding at the i3 (site 4) and two of three of the q3 binding sites (sites 2 and 3), allowing for 60
binding sites per virion at site 1 (Figure 2.15). We note that electron density for Mxra8 on the
CHIKV VLP is strongest at site 1, which corresponds to the Mxra8 binding site on the infectious
virion (Figure 2.14C). This finding is consistent with our binding analysis of Mxra8 to CHIKV
VLPs by surface plasmon resonance, where the raw traces did not fit well to kinetic and
equilibrium 1:1 binding models (Figure 2.14D). One explanation for the higher occupancy of
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Figure 2.14: Modes of Mxra8 engagement by CHIKV. A. Two-dimensional equatorial slice (top panel) and Fourier shell
correlation (FSC) plot (bottom panel) of CHIKV infectious particles in complex with Mxra8. B-C. Views of asymmetric units of
CHIKV infectious particles (B) or CHIKV VLP (C) with bound Mxra8 electron density at high contour (left panel) and low contour
(middle and right panels), colored by structural proteins if within 6 Å of docked model coordinates. Mxra8 coordinates were
removed from the model, and E3 was docked in for (B). The value is the standard deviation of density values above the mean. Color
scheme: grey, E1; cyan, E2; yellow, E3; capsid, green; Mxra8 and other unexplained density, magenta. D-E. Kinetic sensograms
and steady-state analysis of murine Mxra8 binding to CHIKV VLPs fit to a 1:1 binding model (D) or two-site model (one high
affinity site and three lower but equal affinity sites) (E). Raw experimental traces are in black, fit traces are in red. Inset, Scatchard
plot (4 experiments; mean, standard error of the mean (SEM), and χ2 values). See Figures 2.15 and 2.16.
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Figure 2.15. Presence of E3 can sterically hinder Mxra8 binding. A. View of asymmetric unit of CHIKV infectious particles with
difference map of Mxra8 docked on. E1, E2, E3, and Mxra8 sites are labeled, with the high affinity site 1 labeled with a square. BD. Zoomed-in views highlight the amount of steric clashing of Mxra8 at site with E3 from the adjacent spike. We calculated the
surface area of occluded Mxra8 density (zoned within 2 Å of E3 coordinates) as follows: site 1 (B), 19.6 Å2; site 2 (C), 218.4 Å2;
site 3 (D), 421.4 Å2; and site 4 (E), 400.3 Å2. Color scheme for A-E: grey, E1; cyan, E2; transparent yellow, E3; capsid, green;
Mxra8, magenta. Prime labels refer to Mxra8 sites on adjacent spikes. F. Cartoon schematic summary of results: the red triangle
and the dashed lines depict two distinct representations of one icosahedral asymmetric unit. The 5-fold (i5), 3-fold (i3), and 2-fold
(i2) icosahedral axes of symmetry are indicated with a black pentagon, triangles, and oval, respectively. The white triangles and
ovals indicate the quasi 3-fold and 2-fold axes of symmetry, respectively. Trimeric spikes are labeled “i3” if coincident with the i3
axes, and “q3” if on a quasi 3-fold axes. Color scheme: grey, E1; cyan, E2; transparent yellow, E3; site 1 Mxra8, magenta; sites
2, 3, and 4 Mxra8, purple. X denotes sites of large steric clashes. See Figure 2.14.

Mxra8 at one site in an asymmetric unit is a site-specific higher binding affinity, due to the slightly
different chemical environments of each of the four E2-E1 heterodimers within the asymmetric
unit. We generated a model assuming one high affinity site and three lower but equal affinity sites
(see Methods); this model produced a substantially better fit to our SPR binding data (Figure
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2.14E). Mxra8 binds the high affinity site with a kinetically derived KD of ~84 nM and the lower
affinity sites with a KD of ~270 nM. Similar SPR measurements and two-site binding analysis were
performed for human monomeric MXRA8 (as determined by SEC-MALS), which is 78% identical
to the murine protein (Figure 2.3 and 2.16).
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Figure 2.16. Human Mxra8 binding to CHIKV VLPs. A. SEC-MALS of cleaved human Mxra8 showing a monomeric form at ~34
kDa. B-C. Kinetic sensograms and steady-state analysis of human Mxra8 binding to CHIKV VLPs fit to a 1:1 binding model (B)
or a two-site binding model (C) (one high affinity site and three low but equal affinity sites). Raw experimental traces are in black,
fit traces are in red. Inset, Scatchard plot (2 experiment: mean, standard error of the mean (SEM), 𝜒2 values). See Figure 2.14.
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2.4 Discussion
Cell culture infection experiments with mouse and human cells and in vivo pathogenesis
studies in mice defined Mxra8 as a cell surface receptor required for optimal infectivity and
induction of musculoskeletal disease by multiple arthritogenic alphaviruses23. Here, our X-ray
crystallography and single particle cryo-EM analyses of Mxra8, VLPs, and infectious virus
provide structural insight into how CHIKV engages Mxra8 to facilitate interactions with target
cells. Our study adds to the limited structural knowledge of how receptors bind to enveloped
icosahedral virions. Only one other structure of an enveloped, icosahedral virus complexed with
its receptor exists. In a 25 Å resolution cryo-EM structure, Dengue virus (DENV) was complexed
with the carbohydrate recognition domain of DC-SIGN; the only contacts were with protruding
N-linked glycans in domain II of the E protein41. In contrast, we observed a complex network of
quaternary protein-protein interactions with Mxra8 engaging two E2-E1 heterodimers within one
trimeric spike as well another heterodimer on a neighboring spike. The specific binding
determinants we observed are supported by our previous mutagenesis analysis of E2, structureguided mutations that we introduced into Mxra8, and epitope maps of mAbs against CHIKV and
Mxra8 that directly block virus-receptor interactions. Our structures indicate that Mxra8 can bind
at four distinct sites in the icosahedral asymmetric unit of the CHIKV VLP but only one site in the
infectious virus, which retains E3.
The quaternary interactions formed between Mxra8 and multiple envelope proteins would
effectively cross-link CHIKV spikes in a manner analogous to a previously defined broadly
neutralizing mAb (CHK-265) that binds domain B on one trimer and domain A on an adjacent
spike42. The cross-linking of the viral structural proteins by Mxra8, while facilitating attachment
and entry, might create a conundrum for viral fusion in the endosome, which requires domain B
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on E2 to undergo a substantive conformational shift to expose fully the underlying hydrophobic
fusion loop in domain II of E114,16. After clathrin-mediated endocytosis, fusion of CHIKV occurs
within the acidic environment of early endosomes43. Although further studies are required, we
speculate that some of the Mxra8 binding interactions with CHIKV E1 and E2 may be sensitive to
acidic pH, such that upon transiting to the early endosome the cross-linked trimers can separate
and allow the structural transitions required for fusion to occur. In preliminary experiments, we
observed deceased affinity of binding of Mxra8 to recombinant pE2-E1 under conditions of mildly
acidic pH (K. Basore, unpublished results). It is plausible that the strength of Mxra8 interactions
with viral proteins may regulate the stage of endocytosis and pH of fusion of some arthritogenic
alphaviruses.
The alphavirus structural polyprotein is processed in the endoplasmic reticulum to yield
E3-E2 (p62) and E1, which form heterodimers and oligomerize as trimers to generate the immature
spike 44. In the Golgi network, furin-like proteases cleave E3 from E2 (yielding E2-E1) to render
the spikes optimally fusogenic. However, the cleavage and dissociation event can be variable in a
cell-type and virus-type specific manner, as E3 remains covalently or non-covalently associated
with the mature virus in some alphaviruses, including Sindbis virus, Semliki Forest virus, and
VEEV10,21,45. The comparison of our cryo-EM structures of Mxra8 bound to CHIKV VLPs and
infectious virus reveals a difference in stoichiometry of binding, with 240 Mxra8 proteins bound
to CHIKV VLP and only 60 bound to our infectious CHIKV particles. One reason for the
decreased occupancy on the infectious CHIKV is the retention of the E3 protein, which appears to
occlude Mxra8 binding at three of four chemical environments in the asymmetric unit.
Biochemical and structural analysis confirmed that E3 was absent from our CHIKV VLP
preparation, possibly because of the mildly alkaline buffers used in the chromatography
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purification steps. Our binding studies with soluble mouse or human Mxra8 and CHIKV VLPs
defined two classes of sites, one of high affinity (~60 nM) and a second of lower affinity (~300
nM). In comparison, infectious CHIKV had only the high-affinity binding site. These data suggest
that while Mxra8 can bind mature CHIKV virions in two binding modes with full occupancy,
regions of partial maturity that retain E3 will bind in only a single mode. At present, the
contribution of the low affinity binding site to infectivity remains unclear, although these same
infectious virus preparations still showed a strong Mxra8-dependence23. It is plausible that E3
retention on some arthritogenic (e.g., SINV) alphaviruses could result in a lack of contribution of
Mxra8 to entry and infection. Future studies with fully mature, infectious alphaviruses propagated
in cells over-expressing furin46 that lack E3 might address this hypothesis directly.
Mxra8 contains two strand-swapped Ig-like domains oriented in a unique disulfide-linked
head-to-head arrangement withdomain 1 essentially being an insertion into the BC loop region of
domain 2. Despite this unusual architecture, the order and placement of the β-strands in each
Mxra8 domain closely resemble the topology of a typical V-set Ig domain, with the closest match47
being the coxsackievirus and adenovirus receptor48. Each Mxra8 domain appears as a two β-sheet
sandwich containing a conventional cysteine bridge between strands B and F, and also containing
C’ and C” strands. However, some differences exist. In both domains of Mxra8, the A strands
occur only in one face, along the G strand (AGFCC’C”). Domain 1 contains an additional β-strand
not normally found in Ig-like domains. This H strand allows the A and B strands to complete
domain 1 although not in the normal order (i.e., after the G strand). In canonical Ig-like domains,
the BC loop passes from one face of the β-sandwich to the other. In Mxra8, the A and B strands
are swapped between domains, and the BC loops pass between the two domains to serve as
interdomain linkers. The only similar arrangement we could find is an artificially engineered Ig54

like monomer that homodimerized by swapping the A and B strands to pack in a head-to-head
fashion49.
Our cryo-EM map of Mxra8 bound to CHIKV is corroborated by mutational analysis and
coincidence mapping of antibodies that blocked Mxra8 or CHIKV binding. We previously
identified solvent-accessible residues W64, D71, T116, and I121 in the A domain of E2 as essential
for optimal Mxra8 engagement by using an E2 alanine-scanning mutagenesis library23,36,42. Our
cryo-EM analysis identified three of these amino acids as direct interface residues (W64, D71,
I121) with one additional residue (T116) positioned in close proximity to Mxra8. When chargereversal point mutations were introduced in Mxra8 residues at the wrapped heterodimer interface
(D89, G94, R97, V98, Y99), reductions in CHIKV infection were observed. In further support of
the structurally determined Mxra8 binding site on CHIKV, neutralizing human mAbs recognizing
epitopes in the A domain inhibited Mxra8 binding, whereas others localizing to distinct sites had
less effect23. The epitopes of the anti-CHIKV mAbs36 that completely blocked Mxra8 binding
directly overlap the structural binding sites of Mxra8 and CHIKV E2. Our epitope mapping of a
panel of anti-Mxra8 mAbs and experiments assessing their ability to block virus binding provides
further support for the cryo-EM atomic model.
Mxra8 is a receptor for multiple arthritogenic but not encephalitic alphaviruses23. An
alignment of amino acid sequences corresponding to CHIKV residues comprising the Mxra8
binding site reveals that determinants are generally conserved among arthritogenic alphaviruses
(44% conserved) but are more divergent in encephalitic alphaviruses (14% conserved) (Figures
2.9 and 2.10), which likely explains the negligible interaction or binding requirement for
infectivity of Mxra8 with VEEV or related encephalitic alphaviruses23. Cryo-EM structures with
other alphaviruses including ONNV, MAYV, and RRV should provide further insight into the
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critical E2, E1, and Mxra8 contacts that facilitate attachment, entry, and infection. Such analysis
could identity targets on either the viral structural proteins or Mxra8 to facilitate the development
of agents capable of disrupting these interactions. This approach could form the basis of a therapy
that mitigates infection by multiple arthritogenic alphaviruses.
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2.5 Methods
Viruses. CHIKV strain 181/25 was obtained from the World Reference Center for Emerging
Viruses and Arboviruses (S. Weaver and K. Plante, Galveston, TX). The virus was propagated in
Vero cells (ATCC) in DMEM supplemented with 10% FBS, concentrated by sucrose gradient
ultracentrifugation, and titrated by standard focus-forming assays50,51.
VLP production and purification. CHIKV VLPs were produced via transient transfection of CE3-E2–6K-E1 (CHIKV strain 37997) plasmid DNA26 into HEK293 cells (obtained from Vaccine
Research Center, NIH), and purified via Q Sepharose XL (GE Healthcare, GE17–5072-01) anion
chromatography. The peak of interest was diafiltered into a buffer containing 218 mM sucrose, 10
mM potassium phosphate, and 25 mM citrate, pH 7.2. The material was sterile-filtered using a 0.2
μM filter, 500 μL aliquots were made and stored at −80°C. The final material was analyzed by
BCA assay for protein concentration, Coomassie-stained SDS-PAGE gel with densitometry, and
Western blotting with rabbit polyclonal anti-CHIKV 181/25 (04–0008, IBT Bioservices) and a
secondary horseradish peroxidase conjugated goat anti-rabbit antibody (65–6120, ThermoFisher
Scientific).
Mxra8 protein generation and purification. To generate recombinant bacterially-derived mouse
Mxra8 protein, residues 23–296 (Accession number NM_024263) were codon optimized,
synthesized, and inserted into the pET21a expression vector. After sequence verification, Mxra8
was expressed in BL21(DE3) E. coli cells. Cell were grown to an OD600 of 0.8, induced with 1
mM IPTG for 5 h at 37°C, resuspended in 50 mM Tris-HCl, 1 mM EDTA, 0.01% NaN3, and 1
mM DTT (TEND) buffer supplemented with 25% sucrose, and lysed in 50 mM Tris-HCl, 1 mM
EDTA, 0.01% NaN3, 1 mM DTT, 200 mM NaCl, 1% sodium deoxycholate and 1% Triton X-100.
Inclusion bodies were isolated and washed extensively in TEND buffer with 100 mM NaCl and
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0.5% Triton X-100 and then TEND buffer alone. Inclusion bodies (~200 mg) were denatured in
6M guanidinium hydrochloride, 100 mM Tris-HCl, and 20 mM β-mercaptoethanol. Denatured
protein was oxidatively refolded overnight at 4°C in 100 mM Tris-HCl, 400 mM L-arginine, 5
mM reduced glutathione, 0.5 mM oxidized glutathione, 10 mM EDTA and 200 mM
phenylmethylsufonyl flouride. Protein was concentrated using a 10 kDa molecular weight cut-off
stirred cell concentrator (EMD Millipore) and purified by HiLoad 16/600 Superdex 75 size
exclusion chromatography (GE Healthcare). Mxra8 mutants were generated using a QuikChange
II XL Site-Directed Mutagenesis Kit (Agilent) and verified by DNA sequencing. Mxra8 mutant
proteins were expressed and purified as described above.
To generate mammalian Mxra8 protein, residues 23–336 (Accession number NM_024263)
were codon optimized, synthesized, and inserted into the pCDNA3.4 vector upstream of the HRV
3C cleavage sequence (LEVLFQGP) and the mouse IgG2b Fc region. After sequence
confirmation, Mxra8-HRV-Fc protein was expressed using the Expi293 mammalian expression
system (Thermo Fisher). Briefly, 200 μg of plasmid was diluted in Opti-MEM, incubated with
HYPE-5 transfection reagent (OZ Biosciences), and added dropwise to cells (106 cells/ml).
Transfected cells were supplemented daily with Expi293 media and 2% (w/v) Cell Boost
Supplement (HyClone). Four days post transfection, supernatant was harvested by centrifugation
and purified by Protein A Sepharose (Thermo Fisher) chromatography. The mouse IgG2b region
was cleaved using the Pierce HRV 3C Protease Solution Kit (Thermo Fisher). Cleaved Fc
fragments were depleted using Protein A Sepharose chromatography, and HRV-cleaved Mxra8
was purified by HiLoad 10/600 Superdex 75 size exclusion chromatography (GE Healthcare).
Purity was determined by SDS-PAGE analysis.
Multi-angle light scattering analysis. Recombinant Mxra8 proteins were loaded onto a size
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exclusion chromatography column in sizing buffer (150 mM NaCl, 20 mM HEPES pH 7.4, 0.01%
NaN3) in series with a Dawn HELEOS-II 18-angle light scattering detector (Wyatt), Optilab rEX
refractive index monitor (Wyatt), and photodiode array detector 996 (Waters). The light scattering,
refractive index change, and UV light absorbance were measured, and the molecular weight of the
eluted protein was calculated using the Astra V macromolecular characterization software package
(Wyatt).
Mxra8 crystallography and structural analysis. Mouse Mxra8 was crystallized by hanging drop
vapor diffusion at 15.0 mg/ml in 100 mM Tris-HCl, pH 8.5, and 8% PEG 8000. Crystals were
looped and flash cooled in mother liquor supplemented with 25% ethylene glycol. Data was
remotely collected at Advanced Light Source MBC Beamline 4.2.2 and merged and processed
with XDS52. Molecular replacement was performed using Phaser in the Phenix software53 and
junctional adhesion molecule-like protein (JAML; PDB code 3MJ630) as the search model.
Refinement and model building were carried out in Phenix and COOT34. Data collection and
refinement statistics are reported in Table 2.1. Structures were assessed using Molprobity and
figures were generated using Chimera (http://www.cgl.ucsf.edu/chimera) and PyMOL54.
SPR-based Mxra8 binding assay. SPR binding experiments were performed on a Biacore T200
system (GE Healthcare) to measure the kinetics and affinity of Mxra8 binding to CHIKV VLPs.
Experiments were performed at 30 μl/min and 25°C using HBS-EP (0.01 M HEPES pH 7.4, 0.15
M NaCl, 3 mM EDTA, 0.005% v/v Surfactant P20) as running buffer. CHK-265 mAb51 was
immobilized onto a CM5 sensor chip (GE Healthcare) using standard amine coupling chemistry,
and CHIKV VLPs were captured. Recombinant Mxra8 was injected over a range of concentrations
(2 μM to 20 nM) for 200 sec, followed by a 600 sec dissociation period. As a negative control,
murine norovirus was captured with mAb A6.2, as described previously55. Real-time data was
59

analyzed using BIAevaluation 3.1 (GE Healthcare). For the equal affinity binding sites model,
kinetic profiles and steady-state equilibrium concentration curves were fitted using a global 1:1
binding algorithm with drifting baseline. For the model of Mxra8 binding to 1 of 4 sites with higher
affinity, the following fits were used:
Equilibrium Analysis:
𝑅𝑈 =

𝑘! [𝐴]
3𝑘" [𝐴]
+
1 + 𝑘! [𝐴] 1 + 𝑘" [𝐴]

where 𝑘! corresponds to the high affinity site and 𝑘" denotes the low affinity sites.
Kinetic Analysis:
Reaction equations:

𝑘#!
𝐴 + 𝐵1 ⇄ 𝐴𝐵1
𝑘$!

3𝑘#"
𝐴 + 𝐵2 ⇄ 𝐴𝐵2
3𝑘$"

where 𝐴=analyte (Mxra8), 𝐵1=high affinity sites of ligand (CHIKV VLP), and
𝐵2=low affinity sites of ligand (CHIKV VLP)
Differential equations:
𝑑[𝐵1]
= −(𝑘#! [𝐴][𝐵1] − 𝑘$! [𝐴𝐵1])
𝑑𝑡
𝑑[𝐵2]
= −3(𝑘#" [𝐴][𝐵2] − 𝑘$" [𝐴𝐵2])
𝑑𝑡
𝑑[𝐴𝐵1]
= (𝑘#! [𝐴][𝐵1] − 𝑘$! [𝐴𝐵1])
𝑑𝑡
𝑑[𝐴𝐵2]
= 3(𝑘#" [𝐴][𝐵2] − 𝑘$" [𝐴𝐵2])
𝑑𝑡
BLI-based competition binding assay. Binding of Mxra8 and anti-Mxra8 mAbs to captured
CHIKV VLP was monitored in real-time at 25°C using an Octet-Red96 device (Pall ForteBio).
CHK-265 (100 μg) was mixed with biotin (EZ-Link-NHS-PEG4-Biotin, Thermo Fisher) at a molar
ratio of 20:1 biotin:mAb, incubated at room temperature for 30 min, then unreacted biotin was
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removed by passage through a desalting column (5 mL Zeba Spin 7K MWCO, Thermo Fisher).
Biotinylated-CHK-265 was loaded onto streptavidin biosensors (ForteBio) until saturation,
typically 10 μg/ml for 2 min, in 10 mM HEPES (pH 7.4), 150 mM NaCl, 3 mM EDTA, and 0.005%
P20 surfactant with 1% BSA. CHIKV VLP was then added for 5 min. The biosensors then were
dipped into wells containing 1 μM Mxra8 alone or with 1μM of hamster anti-Mxra8 mAbs
(1G11.E6, 1H1.F5, 3G2.F5, 4E7.D10, 8F7.E1, or an isotype control mAb) for 5 min, followed by
a 5-min dissociation.
Cryo-EM sample preparation, data collection, and single particle reconstruction. CHIKV
VLP with and without cleaved Mxra8 and CHIKV infectious virus (181/25 strain) with cleaved
Mxra8 in molar excess were flash cooled on holey carbon EM grids in liquid ethane under BSL-2
containment conditions using an FEI Vitrobot (ThermoFisher). Movies of the samples were
recorded with the software EPU (Thermo Fisher) using a K2 Summit electron detector (Gatan)
mounted on a Bioquantum 968 GIF Energy Filter (Gatan) attached to a Titan Krios microscope
operating at 300 keV with an electron dose of 50 e−/Å2 and a magnification of 18,000x. The
movies (30 frames, 300 msec exposure per frame) were corrected for beam-induced motion using
MotionCor232. Contrast transfer function parameters of the electron micrographs were estimated
using CTFFIND456 in cisTEM33. Particles were auto-picked, and underwent reference-free 2D
classification, ab initio 3D reconstruction, and 3D refinement in cisTEM. Local resolution was
estimated using RELION-357. Additional information regarding the number of images and
particles is listed in Table 2.2. Structural visualization of the 3D reconstructions were performed
using the programs Chimera (http://www.cgl.ucsf.edu/chimera) and PyMOL54.
Model building. The initial models of the CHIKV structural proteins (E1, E2, TM regions, and
Capsid) with or without Mxra8 were built into the density of a subunit by docking the components
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from the crystal structures of CHIKV p62-E1 (PDB: 3N4216), the CHIKV capsid (PDB: 5H2358),
and the modeled TM regions of VEEV (PDB: 3J0C21) using the fitmap command in Chimera. All
components were docked in as one rigid body except for Mxra8, where D1 (residues 70–188) and
D2 (32–59; 201–294) were docked as two separate bodies. Amino acid substitutions and Mxra8
hinge regions (residues 60–69; 189–200) were added or built manually in COOT to reflect the
strain of CHIKV used for VLP production (CHIKV-37997) and infectious virus (CHIKV-181/25)
for cryo-EM studies. The subunit models then underwent real-space refinement using PHENIX
with default parameters plus rigid body refinement and secondary-structure and torsion restraints
with the initial components as the reference. Rigid bodies for E1 were divided into domains I and
II (residues 1–292), domain III (293–381), stem (382–412), and transmembrane region (413–442).
E2 was divided into the N-linker region (residues 5–15), domain A (residues 16–134), domain B
(residues 173–231), domain C (residues 269–341), β-linker (residues 135–172, 232–268), and the
stem, transmembrane region, and cytoplasmic tail (residues 342–423). The capsid protein was
divided into two rigid bodies (residues 111–176 and residues 177–261), and Mxra8 was divided
into D1 (residues 70–188) and D2 (32–59; 201–294). The refined subunits were used to build the
asymmetric unit with adjacent subunits to prevent clashes and optimize interactions. These models
underwent further real-space refinement. COOT was used to fix regions manually with poor
geometry. After optimization, coordinates of the asymmetric units were checked by MolProbity
(Table 2.3). Contact residues were identified and buried surface areas were calculated using
PDBePISA (www.ebi.ac.uk/pdbe/pisa/).
Mxra8 expression experiments in 293T cells. The C-terminal FLAG tagged mouse Mxra8
corresponding to the transcript (NM_024263) and its corresponding charge reversal mutants were
synthesized commercially (Genewiz) in a pCAGGS mammalian expression vector. Plasmids were
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transfected transiently in 293T cells using Fugene®HD according to the manufacturer’s
instructions. One day after transfection cells were inoculated with CHIKV-181/25 (MOI 3) for
12.5 h, and then harvested, fixed with paraformaldehyde (PFA), permeablized, and processed for
CHIKV expression using 1 μg/ml of humanized CHK-16651 and anti-FLAG® M2 antibody
(Sigma-Aldrich #1804). After washing, cells were stained with 2 μg/ml of goat anti-human IgG
conjugated with Alexa Fluor® 647 (Thermo Scientific) and 2 μg/ml of goat anti-mouse IgG
conjugated with Alexa Fluor® 488 (Thermo Scientific) and subjected to flow cytometry analysis
on a MACSQuant® Analyzer 10 (Miltenyi Biotec). To assess surface versus intracellular
expression of Mxra8, cells were harvested at 36 h post transfection using TrypLE (Thermo
Scientific), and incubated with a serum polyclonal hamster anti-mouse Mxra8 antibody (1:400) at
4°C for 25 min. After washing, intact cells were stained with 2 μg/ml of goat anti-Armenian
hamster IgG H&L conjugated with Alexa Fluor® 647 (Abcam #173004) for 25 min at 4°C. After
two additional washes, cells were fixed with 2% PFA for 10 min at room temperature. After
permeablization, cells were stained with 1 μg/ml of anti-FLAG® M2 antibody (Sigma-Aldrich
#1804), and then with 2 μg/ml of goat anti-mouse IgG conjugated with Alexa Fluor® 488 (Thermo
Scientific). Cells were subjected to flow cytometry analysis and processed using FlowJo software
(Tree Star).
Hydrogen-deuterium exchange mass spectrometry. Continuous HDX labeling of Mxra8 with
or without the anti-Mxra8 mAbs was performed at 25°C for 0, 10, 30, 60, 120, 900, 3,600 and
14,400 sec as previously described with the following modifications59. Briefly, stock solutions of
both Mxra8 with or without the mAbs (50 μM) were prepared in 1X PBS pH 7.4 and incubated at
25°C for at least 1 h. Continuous labeling with deuterium was initiated by diluting 1 μl of the stock
samples 25-fold in 24 μl of deuterated 1X PBS buffer (Sigma-Aldrich). HDX control samples
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(non-deuterated) were prepared in the same way with H2O. Quenching was performed under
reducing condition by adding a solution of 500 mM Tris (2-carboxyethyl)phosphine hydrochloride
(TCEP HCl) and 4 M guanidine hydrochloride in 1X PBS buffer pH 7.4 (adjusted using sodium
hydroxide to pH 2.5) to the reaction vial at a 1:1 volume ratio. The sample was mixed and
incubated for 1 min at 25°C before loading on to a custom-built HDX platform for desalting, online pepsin digestion, and reversed-phase separation and directly injected into the mass
spectrometer for analysis.
The sample was passed over a custom-packed 2 × 20 mm pepsin column at 200 μL/min;
immobilized pepsin was prepared by a published procedure60. The peptides resulting from
digestion were captured by a 2.1 × 20 mm Zorbax Eclipse XDB-C8 trap column (Agilent) and
desalted at 200 μL/min of H2O containing 0.1% triflouroacetic acid for 3 min. The peptides were
separated by a 2.1 × 50 mm C18 column (2.5 μm XSelect CSH C18; Waters) with a 9.5-min
gradient of 5%−100% acetonitrile in 0.1% formic acid at a flow rate of 100 μl/min delivered by a
LEAP 3× Ti pump (LEAP technologies, NC). The linear part of the gradient from 0.3 min to 5.5
min raised the acetonitrile content from 15% to 50%, during which time most of the peptides eluted
from the C18 column. The entire fluidic system was kept in an ice bath except for the pepsin
column to minimize back exchange. Duplicate measurements were carried out for each of the time
points.
Acquired spectra were analyzed using HDX workbench software61 against a peptide set
generated as described below. The deuterium level was normalized to the maximum deuterium
concentration (96%) contained in the reaction vial. A peptide list used to search the HDX data was
identified first by a tandem MS experiment in a data-dependent mode on a LTQ-FT mass
spectrometer (Thermo Scientific). The six most abundant ions were submitted to collision-induced
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dissociation fragmentation. Product-ion spectra were submitted to Byonic™ (Protein Metrics,
version 2.11.062) for identification and peptide set build-up, then manually inspected, and the
validated peptides were used for the HDX analysis.
HDX data analysis and epitope assignment. The epitopes were identified as regions/sequences
of amino acids (not single residues) and determined from peptide level HDX-MS data. The data
trends in the overlapping peptides were analyzed using a conservative approach in making
assignments. For each peptide, the relative difference in deuterium uptake was calculated by
dividing the difference in deuterium uptake between Mxra8 alone and Mxra8 with mAb for each
of the time points. Epitope peptides were initially identified as those peptides with relative
differences in deuterium uptake of greater than 15% at two or more consecutive time points. If two
or more overlapping peptides corresponded to a given region, the larger peptide was chosen.
Selected peptides were screened to exclude the regions/sequences of amino acids exhibiting less
than 15% relative difference in deuterium uptake between the apo- and the holo- states, as
evidenced by another constituent peptide with shorter sequence length.
Data Availability. The authors declare that all data supporting the findings of this study are
available within the paper and its Supplementary information. All structures are deposited in the
PDB and EMDB databases (PDB 6NK3, 6NK5–6NK7; EMDB 9394–9395). The mapping data of
anti-Mxra8 mAbs are deposited in the Immune Epitope Database and Analysis Resource.
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Chapter 3:
Structural basis of Venezuelan equine encephalitis virus engagement
of the LDLRAD3 receptor
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Basore, K., Ma, H., Kafai, N.M., Mackin, S., Kim, A. S., Nelson, C. A., Diamond, M. S., &
Fremont, D. H. (2021). Structural basis of Venezuelan equine encephalitis virus
engagement of the LDLRAD3 receptor. Accepted to Nature.
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3.1 Summary
LDLRAD3 is a recently defined attachment and entry receptor for Venezuelan equine
encephalitis virus (VEEV), a New World alphavirus that causes severe neurological disease in
humans. Here we present near-atomic resolution cryo-electron microscopy (cryo-EM)
reconstructions of VEEV virus-like particles (VLPs) alone and complexed with ectodomains of
LDLRAD3. Domain 1 (D1) of LDLRAD3 is a low-density lipoprotein receptor type-A (LA)
module that binds VEEV by wedging into a cleft created by two adjacent E2-E1 heterodimers in
one trimeric spike and engaging domains A and B of E2 and the fusion loop in E1. Atomic
modeling of this interface is supported by mutagenesis and anti-VEEV antibody binding
competition assays. Remarkably, VEEV engages LDLRAD3 in a manner similar to the way
arthritogenic alphaviruses bind the structurally unrelated Mxra8 receptor, but with an
exceptionally smaller interface. These studies further elucidate the structural basis of alphavirusreceptor interactions, which could inform development of therapies to mitigate infection and
disease against multiple members of this family.
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3.2 Introduction
Alphaviruses are enveloped, arthropod-transmitted, single-stranded positive-sense RNA
viruses that infect many vertebrate hosts including humans, horses, rodents, birds, and fish1.
Alphaviruses can be categorized based on their clinical syndromes: arthritogenic alphaviruses,
such as chikungunya (CHIKV), Ross River (RRV), Sindbis (SINV), and O’nyong-nyong (ONNV)
cause arthritis, polyarthralgia and musculoskeletal-associated diseases; encephalitic alphaviruses,
including Venezuelan (VEEV), Eastern (EEEV), and Western (WEEV) equine encephalitic
viruses, cause meningitis, encephalitis, and long-term neurological sequelae in survivors. The
global distribution of alphaviruses has increased in recent decades due to international travel,
expansion of mosquito vectors, deforestation, and urbanization2.
Alphaviruses enter host cells via receptor-mediated endocytosis3. Within the low pH
endosomal compartment, the virion envelope rearranges to allow membrane fusion and
nucleocapsid penetration into the cytoplasm4. The 12-kilobase alphavirus RNA genome is released
after capsid disassembly and translated from two open reading frames. The structural proteins
(capsid (C)-envelope (E)3-E2-6K-E1) undergo processing and modification in the ER-Golgi
network. The E1 envelope glycoprotein drives membrane fusion during viral entry5, whereas the
E2 envelope glycoprotein binds to entry factors6,7. The E3 protein is essential for the proper folding
of p62 (precursor to E2) and the formation of the p62-E1 heterodimer8,9 but is cleaved by furinlike proteases during maturation10. Mature E2-E1 heterodimers assemble into trimeric spikes at
the plasma membrane before budding and release of the virion from the host cell11. The 70 nm
diameter mature alphavirus virion is comprised of 240 E2-E1 heterodimers arranged into 80
trimeric spikes with T=4 icosahedral symmetry12,13,14. Twenty of these trimeric spikes sit on the
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icosahedral three-fold (i3) symmetry axes, and the other 60 spikes sit on the quasi-three-fold (q3)
axes.
We recently identified low-density lipoprotein receptor class A domain-containing 3
(LDLRAD3) as an attachment and entry receptor for VEEV and showed it was essential for
optimal infection in cell culture and pathogenesis in mice (see Appendix 3)15. LDLRAD3 is a
conserved yet poorly characterized cell surface protein expressed in neurons, epithelial cells,
myeloid cells, and muscle tissue whose endogenous ligand(s) remains unknown. Biolayer
interferometry experiments established that Domain 1 (D1) of LDLRAD3 binds directly to VEEV,
and anti-LDLRAD3 antibodies and LDLRAD3(D1)-Fc fusion proteins block VEEV attachment
and infection of cells. Only VEEV utilizes LDLRAD3 as a receptor, as neither EEEV, WEEV nor
other distantly related alphaviruses bind to it. How LDLRAD3 engages VEEV, and why only
VEEV binds to LDLRAD3 remains unknown. We set out to address these questions using
structural, genetic, and biophysical approaches.
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3.3 Results
3.3.1 Cryo-EM reconstruction of LDLRAD3(D1) bound to VEEV VLPs
Mammalian cell-expressed soluble LDLRAD3(D1) was produced in Expi293 cells15.
Electron micrographs of VEEV VLPs33 with or without bound LDLRAD3(D1) were acquired
using a 300 kV Titan Krios equipped with a Gatan K2 detector (Figure 3.1a and Table 3.1).
Single-particle analysis with imposed icosahedral symmetry yielded reconstructions at 4.2 Å and
4.3 Å resolutions for the apo and complexed structures, respectively (Figures 3.2a-b and 3.1b).
Two-hundred and forty molecules of LDLRAD3(D1) bound to sites on VEEV VLP (100%
saturation), each one wedged into a cleft formed between two adjacent E2-E1 heterodimers within

Figure 3.1: Quality validation of cryo-EM maps. (a) Representative electron micrograph (micrograph number 1453) of VEEV
VLPs. Scale bar: 500 Å. (b) Fourier shell correlation (FSC) plots for VEEV VLP alone (left panel) and with LDLRAD3(D1) (right
panel). (c) Side views of the unsharpened (left panel), globally sharpened by RELION postprocessing (middle panel), or modified
by DeepEMhancer (right panel) electron densities of one asymmetric unit of VEEV-LDLRAD3 complex. Maps are colored by radial
distance from the VLP center, with LDLRAD3(D1) shown in purple, analogous to Figure 3.2b.
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Table 3.1: Summary of Cryo-EM data collection.

Sample
# of Micrographs
# of particles picked
# of particles after 2D
classification
# of particles after 3D
classification
ResolutionFSC=0.5 (Å)
ResolutionFCS=0.143 (Å)

VLP alonea
(EMDB 24117)
2237
19516
9816

VLP + LDLRAD3 D1a
(EMDB 24116)
8979
30242
14648

VLP + LDLRAD3 D1D2b
(EMDB 24394)
6693
47820
19115

7993

12216

9634

4.75
4.23

5.03
4.28

6.49
4.97

a

The microscope settings for image collection were: Dose: 35 e-/Å2; Magnification: 105,000x; Pixel size: 1.1 Å; Voltage: 300 keV.
Movies were recorded with a Gatan K2 Summit electron detector. bThe microscope settings for image collection were: Dose: 35 e/Å2; Magnification: 59,000x; Pixel size: 1.16 Å; Voltage: 300 keV. Movies were recorded with a Falcon 4 Direct Electron Detector.

each trimeric spike (Figure 3.2c). This cleft widens slightly when LDLRAD3 D1 is bound. Local
resolution estimation performed in RELION revealed heterogenous resolution; the capsid proteins
and membrane proximal regions of the E2-E1 heterodimers were best resolved (~4 Å) and the
membrane distal regions and LDLRAD3(D1) were less well resolved (~5-6 Å) (Figure 3.2d). To
avoid under- and over-sharpening of the reconstructions by conventional global B-factor
correction, post-processing was performed using DeepEMhancer16. This resulted in improved
continuity and reduced noise in the density (Figure 3.1c). The visibly clear tracing of the carbon
backbone simplified subsequent model building.
3.3.2 Atomic model building and refinement
LDLRAD3(D1) was identified as an LDL receptor type A (LA) domain by the Pfam
database17. LA domains are approximately 40 amino acids in length and contain six disulfidebound cysteines and a cluster of conserved acidic residues that coordinate calcium ions (Figure
3.3a). The LA domain architecture is well characterized with over 200 structures in the PDB,
revealing a highly conserved fold. The initial model of LDLRAD3(D1) was built from its primary
amino acid sequence by threading using the SWISS-MODEL server18 with multiple highresolution crystal structures of related LA domains as templates. Starting coordinates of the VEEV
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Figure 3.2: Cryo-EM reconstruction of VEEV VLPs in complex with LDLRAD3(D1). a. Colored surface representation (left)
and equatorial cross-section (right) of VEEV VLP + LDLRAD3(D1). The surfaces are colored by radial distance in Angstroms,
with density of LDLRAD3 colored purple. The white triangle indicates one icosahedral asymmetric unit. The 5-fold (i5), 3-fold
(i3), and 2-fold (i2) icosahedral axes of symmetry are indicated with a pentagon, triangles, and an oval, respectively. Trimeric
spikes are labeled ‘‘i3’’ if coincident with the i3 axes and ‘‘q3’’ if on a quasi-3-fold axis. Black arrows: directions of icosahedral
symmetry axes (i2, i3, q3, and i5). Scale bar: 100 Å. b-c. Paired, electron density of one asymmetric unit of VEEV-LDLRAD3
complex, colored by protein: E1, grey; E2, cyan; capsid, forest green; and LDLRAD3(D1), purple (b) or by local resolution (c).
Scale bar: 20 Å.

VLP structural proteins came from a previously built model of the same VEEV strain (PDB
3J0C19). Both models were docked into the DeepEMhancer modified electron density of the
asymmetric unit and underwent manual and computational real-space refinement employing
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COOT20 and PHENIX21 (see Methods), with LDLRAD3(D1) unambiguously oriented with the Nterminus proximal to the core of the virus particle (Figure 3.3b-d and Table 3.2).

Figure 3.3: Atomic model of LDLRAD3 interactions with VEEV. a. Structure-based sequence alignment with labeled secondary
structure of various LDL receptor type A (LA) domains, including murine LDLRAD3 domains 1-3, human LDLR CR2 and CR3
(PDB 5OYL and PDB 5OY9, respectively31), and human VLDLR-VR3 (PDB 3DPR32). LDLRAD3(D1) contact residues to the
wrapped and intraspike VEEV E2-E1 heterodimers are shaded dark and/or light purple, respectively. Contact residues of
LDLR-CR2 and -CR3 to glycoprotein G of vesicular stomatitis virus (VSV G) are shaded in green and contact residues of VLDLRV3 to glycoprotein G of vesicular stomatitis virus (VSV G) are shaded pink, as determined by PDBePISA
(www.ebi.ac.uk/pdbe/pisa/) (see Figure 3.9c-e). Brackets and rectangles indicate residues that form disulfide bonds and
coordinate calcium, respectively. The Figure was prepared using ALINE33. b. Ribbon diagram of LDLRAD3(D1) and surface
representation of its wrapped and intraspike E2-E1 heterodimers. LDLRAD3(D1) and VEEV E2-E1 are colored by domain.
LDLRAD3(D1): purple. Chain E1: DI, light grey; DII, medium grey; DIII, dark grey; fusion loop (FL), orange. Chain E2: A
domain, cyan; 𝛽-linker, medium blue; B domain, dark cyan; C domain, blue. The disulfide bonds and calcium ion in ribbon
diagram are colored yellow and green, respectively. c-d. Paired, isolated views of electron density and model of LDLRAD3(D1)
and its wrapped (c) or intraspike (d) heterodimers. “Wrapped” refers to the E2-E1 heterodimer whose fusion loop is covered
by LDLRAD3; “intraspike” refers to heterodimer adjacent to the wrapped heterodimer but within the same trimeric spike.
The naming convention is consistent with previous alphavirus-receptor structural studies22. Arrows point to insets containing
zoomed-in views of LDLRAD3(D1). Proteins are colored by domain likewise to Figure 3.3b. N-linked glycans are depicted
as balls and sticks and colored by heteroatom. The disulfide bonds and calcium ion are colored yellow and green, respectively.
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Table 3.2: Refinement and model statistics.

Asymmetric Unit Model
# of chains
# of residues
# of carbohydrates
# of CA ions
Resolution (Å)
MolProbity score
All-atom clash score
Rotamer outliers (%)
C𝜷 outliers (%)
Ramachandran Plot values
R.M.S. Deviations

Favored (%)
Allowed (%)
Outliers (%)
Bond lengths (Å)
Bond angles (°)

VLP alone
(PDB 7N1I)
12
4108
8
0
4.2
1.87
8.33
0.00
0.00
93.63
5.38
0.78
0.002
0.573

VLP + LDLRAD3(D1)
(PDB 7N1H)
16
4264
8
4
4.3
1.90
8.79
0.00
0.00
93.48
5.77
0.76
0.002
0.572

The resultant model details the domains and residues of the VEEV E2-E1 heterodimers at
the LDLRAD3 binding interface. The two E2-E1 heterodimers at each binding site were termed
“wrapped” and “intraspike”, as we described previously for the structure of CHIKV22 in complex
with its Mxra8 receptor. At the wrapped heterodimer interface, LDLRAD3 engages domains A
and B of E2 (residues 24-28, 70-71, 166-199, 176-177, 223) and the fusion loop in E1 (residues
85, 87-92). On the intraspike heterodimer, LDLRAD3 interacts with domain A and the 𝛽-linker of
E2 (residues 5, 63-64, 79, 92-95, 148, 153-159, 262-267) (Figures 3.3c-d, 3.4, 3.5, and Table
3.3). The binding interface is ~900 Å with equal contribution between the interfaces of the wrapped
and intraspike E2-E1 heterodimers. LDLRAD3 residues at the interaction interface that contribute
to binding of the wrapped heterodimer are 29, 34, 36, 38-44, 47, 54-57, and 62. At the intraspike
heterodimer interface, residues 28-34, 42-47, and 50-52 form contacts (Table 3.3).
3.3.3 Functional assessment of the atomic model
To assess our model, non-conservative point mutations were introduced throughout D1 of
LDLRAD3 and used for complementation experiments in Neuro2a cells lacking Ldlrad3
(∆Ldlrad3) and glycosaminoglycan (∆B4galt7) expression15; we performed these experiments in
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Figure 3.4: Sequence alignment of E2 proteins of the VEEV complex and other alphaviruses. Amino acid sequence alignment
of E2 proteins of various VEEV strains (IAB strain TC-83, AAB02517; IAB strain TrD, AAC19322; IC strain INH9813, AJP13627;
ID strain ZPC738, AUV65225), and other alphaviruses (EEEV strain FL93-939, ABL84687; WEEV strain CBA87, ABD98014;
SINV strain Girdwood, AUV65223; CHIKV strain 37997, ABX40011). Structure-based sequence alignments were performed
between alphaviruses that do (group 1, left margin) or do not (groups 2 and 3, left margin) utilize LDLRAD3 as a receptor for
infection using PROMALS3D with VEEV numbering. The Figure was prepared using ESPript 3.0. Domains are colored (A, light
cyan; B, medium cyan; C, blue; 𝛽-linker, medium cyan) and indicated above the sequence, along with the secondary structure
features and nomenclature (PDB: 3J0C19). Red boxes, 100% conserved; white boxes and red letters; homologous residues within
the specific group; white boxes and black letters, non-conserved residues. Determinants of receptor binding to the individual E2E1 heterodimers are indicated by stars below the alignment and are colored magenta if specific to LDLRAD3, cyan is specific to
Mxra8, or yellow if shared between the two receptors. ‘‘Wrapped’’ denotes contacts to the wrapped E2-E1 heterodimer whose
fusion loop is covered by LDLRAD3(D1) or Mxra8. ‘‘Intraspike’’ refers to the intraspike heterodimer, which is adjacent to the
wrapped heterodimer but within the same trimeric spike. Contact residues determined by PDBePISA.
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Figure 3.5: Sequence alignment of E1 proteins of the VEEV complex and other alphaviruses. Amino acid sequence alignment
of E1 proteins of various VEEV strains (IAB strain TC-83, AAB02517; IAB strain TrD, AAC19322; IC strain INH9813, AJP13627;
ID strain ZPC738, AUV65225), and other alphaviruses (EEEV strain FL93-939, ABL84687; WEEV strain CBA87, ABD98014;
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SINV strain Girdwood, AUV65223; CHIKV strain 37997, ABX40011). Structure-based sequence alignments were performed
between alphaviruses that do (group 1, left margin) or do not (groups 2 and 3, left margin) utilize LDLRAD3 as a receptor using
PROMALS3D with VEEV numbering. The Figure was prepared using ESPript 3.0. Domains are colored (I, light grey; II, medium
grey; III, dark grey; fusion loop, orange) and indicated above the sequence, along with the secondary structure features and
nomenclature (PDB: 3J0C19). Red boxes, 100% conserved; white boxes and red letters; homologous residues within the specific
group; white boxes and black letters, non-conserved residues. Determinants of receptor binding to the individual E2-E1
heterodimers are indicated by stars below the alignment and are colored magenta if specific to LDLRAD3, cyan is specific to
Mxra8, or yellow if shared between the two receptors. ‘‘Wrapped’’ denotes contacts to the wrapped E2-E1 heterodimer whose
fusion loop is covered by LDLRAD3(D1) or Mxra8. ‘‘Intraspike’’ refers to the intraspike heterodimer, which is adjacent to the
wrapped heterodimer but within the same trimeric spike. Contact residues determined by PDBePISA.
Table 3.3: List of contact residues at the VEEV E2-E1 and LDLRAD3(D1) binding interface

E2-E1 heterodimer
wrapped

E2-E1 domain
Domain A of E2
Domain B of E2
Fusion loop of E1

intraspike

Domain A of E2
𝛽-linker of E2

E2-E1 residues
V24, G25, S26, C27, H28,
M70, H71, K116, S118,
V119
S176, S177, K223

LDLRAD3(D1) residues
C29, N34, N39, R41, C42, I43,
P44, W47, L52, D54, F56

Y85, F87, M88, W89, G90,
G91, A92, K225
L5, G63, R64, L79, I92,
V93, D94, G95
E148, V153, Y154, A155,
H156, D157, A158, Q159,
A262, D263, G264, K265,
C266, T267

M36, S38, N39, G40, R41,
C55, F56, D57
C42, I43, P44, G45, A46,
W47, D50, G51, L52
E28, C29, N30, I31, P32, G33,
N34

S38, D57, K62

Contact residues were identified using PDBePISA (www.ebi.ac.uk/pdbe/pisa/).

cells lacking glycosaminoglycans to minimize background infection, as some alphaviruses also
attach to cells via engagement of heparan sulfates moieties23,24,25. WT and single point mutants of
LDLRAD3 were transduced into in ∆B4galt7 ∆Ldlrad3 Neuro2a cells, then inoculated with a
chimeric, attenuated SINV-VEEV virus that expresses the structural genes of VEEV Trinidad
Donkey (TrD) so the screen could be performed by flow cytometry at lower biosafety containment
level (BSL2) yet with VEEV structural proteins from a pathogenic subtype IAB isolate. Whereas
most mutant forms of LDLRAD3 promoted SINV-VEEV infection, several (e.g., G33D, M36T,
P44R, and D57V) did not support infection even though the proteins were expressed on the cell
surface at similar levels compared to the wild-type form of LDLRAD3 (Figures 3.6a-b and 3.7).
The residues identified as loss-of-function for infectivity all sit in a pocket of LDLRAD3 that
supports direct contact with residues of E2-E1 in both the wrapped and intraspike heterodimers
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(Table 3.3). We note that several other mutations in LDLRAD3(D1) that correspond to contact
residues (e.g., P32D, N39T, A46K, and F56D) appear to show slight increases in infectivity with
normal surface expression patterns. Although further studies are required, these changes could
enhance the affinity of VEEV binding.

Figure 3.6: Experimental assessment of the VEEV-LDLRAD3 model. a-b. ∆B4galt7 ∆Ldlrad3 N2a cells complemented with
wild-type Ldlrad3 or indicated charge reversal mutants of Ldlrad3 were inoculated with chimeric SINV-VEEV-GFP viruses (IAB
strain TrD). Subsequently (7.5 h later), infection levels were assessed by monitoring GFP expression. Data are the mean ± SD of
three experiments performed in technical duplicate; each data symbol is the average of a technical duplicate from one experiment
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(n=3; one-way ANOVA: *, P=0.0317 for N39T or 0.0453 for R41E; **, P=0.0054; ***, P=0.001; ****, P < 0.0001). The Ldlrad3
transgene contains an N-terminal FLAG tag downstream of the signal sequence for monitoring plasma membrane expression by
flow cytometry (see Figure 3.7). c. Competition binding analysis of LDLRAD3(D1)-human Fc and anti-VEEV murine mAbs (3B4C4 and TRD-14) by ELISA. VEEV VLPs were incubated with anti-VEEV mAbs 3B4C-4, TRD-14, or anti-HCV H77.39 isotype control
followed by detection with LDLRAD3(D1)-human Fc. Data are the mean ± SD of three experiments performed in technical
triplicate; each data symbol is the average of a technical triplicate from one experiment (n=3; one-way ANOVA: ***, P=0.0004;
ns, not significant). d. Ribbon diagram of LDLRAD3(D1) and surface representation of its wrapped and intraspike E2-E1
heterodimers with labeled epitopes of anti-VEEV murine mAbs (3B4C-4 and TRD-14) and labeled positions of LDLRAD3 mutants.
Proteins are colored by domain. LDLRAD3(D1): purple. Chain E1: DI, light grey; DII, medium grey; DIII, dark grey; fusion
loop (FL), orange. Chain E2: A domain, cyan; 𝛽-linker, medium blue; B domain, dark cyan; C domain, blue. Inset, zoomedin view of LDLRAD3(D1) ribbon diagram. Positions of mutations that resulted in reduced VEEV infection (G33, light yellow; M36,
dark green; P44, light pink; D57, dark blue) are depicted as balls and sticks. The amino- and carboxy-termini are labeled, and the
disulfide bonds and calcium ion are colored yellow and green, respectively.

Several years ago, a high-resolution cryo-EM structure of Fab fragments of the 3B4C-4
murine mAb bound to VEEV was published26. 3B4C-4 binds to the tip of the E2 B domain27 and
inhibits cellular attachment and entry of VEEV28. As the principal binding footprint (S177, V179,
S180, L181, S184, T214, N216, and K223)26 of this mAb is proximal to the LDLRAD3 binding
site, we tested whether 3B4C-4 could inhibit binding LDLRAD3 using a competition binding
ELISA assay. 3B4C-4 mAb was pre-bound to VEEV VLP-coated plates before addition of
LDLRAD3(D1)-human Fc fusion protein. Notably, 3B4C-4 markedly inhibited LDLRAD3(D1)binding, whereas another anti-VEEV mAb (TRD-14), which maps to a distinct epitope on the E2
B domain (G203, G204, and T205) (N. Kafai and M. Diamond, unpublished data), did not compete
for binding (Figure 3.6c). A structural comparison of the mAb epitopes on the E2 B domain
reveals that 3B4C-4 binds residues that are immediately adjacent to the LDLRAD3 binding site,
which likely result in steric hindrance (Figure 3.6d). In comparison, the TRD-14 epitope is located
at the distal end of the E2 B domain.
3.3.4 Domain 2 of LDLRAD3 does not contribute to VEEV binding
D1 of LDLRAD3 is necessary and sufficient to support infection by VEEV15, but it remains
unclear whether D2 also contributes to VEEV binding. To evaluate this question, we expressed
soluble LDLRAD3(D1+D2) in Expi293 cells (Figure 3.8). Electron micrographs of VEEV VLPs
with or without bound LDLRAD3(D1+D2) were acquired using a 300 kV Titan Krios equipped
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Figure 3.7: Expression of LDLRAD3(D1) mutants on the cell surface and effect on SINV-VEEV infection. B4galt7 ∆Ldlrad3
N2a cells complemented with indicated non-conservative point mutations of Ldlrad3 in D1 (encoding an N-terminal FLAG tag)
were inoculated with chimeric SINV-VEEV-GFP viruses (IAB strain TrD). Seven and a half hours later, the levels of cell surface
expression of LDLRAD3 (via anti-FLAG, panels a and c) or SINV-VEEV-GFP infection (via GFP, panel b) were assessed by flow
cytometry. a. Data are the mean ± SD of three experiments performed in technical duplicate; each data symbol is the average of a
technical duplicate from one experiment. b-c. Representative flow cytometry contour plots for each indicated LDLRAD3 mutant.
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with a Falcon 4 detector (Table 3.1). Single-particle analysis with imposed icosahedral symmetry
yielded a reconstruction at 5.0 Å (Figure 3.8b). Electron density of D2 of LDLRAD3 was weak
and projected away from VEEV (Figure 3.8c). Binding of purified LDLRAD3(D1+D2) to
captured VLPs by surface plasmon resonance yielded a monovalent affinity of approximately 50
nM that was similar to LDLRAD3(D1) (Figure 3.8d). Based on this structural and biophysical
analysis, and our prior functional data15, D2 of LDLRAD3 does not significantly contribute to
VEEV binding or infection.

Figure 3.8. Domain 2 of LDLRAD3 does not contribute to VEEV binding. (a) Cartoon schematic of LDLRAD3 with labeled
ectodomains and amino (n) and carboxy (c) termini. Domain 1 (D1) is colored in a rainbow spectrum of blue to red. (b) Fourier
shell correlation (FSC) plots for VEEV VLP with LDLRAD3(D1+D2) (c) Electron density of one asymmetric unit of VEEVLDLRAD3(D1+D2) complex colored by protein: E1 (grey), E2 (cyan), capsid (forest green), and LDLRAD3(D1+D2) (purple).
Density map viewed at low contour level to show weak density for D2 of LDLRAD3. Ribbon diagram of docked LDLRAD3(D1)
model is shown with the amino to carboxy termini in a rainbow spectrum of blue to red. Shown as balls and sticks are the cysteine
residues and the acidic residues responsible for calcium ion coordination. The disulfide bonds and calcium ion are colored yellow
and green, respectively. Inset, zoomed-in view of LDLRAD3 with the weak density for D2 circled. (d) Representative surface
plasmon resonance sensograms with binding parameters (mean + SEM) of LDLRAD3(D1+D2) (n=4; left panel) and
LDLRAD3(D1) (n=3; right panel) to VEEV VLPs. A 1:1 binding model (red traces) was used to fit the experimental curves (black
traces).
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3.4 Discussion
Cell culture infection experiments with mouse and human cells and in vivo pathogenesis
studies in mice defined LDLRAD3 as a cell surface receptor for VEEV that was required for
optimal infectivity and induction of encephalitis in mice15. Here, our single particle cryo-EM
analyses of LDLRAD3 and VEEV VLPs provide structural insight into how VEEV engages
LDLRAD3 to facilitate interactions with target cells. We observed a network of quaternary
protein-protein interactions with D1 of LDLRAD3 engaging two E2-E1 heterodimers within one
trimeric spike. The specific binding determinants we observed are supported by structure-guided
mutations that we introduced into LDLRAD3, and binding competition studies with
LDLRAD3(D1) and a neutralizing mAb against VEEV that engages the top of the E2 B domain
and directly blocks virus attachment. Our structures indicate that D1 of LDLRAD3 can bind with
full occupancy at four distinct sites in the icosahedral asymmetric unit of the mature VEEV VLP.
VEEV binds to LDLRAD3 in a manner that is remarkably similar to CHIKV with its receptor
Mxra8, which consists of two immunoglobulin-related folds22,29,30 (Figure 3.9a-b). Even though
LDLRAD3 and Mxra8 have similar sites of virion engagement, the former forms a significantly
smaller interface (~900 versus ~2100 Å2) even though the monovalent affinity of virus-receptor
binding is similar (Figure 3.8d)22. Inspection of contact residues indicates that LDLRAD3 makes
greater use of hydrophobic residues to bind virus than Mxra8 (~40% of interface residues versus
~24%). Approximately 65% of the receptor contact positions on VEEV spikes are shared with
CHIKV (Figures 3.4 and 3.5). Both receptors effectively shield the hydrophobic fusion loop from
solvent access, and all 7 of the VEEV E1 contact residues are conserved with CHIKV E1. We
speculate that the common positioning of these receptors near the fusion loop might serve to
modulate viral fusion during endocytosis. However, the primary contact residues used by
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LDLRAD3 and Mxra8 are not conserved, with Mxra8 notably employing a significant number of
histidine residues (7% of the ectodomain) and LDLRAD3(D1) having no histidine residues.

Figure 3.9: Comparisons of VEEV-LDLRAD3 to other virus receptor complexes. a. Surface representation of the wrapped (dark
grey) and intraspike E2-E1 (light grey) heterodimers of CHIKV, labeled by domain and colored by determinants of Mxra8 receptor
binding. Positions of determinants specific to Mxra8 are colored cyan; positions shared with LDLRAD3 are yellow. The Mxra8
binding interface is ~2100 Å2. b. Surface representation of the wrapped (dark grey) and intraspike E2-E1 (light grey) heterodimers
of VEEV, labeled by domain and colored by determinants of LDLRAD3 receptor binding. Positions of determinants specific to
LDLRAD3 are colored magenta; positions shared with Mxra8 are colored yellow. The LDLRAD3(D1) binding interface is ~900
Å2. c-e. Paired, ribbon and surface diagrams of virus-LDL receptor structures. The calcium ions and tryptophan residues are
colored light green and yellow, respectively. c. Fragments of domains of the wrapped and intraspike E2-E1 heterodimers of VEEV
(fusion loop (FL) of E1; orange; domain A of E2, cyan; 𝛽-linker of E2, medium blue; domain B of E2, dark cyan) at the interface
of LDLRAD3(D1) (grey). 29.0% of the solvent-accessible surface area (SASA) of LDLRAD3(D1) is lost upon VEEV binding. d.
Fragments of glycoprotein G of vesicular stomatitis virus (VSV G; green) at the interface of cysteine-rich domain 2 of LDL receptor
(LDLR-CR2; grey) (PDB 5OYL31). 25.3% of the solvent-accessible surface area (SASA) of LDLR-CR2 is lost upon VSV binding.
e. Loops from two different copies of viral protein 1 (VP1; light and dark pink) from human rhinovirus 2 (HRV2) engage VLDL
receptor module 3 (VLDLR-V3; grey) (PDB 3DPR34). 13.1% of the solvent-accessible surface area (SASA) of VLDLR-V3 is lost
upon HRV2 binding.
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The distinct receptor specificities of VEEV and CHIKV are likely explained by the low
level of sequence conservation of E2 binding residues (26% of 35 LDLRAD3 contact positions).
Our structural analysis also suggests why LDLRAD3 is a receptor for VEEV but not for WEEV
and EEEV, other related encephalitic alphaviruses. Beyond the aforementioned conserved contact
site in the E1 fusion loop (100% conservation for 7 residues), the receptor determinants in E2 of
VEEV generally are not conserved in WEEV and EEEV (17% and 23% identity for 35 contact
residues) (Figures 3.4 and 3.5). In contrast, these determinants are essentially conserved among
VEEV complex members, which likely explains why LDLRAD3 supports infection of all VEEV
strains (IAB, IC, and ID) that we tested15.
LDL-receptor family members mediate entry of several viruses belonging to different
families. High-resolution structures have been solved for LDL-R LA domains complexed with
vesicular stomatitis virus (VSV) and human rhinovirus (HRV)31,32. Remarkably, an unrelated
negative stranded rhabdovirus (VSV) and non-enveloped picornavirus (HRV) engage the same
tryptophan residue near the calcium binding site of the conserved cysteine-rich domain that also
is a major contact for LDLRAD3 (W47) (Figures 3.3a and 3.9c-e). Thus, evolutionarily distinct
viruses have evolved similar structural strategies for engaging related members of a protein
superfamily to enable entry into target cells. As such, it is plausible that structure-guided design
of small molecule inhibitors could inhibit engagement of entry of viruses from multiple families.
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3.5 Methods
Recombinant LDLRAD3 protein generation and purification. Monomeric LDLRAD3
ectodomain constructs were prepared as previous described15. Briefly, mouse LDLRAD3(D1)
(residues 18-70) and (D1+D2) (residues 18-112) were cloned into the pCDNA3.4 vector (Thermo
Fisher) with the native signal peptide sequence, followed by an HRV 3C cleavage site
(LEVLFQGP) and the mouse IgG2b Fc region. The RAP chaperone protein (residues 1-357;
GenBank NM_002337) was cloned into the pCDNA3.4 vector. 50 ml Expi293 cells were seeded
at 1.5 x 106 cells/ml, then transfected with 50 µg of LDLRAD3 and 10 µg of RAP in diluted OptiMEM with complexed with ExpiFectamine 293 transfection reagent (Thermo Fisher) Cells were
supplemented with ExpiFectamine 293 Transfection enhancers 1 and 2 to boost transfection levels
one day later. Supernatant was harvested four days post-transfection. Protein was purified using
Protein A Sepharose 4B (Thermo Fisher) and then dialyzed into 1X HBS with 1 mM CaCl2 and
EDTA-free protease inhibitors (Roche). The cleaved monomeric LDLRAD3 ectodomain was
obtained after incubation with HRV 3C protease (Thermo Fisher) at a 1:10 ratio overnight at 4ºC
and then purified by sequential Protein A Sepharose 4B and Superdex 75 size exclusion (GE
Healthcare) chromatography in 20 mM HEPES pH 7.4, 150 mM NaCl, and 0.01% NaN3.
Cryo-EM sample preparation, data collection, and single particle reconstruction. VEEV
VLPs33 (gift of K. Carlton and J. Mascola, Vaccine Research Center of the National Institutes of
Allergy

and

Infectious

Diseases)

with

and

without

cleaved

LDLRAD3(D1)

or

LDLRAD3(D1+D2) in molar excess were flash cooled on lacey carbon grids in liquid ethane using
an FEI Vitrobot (Thermo Fisher). Movies of the VEEV VLP alone and with LDLRAD3(D1)
samples were recorded with the software EPU (ThermoFisher) using a K2 Summit electron
detector (Gatan) mounted on a Bioquantum 968 GIF Energy Filter (Gatan) attached to a Titan
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Krios microscope operating at 300 keV with an electron dose of 35 e-/Å2 and a magnification of
105,000X. Movies of VEEV VLP with cleaved LDLRAD3(D1+D2) were recorded using a Falcon
4 Direct Electron Detector (Thermo Fisher) with a magnification of 59,000X. Movies from all
samples were corrected for beam-induced motion using MotionCor234. Contrast transfer function
parameters of the electron micrographs were estimated using Gctf35, and particles were autopicked using crYOLO36. Single-particle analysis, specifically reference-free 2D classification, 3D
refinement, Movie refinement, Bayesian polishing, post-processing and local resolution estimation
were performed in RELION-3.137. Post-processing of maps for model building and figure
presentation was done using DeepEMhancer16. Additional information for all samples is listed in
Table 3.1. Structural visualization of the electron maps was performed using ChimeraX38.
Model building and refinement. The initial models of the VEEV structural proteins (E1, E2, TM
regions, and Capsid) with or without LDLRAD3 were constructed by docking coordinates of the
previously built model of VEEV strain TC-83 (PDB 3J0C19) and the SWISS-MODEL server18
predicted model of LDLRAD3(D1) into the electron density of the asymmetric units of the cryoEM maps using the fitmap command in ChimeraX. N-linked glycans and coordinated calcium ions
were built manually using COOT20. The model underwent real-space refinement in PHENIX21
using default parameters plus Morphing and secondary-structure, rotamer, and torsion restraints
with the initial model as the reference. Bond and angle restraints also were applied for the modeled
N-linked glycans and calcium ions. After optimization, coordinates of the asymmetric units were
checked by MolProbity. Contact residues were identified, and buried surface areas were calculated
using PDBePISA (www.ebi.ac.uk/pdbe/pisa/).
Surface plasmon resonance. Binding kinetics and affinity of cleaved LDLRAD3(D1) or
LDLRAD3(D1+D2) to VEEV VLPs were measured using a Biacore T200 system (GE
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Healthcare). Experiments were performed at 30 µL/min and 25ºC using HBS-P (0.01 M HEPES
pH 7.4, 0.15 M NaCl, 3 mM EDTA, 0.005% v/v Surfactant P20) + 1 mM CaCl2 as running buffer.
VEEV-57 mAb (anti-VEEV E2, N. Kafai and M. Diamond, unpublished results) was immobilized
onto a CM5 sensor chip (GE Healthcare) using standard amine coupling chemistry, and VEEV
VLPs were captured. LDLRAD3 proteins were injected over a range of concentrations (1 µM to
16 nM) for 300 sec, followed by a 600 sec dissociation period. The sensor chip was regenerated
after each analyte concentration with 60s of 10mM Glycine, pH 1.7. Before the next analyte
concentrated was tested, VEEV VLPs were recaptured; the response units of captured VLP were
consistent for each cycle. All sensorgrams were double-reference subtracted using the reference
flow cell (immobilized VEEV-57 mAb, no captured VLP) and the running buffer blank sample.
The kinetic profiles and steady-state equilibrium concentration curves were fitted using a global
1:1 binding algorithm with drifting baseline using BIAevaluation 3.1 (GE Healthcare).
Infection assay. A comprehensive mutation library was made using gene synthesis by mutating
single amino acid in D1 of the LDLRAD3 protein. The amino acids essential for maintaining the
structural integrity of LDLRAD3 (the cysteines forming disulfide bonds, the amino acids
coordinating the calcium, and those forming the hydrophobic core were kept intact)39. The
substitutions were determined using the BLOSUM scoring matrix40 (Table 3.4). The mutants were
cloned into lentivirus vector pLV-EF1a-IRES-Hygro (Addgene no. 85134) between the BamHI
and MluI restriction enzyme sites (Genscript). An N-terminal FLAG tag was added to each
LDLRAD3 mutant to monitor protein expression. ∆B4galt7 ∆Ldlrad3 Neuro 2a cells were
transduced with each LDLRAD3 mutant, and 7 days later inoculated with SINV-VEEV (TrD)GFP infection at a multiplicity of infection (MOI) of 20 for 7.5 h. Cells were stained with an antiFLAG antibody (1:2000 dilution, Cell Signal Technology, clone D6W5B) to measure the cell
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Table 3.4: LDLRAD3 substitutions determined by BLOSUM scoring matrix
Position
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70

Original Residue:
Q
L
L
P
G
N
N
F
T
N
E
C
N
I
P
G
N
F
M
C
S
N
G
R
C
I
P
G
A
W
Q
C
D
G
L
P
D
C
F
D
K
S
D
E
K
E
C
P
K
A
K
S
K

Mutate to:
K
D
S
Y
D
K
E
D
E
L
R
E
R
D
D
Y
K
T
K
T
K
E
R
E
K
V
V
H
D
D
D
V
D
R
E
K
D
Y
R
E
H
E

The amino acids important for the structural integrity of LDLRAD3 protein (the disulfide bond-forming cysteines, residues
coordinating calcium, or those buried in the hydrophobic core) were not mutated and are indicated in red.
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surface expression levels of the wild-type and mutant forms of LDLRAD3. Inoculated and stained
cells were analyzed on a MACSQuant Analyzer 10 (Miltenyi Biotec), and all flow cytometry data
were processed using FlowJo (FlowJo).
Competition binding ELISA. Nunc MaxiSorp plates (Thermo Fisher) were coated with 2 µg/mL
of capture mAb (murine anti-VEEV-1A4A)41 in 100 µL of sodium bicarbonate coating buffer (0.1
M Na2CO3, pH 9.3) and incubated overnight at 4°C. Plates were washed four times with PBS and
incubated with 150 µL of blocking buffer (PBS, 4% BSA) for 1 h at room temperature. VEEV
VLPs were diluted to 1 µg/mL in PBS containing 2% BSA and added (100 µL/well) to plates for
1 h at room temperature. After four additional PBS washes, 50 µL of murine anti-VEEV mAb
(3B4C-4 or TRD-14) at 20 µg/mL in PBS with 2% BSA were added to plates for 30 min at room
temperature to allow for binding to VEEV VLPs. 50 µL of human LDLRAD3(D1)-Fc15 at 20
µg/mL was added directly, with no additional washes. One hour later, plates were washed four
times with PBS and incubated with 100 µL/well, 1:5000 horseradish peroxidase (HRP)-conjugated
goat anti-human IgG (H+L; Jackson ImmunoResearch) diluted in PBS with 2% BSA for 1 h at
room temperature for detection of LDLRAD3(D1)-Fc binding. Plates were washed four times with
PBS and then incubated with 100 µl of 3,3’,5,5’-tetramethylbenzidine (TMB) substrate (Thermo
Fisher) for 3 min at room temperature before quenching by addition of 50 µl of 2 N H2SO4.
Absorbance was read at OD 450 nm with a TriStar Microplate Reader (Berthold Technologies).
Statistical analysis. Statistical significance was assigned when P values were < 0.05 using Prism
(Version 8, GraphPad) and are indicated in each of the Figure legends. Cell culture or ELISA
experiments were analyzed by one-way ANOVA.

93

Data Availability. The authors declare that all data supporting the findings of this study are
available within the paper and its Supplementary information. All structures are being deposited
in the PDB and EMDB databases (PDB 7N1I, 7N1H; EMDB 24117, 24116, 24394).
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4.1 Summary
Despite causing outbreaks of fever and arthritis in multiple countries, no countermeasures
exist against Mayaro virus (MAYV), an emerging mosquito-transmitted alphavirus. We generated
18 neutralizing mAbs against MAYV, 11 of which had “elite” activity that inhibited infection with
EC50 values of <10 ng/ml. Antibodies with the greatest inhibitory capacity in cell culture mapped
to epitopes near the fusion peptide of E1 and in domain B of the E2 glycoproteins. Unexpectedly,
many of the elite neutralizing mAbs failed to prevent MAYV infection and disease in vivo. Instead,
the most protective mAbs bound viral antigen on the cell surface with high avidity and promoted
specific Fc effector functions, including phagocytosis by neutrophils and monocytes. In subclass
switching studies, murine IgG2a and humanized IgG1 mAb variants controlled infection better
than murine IgG1 and humanized IgG1-N297Q variants. An optimally protective antibody
response to MAYV and possibly other alphaviruses may require tandem virus neutralization by
the Fab moiety and effector functions of the Fc region.

Figure 4.1: Graphical summary of Chapter 4.
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4.2 Introduction
Mayaro virus (MAYV) is a mosquito-transmitted arthritogenic alphavirus in the
Togaviridae family of positive-stranded RNA viruses. MAYV was first described in 1954 in
Trinidad1 and now circulates in the Caribbean Islands and South America1,2,3. MAYV infection
causes an acute febrile illness that initially is indistinguishable from other arboviruses, including
chikungunya virus (CHIKV), dengue, and Zika viruses. A study of a MAYV outbreak in Brazil
showed a high incidence of severe arthralgia (55%) and myalgia (49%), which can persist for
months to years4. There are no vaccines or therapeutics available for the prevention or treatment
of MAYV infection.
MAYV is transmitted principally by Haemagogus species mosquitoes among primates in
a sylvatic cycle, with intermittent spillover to human populations. However, there is concern that
even single mutations in MAYV could lead to changes in vector competence, as occurred with
CHIKV in La Reunion Island in 2006. In that case, CHIKV acquired the ability to infect Aedes
albopictus mosquitoes more efficiently, which resulted in an urban transmission cycle5. Aedes
mosquitoes can be infected by MAYV, although the levels of virus in blood required for
transmission from viremic humans are considered insufficient for epidemic transmission6. In
comparison, four different Anopheles mosquitoes can transmit MAYV6. As these species are
native to distinct geographic regions (Africa, Asia, and North America), they could facilitate the
global spread of MAYV.
The MAYV genome encodes for four nonstructural proteins (nsp1–nsp4) and five
structural proteins (capsid, E3, E2, 6K, and E1). Alphavirus envelope glycoproteins associate in
the endoplasmic reticulum and form a heterotrimer comprised of the E3, E2, and E1 proteins7. E3
is cleaved by furin-like proteases during the maturation process in the trans-Golgi network8. The
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mature alphavirus virion is ∼700 Å in diameter and contains a lipid bilayer with 240 E2–E1
heterodimers assembled into 80 trimeric spikes with T = 4 icosahedral symmetry9,10,11 and a
nucleocapsid containing a single copy of genomic RNA. As the E1 and E2 glycoproteins are
displayed prominently on the viral spike, they are targets of antibody responses.
Although mAbs that specifically bind the envelope glycoproteins of MAYV have not yet
been described, others generated in the context of immunization with CHIKV antigens have shown
cross-reactivity and cross-neutralizing activity with MAYV12. In the context of human polyclonal
antibody responses to MAYV, antibody responses to E1 and E2 proteins have been detected, with
greater cross-reactivity among those recognizing E213. However, these studies have not fully
elucidated the epitopes and mechanisms by which antibodies against MAYV are protective in vivo.
Here, we produced and characterized a panel of 18 neutralizing anti-MAYV mAbs after
immunizing mice with infectious virus and recombinant MAYV E2 protein. 11 of these antiMAYV mAbs showed exceptional potency in cell culture with half-maximal effective inhibitory
concentration (EC50) of <10 ng/ml. All but two of these antibodies were capable of neutralizing
11 different strains of MAYV that we tested. Several anti-MAYV mAbs cross-neutralized related
arthritogenic alphaviruses, including CHIKV, Una virus (UNAV), Ross River virus (RRV), and
O’nyong’nyong virus (ONNV), whereas others were MAYV specific. Our neutralizing antiMAYV mAbs generally blocked infection at a post-attachment step, preventing fusion of virus–
host membranes and impairing viral egress. Epitope mapping analyses revealed that 16 of the
mAbs bound epitopes in the B domain of the E2 glycoprotein, with two others recognizing a site
in the E1 glycoprotein proximal to the fusion loop (FL) peptide. A subset of the strongly
neutralizing mAbs protected mice from lethal MAYV challenge and virus-induced joint swelling
and dissemination. Despite the potent neutralizing activity observed in cell culture, protection
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required fragment crystallizable (Fc) effector functions, since isotype-switched or aglycosyl
variants with less or no capacity to interact with the complement component C1q or activating Fcγ receptors (FcγR) lost protective activity in vivo. Our results in mice suggest that strategies to
induce highly protective antibodies against MAYV may require designs that optimize both
neutralizing activity and Fc effector functions.
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4.3 Results
4.3.1 Generation of anti-MAYV mAbs
We inoculated BALB/c mice with MAYV strain CH and boosted twice with recombinant,
bacterially produced MAYV E2 ectodomain (amino acids 1–340) in Freund’s incomplete adjuvant
and then one additional time with MAYV-CH (see Materials and methods), as we did to generate
anti-CHIKV mAbs14. Serum had neutralization titers in cell culture of >1/10,000 against MAYVCH. After a final intravenous boost with MAYV-CH, we performed splenocyte-myeloma fusions
from four mice. Subsequently, 151 anti-MAYV mAbs were subcloned and isolated. Supernatant
from 18 of these hybridomas contained antibodies that reduced MAYV infection by >80% in Vero
cells. These mAbs were isotyped (Table 4.1) and purified by protein A affinity chromatography.
Table 4.1: Anti-MAYV mAbs

IgG subclasses, KD, equilibrium values, and neutralization values of the 18 inhibitory anti-MAYV mAbs. IgG subclasses were
determined by ELISA. KD, equilibrium values (nanomoles) were measured by BLI using recombinant MAYV E2 protein. EC50 values
(ng/ml) along with 95% confidence intervals (in parentheses) were calculated from FRNT. Data are the mean and 95% confidence
of two experiments performed in triplicate. Bold font indicates antibodies with elite neutralizing activity (<10 ng/ml) against the
indicated MAYV strain. n.b., nonbinding.

The purified mAbs were evaluated by focus reduction neutralization test (FRNT) for
inhibition of infection of the immunizing MAYV-CH strain as well as 10 other MAYV strains15
encompassing the predominant D and L genotypes (Figures 4.2a and 4.3), isolated between 1955
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and 2002 (Table 4.2). These strains exhibit a high degree of amino acid sequence identity in the
E1 (94–100%; Figure 4.4) and E2 (96–100%; Figure 4.5) glycoproteins. Only a single strain in
the N genotype exists16, and it was not available to us for evaluation. 11 of the 18 mAbs potently

Figure 4.2: Anti-MAYV mAbs neutralize strains from both D and L genotypes. a. Viral strains were subjected to next-generation
sequencing. A phylogenetic tree was generated using a Jukes–Cantor genetic distance model by aligning structural gene nucleotide
sequences for each MAYV strain. b. Serial dilutions of mAbs were incubated with 102 FFU of the indicated MAYV strain,
representing either genotypes D (top) or L (bottom), before inoculation of Vero cells. Cells were overlaid with methylcellulose and
incubated for 18 h. Viral foci were stained, counted, and plotted relative to a no-antibody control. Data are representative of two
experiments performed in triplicate. Error bars represent SD within one experiment.
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Figure 4.3: Anti-MAYV mAbs neutralization of different MAYV strains. Serial dilutions of mAbs were incubated with 102 FFU
of the indicated MAYV strain before inoculation of Vero cells, unless otherwise indicated. mAb neutralization of MAYV-BeH407
also was tested in C2C12 myoblasts and MEFs. Cells were overlaid with methylcellulose and incubated for 18 h. Viral foci were
stained, counted, and plotted relative to a no-antibody control. Data are representative of two experiments performed in triplicate.
Error bars represent SD within one experiment. See Figure 4.2.
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Table 4.2: MAYV strains

MAYV strains used in this study are listed along with GenBank accession numbers, genotype, isolation date, host source, and
country of origin. All strains were provided by the World Reference Center for Emerging Viruses and Arboviruses and described
in Powers et al. (2006)15.

inhibited infection of MAYV-CH (Table 4.1 and Figure 4.2b) and the majority neutralized a
range of MAYV strains from the D and L genotypes. Only two mAbs showed a complete loss of
neutralization activity against one or more MAYV strains (MAY-133: Uruma strain; and MAY140: FSB0311, OBS6443, and BeH473130 strains; Table 4.1). For others, a >10-fold decrease in
inhibitory activity against different MAYV strains compared with MAYV-CH was observed with
13 of the 18 mAbs. Only mAbs MAY-116, MAY-122, MAY-131, MAY-146, and MAY-151
maintained potency (<10-fold reduction in EC50 values compared with CH strain) across all tested
MAYV strains (Table 4.1). We also performed neutralization assays with MAYV-BeH407 in
C2C12 myoblast and embryonic fibroblast cells and observed similar inhibitory activity (Figure
4.3). Because our vaccination strategy included boosting with recombinant E2 protein, we
measured antibody affinity to E2 protein using biolayer interferometry (BLI; Figure 4.6; Tables
4.1 and 4.3). The KD, equilibrium rate for the mAbs ranged from 3 to 243 nM, with eight demonstrating
high-affinity monovalent binding of <20 nM. MAY-115 and MAY-131 had no detectable binding
to E2, suggesting they recognized a different structural protein (i.e., E1) or a quaternary epitope
on E2 displayed exclusively on the virion. MAY-122, likely the most consistently potent
neutralizing antibody across all MAYV strains, had the second highest affinity, with a KD of 4 nM.
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Figure 4.4: Amino acid alignment of MAYV E1 proteins. a. MAYV strains were subjected to next-generation sequencing, and the
consensus E1 amino acid sequences were compiled and aligned using Geneious v10.2.2 software. Red indicates sequence
agreement among strains, whereas residues that vary among strains are highlighted white. Components of domains I (DI), II (DII),
and III (DIII), the FL (orange), and the stem, transmembrane, and cytoplasmic tail (black) are indicated above the sequences.
Predictedβ-sheet (arrows) andα-helical (spirals) secondary structure are indicated above the sequences. b. The amino acid
similarity was compiled in a matrix with each strain. TM, transmembrane. See Figures 4.1 and 4.10; Table 4.1.
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Figure 4.5: Amino acid alignment of MAYV E2 proteins. a. MAYV strains were subjected to next-generation sequencing and
consensus E2 amino acid sequences were compiled and aligned using Geneious v10.2.2 software. Sequence agreement among
strains is indicated by red color whereas residues that vary among strains are highlighted in white. Components of domains A, B,
C, the B-linker, and the stem, transmembrane, and cytoplasmic tail (dark blue) are indicated above the sequences. Predictedβsheet (arrows) andα-helical (spirals) secondary structure are indicated above the sequences. b. The amino acid similarity was
compiled in a matrix with each strain. TM, transmembrane.
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Figure 4.6: BLI Binding Data. Recombinant MAYV E2 ectodomain binding to MAYV mAbs was assayed by BLI. Randomly
biotinylated mAbs were coated onto Streptavidin biosensor pins. The pins were equilibrated in binding buffer alone (HBS-EP +
1% BSA) before being plunged into wells containing various concentrations of recombinant MAYV E2 ectodomain protein. The
association lasted 5 minutes before the pins were placed back into binding buffer to allow for dissociation for 5 minutes. The realtime data were analyzed using BIAevaluation 3.1 (GE Healthcare). Association and dissociation profiles, as well as steady-state
equilibrium concentration curves, were fitted assuming a 1:1 binding model.
Table 4.3: Kinetic and equilibrium binding to E2 protein by anti-MAYV mAbs as measured by BLI

Binding of anti-MAYV mAbs to recombinant MAYV E2 protein was measured by BLI. Values are mean ± SD of three experiments.
The rates of association (ka), dissociation (kd), the t1/2 of association, and the kinetic (KD, kinetic) and equilibrium (KD, equilibrium)
association constants are shown with SDs. KD, kinetic=kd/ka; t1/2=ln(2)/kd. n.b., nonbinding.
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4.3.2 Breadth of alphavirus neutralization of anti-MAYV mAbs
To assess whether the anti-MAYV mAbs inhibited related arthritogenic alphaviruses, we
first assessed cross-reactive binding by flow cytometry to permeabilized cells infected with
UNAV, CHIKV, RRV, and ONNV (Figure 4.7a). Of the 18 mAbs tested, 16, 10, 3, and 1 cross-

Figure 4.7: Cross-reactivity and cross-neutralization of related arthritogenic alphaviruses. a. Dendrogram showing the
phylogenetic relationship of the structural genes of related alphaviruses used for cross-neutralization testing. b-e. Neutralization
assays were performed with anti-MAYV mAbs that bound to cells infected by UNAV (b), CHIKV (c), RRV (d), or ONNV (e). Serial
dilutions of the indicated mAbs were incubated with 102 FFU of the indicated alphavirus before inoculation of Vero cells as (see
Figure 4.2). Data are representative of two experiments performed in triplicate. Error bars represent SD within one experiment.
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reacted with UNAV, CHIKV, RRV, and ONNV, respectively (Table 4.4). We next tested the
cross-reactive mAbs for their ability to cross-neutralize infection. All 16 mAbs that bound UNAVinfected cells neutralized this virus (Figure 4.7b). Similar results were observed with RRV and
ONNV, with all mAbs that bound infected cells neutralizing the respective virus (Figure 4.7d and
e). For CHIKV, only 3 of the 10 mAbs that bound infected cells substantially inhibited CHIKV
infection in cells (Figure 4.7c). Although MAY-117 and MAY-120 neutralized UNAV, CHIKV,
and RRV, none of our anti-MAYV mAbs inhibited infection of all of the arthritogenic alphaviruses
that we tested (Figure 4.7).
Table 4.4: Cross-reactivity of anti-MAYV mAbs with other alphaviruses

Vero cells infected with the indicated alphavirus were incubated with anti-MAYV mAbs. Binding to infected cells was determined
by flow cytometry. Data are representative of two experiments performed in triplicate. + indicates cross-reactive and − indicates
non–cross-reactive.
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4.3.3 Mechanism of neutralization by anti-MAYV mAbs
Antibodies against alphaviruses can inhibit attachment, internalization, fusion, or budding
and egress12,17,18. To assess how the panel of neutralizing anti-MAYV mAbs blocked infection, we
first performed attachment inhibition assays in which mAbs and virus were premixed at 4°C before
addition to Vero cells. After extensive washing, viral RNA adsorbed to cells was measured by
quantitative RT-PCR (qRT-PCR). As a positive control, pretreatment of MAYV with soluble
heparin, a molecule that closely mimics the attachment factor heparan sulfate19, blocked MAYV
attachment dose dependently (Figure 4.8a). Only MAY-118 and MAY-122 modestly inhibited
virus binding, with 28% and 24% reductions, respectively (Figure 4.8b).
We next determined whether our panel of neutralizing mAbs inhibited at a post-attachment
step. Neutralization assays were performed by adsorbing virus to cells at 4°C before adding mAbs.
All anti-MAYV mAbs tested potently inhibited infection when added before virus attachment to
cells (Figure 4.8c), as expected. The mAbs also had similar EC50 values when added after virus
attachment (Figure 4.8d). As these results suggested that mAb inhibition occurred after virus
binding to cells, we assessed their capacity to block viral fusion. We performed fusion-fromwithout (FFWO) assays20. MAYV was bound to target cells at 4°C before addition of mAbs. After
removing unbound antibody and virus, membrane fusion was induced by a pulse exposure to acidic
medium. After pH neutralization, cells were incubated in medium supplemented with 20 mM
NH4Cl to prevent MAYV fusion via canonical endosomal pathways. After 18 h, cells were stained
for intracellular MAYV E2 proteins. As expected, neutral pH medium did not result in expression
of MAYV E2 antigen, as membrane fusion did not occur (Figure 4.8e). However, a short exposure
of cell surface–adsorbed virus to acidic pH resulted in viral fusion and MAYV E2 antigen
expression; 16 of the 18 mAbs blocked this, whereas the isotype controls did not (Figure 4.8f).
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Figure 4.8: Neutralizing mAbs block MAYV infection at post-attachment steps. a-b. Attachment inhibition assay. MAYV-CH was
incubated with soluble heparin (0.5 to 2 mg/ml; a), BSA (0.5–2 mg/ml; a), or anti-MAYV mAbs (10 µg/ml; b) for 1 h before addition
to Vero cells at 4°C. After unbound virus was removed by extensive rinsing, cell-adsorbed viral RNA was quantified by qRT-PCR,
standardized to GAPDH levels, and plotted relative to an untreated (a) or isotype mAb-treated (b) control. Data are the mean and
SD of three experiments performed in triplicate (one-way ANOVA with Dunnett’s post-test compared with the isotype control mAb).
c. Pre- and post-attachment neutralization assays. Serial dilutions of anti-MAYV mAbs were incubated with 102 FFU of MAYV and
added to Vero cells. Infection proceeded for 18 h before foci were stained, counted, and plotted relative to a no-antibody control.
Data are the mean and SD of two experiments performed in triplicate. d. Post-attachment neutralization assay. 102 FFU of MAYV
was adsorbed to Vero cells at 4°C. Unbound virus was removed by extensive washing, and serial dilutions of anti-MAYV mAbs
were added. Infection proceeded for 18 h at 37°C. Viral foci were stained, counted, and plotted relative to a no-mAb control. e-f.
FFWO assay. Cells were incubated with virus at 4°C. After removing unbound virus by rinsing, cells were treated with 1 µg/ml of
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the indicated mAbs and then pulsed for 2 min with medium at pH 7.6 (e) or pH 5.5 (f) at 37°C. After pH neutralization, cells were
cultured in medium supplemented with 20 mM NH4Cl to prevent viral fusion via canonical endosomal pathways. Fusion inhibition
was measured by flow cytometry by staining cells for MAYV E2 antigen 18 h later. Data are the mean and SD of three experiments
performed in duplicate (one-way ANOVA with Dunnett’s post-test compared with the isotype mAb control). g-h. Egress inhibition
assay. RNA isolated from MAYV-infected cells was transfected into Vero cells. Medium was added with the indicated
concentrations of anti-MAYV mAbs. RNase A–resistant encapsidated viral RNA in the supernatant was quantified by qRT-PCR at
1 h (g) or 6 h (h) after transfection. Data are the mean and SD of three experiments performed in duplicate (one-way ANOVA with
Dunnett’s post-test compared with the isotype mAb control). *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.

We evaluated whether anti-MAYV neutralizing mAbs could block viral egress,
presumably by binding to structural glycoproteins on the plasma membrane and inhibiting
assembly or budding12,17,21. Vero cells were transfected with RNA isolated from MAYV-infected
cells. The cells were treated with anti-MAYV mAbs, and the amount of RNase A–resistant,
encapsidated viral RNA released into the supernatant was monitored. At 1 h, the levels of viral
RNA in the supernatant were at the limit of detection (Figure 4.8g), indicating an absence of de
novo synthesized and secreted virions. By 6 h, however, a 10,000-fold increase in encapsidated
viral RNA was observed in the supernatant of the isotype control mAb–treated cells (Figure 4.8g).
All of the mAbs tested, except MAY-125 and MAY-133, diminished the amount of viral RNA in
the supernatant at doses of 10 µg/ml, suggesting a capacity to block MAYV egress. The potency
of this inhibition was variable among the mAbs tested, as 11 of the 18 mAbs lost the ability to
inhibit egress when a concentration of 0.1 µg/ml was used (Figure 4.8h).
4.3.4 Epitope mapping of anti-MAYV mAbs
Our BLI data indicated that the majority of mAbs bound to the E2 protein (Tables 4.1 and
4.3). We next tested whether these mAbs recognized the B domain of E2, a target of neutralizing
antibodies against other alphaviruses12,22. Of the 18 mAbs tested, 16 bound to the E2 B domain by
ELISA (Figure 4.9a-b). We used two methods to map these B domain–specific mAbs at the amino
acid level: (1) mAb binding to recombinant E2 proteins produced with substitutions in predicted
solvent-exposed amino acids in the B domain (based on the CHIKV pE2-E1 structure; PDB:
3N4223) from nonconserved residues present in other alphaviruses (Figures 4.9c and 4.10a-c);
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and (2) alanine scanning mutagenesis of the E2 B domain in the context of the full-length structural
polyprotein (C-E3-E2-6K-E1). 293T cells were transfected with plasmids containing a single
alanine substitution in residues 173–231 of the E2 protein, except at position 227, when the alanine
was substituted to serine (Figures 4.9d and 4.10d-f). The 16 mAbs mapped to three regions within
the E2 B domain: residues 181–190 (Figure 4.10a,d,g; blue), 205–211 (Figure 4.10b,e,g; red),
and 214–218 (Figure 4.10c,f,g; green). A majority of the mAbs bound to one of two loops (amino
acids 179–186 and 212–218) that are predicted to protrude from the E2–E1 heterodimer. We made
additional charge substitutions in these loops to determine if secondary structure was important
for mAb binding. Whereas mutations to residues T212 and T213 impacted protein expression and
could not be evaluated, the remaining mutations in these loops led to protein expression and could
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Figure 4.9: Binding and mapping of mAbs to recombinant MAYV E2-B domain. a-b. Binding of mAbs to E2 protein. ELISA
plates were coated with 100 ng/well of recombinant MAYV E2 (a) or the E2 B domain (b) before incubation with 500 ng/ml of antiMAYV mAbs. Antibody binding to recombinant proteins was detected by an anti-mouse secondary antibody. Binding of the mAbs
to the proteins is shown relative to an oligoclonal mixture of MAYV mAbs. Data are the mean and SD of two experiments, each
with three replicates. c-d. Mapping of anti-E2 mAbs to MAYV B domain. E2 Bdomain–specific mAbs were mapped by ELISA (c)
and flow cytometry (d) (see Figure. 4.10).

not be evaluated, the remaining mutations in these loops led to decreased binding of the mAbs
mapping to these regions (Figures 4.9d and 4.10d,f). In several instances, charge mutations led
to loss of mAb binding when alanine mutations did not. Likely, the mAbs do not recognize these
residues directly but rather the chemical properties of the amino acid side chains maintain the
architecture of the loop and preserve the epitopes.
Two mAbs, MAY-115 and MAY-131, did not bind to recombinant E2 proteins (Figure
4.9a-b). To determine their epitopes, we selected for neutralization escape viruses. MAYV CH
was propagated in Vero cells in the presence of MAY-115 or MAY-131 for at least six passages
until neutralization activity was lost. The structural genes of the escape mutants were sequenced.
Mutations in the E1 gene were identified for both MAY-115 (Y59S and K61L) and MAY-131
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Figure 4.10: Mapping of neutralizing anti-MAYV mAbs to sites within E1 and E2 proteins. a-c. Solvent-exposed residues on the
MAYV E2 B domain were changed to the indicated amino acids. WT and mutant MAYV B domain proteins were purified, and
binding to anti-MAYV mAbs was tested by ELISA. Regions were divided into groups A (blue), B (red), and C (green) based on
patterns of mutations that resulted in loss of binding of mAbs. Representative mAbs from each group are shown (MAY-117, group
A [a]; MAY-125, group B [b]; and MAY-139, group C [c]) (see Figure 4.9). d-f. 293T cells were transfected with a C-E3-E2-6KE1 plasmid containing alanine mutations in the B domain of E2 and tested for binding with anti-MAYV mAbs by flow cytometry.
Additional arginine or glutamic acid changes were made to residues in two loops in the B domain (residues 179–186 and 212–
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218). Representative mAbs from three binding groups are shown (MAY-117, group A [d]; MAY-125, group B [e]; and MAY-139,
group C [f]) (see Figure 4.9). Critical residues were defined as those with ≤25% binding to an individual mAb but ≥75% binding
to an oligoclonal pool of anti-MAYV mAbs. Data are from three experiments performed in triplicate. Error bars represent SD
within one experiment. g. Alignment of the B domain of E2 of MAYV, UNAV, CHIKV, RRV, and ONNV with the critical interaction
residues identified for each mAb marked. Residues mapped by structure-guided mutagenesis and ELISA (circles), alanine scanning
mutagenesis and flow cytometry (triangles), or both (squares) are marked. Boxes around amino acids 179–186 and 212–218
indicate loops in the B domain. Bars above the B domain indicate regions used to define binding groups A (blue), B (red), and C
(green). h-j. Neutralization escape mutants were generated by serial passage of MAYV (strain CH) in the presence of MAY-115 or
MAY-131. Sequence-confirmed mutations were introduced into an infectious cDNA clone of the parental MAYV strain and tested
for neutralization by MAY-117 (h), MAY-115 (i), or MAY-131 (j). Data are representative of two experiments performed in
triplicate. Error bars represent SD within on experiment. k. Key residues necessary for mAb engagement are highlighted on the
surface representation of CHIKV (left; PDB: 6NK524) and depicted as balls and sticks on a ribbon diagram of the predicted
structure of MAYV E2-E1 monomer generated using Phyre2 (right). Inset: Zoomed-in view of a trimeric spike. The E1 glycoprotein
is in light grey, with the FL in green and the B-, C-, and D-strands of domain II in cyan. The E2 glycoprotein is in dark grey, with
the B domain in yellow. Epitope-mapped residues in E2 domain B and E1 domain II are colored in blue and magenta, respectively.

(K61N and G64E) escape mutants. These changes were introduced into the MAYV-CH infectious
cDNA plasmid25, and mutant viruses were produced. As expected, these mutant viruses were
neutralized by the anti-E2 MAY-117 (Figure 4.10h). In comparison, both MAY-115 (Figure
4.10i) and MAY-131 (Figure 4.10j) showed reduced neutralizing activity against viruses
containing any of the single mutations. All of the neutralizing mAbs we mapped localized to sites
proximal to the FL in the E1 protein of the heterodimer (Figure 4.10k; E2 B domain mAb epitopes
in blue, E1 domain II mAb epitopes in magenta, and FL in green).
4.3.5 Protection against lethal MAYV challenge by mAbs
To determine if mAbs could protect in vivo, we developed a challenge model of MAYV
infection in mice that resulted in uniform mortality. 4-wk-old C57BL/6 mice were administered a
single intraperitoneal injection of 100 µg of anti-interferon alpha and beta receptor subunit 1 (antiIfnar1) mAb (MAR-5A326) 1 d before subcutaneous inoculation with MAYV strain BeH407 in
the footpad. Although MAYV is not lethal in immunocompetent mice, infected animals treated
with anti-Ifnar1 mAbs began to succumb at 3 d post infection (dpi) and experienced 100%
mortality by 6 dpi (Figure 4.11a-b). To test whether anti-MAYV mAbs could protect in this
model, we administered a single 100-µg mAb dose as prophylaxis 1 d before virus inoculation.
Even though many mAbs had strong neutralizing activity (11 had EC50 values against MAYV
119

BeH407 of <10 ng/ml, and 17 had values <100 ng/ml), only 9 of 18 protected mice against lethal
challenge (Figure 4.11a-b), with only two mAbs (MAY-115 and MAY-134) preventing mortality
completely. Remarkably, all of the mAbs that protected mice against lethal MAYV infection were
of the IgG2a subclass (Figure 4.11b). Despite similar EC50 values to their IgG2a counterparts
(Table 4.1), strongly neutralizing anti-MAYV IgG1 mAbs failed to protect against virus-induced
mortality (Figure 4.11).

Figure 4.11: Antibody protection against lethal MAYV challenge. A lethal MAYV challenge model was developed by treating 4
wk-old C57BL/6J male mice with a single 100-µg dose of anti-Ifnar1 mAb 1 d before subcutaneous virus inoculation. a-b.
Prophylaxis studies. A single dose of anti-MAYV mAbs (100 µg/mouse; ∼6/mg/kg) was administered 1 d before inoculation with
MAYV-BeH407, and survival was monitored. Antibodies are presented in IgG subclass groups: mouse IgG1 (a) or mouse IgG2a
(b). Data are from two experiments. c-d.Therapeutic studies. Indicated mAbs (100 µg/mouse) were given 1 d after virus inoculation,
and survival was monitored. Data are from two experiments. e-g. Combination mAb therapy. 200 total µg of MAY-115, MAY-134,
or a combination (100 µg each) was given to mice beginning at 1, 2, or 3 dpi, and survival was monitored. Data are from two
experiments. In this figure, n = 10, log-rank test with Bonferroni correction compared with the isotype mAb control treated group.
*, P < 0.05; ***, P < 0.001.
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For the protective IgG2a mAbs, we determined their therapeutic activity in a postexposure
treatment design. We administered MAY-115, MAY-122, MAY-131, MAY-133, MAY-134,
MAY-139, or MAY-140 as well as the slightly protective (MAY-121) and nonprotective (MAY117) mAbs 24 h after virus inoculation of anti-Ifnar1 mAb–treated mice. Only MAY-115 and
MAY-134 conferred substantial protection, with 80% and 100% survival rates, respectively
(Figure 4.11c-d). Because MAY-115 and MAY-134 bound distinct epitopes (Figure 4.10b), we
tested them in combination. We treated mice with 200 µg of MAY-115, MAY-134, or a
combination of 100 µg each of MAY-115 and MAY-134 at 1, 2, or 3 dpi in the lethal challenge
model. The higher dose of antibody conferred protection in all mice treated 1 dpi (Figure 4.11e).
MAY-115 and MAY-134 protected 50% and 60% of mice when given individually at 2 dpi,
whereas combination therapy protected all mice (Figure 4.11f). When treatment was begun at 3
dpi, MAY-115 or MAY-134 protected 10% and 30%, respectively, whereas combination therapy
protected 50% of mice (Figure 4.11g). Thus, a combination of anti-E1 and E2 mAbs provided
superior therapeutic activity compared with the individual mAbs against MAYV in the lethal
challenge model.
4.3.6 Protection against MAYV-induced musculoskeletal disease by mAbs
As MAYV causes arthritis and musculoskeletal disease, we assessed whether our
protective mAbs also mitigated joint-associated infection and swelling. 4-wk-old C57BL/6 mice
were inoculated subcutaneously in the foot with MAYV-BeH407, and ipsilateral and contralateral
ankle joint swelling was measured. In the ipsilateral ankle, MAYV caused swelling beginning at
2 dpi that persisted until ∼12 dpi (Figure 4.12a-b); in the contralateral ankle, swelling was
observed at 7 dpi (Figure 4.12a). We tested mAbs with therapeutic activity in the lethal challenge
model for their ability to limit MAYV-associated joint swelling along with the nonprotective
121

MAY-117 (IgG1) and an isotype control mAb. For each mAb, 100 µg was administered 1 d before
subcutaneous inoculation with MAYV-BeH407, and ankle swelling was measured using digital
calipers (Figure 4.12b-g). Compared with an isotype control mAb, all tested anti-MAYV mAbs
reduced swelling in both the ipsilateral and contralateral feet. MAY-115, MAY-130, MAY-131,
and MAY-133 blocked swelling in both feet. Mice treated with MAY-117, which failed to protect

Figure 4.12: Antibody protection of MAYV-induced musculoskeletal disease. a. Swelling observed in the ipsilateral (4 dpi, left)
and contralateral (7 dpi, right) ankle following infection with MAYV-BeH407. b-g. Protective mAbs in the lethal challenge model
(see Figure 4.11) were tested for activity against MAYV-induced musculoskeletal disease. 4-wk-old C57BL/6J male mice were
given 100 µg of indicated mAbs via intraperitoneal route 1 d before subcutaneous inoculation of 103 FFU MAYV-BeH407 in the
foot. Swelling was measured in the ipsilateral (b, d, and f) and contralateral (c, e, and g) ankles using digital calipers. Data are
the mean and SEM of two experiments (n = 10 mice, two-way ANOVA with Tukey’s post-test). h-m. Virus titers in the ipsilateral
(h and i) or contralateral (j and k) feet or draining inguinal lymph node (l and m) at 1 (h, j, and l) and 7 (i, k, and m) dpi after
prophylaxis of mice with 100 µg of the indicated mAbs. Animals were perfused with PBS before tissue collection. Viral titers were
determined by qRT-PCR. Data are from two experiments (n = 10 mice, one-way ANOVA with Dunnett’s post-test). *, P < 0.05;
**, P < 0.01; ***, P < 0.001, ****, P < 0.0001. The experiments in B, D, and F or C, E, and G were performed concurrently, and
thus a single isotype control mAbs was used and included in each graph.
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against lethal challenge in anti-Ifnar1 mAb–treated mice, showed swelling of the contralateral foot,
although less than the isotype control mAb (Figure 4.12c). Animals treated with MAY-122
exhibited a partial reduction in swelling of the ipsilateral foot and delayed swelling in the
contralateral foot (Figure 4.12d-e).
To determine the effect of anti-MAYV mAbs on viral dissemination, we treated mice in
the musculoskeletal disease model with either highly (MAY-115 or MAY-134) or partially (MAY117) protective mAbs. Mice treated with MAY-115 or MAY-134 had less viral RNA in the
ipsilateral foot at 1 dpi compared with the isotype control, and viral RNA was cleared at 7 dpi
(Figure 4.12h-i). Mice treated with MAY-117 had less viral RNA in the ipsilateral foot than
animals given the isotype control mAb but had higher levels at both 1 and 7 dpi than animals
treated with MAY-115 or MAY-134. Consistent with these data, MAY-115 and MAY-134
prevented viral dissemination to the contralateral foot and the draining lymph node, whereas
MAY-117 did not (Figure 4.12j-m).
4.3.7 Antibody effector functions are required for anti-MAYV mAb–mediated protection
We observed marked differences in mAb protection against MAYV challenge (Figure
4.11) despite similarities in neutralization potency and epitope localization (Table 4.1 and Figure
4.10). Because the protective IgG2a mAbs against MAYV bound avidly to viral antigens on the
surface of infected cells (Table 4.5), we hypothesized that optimal in vivo activity required Fc
effector functions of the antibody and recognition of viral proteins on the plasma membrane. To
begin to evaluate the contribution of Fc effector functions to protection, we tested the ability of
anti-MAYV mAbs to promote neutrophil and monocyte-dependent phagocytosis of beads coated
with recombinant MAYV E2 protein; we were unable to express MAYV E1 protein and thus could
not interrogate anti-E1 mAbs for these studies. Several of the protective anti-MAYV E2 mAbs
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Table 4.5: Summary of properties of anti-MAYV IgG2a mAbs

IgG2a mAbs that bind to MAYV-E2 (top) or E1 (bottom) are listed along with the mapped binding group, percentage of mice
protected from lethal challenge, EC50 values for binding to MAYV-BeH407 infected Vero cells (EC50 binding) at 4°C, neutralization
of MAYV-BeH407 (EC50 neutralization), glycan profile, and antibody-dependent neutrophil phagocytosis and antibody-dependent
cellular phagocytosis activity. Antibodies are listed in order from most protective to least protective in each class. EC50 values are
nanograms per milliliter. ADCP, antibody-dependent cellular phagocytosis; ADNP, antibody-dependent neutrophil phagocytosis;
N/A, not applicable.

(e.g., MAY-122, MAY-133, and MAY-134) promoted phagocytosis of MAYV antigen–coated
beads in murine neutrophils and monocytes (Figure 4.13a-b). Capillary electrophoresis analysis
revealed heterogeneity in the abundance of specific glycans on anti-MAYV E2 mAbs (Figure
4.13c). Dominant afucosylated, digalactosylated, and sialylated (G2S1 and GS2S) glycans
appeared to associate positively with protection, whereas fucosylated (G2S1F) and highly
inflammatory agalactosylated (G0) glycoforms were negatively associated (see Table 4.5).
We next evaluated the effect of mAb isotype on protective anti-MAYV mAb activity in
anti-Ifnar1 mAb-treated C57BL/6 mice lacking the common signaling γ chain and activating
FcγRs (FcγR−/−). We performed prophylaxis studies with MAY-115 and MAYV-134 by
administering 100 µg of mAb 1 d before virus inoculation. Isotype control mAb–treated FcγR−/−
mice sustained 100% mortality by day 4 (Figure 4.14a), whereas animals treated with MAY-115
or MAY-134 were protected only partially, with a 30–40% survival rate, respectively. This result
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contrasts with the ability of the mAbs to confer complete protection as prophylaxis in anti-Ifnar1
mAb–treated WT mice (see Figure 4.11). As expected, MAY-117, a neutralizing mAb of the IgG1
isotype, failed to protect against MAYV in FcγR−/− mice.

Figure 4.13: Effector function and glycan profiles of anti-MAYV mAbs. a-b. Anti-MAYV E2 mAbs were evaluated for neutrophil(a) and monocyte-dependent (b) phagocytosis of MAYV E2 protein-conjugated beads relative to a no-antibody–treated control;
data are the average of two experiments performed in duplicate. Error bars represent SD of each replicate. c. The glycan profiles
of the mAbs were detected by capillary electrophoresis of isolated Fc regions. The relative abundance of the indicated glycans is
shown with glycans present shaded in blue. d. Efficacy of combination therapy with isotype switched mAbs. 100 μg each of a
combination of MAY-115 and MAY-134 of the indicated IgG subclass was given to anti-Ifnar1 mAn treated mice beginning at 2
dpi, and survival was monitored. Data are from two experiments (n=10). e-j. The clearance rate of isotype-switched mAbs in vivo.
Antibody clearance in vivo. WT C57BL/6J mice were inoculated with 200 μg/mouse of MAY-115 (e-g) or MAY-134 (h-j) of mouse
IgG2a (e and h), human IgG1 (f and i),or human IgG1-N297Q (g and j). At the indicated time points, mice were sacrificed and
perfused with PBS. The feet were harvested, homogenized, and analyzedfor levels of anti-MAYV mAbs by ELISA. See Figure 4.14.

To further define the role of mAb subclass in MAYV protection, we performed isotypeswitching studies. Antibody isotypes bind FcγRs with different affinities: mouse IgG2a binds
strongly to mouse FcγR I and FcγR IV, whereas mouse IgG1 does not27. We cloned the variable
regions of MAY-115 and MAY-134 and inserted them into mouse IgG1 and IgG2a antibody heavy
chain expression vectors. We also cloned the variable regions of MAY-115 and MAY-134 as
human IgG1 antibodies, which have comparable binding to mouse FcγR I and FcγR IV as
mIgG2a28. Finally, we generated an aglycosyl variant of human IgG1 (N297Q) that abrogates
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binding to FcγR and C1q29. We first tested the binding of the isotype-switched mAbs to mouse
and human FcγRs by ELISA; we observed little or no binding of mouse IgG1 and human IgG1N297Q antibodies to mouse FcγR I, mouse FcγR III, mouse FcγR IV, human FcγR I, and human
FcγR IIIa (Figure 4.14b). Human IgG1 mAbs bound to mouse FcγR I and FcγR IV similarly to
mouse IgG2a but showed less binding to mouse FcγR III. FRNT assays confirmed that isotypeswitched mAbs retained neutralizing activity (Figure 4.14c and d). As expected, all isotypeswitched variants of MAY-115 had similar defects in protection against MAYV challenge in
FcγR−/− mice (Figure 4.14e).
We administered the isotype-switched mAbs to mice in both the lethal challenge and
musculoskeletal disease models. When switched from mouse IgG2a to IgG1, both MAY-115 and
MAY-134 lost their ability to fully protect mice, with 60% of animals succumbing in each case
(Figure 4.14f and h). Human IgG1 isotype-switched variants of MAY-115 and MAYV-134
exhibited slightly reduced activity in vivo compared with mouse IgG2a but were more protective
than mouse IgG1 or human IgG1-N297Q mAbs. Combination therapy experiments showed
decreased efficacy when one of the two mAbs was a human IgG1-N297Q variant, suggesting that
protection depends on effector functions of both mAbs (Figure 4.13d). In the musculoskeletal
disease model, all isotype-switched mAbs reduced joint swelling in the ipsilateral foot compared
with isotype control mAbs, although differences were apparent (Figure 4.14g and i). Whereas
mouse IgG2a and human IgG1 forms of MAY-115 and MAY-134 mAbs prevented swelling
completely, mouse IgG1 and human IgG1-N297Q variants showed only partial decreases in
swelling. We observed roughly equivalent half-lives of all of the isotype-switched mAbs we tested
(Figure 4.13e-j), which indicated that the decreased protection observed with particular mAb
variants was not due to more rapid clearance in vivo.
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Figure 4.14: Antibody protection against MAYV depends on the IgG subclass and Fc effector functions. a. 4-wk-old C57BL/6
male and female FcγR−/− mice were administered 100 µg of the indicated anti-MAYV mAbs and 100 µg of anti-Ifnar1 mAb 1 d
before subcutaneous inoculation with 103 FFU of MAYV-BeH407. Data are from two experiments. b. Recombinant, isotype-
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switched mAbs (MAY-115 and MAY-134) were tested by ELISA for binding to soluble mouse and human FcγRs. Binding is
presented relative to the mouse IgG2a isotype control of MAY-115 (left) or MAY-134 (right). Data are the mean and SD of two
experiments performed in triplicate. c-d. Neutralizing activity of isotype-switched MAY-115 (c) or MAY-134 (d) was measured by
FRNT against MAYV-BeH407. Data are representative of three experiments performed in triplicate. e. 4-wk-old FcγR−/− mice were
administered 100 µg of the indicated MAY-115 IgG and 100 µg of anti-Ifnar1 mAb 1 d before subcutaneous inoculation with 103
FFU of MAYV-BeH407. Data are from two experiments. f-i. Protection by isotype-switched mouse IgG2a mAbs. MAY-115 (f and
g) and MAY-134 (h and i) isotype-switched mAbs were tested as prophylaxis against lethal challenge (f and h) or musculoskeletal
disease (g and i) (see Figures 4.11 and 4.12). Survival data are from two experiments. Swelling data are the mean and SD from
two experiments (n = 10 mice, two-way ANOVA with Sidak’s post-test). j-l. Protection by isotype-switched mouse IgG1 mAbs.
MAY-117 (j) and MAY-130 (k) isotype-switched mAbs were tested as prophylaxis against lethal challenge (l). Survival data are
from two experiments (a, e, f, h, and l; n = 10 mice, log-rank test with Bonferroni correction compared with the isotype control or
indicated treatment groups). The experiments in f and h or g and i were performed concurrently, and thus a single isotype control
mAbs was used and included in each graph. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.

Even though many of our IgG1 mAbs had similarly potent neutralizing activity against
MAYV compared with IgG2a mAbs, they failed to protect against lethal challenge. To corroborate
a key role for IgG subclass in protection against MAYV, we switched the isotype of MAY-117
and MAY-130, two nonprotective neutralizing mAbs, from mouse IgG1 to human IgG1, which
engage FcγRs weakly and strongly, respectively. The isotype-switched mAbs had similar
neutralization activity against MAYV BeH407 as the parental mAbs (Figure 4.14j and k). As
expected, uniform mortality was seen in MAYV-infected mice treated with the mouse IgG1 forms
of MAY-117 or MAY-130 (Figure 4.14l). In contrast, we observed significant protection against
lethal MAYV challenge when mAbs MAY-117 or MAY-130 of the human IgG1 isotype was
administered. These experiments confirm that effector functions contribute to optimal antibodymediated protection of mice from lethal MAYV infection.
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4.4 Discussion
Our goal was to produce type-specific and broadly neutralizing mAbs that have therapeutic
utility and can shed light on the requisite components of a protective humoral immune response
against MAYV. We generated 151 hybridomas and identified 18 that produced mAbs with potent
neutralizing activity. Of these, 11 had “elite” activity, with EC50 values against the immunizing
MAYV strain of <10 ng/ml. 16 of these mAbs neutralized the closely related UNAV, with a
smaller subset showing a breadth of inhibitory activity against the more distant CHIKV, RRV, and
ONNV.
Although many mAbs neutralized a broad spectrum of MAYV isolates from both the D
and L genotypes, there were exceptions. MAY-133 had no neutralizing activity against MAYVUruma, and MAY-140 lacked activity against MAYV-FSB0311, MAYV-OBS6443, and MAYVBeH473130. This observation was unexpected, because both mAbs engage residues (for MAY133: Q183, Q184, I190, G209, T210, I217, N218, and D223; for MAY-140: Q183, I190, G209,
T210, I217, and D223) on the E2 protein that are shared by other mAbs that neutralized all MAYV
strains and even some other alphaviruses. Indeed, these interaction residues are conserved across
all MAYV strains that we tested. Although further studies are warranted, we hypothesize that the
display of particular residues on E2 varies in a strain-dependent manner, which could affect
neutralization by a given antibody. Thus, substitutions in the envelope proteins of Uruma,
FSB0311, OBS6443, and BeH473130 strains of MAYV could affect epitope exposure, as has been
described for flaviviruses30,31,32. Analysis of the virion structures of these different MAYV strains
and the display of their structural glycoproteins may elucidate why certain antibodies fail to
neutralize individual viruses even though their binding residues appear conserved.
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The neutralizing mAbs that we characterized all blocked virus entry at post-attachment
steps. Only mAbs MAY-117 and MAY-122 showed nominal blocking of viral binding to cells,
and these mAbs also blocked post-attachment entry steps. The majority of the mAbs, with the
exception of MAY-120 and MAY-122, inhibited plasma membrane fusion. These results are
similar to studies with other alphaviruses, including CHIKV12,17,21, Venezuelan equine
encephalitis33, and eastern equine encephalitis virus18, indicating that potently neutralizing mAbs
may share a common mechanism of action. Indeed, all of the strongly inhibitory mAbs we
analyzed bound to regions in E2 and E1 that are proximal to the FL peptide. While entry blockade
likely contributed to the potency of virus neutralization, 16 of the 18 mAbs also inhibited viral
egress. This activity may occur as a result of cross-linking of adjacent E protein complexes at the
cell surface and/or conformational shifts induced by anti-B domain antibodies17,21 that prevent
budding from infected cells. As the regions in E1 and in the B domain of E2 to which our mAbs
mapped are conserved among MAYV strains, they could be targeted by vaccines to induce broadly
inhibitory humoral responses against MAYV and closely related viruses.
Although all of the neutralizing E2-specific anti-MAYV mAbs that we mapped localized
to the B domain, it is likely that neutralizing epitopes also exist in the A domain. Neutralizing
mAbs that bind to the A domain of E2 of CHIKV12,13,17,21 and eastern equine encephalitis virus18
have been described. Furthermore, vaccine-generated anti-MAYV-neutralizing antibodies
preferentially bound to epitopes within the A domain of E234. Our isolation of B rather than A
domain mAbs may be a product of our vaccination strategy. Although the initial immunization and
the final boosts were performed with infectious virus, we boosted with recombinant E2 protein,
which may have skewed the immune response toward B domain antibodies. Analysis of the
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antibody responses of different mouse strains or naturally infected humans will be necessary to
establish the immunodominance of neutralizing epitopes in the MAYV envelope proteins.
The neutralizing mAbs showed disparate levels of protection in mice. Although many had
exceptional neutralizing potency in cell culture, only 8 of the 18 mAbs conferred significant
protection in vivo. In this subset, there were differing levels of protection ranging from partial to
complete protection (Table 4.5), and there was no correlation with the shape of the neutralization
curve or presence of a resistant fraction. The most protective anti-E2 mAbs bound viral antigen on
the surface of infected cells with high avidity and promoted phagocytosis of E2 protein–coated
beads by both neutrophils and monocytes. These results are consistent with prior studies with the
related Sindbis and Semliki Forest viruses, which showed that nonneutralizing mAbs can protect
against lethal infection35,36. We observed a preliminary correlation with protection in vivo and
dominant afucosylated, digalactosylated, and sialylated glycan specifies (sialic acid: G2S2 and
G2S1). The cytotoxic function of afucosylated glycans, which enhance Fc-effector function,
coupled to enhanced galactosylation/sialylation, which dampen inflammation37,38, may promote
optimal viral clearance and minimize pathology. Further glycan analysis and protection data with
a larger panel of anti-MAYV mAbs is needed to corroborate these results, as was performed with
anti-Ebola virus mAbs39.
Antibody protection against lethal challenge and musculoskeletal disease required Fc
effector functions, albeit the latter to a lesser degree. Our 18 neutralizing mAbs were composed of
two IgG subclasses: 10 IgG1 and 8 IgG2a. Remarkably, only the IgG2a anti-MAYV mAbs
conferred substantial protection against lethal challenge. Mouse IgG2a antibodies not only interact
with more FcγRs on immune cells but also bind specific receptors (e.g., FcγR I) with higher affinity
than IgG127,28. The capacity for an IgG subclass to engage FcγRs correlated with in vivo activity,
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as MAY-115 and MAY-134 were more protective as IgG2a than IgG1 antibodies even though
their neutralizing activity in vitro and half-lives in vivo were essentially equivalent. The
dependence of protection on effector function was corroborated by comparing isotype-switched
anti-MAYV human IgG1 variants with and without (N297Q) heavy-chain N-linked glycosylation.
Moreover, nonprotective mouse IgG1 mAbs (MAY-117 and MAY-130) became protective when
they were switched to a human IgG1 subclass, which engages activating FcγRs more efficiently.
The contribution of FcγRs to anti-MAYV-mediated protection was confirmed through challenge
studies in mice lacking all activating FcγRs. Antibody recognition of MAYV or other alphavirus
antigens on the cell surface may be an important mechanism for clearance of infected cells through
Fc effector–function dependent phagocytosis or cytolysis by specific myeloid cell subsets12.
Studies are planned to define the dominant effector functions and individual FcγRs that contribute
to mAb protection in our MAYV models, as has been performed to varying degrees with antibodies
against influenza40, hepatitis B41, human immunodeficiency virus42, West Nile virus43, and
CHIKV44. Experiments are needed to determine if other IgG subclasses (e.g., mouse IgG2b, human
IgG2, and human IgG3) confer protection against MAYV in these models and whether there is an
impact of C1q, which differentially binds IgG subclasses, on protection. Finally, our combination
therapy studies with MAY-115 and MAY-134, which bind discrete epitopes on E1 and E2
proteins, suggest that inclusion of multiple mAbs in a cocktail likely will confer greater protection
than either constituent alone. This effect could be due to synergy of neutralization, effector
functions, or the control of resistance against either of the two individual mAbs14,45.
Antibodies with similar neutralization profiles and mechanisms of action did not protect
mice from MAYV infection equivalently. Thus, the importance of IgG subclass and effector
function activity likely should be optimized for vaccines or therapeutic antibodies against MAYV
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and other alphavirus infections. Three candidate MAYV vaccines have been described, including
a chemically inactivated virion46, a live-attenuated virus25, and a DNA plasmid vaccine34.
Although all protected in mice, the antibody repertoires were not fully analyzed. Whereas the DNA
plasmid vaccine produced IgG2a antibodies in mice, the majority were against epitopes on E1 and
E2 not identified in our screens. Our results in mice suggest than immunization strategies that use
protein scaffolds47 and specific TH1-skewing adjuvants could target regions in the B domain of E2,
the FL of E1, and possibly other sites to generate neutralizing antibodies that block viral fusion
and egress and optimize Fc effector functions.
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4.5 Methods
Animal ethics statement. All animal experiments and procedures were performed in accordance
with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health, Bethesda, MD. The protocols were approved by the Institutional Animal Care
and Use Committee at the Washington University School of Medicine (assurance number A338101). Injections were performed under anesthesia that was induced and maintained with ketamine
hydrochloride and xylazine, and all efforts were made to minimize animal suffering.
Cell lines. Vero, HEK-293T, C2C12, and MEF cells were cultured in DMEM supplemented with
10% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, 1× MEM nonessential amino acids, 1
mM sodium pyruvate, 2 mM L-glutamine, and 10 mM Hepes, pH 7.3. Hybridomas were cultured
in IMDM supplemented with 20% FBS, 100 U/ml penicillin, 100 µg/ml streptomycin, and 1 mM
sodium pyruvate. Expi293 cells were maintained in Expi293 medium (Gibco).
Viruses. MAYV strains (Beh428890, BeH473130, BeH343155, BeH506151, FSB0311,
IQU2950, OBS6443, TRVL15537, BeH407, and Uruma), CHIKV (La Reunion OPY1), UNAV
(CoAr2380), RRV (T48), and ONNV (M30) all were obtained from the World Reference Center
for Emerging Viruses and Arboviruses (R. Tesh, K. Plante, and S. Weaver, University of Texas
Medical Branch, Galveston, TX) and passaged in Vero cells from lyophilized stocks. Recombinant
viruses were produced after linearization of a prS2 vector containing cDNA from MAYV strain
CH25 that was generously provided by S. Weaver (University of Texas Medical Branch, Galveston,
TX). After in vitro transcription with mMESSAGE mMACHINE SP6 transcription kit
(Invitrogen) and transfection into BHK-21 cells, p0 virus stocks were harvested and passaged once
(p1) in Vero cells. Virus titers were determined by focus forming assay12.
Mouse studies. 4-wk-old WT C57BL/6J male mice were purchased from the Jackson Laboratory.
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4-wk-old common γ-chain–deficient (FcRγ−/−) C57BL/6 mice were obtained commercially
(Taconic) and bred at the Washington University Animal Facility. Anti-MAYV mAbs were
administered by intraperitoneal injection at specified times before or after inoculation in the left
footpad with 103 focus-forming units (FFU) MAYV in HBSS supplemented with 1% heatinactivated FBS. Foot swelling was monitored via measurements (width × height) using digital
calipers. Tissues were harvested after perfusion with 40 ml PBS and titered by qRT-PCR using
RNA isolated from viral stocks as a standard curve to determine FFU equivalents. For lethal
challenge experiments, mice were administered via intraperitoneal injection a single 100-µg dose
of anti-Ifnar1 mAb MAR1-5A326 (Bio X Cell) 1 d before infection.
mAb generation. 10-wk-old female BALB/c mice were inoculated with 103 FFU of MAYV-CH.
Mice were boosted with 100 µg of recombinant MAYV E2 protein mixed 1:1 with Freund’s
incomplete adjuvant at 14, 28, and 42 d after initial infection. At 56 dpi, mice were boosted with
106 FFU of MAYV-CH. 3 d before splenocyte harvest, at 70 dpi, mice were inoculated with 1010
FFU of MAYV-CH that was produced by centrifuging MAYV through a 20% sucrose cushion at
∼175,000 ×g for 2 h. Spleens were harvested at 73 dpi and fused with P3X63 Ag.8.6.5.3 mouse
myeloma cells as described previously14. Hybridoma supernatants were screened for antibodies
that bound to recombinant MAYV E2 in an ELISA and/or to MAYV-infected cells by flow
cytometry. Neat hybridoma supernatants were screened for neutralization of MAYV-CH using an
FRNT (described below). Selected mAbs were isotyped by ELISA and purified by protein A
affinity columns using a commercial vendor (Bio X Cell).
FRNTs. Anti-MAYV mAbs were diluted serially and incubated with 102 FFU of the specified
MAYV strain for 1 h at 37°C in triplicate wells. Virus-mAb mixtures were incubated on Vero cells
for 60 min at 37°C before being overlaid with 1% methylcellulose in MEM supplemented with 10
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mM Hepes, pH 7.3, 100 U/ml of penicillin, 100 µg/ml of streptomycin, 2 mM L-glutamine, and
2% FBS. 18 h after virus inoculation, cells were fixed with 1% paraformaldehyde (PFA) in PBS.
Cells were then washed and incubated with 1 µg/ml CHK-4812, a cross-reactive anti-CHIKV mAb,
for 2 h. Cells were washed and incubated with 500 ng/ml HRP-conjugated goat anti-mouse IgG
(Sigma-Aldrich) for 1 h. Foci of infection were detected using TrueBlue substrate (KPL) and
counted using a Biospot plate reader (Cellular Technology). Wells containing virus incubated with
mAbs were compared with wells treated with virus containing no mAb. The EC50 value was
calculated using nonlinear regression analysis after constraining the bottom to 0 and the top to 100.
Attachment inhibition assay. 104 FFU of MAYV was incubated with mAbs, soluble heparin
(H3393; Sigma), or BSA (Sigma) at the specified concentration for 1 h at 37°C. The mixture was
chilled on ice and added to Vero cells and incubated at 4°C for 1 h. Cells were washed six times
with chilled PBS before addition of lysis buffer and extraction of RNA using an RNAeasy Mini
Kit (QIAGEN). MAYV RNA was quantified using a Taqman RNA-to-Ct 1-step kit (Thermo
Fisher Scientific) and a 5′ untranslated region and nsp1 specific primer/probe set48. MAYV RNA
levels were normalized to GAPDH, and the relative fold change was compared with cells treated
with an isotype control mAb.
Pre- and post-attachment assays. Pre- and post-attachment neutralization assays were performed
by first incubating serially diluted anti-MAYV mAbs with 102 FFU of MAYV for 1 h at 37°C.
The mAb–virus complexes were then added to Vero cells for 1 h at 37°C. Cells were overlaid with
1% (wt/vol) methylcellulose in modified Eagle medium supplemented with 2% FBS. Postattachment neutralization assays were performed by first incubating Vero cells with 102 FFU of
MAYV for 1 h at 4°C. Cells were washed extensively with cold DMEM to remove unbound virus.
Diluted anti-MAYV mAbs were added to virus-adsorbed cells and incubated for 1 h at 4°C. After
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a 15-min incubation at 37°C to allow virus internalization, cells were overlaid with
methylcellulose. Pre- and post-attachment neutralization assays were processed similarly using the
FRNT described above.
Fusion inhibition assays. FFWO assays were performed after allowing virus adsorption to BHK21 cells (multiplicity of infection [MOI] of 25) for 1 h at 4°C. Unbound virus was removed by
rinsing cells with chilled PBS. Diluted anti-MAYV mAbs (1 µg/ml) were added to virus-adsorbed
cells for 30 min at 4°C. Cells were washed with chilled PBS. FFWO was induced by pulsing with
fusion medium (RPMI 1640, 10 mM Hepes, 0.2% BSA, and 30 mM succinic acid, pH 5.5) for 2
min at 37°C. A nonfusion control was included using control media (RPMI 1640, 10 mM Hepes,
pH 7.6, and 0.2% BSA). After the pulse, cells were washed twice with chilled PBS and incubated
in DMEM supplemented with 5% FBS, 10 mM Hepes, pH 7.3, 100 U/ml of penicillin, 100 µg/ml
of streptomycin, and 20 mM NH4Cl to prevent de novo infection via canonical endocytosis
pathways. Infection was allowed to proceed for 6 h, and cells were detached and fixed with 4%
PFA in PBS. Cells were stained with MAY-118 (0.5 µg/ml) in permeabilization buffer (PBS + 1%
BSA + 0.1% saponin) and incubated for 1 h at 4°C. After two washes with permeabilization buffer,
MAYV E2 antigen was detected with Alexa Fluor 647–conjugated goat anti-mouse IgG (1:1,000
dilution; Thermo Fisher Scientific). After two washes with permeabilization buffer, cells were
resuspended in 100 µl and analyzed on a MACSQuant Analyzer (Miltenyi Biotec).
Egress inhibition assays. Vero cells were inoculated with MAYV at an MOI of 0.1. After 24 h,
cells were washed and lysed, and total RNA was collected using an RNAeasy Mini kit (QIAGEN).
The amount of viral RNA present was measured by qRT-PCR, and the stocks were aliquoted and
stored at −80°C. Vero cells were transfected with viral RNA (equivalent to an MOI of 10) and
incubated for 3 h at 37°C. The cell culture media was replaced with 50 µl of medium containing
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dilutions of anti-MAYV mAbs. The cells then were incubated for 3 h at 37°C before supernatant
was collected. The samples were incubated with PBS containing 50 µg/ml RNase A (Sigma) to
remove nonencapsidated RNA. RNA was isolated from the supernatant using an RNAeasy Mini
kit, and MAYV RNA was measured using qRT-PCR as described above.
Protein expression and purification. The MAYV E2 ectodomain (residues 1–340) was cloned
into the pET21a expression vector and expressed in BL21 (DE3) Escherichia coli cells. Protein
production was induced using 1 mM IPTG, where E2 partitioned into the inclusion body fraction
and was refolded using an oxidative refolding protocol49. Briefly, 10 ml solubilized inclusion body
was injected at 1 ml/h into a 1-liter volume of arginine refolding buffer (400 mM L-arginine, 100
mM Tris, pH 8.5, 5 mM reduced glutathione, 0.5 mM oxidized glutathione, and 0.2 mM PMSF)
and then allowed to stir slowly overnight at 4°C. The refolded protein was filtered, concentrated
using a 30-kD-cutoff stirred cell concentrator (EMD Millipore), and purified by HiLoad 16/600
Superdex 75 size exclusion chromatography (GE Healthcare). B domain mutants were generated
using a QuikChange II XL Site-Directed Mutagenesis Kit (Agilent) and verified by DNA
sequencing. Mutants were confirmed by direct sequencing of plasmid DNA and expressed and
purified as described above.
MAYV E2-E1 structure prediction and substitution design. The predicted structure of the
MAYV E2-E1 heterodimer was generated for strain TRVL4675 (GenBank accession no.
AAO33335.1) using the intensive modeling mode of Phyre250. Cutoffs of residues to display were
based on the crystal structure of CHIKV p62E1 (PDB: 3N4223). Substitution mutations in the B
domain of E2 were designed by first estimating the solvent accessibility of each residue using
Naccess51. A residue was chosen to undergo substitution if it was predicted to be solvent accessible
and conserved among arthritogenic alphaviruses, but not encephalitic alphaviruses.
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BLI binding assays. The binding affinity of purified recombinant MAYV E2 ectodomain protein
to MAYV mAbs was monitored at 25°C using an Octet-Red96 device (Pall ForteBio). 100 µg of
each mAb was mixed with biotin (EZ-Link-NHS-PEG4-Biotin; Thermo Fisher Scientific) at a
molar ratio of 20:1 biotin/protein and incubated at room temperature for 30 min. The unreacted
biotin was removed by passage through a desalting column (5 ml Zeba Spin 7 kD molecular weight
cutoff; Thermo Fisher Scientific). The biotinylated mAbs were loaded onto streptavidin biosensor
pins (ForteBio) until saturation, typically 10 µg/ml for 2 min, in 10 mM Hepes, pH 7.4, 150 mM
NaCl, 3 mM EDTA, 0.005% P20 surfactant, and 1% BSA. The pins were equilibrated in binding
buffer alone before being plunged into wells containing various concentrations of MAYV E2 and
then placed back into binding buffer to allow for dissociation. Real-time data were analyzed using
BIAevaluation 3.1 (GE Healthcare). Kinetic profiles and steady-state equilibrium concentration
curves were fitted using a global 1:1 binding algorithm with drifting baseline.
MAYV mAb mapping by ELISA. Purified recombinant MAYV E2 ectodomain WT or mutant
proteins (100 ng/well) were adsorbed overnight at 4°C on Maxisorp immunocapture ELISA plates
(Thermo Fisher Scientific) in a sodium bicarbonate buffer (pH 9.3). Plates were washed three times
with PBS and 0.05% Tween 20 for 1 h at 37°C followed by incubation of 0.5 µg/ml of indicated
mAbs for 1 h at room temperature. Plates were washed again and then sequentially incubated with
2 µg/ml of HRP-conjugated goat anti-mouse IgG and tetramethylbenzidine substrate (Invitrogen).
The reaction was stopped by the addition of 1 N H2SO4, and emission at 450 nm was read using
an iMark microplate reader (Bio-Rad). Critical residues were defined as those with ≤25% binding
to an individual mAb but ≥75% binding to an oligoclonal pool of anti-MAYV mAbs.
Alanine scanning mutagenesis. A pcDNA3.1(+) plasmid expressing a codon-optimized MAYVTRVL4675 structural polyprotein (C, E3, E2, 6K, and E1 genes) was synthesized and mutated by
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Genewiz. Alanine scanning mutagenesis was performed on amino acids in the B domain of the E2
protein (residues 189–231), whereas charge mutations to arginine were made on residues 179–186
and 212–218, with the exception of 215, which was changed to glutamic acid. Plasmids were
transfected into HEK-293T cells using Lipofectamine 3000 (Thermo Fisher Scientific). 18 h later,
cells were chilled to 4°C, washed with PBS, and incubated with anti-MAYV mAbs (10 µg/ml) in
PBS with 2% FBS for 1 h at 4°C. An oligoclonal mixture of all the anti-MAYV mAbs was used
as a control for mutant E2 protein expression. Anti-MAYV mAb binding was detected using Alexa
Fluor 647–conjugated goat anti-mouse IgG (Thermo Fisher Scientific) diluted 1:1,000. After 1 h,
cells were washed, fixed with 1% PFA in PBS and analyzed by flow cytometry using a
MACSQuant Analyzer (Miltenyi Biotec). Using previously described criteria13, critical residues
were defined as those with ≤25% binding to an individual mAb but ≥75% binding to an oligoclonal
pool of anti-MAYV mAbs when detected by flow cytometry.
Generation of neutralization escape mutants. 105 FFU of MAYV-CH was incubated with 1
µg/ml of MAY-115 or MAY-131 for 1 h at 37°C. The virus–mAb mixtures were added to Vero
cells. After 24 h, half of the virus supernatant was frozen at −80°C, whereas the other half was
incubated with 1 µg/ml of MAY-115 or MAY-131 for 1 h at 37°C. This virus–mAb mixture was
added to Vero cells and harvested after 24 h. This protocol was performed a total of six passages
before escape mutants were confirmed by FRNT. Viral RNA was isolated from supernatant pools
using a MagMAX Viral Isolation kit (Applied Biosystems), and cDNA was generated using
SuperScript IV Reverse transcription using Oligo(dT)20 primers (Thermo Fisher Scientific). Viral
structural genes were amplified using the forward primer 5′-GGTCCTAAATAGGTGCTCTAC
ACG-3′ and reverse primer 5′-ACTTTGAGAAGGTRAATCAWAAGTACCG-3′. The amplicons
were sequenced by Genewiz, and mutants were produced using a Phusion Site-Directed
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Mutagenesis Kit (Thermo Fisher Scientific) in the MAYV-CH infectious cDNA clone described
above.
Isotype switching of mAbs. MAY-115 and MAY-134 variable regions were sequenced and
cloned using previously described methods52. Total RNA was isolated from hybridomas, and
cDNA was produced using random hexamers and Oligo(dT)20 using a SuperScript IV First Strand
Synthesis kit (Invitrogen). Heavy and light chain variable regions were amplified and sequenced
using mouse-specific primer sets52. Allele-specific primers were used to amplify variable regions
and append Gibson assembly sequences to the 5′ and 3′ ends. The variable regions then were
cloned into plasmids containing the constant regions of human IgG1 (pAbVec-hIgG1) or mouse
IgG1 (pAbVec-mIgG1) or the appropriate kappa chain (pAbVec-hIgKappa or pAbVectmIgKappa) using NEBuilder (New England Biolabs). The human IgG1-N297Q vector was
produced by site-directed mutagenesis of the human IgG1 vector using a Phusion site-directed
mutagenesis kit. Antibodies were produced by cotransfecting Expi293 cells with an appropriate
heavy and kappa chain plasmid using Hype5 transfection reagent (Oz Biosciences). 4 d after
transfection, supernatant was collected and mAbs were purified on a Protein A Agarose column
(Pierce).
Antibody half-life measurement. 4-wk-old WT C57BL/6J male mice were administered 200 µg
of anti-MAYV mAbs by intraperitoneal injection. At specified time points, mice were euthanized
and perfused with 40 ml PBS, and feet were collected. The supernatant from foot homogenates
was analyzed for anti-MAYV mAbs by whole-virus capture ELISA using a standard curve of
MAY-115 mIgG2a. Briefly, ELISA plates were coated with 104 FFU/well MAYV-CH at 4°C
overnight. Plates were blocked using 5% BSA in PBS for 2 h at 37°C and then incubated for 2 h
with serial dilutions of foot homogenate supernatant in parallel with a serial dilution of a known
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quantity of MAY-115 mIgG2a. After washing, bound antibody was detected using goat anti-mouse
or anti-human HRP-conjugated antibodies (1:1,000; Southern Biotech). Plates were developed
using tetramethylbenzidine substrate (Invitrogen), and the reaction was stopped with H2SO4.
ELISA plates were read using a TriBar LB941 plate reader (Berthold Technologies). The optical
density values from the known quantity of MAY-115-mIgG2a were fitted to a standard curve and
compared with the optical density values of the foot homogenate supernatant to determine amount
of MAYV-specific antibody present in the tissue.
FcγR ELISA. ELISA plates were coated with 200 ng/well of soluble FcγR proteins (R&D
Systems) at 4°C overnight. Plates were blocked using 5% BSA in PBS for 2 h at 37°C. AntiMAYV mAbs were added (1 µg/well) and incubated at room temperature for 2 h. Unbound
antibody was washed from the plate, and bound antibody was detected as described above.
Next-generation sequencing
Following vRNA extraction of MAYV strains, samples were amplified using a random RT-PCR
protocol. The resulting amplicons were used to generate a library using the NEBNext (NEB) kit
with indexing as described53. Libraries from multiple indexed samples were pooled and sequenced
on the 2 × 250 bp Illumina MiSeq platform. Consensus sequences were generated using Geneious
v10.2.2 by mapping short reads onto the genome of MAYV-BeH742930.
Antibody binding to infected cells. Vero cells were inoculated with MAYV-BeH407 at an MOI
of 1. 18 h later, cells were detached with TrypleE (Thermo Fisher Scientific) and washed with PBS
supplemented with 2% BSA at 4°C. Cells were incubated with fivefold dilutions (1 µg/ml to 20.5
pg/ml) of anti-MAYV mAbs for 30 min at 4°C. Bound mAbs were detected using an Alexa Fluor
647–conjugated goat anti-mouse IgG antibody (Thermo Fisher Scientific) before fixation with 2%
PFA for 10 min. Antibody-bound cells were detected by flow cytometry using a MACSQuant
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analyzer (Miltenyi Biotec). The percentage of cells positive for a given mAb was compared with
cells stained with a saturating amount of (100 µg/ml) an oligoclonal mixture of anti-MAYV mAbs.
Binding EC50 values were determined by plotting the percentage of positive cells relative to the
oligoclonal mAb control and fitting the data to a nonlinear regression curve.
Antibody-dependent neutrophil phagocytosis. Recombinant MAYV E2 protein was
biotinylated and conjugated to streptavidin-coated Alexa Fluor 488 beads. MAYV E2–coated
beads were incubated with fivefold dilutions of antibodies (mAbs: 5–0.0016 µg/ml) in cell culture
medium for 2 h at 37°C. Bone marrow cells were harvested from C57BL/6 mice. Cells were
washed with PBS, and 5.0 × 104 cells per well were added to bead-antibody immune complexes
and incubated for 1 h at 37°C. Cells were stained with the following antibodies: CD11b APC
(clone M1/70; BioLegend), CD11c APC/Cy7 (clone N418; BioLegend), Ly6G Pacific Blue (clone
1A8; BioLegend), Ly-6C BV605 (clone HK1.4; BioLegend), and CD3 PE/Cy7 (clone 17A2;
BioLegend). Cells were fixed with 4% PFA and analyzed on an IntelliCyt iQue Screener Plus flow
cytometer. Neutrophils were defined as CD3− and CD11c− cells that were Ly6C−, CD11b+, and
Ly6G+. The phagocytic score was determined using the following calculation: (percentage of
Alexa Fluor 488+ cells) × (Alexa Fluor 488 geometric mean fluorescent intensity of Alexa Fluor
488+ cells)/10,000.
Antibody-dependent cellular phagocytosis. Recombinant MAYV E2 protein was biotinylated
and conjugated to streptavidin-coated Alexa Fluor 488 beads. MAYV E2–coated beads were
incubated with fivefold dilutions of antibodies (mAbs: 5–0.0016 µg/ml) in cell culture medium for
2 h at 37°C. J774A.1 (TIB-67; ATCC) murine monocyte cells were added to bead–antibody
immune complexes (5.0 × 104 cells per well) and incubated for 1 h at 37°C. Cells were washed in
5 mM EDTA PBS, fixed with 4% PFA, and analyzed on an IntelliCyt iQue Screener Plus flow
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cytometer. The phagocytic score was determined using the following calculation: (percentage of
Alexa Fluor 488+ cells) × (Alexa Fluor 488 geometric mean fluorescent intensity of Alexa Fluor
488+cells)/10,000.
Glycan analysis. The relative abundance of antibody glycan structures was quantified by capillary
electrophoresis, as previously described54. Briefly, mAbs were purified using protein G magnetic
beads (New England Biolabs) and then treated with IdeZ protease (New England Biolabs) to
release the antibody Fab portion. The Fc-attached beads were washed, and N-glycans were
removed from the Fc domains and labeled with 8-aminopyrene-1,3,6-trisulfonic acid (APTS) using
the GlycanAssure APTS Kit (Thermo Fisher Scientific), as described in the manufacturer’s
protocol. Labeled glycans were loaded onto the 3500 Genetic Analyzer (Thermo Fisher Scientific).
Peaks for differentially galactosylated, fucosylated, bisected (GlcNAc), and sialylated structures
were identified (13 peaks were reproducibly observed). The relative abundance of each glycan
structure was determined by calculating the area under the curve, normalized for equal amounts of
loaded APTS dye, of each peak divided by the total area of all peaks.
Statistical analysis. Statistical significance was assigned with P values <0.05 using GraphPad
Prism version 7.0. The specific test for each dataset is indicated in respective figure legends and
was selected based on the number of comparison groups and variance of the data. For foot swelling
analysis, significance was determined by a two-way ANOVA with Tukey’s post-test (more than
two groups) or Sidak’s post-test (between two groups). Viral burden data were analyzed by a oneway ANOVA with a Dunnett’s post-test. Survival curve analysis was analyzed by the log rank
test. A Bonferroni correction was used depending on the number of comparison groups.
Data availability. Next-generation sequencing data have been deposited in the National Center
for Biotechnology Information Trace and Short-Read Archive accession number PRJNA525867
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and consensus sequences were deposited with GenBank accession numbers MK573238–
MK573246. No proprietary software was used in the data analysis.
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5.1 Summary and Future Directions: Alphavirus entry receptors
Alphaviruses have a broad range of hosts and tissue tropisms, suggesting that they utilize
multiple entry factors. To date, several molecules have been identified that meet most but not all
the criteria for a bona fide virus receptor1: for SINV, NRAMP22 and laminin receptor3; for CHIKV,
PHB14. Only two proteins have met all criteria to be classified as bona fide receptors: Mxra8 for
multiple arthritogenic alphaviruses such as CHIKV, MAYV, RRV, and ONNV (Appendix 1)5;
and LDLRAD3 for the encephalitic alphavirus VEEV (Appendix 3)6.
Both Mxra8 and LDLRAD3 were identified as alphavirus receptors using genome-wide
CRISPR/Cas9-based screens. Mxra8 is a cell adhesion molecule containing two Ig-like domains
and is expressed on epithelial, myeloid, and mesenchymal cells of mammals, birds, and
amphibians. It binds directly to CHIKV particles, resulting in enhanced attachment and
internalization into cells. Mxra8-deficient mice have reduced infection of musculoskeletal tissues
with various arthritogenic alphaviruses—CHIKV, MAYV, RRV, and ONNV—and reduced
CHIKV-induced joint swelling (Appendix 1)5. Moreover, ectopic Mxra8 expression is sufficient
to enhance CHIKV infection and lethality in transgenic flies7. Bovinae Mxra8, which contains a
15-amino acid insertion in the ectodomain, does not enable alphavirus binding and infection.
Removal of the insertion restored alphavirus infection in vitro, and introduction of the insertion
into Mxra8 of mice prevented CHIKV-induced pathogenesis (Appendix 2)8.
LDLRAD3 is a conserved yet poorly characterized plasma membrane protein of the LDL
scavenger-receptor family that is expressed in neurons and in epithelial cells of the gastrointestinal
tract, myeloid cells, and muscle tissue of mammals, birds, reptiles, amphibians, and fish. Knockout
of the Ldlrad3 gene in neuronal cells resulted in reduced viral infection, which was restored upon
complementation. Domain 1 (D1) of LDLRAD3 binds directly to VEEV and enhances virus
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attachment and internalization into host cells. Both anti-LDLRAD3 antibodies and an
LDLRAD3(D1)–Fc fusion protein block VEEV infection in cell culture. Furthermore, deletion of
Ldlrad3 or prophylactic administration of LDLRAD3(D1)-Fc prevented morbidity and mortality
in mice by pathogenic VEEV strains (Appendix 3)6. Since Mxra8 and LDLRAD3 are necessary
for optimal in vivo infection, dissemination, and pathogenesis of multiple alphaviruses with high
epidemical potentials, pharmacologically targeting these receptors may make a good strategy for
mitigating infection and disease. To help inform the basis of such therapies, we structurally
characterized how CHIKV engages Mxra8 and how VEEV engages LDLRAD3.
In Chapter 2, we show that Mxra8 has an unusual architecture: its two Ig-like domains are
oriented in a disulfide-linked head-to-head arrangement, with domain 1 inserted into a loop of
domain 2. Mxra8 binds into a cleft formed between two CHIKV E2-E1 heterodimers within a
trimeric spike and also extends to engage an adjacent trimeric spike. Two binding modes for Mxra8
were observed with mature CHIKV VLPs, which is consistent with a high and low affinity binding
site model supported by surface plasmon resonance measurements. The low affinity binding sites,
however, were sterically obscured by the retention of E3 on infectious CHIKV9. Our studies were
published back-to-back with an independent group whose work agrees with ours10, and were the
first atomic structures of an alphavirus-receptor complex.
In Chapter 3, we show that VEEV engages LDLRAD3 in a manner that is remarkably
similar to CHIKV with Mxra8 with comparable affinity, but with an exceptionally smaller
interface. D1 alone is required to bind VEEV and comprises of a highly conserved network of
disulfide bonds and calcium-coordinated acidic residues. LDLRAD3(D1) binds VEEV by
wedging into a cleft created by two adjacent E2-E1 heterodimers in one trimeric spike and
engaging domains A and B of E2 and the fusion loop in E1. Atomic modeling of this interface is
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supported by mutagenesis and anti-VEEV antibody binding competition assays11.
Although Mxra8 and LDLRAD3 bind equivalent sites on their respective alphaviruses,
their structures greatly differ. The ectodomain of Mxra8 contains two Ig-like domains, both of
which participate in binding, along with a 30-residue stalk region5,9. Based on our structural
studies, the stalk must be curved like a hook so that domain 1 is more proximal to the host cell for
viral engagement to occur (Figure 5.1). Indeed, when the stalk region was truncated, cell binding
and CHIKV infectivity was diminished10. LDLRAD3 contains 3 domains in its ectodomain, all of

Figure 5.1: Cartoon schematic of the Mxra8 and LDLRAD3 receptors. Figure created with BioRender.com.

which are LDL receptor type A (LA) modules that are ~40 amino acids in length with 6 disulfidebound cysteines and a cluster of conserved acidic residues coordinating a calcium ion6,11. Domain
1 alone is necessary and sufficient for VEEV binding and is oriented so that the N-terminus is
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more distal to the host cell. This indicates that LDLRAD3 does not curve to form a hook like
Mxra8. Convincingly, the removal of domains 2 and 3 of LDLRAD3 did not affect VEEV
infectivity6.
While the discoveries and structural characterizations of the Mxra8 and LDLRAD3
receptors have provided great insight into alphavirus cell entry, many unknowns persist. First and
foremost, the receptors for other alphaviruses such as EEEV and WEEV remain elusive. As two
highly divergent alphaviruses—CHIKV and VEEV—engage their respective receptors in a similar
manner, it is likely that EEEV and WEEV do so as well with their unknown receptor(s). The
LDLRAD3 determinants in E2 of VEEV are not conserved in WEEV and EEEV (23% identity)11,
which likely explains why this receptor is not shared among the encephalitic alphaviruses despite
the strong resemblances in structure12,13,14,15, tropism1, and disease presentation16. For comparison,
the Mxra8 determinants are more conserved between arthritogenic alphaviruses (44% identity)9.
For both CHIKV and VEEV, low levels of residual infections were observed in the absence
of receptor expression in cells5,6 (and in Mxra8-lacking mice infected with CHIKV7), signifying
the existence of Mxra8- and LDLRAD3-independent pathways for cell binding and entry. Also,
mosquitoes lack apparent orthologues of Mxra8 or LDLRAD3 and thus must have separate entry
receptors. To identify these enigmatic receptors, further genetic screens in Mxra8- or LDLRAD3deficient cells are warranted.
Little is known about the endogenous functions of Mxra8 and LDLRAD3. Previous studies
suggest that Mxra8 functions in mesenchymal cell differentiation17, blood-brain barrier
homeostasis18, osteoclast development19, cell adhesion20, and angiogenesis21. Notably, mice
lacking Mxra8 are viable and fertile7,22, indicating a non-essential role. For LDLRAD3, previous
studies suggest a role in modulating amyloid precursor protein function in neurons23 and promoting
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the activity of E3 ubiquitin ligases24. Undoubtedly, further studies are necessary, which may
provide further insight into alphavirus pathogenesis.
The roles of Mxra8 and LDLRAD3 in the sequential steps in the alphavirus entry pathway
beyond receptor binding remain enigmatic. Following endocytosis into the host cell, alphaviruses
are in an early endosomal compartment where the low pH triggers viral and host membrane fusion.
For the fusion event to occur, the envelope proteins must undergo significant conformational
changes to expose the hydrophobic fusion loops in E125. Yet based on our structural studies, both
Mxra8 and LDLRAD3 effectively shield the fusion loop from solvent access. One possible
explanation is that the receptors no longer bind the alphavirus particles within the low-pH
endosome, therefore playing a modulatory role by preventing fusion from occurring at suboptimal
steps. This theory is supported by the decreased binding affinity of Mxra8 to recombinant CHIKV
pE2-E1 heterodimer at a mildly acidic pH9. Mxra8 also has a significantly high number of histidine
residues (7% of the ectodomain), many of which are contact residues in CHIKV binding. As the
imidazole side chain in histidine has a pKa of ~6.0, it is feasible that the changes in electrostatic
properties within the endosomal compartartment could disrupt the Mxra8-CHIKV binding
interaction. However, LDLRAD3(D1) has no histidine residues, and it makes greater use of
hydrophobic residues to bind virus than Mxra8. Another explanation is receptor binding and fusion
occurs at different areas of the virion. It is unclear how many receptors the virus needs to bind to
for entry to occur, but due to the curvature of the ~70 nm spherical particle, we hypothesize that
only a few sites are necessary. Likewise, it is unclear how many E1 trimers are necessary for
fusion, but cryo-EM images of acidified SINV-liposome complexes at pH 6.4 suggest that the
binding site could cover one asymmetric unit of the SINV structure26. Further studies are needed
to elucidate the steps of alphavirus entry and membrane fusion.
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5.2 Summary and Future Directions: Monoclonal antibodies against alphaviruses
Although there are currently no FDA-approved vaccines or treatments for alphaviruses,
many studies have demonstrated the importance of antibody-mediated protection in controlling
and clearing infection27,28. Protection generally correlates with neutralizing activity for antialphavirus mAbs, and the most potent neutralizing mAbs typically bind epitopes on E2 and block
various steps in the virus replication cycle from attachment to egress29,30,31,32. To elucidate the
epitopes and mechanisms of protection by antibodies against MAYV, an understudied alphavirus,
we generated a panel of anti-MAYV mAbs.
In Chapter 3, we characterized the neutralizing mAbs against MAYV, most of which had
“elite” activity that inhibited infection with EC50 values of <10 ng/ml. The mAbs with the greatest
inhibitory capacity in vitro mapped to epitopes near the fusion peptide of E1 and in domain B of
E2. Unexpectedly, many of the elite neutralizing mAbs failed to prevent MAYV infection and
disease in vivo. Instead, protection required Fc effector functions, as isotype-switched or aglycosyl
variants with less or no capacity to interact with the complement component C1q or activating Fcγ receptors lost protective activity in vivo. These results indicate that an optimally protective
antibody response to MAYV and possibly other alphaviruses may require tandem optimization of
virus neutralization by the Fab moiety and effector functions of the Fc region.
Although all the neutralizing E2-specific anti-MAYV mAbs mapped to the B domain, it is
likely that neutralizing epitopes also exist in the A domain. Our isolation of B rather than A domain
mAbs may be a product of our vaccination strategy, where we boosted with recombinant E2 in
between the initial immunization and final boosts with infectious virus. This may have skewed the
immune response toward B domain antibodies. Analysis of the antibody responses of naturally
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infected humans will be necessary to establish the immunodominance of neutralizing epitopes in
the MAYV envelope proteins.
Not all protective mAbs against alphaviruses have neutralizing activity33,34,35,36,37,38,39,40,41.
The non-neutralizing anti-MAYV mAbs were shown to bind virus and facilitate clearance by Fcdependent internalization and destruction in myeloid cells (See Appendix 4)42. Other nonneutralizing anti-alphavirus mAbs have also been shown to protect via Fc effector functions33 or
by blocking viral egress34. Additional studies on protective non-neutralizing mAbs are warranted
to further elucidate their mechanisms of protection as well as their relative importance compared
to neutralizing mAbs for controlling infection.
5.3 Conclusions
Alphaviruses are a family of RNA viruses that of cause emerging and reemerging diseases
in humans worldwide. Symptoms range from chronic arthritis to lethal encephalitis and there
currently are no approved vaccines or treatments. The studies presented in this dissertation
establish how alphaviruses engage two different entry receptors—Mxra8 and LDLRAD3—and
how a panel neutralizing anti-MAYV mAbs protect against infection. Defining how alphaviruses
interact with the entry receptors and humoral responses of their hosts may inform the development
of future therapies that mitigate infection and disease.

157

5.4 References
1

Holmes, A. C., Basore, K., Fremont, D. H. & Diamond, M. S. A molecular understanding of
alphavirus entry. PLoS Pathogens 16, e1008876 (2020).
2
Rose, P. P. et al. Natural resistance-associated macrophage protein is a cellular receptor for
Sindbis virus in both insect and mammalian hosts. Cell Host Microbe 10, 97–104 (2011).
3
Wang, K. S., Kuhn, R. J., Strauss, E. G., Ou, S. & Strauss, J. H. High-affinity laminin receptor
is a receptor for Sindbis virus in mammalian cells. J. Virol. 66, 4992–5001 (1992).
4
Wintachai, P. et al. Identification of prohibitin as a Chikungunya virus receptor protein. J. Med.
Virol. 84, 1757–1770 (2012).
5
Zhang, R. et al. Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature 557, 570–
574 (2018).
6
Ma, H. et al. LDLRAD3 is a receptor for Venezuelan equine encephalitis virus. Nature 588,
308–314 (2020).
7
Zhang, R. et al. Expression of the Mxra8 Receptor Promotes Alphavirus Infection and
Pathogenesis in Mice and Drosophila. Cell Rep. 28, 2647-2658.e5 (2019).
8
Kim, A. S. et al. An Evolutionary Insertion in the Mxra8 Receptor-Binding Site Confers
Resistance to Alphavirus Infection and Pathogenesis. Cell Host Microbe 27, 428-440.e9 (2020).
9
Basore, K. et al. Cryo-EM Structure of Chikungunya Virus in Complex with the Mxra8
Receptor. Cell 177, 1725-1737.e16 (2019).
10
Song, H. et al. Molecular Basis of Arthritogenic Alphavirus Receptor MXRA8 Binding to
Chikungunya Virus Envelope Protein. Cell 177, 1714-1724.e12 (2019).
11
Basore, K., Ma, H., Kafai, N.M., Mackin, S., Kim, A. S., Nelson, C. A., Diamond, M. S., &
Fremont, D. H. (2021). Structural basis of Venezuelan equine encephalitis virus engagement of
the LDLRAD3 receptor. Accepted to Nature.
12
Sherman, M. B. & Weaver, S. C. Structure of the Recombinant Alphavirus Western Equine
Encephalitis Virus Revealed by Cryoelectron Microscopy. J. Virol. 84, 9775–9782 (2010).
13
Chen, L. et al. Implication for alphavirus host-cell entry and assembly indicated by a 3.5Å
resolution cryo-EM structure. Nat. Commun. 9, 5326 (2018).
14
Williamson, L. E. et al. Human Antibodies Protect against Aerosolized Eastern Equine
Encephalitis Virus Infection. Cell 183, 1884-1900.e23 (2020).
15
Zhang, R. et al. 4.4 Å cryo-EM structure of an enveloped alphavirus Venezuelan equine
encephalitis virus. EMBO J. 30, 3854–3863 (2011).
16
Atkins, G. J. The Pathogenesis of Alphaviruses. ISRN Virol. 2013, 1–22 (2013).
17
Jung, Y. K. et al. Gene expression profile of human chondrocyte HCS-2/8 cell line by EST
sequencing analysis. Gene 330, 85–92 (2004).
18
Yonezawa, T. et al. Limitrin, a Novel Immunoglobulin Superfamily Protein Localized to Glia
Limitans Formed by Astrocyte Endfeet. Glia 44, 190–204 (2003).
19
Jung, Y. K. et al. DICAM inhibits osteoclast differentiation through attenuation of the integrin
αvβ3 pathway. J. Bone Miner. Res. 27, 2024–2034 (2012).
20
Jung, Y. K. et al. DICAM, a novel dual immunoglobulin domain containing cell adhesion
molecule interacts with αvβ3 integrin. J. Cell. Physiol. 216, 603–614 (2008).
21
Han, S. W. et al. DICAM inhibits angiogenesis via suppression of AKT and p38 MAP kinase
signalling. Cardiovasc. Res. 98, 73–82 (2013).
22
Han, S. W. et al. DICAM Attenuates Experimental Colitis via Stabilizing Junctional Complex
in Mucosal Barrier. Inflamm. Bowel Dis. 25, 853–861 (2019).
158

23

Ranganathan, S. et al. LRAD3, a novel low-density lipoprotein receptor family member that
modulates amyloid precursor protein trafficking. J. Neurosci. 31, 10836–10846 (2011).
24
Noyes, N. C., Hampton, B., Migliorini, M. & Strickland, D. K. Regulation of itch and Nedd4
E3 ligase activity and degradation by LRAD3. Biochemistry 55, 1204–1213 (2016).
25
Kielian, M., Chanel-Vos, C. & Liao, M. Alphavirus entry and membrane fusion. Viruses 2,
796–825 (2010).
26
Cao, S. & Zhang, W. Characterization of an early-stage fusion intermediate of Sindbis virus
using cryoelectron microscopy. Proc. Natl. Acad. Sci. U. S. A. 110, 13362–13367 (2013).
27
Jin, J. & Simmons, G. Antiviral functions of monoclonal antibodies against chikungunya virus.
Viruses 11, (2019).
28
Torres-ruesta, A., Chee, R. S. L. & Ng, L. F. P. Insights into antibody-mediated alphavirus
immunity and vaccine development landscape. Microorganisms 9, 899 (2021).
29
Jin, J. et al. Neutralizing Antibodies Inhibit Chikungunya Virus Budding at the Plasma
Membrane. Cell Host Microbe 24, 417-428.e5 (2018).
30
Fox, J. M. et al. Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and
Inhibit Entry and Egress. Cell 163, 1095–1107 (2015).
31
Quiroz, J. A. et al. Human monoclonal antibodies against chikungunya virus target multiple
distinct epitopes in the E1 and E2 glycoproteins. PLoS Pathog. 15, e1008061 (2019).
32
Kim, A. S. et al. Protective antibodies against Eastern equine encephalitis virus bind to
epitopes in domains A and B of the E2 glycoprotein. Nat. Microbiol. 4, 187–197 (2019).
33
Kim, A. S. et al. Pan-protective anti-alphavirus human antibodies target a conserved E1
protein epitope. Cell 184, 4414-4429.e19 (2021).
34
Williamson, L. E. et al. Therapeutic alphavirus cross-reactive E1 human antibodies inhibit
viral egress. Cell 184, 4430-4446.e22 (2021).
35
Pal, P. et al. Development of a Highly Protective Combination Monoclonal Antibody Therapy
against Chikungunya Virus. PLoS Pathog. 9, e1003312 (2013).
36
Boere, W. A. et al. Identification of distinct antigenic determinants on Semliki Forest virus by
using monoclonal antibodies with different antiviral activities. J. Virol. 52, 575–582 (1984).
37
Schmaljohn, A. L., Johnson, E. D., Dalrymple, J. M. & Cole, G. A. Non-neutralizing
monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature 297, 70–72 (1982).
38
Stanley, J., Cooper, S. J. & Griffin, D. E. Alphavirus neurovirulence: monoclonal antibodies
discriminating wild-type from neuroadapted Sindbis virus. J. Virol. 56, 110–119 (1985).
39
Mendoza, Q. P., Stanley, J. & Griffin, D. E. Monoclonal antibodies to E1 and E2
glycoproteins of Sindbis virus: Definition of epitopes and efficiency of protection from fatal
encephalitis. J. Gen. Virol. 69, 3015–3022 (1988).
40
Hunt, A. R. & Roehrig, J. T. Biochemical and biological characteristics of epitopes on the E1
glycoprotein of western equine encephalitis virus. Virology 142, 334–346 (1985).
41
Mathews, J. H., Roehrig, J. T. & Trent, D. W. Role of complement and the Fc portion of
immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with
glycoprotein-specific monoclonal antibodies. J. Virol. 55, 594–600 (1985).
42
Earnest, J. T. et al. The mechanistic basis of protection by non-neutralizing anti-alphavirus
antibodies. Cell Rep. 35, (2021).

159

Appendix 1:
Mxra8 is a receptor for multiple arthritogenic alphaviruses

This appendix is a manuscript published in Nature:
Zhang, R., Kim, A. S., Fox, J. M., Nair, S., Basore, K., Klimstra, W. B., Rimkunas, R., Fong, R.
H., Lin, H., Poddar, S., Crowe, J. E., Jr, Doranz, B. J., Fremont, D. H., & Diamond, M. S.
(2018). Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature, 557(7706),
570–574.

Author contributions: R.Z. performed CRISPR–Cas9 screening and infection studies with J.M.F.,
S.N., H.L. and S.P. A.S.K. generated Mxra8–Fc and performed ELISAs. K.B. performed SPR
experiments. R.R. and R.H.F. performed mapping experiments. R.Z., A.S.K., J.M.F., B.J.D.,
D.H.F. and M.S.D. designed experiments. W.B.K. and J.E.C. provided key reagents. R.Z., A.S.K.,
J.M.F., K.B., R.H.F. and B.J.D. performed data analysis. R.Z. and M.S.D. wrote the initial
manuscript draft.

160

Appendix 2:
An Evolutionary Insertion in the Mxra8 Receptor-Binding Site
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@kogZuhqtrdr Zqd dldqfhmf* lnrpthsn,sqZmrlhssdc
OM@ uhqtrdr vhsg onnqkx tmcdqrsnnc bdkktkZqsqnohrl
Zmc rodbhdr rdkdbshuhsx- LwqZ7 hr Z qdbdosnq enq
ltkshokd ZkogZuhqtrdr hmbktchmf bghjtmftmxZ uhqtr
&BGHJT(- Vd chrbnudqdc sgZs vghkd dwoqdrrhnm ne
lntrd* qZs* bghloZmydd* cnf* gnqrd* fnZs* rgddo*
Zmc gtlZm LwqZ7 dmZakdr ZkogZuhqtr hmedbshnm hm
bdkk btkstqd* bZsskd LwqZ7 cndr mns- BZsskd 8raM7
dmbncdr Z 04,Zlhmn Zbhc hmrdqshnm hm hsr dbsncnlZhm
sgZs oqdudmsr LwqZ7 ahmchmf sn BGHJT- HcdmshbZk
hmrdqshnmr Zqd oqdrdms hm ydat* xZj*Zmc sgd dwshmbs
Ztqnbg- @r nsgdq AnuhmZd khmdZfdr bnmsZhm qdkZsdc
LwqZ7 rdptdmbdr* sghr hmrdqshnm khjdkx nbbtqqdc Zs
kdZrs4 lhkkhnm xdZqr Zfn-Odlnuhmf sgd LwqZ7 hmrdq,
shnm hm AnuhmZd dmgZmbdr ZkogZuhqtr ahmchmf Zmc
hmedbshnm*vghkd hmsqnctbhmf sgd hmrdqshnm hmsn lntrd
LwqZ7 aknbjr BGHJT ahmchmf*oqdudmsr hmedbshnm ax
ltkshokd ZkogZuhqtrdr hm bdkkr*Zmc lhshfZsdr BGHJT,
hmctbdc oZsgnfdmdrhr hm lhbd-Ntq rstchdr nm gnv
sghr hmrdqshnm oqnuhcdr qdrhrsZmbd sn BGHJT hmedbshnm
bntkc eZbhkhsZsd bntmsdqldZrtqdr sgZschrqtosLwqZ7
hmsdqZbshnmr vhsg ZkogZuhqtrdr-

@kog‘uhqtrdr ‘qd dldqfhmf+lnrpthsn,sq‘mrlhssdc onrhshud,rdmrd
QM@ uhqtrdr sg‘sb‘trd dwoknrhud chrd‘rd ntsaqd‘jr hm gtl‘mr
‘mc ‘mhl‘kr-Sgdrd uhqtrdr ‘qd bk‘rrhzdc hmsn fqntor a‘rdc nm
sgdhqfdmdshb qdk‘sdcmdrr ‘mc ghrsnqhb‘kantmc‘qhdr-Nkc Vnqkc ‘k,
og‘uhqtrdr+ hmbktchmf bghjtmftmx‘ ’BGHJU(+ L‘x‘qn ’L@XU(+
N&mxnmf&mxnmf ’NMMU(+‘mc Qnrr Qhudq’QQU(+b‘trd ‘btsd ‘mc
bgqnmhb ltrbtknrjdkds‘k chrd‘rd ‘eedbshmf lhkkhnmr ne odnokd
fkna‘kkx-Mdv Vnqkc ‘kog‘uhqtrdr+hmbktchmf D‘rsdqm ’DDDU(+Udm,
dytdk‘m ’UDDU(+‘mc Vdrsdqm ’VDDU(dpthmd dmbdog‘khshr uhqtrdr+
hmedbs sgd bdmsq‘kmdquntr rxrsdl ne gtl‘mr ‘mc rnld ‘mhl‘k
rodbhdr- Cdrohsd sgd dohcdlhb onsdmsh‘kne ‘kog‘uhqtrdr+ sgdqd
‘qd mn khbdmrdc sgdq‘ohdr nqu‘bbhmdr enq‘mx e‘lhkx ldladqSgd ‘kog‘uhqtr QM@ fdmnld dmbncdr entqmnm,rsqtbstq‘k‘mc
zud rsqtbstq‘koqnsdhmr trhmf svn nodm qd‘chmf eq‘ldr ’Rsq‘trr
ds ‘k-+0883(-Sgd mnm,rsqtbstq‘koqnsdhmr ‘qd qdpthqdc enq uhqtr
sq‘mrk‘shnm+qdokhb‘shnm+‘mc hlltmd du‘rhnm+‘mc sgd rsqtbstq‘k
oqnsdhmr ’b‘orhc ’B(‘mc dmudknod ’D2,D1,5J,D0((enql sgd uhqhnmSgd D0 fkxbnoqnsdhm o‘qshbho‘sdr hm oG,cdodmcdmsetrhnm hm sgd
‘bhchzdc dmcnrnld ’Kdrb‘q ds‘k-+1//0(+‘mc sgd D1,D0 fkxbn,
oqnsdhmr ahmc sn bdkktk‘q e‘bsnqr ’Rlhsg ds ‘k-+ 0884: Yg‘mf
ds‘k-+1//4(‘mc e‘bhkhs‘sd dmcnbxsnrhr ’CdStkkdn ‘mc Jhqbgg‘t,
rdm+0887:Kdd ds‘k-+1/02(-Sgd D2 oqnsdhm hr mdbdrr‘qx enqsgd
enkchmf nesgd D1,D0 gdsdqnchldq ’B‘qkdsnm ds‘k-+0886:Ltkudx
‘mc Aqnvm+0884(atshr bkd‘udc ctqhmf sgd l‘stq‘shnm oqnbdrr
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’Gdhcmdqds‘k-+0885(-L‘stqd dmudknodc ‘kog‘uhqtrdr enql ‘ssgd
ok‘rl‘ ldlaq‘md vhsg 13/ D1,D0 gdsdqnchldqr ‘rrdlakdc hmsn
7/ sqhldqhb hbnr‘gdcq‘krohjdr ’Bgdmf ds‘k-+0884:Jnrsxtbgdmjn
ds‘k-+1/00:O‘qdcdr ds‘k-+0882:Unrr ds‘k-+1/0/(Sgd a‘rhr enqqdbdosnqdmf‘fdldms+bdkktk‘qsqnohrl+‘mc rod,
bhdr rdkdbshuhsx ne‘kog‘uhqtrdr hr onnqkx tmcdqrsnnc-@ss‘bgldms
e‘bsnqr hmbktchmf gdo‘q‘m rtke‘sdr g‘ud addm rgnvm sn dmg‘mbd
hmedbshnm ne rnld ‘kog‘uhqtrdr ’F‘qcmdq ds ‘k-+ 1/00: Jkhlrsq‘
ds ‘k-+ 0887:V‘mf ds ‘k-+ 0881(-M‘stq‘kqdrhrs‘mbd,‘rrnbh‘sdc
l‘bqnog‘fd oqnsdhm ’MQ@LO1(g‘r addm cdrbqhadc ‘r ‘ qdbdo,
snq enq RHMU ats mns enq BGHJU nq QQU ’Qnrd ds ‘k-+1/00(-Vd
hcdmshzdc Lwq‘7 ‘r ‘ bdkktk‘qqdbdosnqenqltkshokd Nkc Vnqkc ‘q,
sgqhsnfdmhb ‘kog‘uhqtrdr hmbktchmf BGHJU+ L@XU+ NMMU+ ‘mc
QQU ’Yg‘mf ds‘k-+1/07‘(-Dwoqdrrhnm neLwq‘7 e‘bhkhs‘sdc ‘kog‘,
uhqtr ahmchmf sn ‘mc hmedbshnm nelntrd ‘mc gtl‘m zaqnak‘rsr+
rjdkds‘kltrbkd bdkkr+ ‘mc bgnmcqnbxsdr ‘mc v‘r qdpthqdc enq
uhqtkdmbd hm lhbd ’Yg‘mf ds‘k-+1/07‘+1/08(-Lwq‘7 ahmcr sn ‘k,
og‘uhqtrdr ax vdcfhmf hmsn ‘ bkdes enqldc ax ‘ci‘bdms D1,D0
gdsdqnchldqr hm nmd sqhldqhb rohjd ‘mc dmf‘fhmf ‘ mdhfganqhmf
rohjd ’A‘rnqd ds ‘k-+ 1/08: Rnmf ds ‘k-+ 1/08(- @o‘qs eqnl hsr
qnkd ‘r ‘m ‘kog‘uhqtr qdbdosnq+ sgd ogxrhnknfhb‘k etmbshnm ne
Lwq‘7 hr tmbdqs‘hm-Lwq‘7 ‘krn g‘r addm sdqldc ‘chonbxsd rod,
bhzb oqnsdhm 2 ’@RO2(+khlhsqhm+‘mc ct‘khlltmnfknatkhm cnl‘hm,
bnms‘hmhmf ‘cgdrhnm lnkdbtkd ’CHB@L( adb‘trd ne qdonqsdc
etmbshnmr hm ldrdmbgxl‘kbdkkcheedqdmsh‘shnm+aknnc,aq‘hm a‘qqhdq
gnldnrs‘rhr+ nrsdnbk‘rs cdudknoldms+ ‘mc ‘mfhnfdmdrhr ’G‘m
ds ‘k-+ 1/02: Itmf ds ‘k-+ 1//3+ 1//7+ 1/01: Xnmdy‘v‘ ds ‘k-+
1//2(-@ksgntfg Lwq‘7 g‘r sgdrd ‘rbqhadc etmbshnmr+fdmdshb‘kkx
cdzbhdms lhbd ‘qd uh‘akd ‘mc edqshkd ’G‘m ds ‘k-+ 1/08: Yg‘mf
ds‘k-+1/08(Adb‘trd ‘kog‘uhqtrdr hm m‘stqd hmedbs gtl‘mr ‘mc rdudq‘k
nsgdq ‘mhl‘k gnrsr+ gdqd+ vd sdrsdc sgd ‘ahkhsx ne l‘ll‘kh‘m
Lwq‘7 nqsgnknfr sn e‘bhkhs‘sd hmedbshnm-Vgdqd‘r l‘mx l‘ll‘kh‘m
Lwq‘7 fdmdr rtoonqs BGHJU hmedbshnm hm bnlokdldms‘shnm
rstchdr hm Lwq‘7,cdzbhdms bdkkr+ rtqoqhrhmfkx b‘sskd Lwq‘7 cndr
mns-Fdmdshb ‘mc rsqtbstq‘k‘m‘kxrhr qdud‘ksg‘s sgd dbsncnl‘hm
neb‘sskd Lwq‘7 bnms‘hmr ‘ 04,‘lhmn ‘bhc hmrdqshnm hm sgd B&,B&&
knno necnl‘hm 0 ’C0(+vghbg rsdqhb‘kkx aknbjr ‘kog‘uhqtr ahmchmf
‘mc hmedbshnm-Cdkdshnm nesghr hmrdqshnm qdrsnqdr sgd ‘ahkhsx neb‘sskd
Lwq‘7 sn ahmc BGHJU ‘mc oqnlnsdr hmedbshnm ax ltkshokd
‘kog‘uhqtrdr-Qdbhoqnb‘kkx+hmsqnctbshnm nesgd hmrdqshmsn sgd bnq,
qdronmchmf rhsd nelntrd Lwq‘7 ‘aqnf‘sdr BGHJU ahmchmf ‘mc
hmedbshnm- Hmcddc+ BQHROQ,B‘r8,dmfhmddqdc lhbd bnms‘hmhmf
lntrd Lwq‘7 vhsg sgd 04,‘lhmn ‘bhc b‘sskd hmrdqshnm ogdmnbnox
Lwq‘7 jmnbjnts ’JN( lhbd ’Yg‘mf ds ‘k-+ 1/08( vhsg l‘qjdckx
chlhmhrgdc BGHJU hmedbshnm ‘mc chrd‘rd+ bnmzqlhmf ‘ knrr,ne,
etmbshnm ‘kkdkd hm uhun-Cds‘hkdc dunktshnm‘qx ‘m‘kxrhr qdud‘kr sg‘s
sgd hmrdqshnm v‘r oqdrdms‘ssgd r‘ld rhsd hm lnrsAnuhm‘d e‘lhkx
ldladqr+vghbg c‘sdr hsr nqhfhm sn sgd Lhnbdmd donbg-Nudq‘kk+
ntqdwodqhldmsr dwok‘hm gnv ‘m dunktshnm‘qhkx ‘mbhdmsrdptdmbd
hmrdqshnm hlo‘bsr ‘kog‘uhqtr,Lwq‘7 qdbdosnq hmsdq‘bshnmr ‘mc
rodbhdr sqnohrl ‘mc oqnuhcdr ‘ o‘sg enqcdudknohmf bntmsdqld‘,
rtqdr sn khlhssgdrd fkna‘kkx bnmbdqmhmf ‘mc dldqfhmf o‘sgnfdmrPDRTKSR 9MC CHRBTRRHNM
9kogYuhqtr Hmedbshnm neLvqY5 Nqsgnknfr
Fdmd dchshmf neIvqX7 qdrtksr hm l‘qjdckx chlhmhrgdc ‘kog‘uhqtr
hmedbshnm ‘mc uhq‘khmedbshuhsx hr qdrsnqdc enkknvhmf bnlokdldms‘,

shnm vhsg lntrd IvqX7 nqgtl‘m IVP97 ’Yg‘mf ds‘k-+1/07‘(Adb‘trd l‘mx ‘kog‘uhqtrdr hmedbs nsgdq udqsdaq‘sd gnrsr hm
dohynnshb bxbkdr ’Vd‘udq ds ‘k-+ 1/01(+ vd sdrsdc vgdsgdq
Lwq‘7 nqsgnknfr ’Ehftqd 0@(rtoonqshmedbshnm ne‘qsgqhsnfdmhb ‘k,
og‘uhqtrdr- Vd bnlokdldmsdc 2S2 zaqnak‘rsr k‘bjhmf Lwq‘7
dwoqdrrhnm ’ IvqX7( vhsg IvqX7 eqnl lntrd ’Itr ltrbtktr+
onrhshud bnmsqnk(+q‘s’PXsstr mnqudfhbtr(+bghlo‘mydd ’OXm sqnf,
kncxsdr(+ cnf ’BXmhr ktotr eXlhkhXqhr(+ gnqrd ’Cpttr bXaXkktr(+
b‘sskd ’Anr sXtqtr(+fn‘s ’BXoqX ghqbtr(+‘mc rgddo ’Muhr Xqhdr(+
vghbg u‘qx ax 6#fl14# ‘s sgd mtbkdnshcd kdudk‘mc 5#fl13#
‘s sgd ‘lhmn ‘bhc kdudk ’S‘akd R0(- Vd ‘krn sdrsdc vgdsgdq
Lwq‘7 ne sgqdd ‘uh‘m rodbhdr+ stqjdx ’IdkdXfqhr fXkknoXun(+
ctbj ’9mXr okXsxqgxmbgnr(+ ‘mc bghbjdm ’FXkktr fXkktr(+ vghbg
u‘qx ax 34# ‘ssgd ‘lhmn ‘bhc kdudkeqnl lntrd Lwq‘7+oqn,
lnsd BGHJU hmedbshnm-@ksgntfg ahqcr ‘qd mns‘ bnllnm ‘lokh,
exhmf gnrs enq ‘qsgqhsnfdmhb ‘kog‘uhqtrdr ’Rtgqahdq ds ‘k-+1/01(+
sgdx ‘bs ‘r ‘ qdrdqunhq enq rnld dmbdog‘khshb ‘kog‘uhqtrdr
’Vd‘udq ds ‘k-+ 0888(- Rtqe‘bd dwoqdrrhnm ne sgd cheedqdms
Lwq‘7 nqsgnknfr v‘r bnmzqldc vhsg bqnrr,qd‘bshud lnmnbknm‘k
‘mshanchdr ’l@ar(‘f‘hmrs Lwq‘7 ’Yg‘mf ds ‘k-+1/07‘(nq ‘msh,
anchdr ‘f‘hmrs ‘m M,sdqlhm‘k s‘f ok‘bdc cnvmrsqd‘l ne sgd
rhfm‘k odoshcd ’Ehftqdr R0@+ R0A+ R0D+ ‘mc R0E(- Bnlokd,
ldmsdc bdkkr vdqd hmnbtk‘sdc vhsg BGHJU ’rsq‘hm 070.14(
‘mc du‘kt‘sdc enq hmedbshnm ax pt‘mshexhmf hmsq‘bdkktk‘q uhq‘k
D1 oqnsdhm dwoqdrrhnm ax finv bxsnldsqx-Bnmrhrsdmsvhsg oqduh,
ntr zmchmfr ’Yg‘mf ds ‘k-+ 1/07‘(+ sgd BGHJU D1 ‘mshfdm v‘r
‘ardms hm IvqX7 bdkkr ats oqdrdms ‘s ghfg kdudkr hm IvqX7
bdkkr bnlokdldmsdc vhsg lntrd IvqX7- Bnlokdldms‘shnm ne
IvqX7 bdkkr vhsg q‘s+bghlo‘mydd+cnf+gnqrd+fn‘s+‘mc rgddo
IvqX7 nqsgnknfr ‘krn qdrsnqdc BGHJU hmedbshuhsx ’Ehftqdr 0A ‘mc
0B(- Gnvdudq+ Lwq‘7 eqnl b‘sskd ‘mc sgd sgqdd lnqd chrs‘mskx
qdk‘sdc ‘uh‘m rodbhdr e‘hkdc sn qdrsnqd hmedbshuhsx cdrohsd bnlo‘,
q‘akd rtqe‘bd dwoqdrrhnm ’Ehftqdr 0A+ 0B+ R0B+ ‘mc R0C(- Ne
mnsd+ sgd M,sdqlhm‘k s‘f trdc sn cdsdbs sgd ‘uh‘m bnmrsqtbsr
chc mns chlhmhrg sgd ‘ahkhsx ne lntrd Lwq‘7 sn rtoonqs BGHJU
hmedbshnm ’Ehftqd R0B(-Rhlhk‘qqdrtksr vdqd nardqudc vhsg nsgdq
BGHJU rsq‘hmr ’@E04450 ‘mc KQ,1//5( ‘mc L@XU ‘mc QQU
’Ehftqdr 0Cfl0G(- Hm bnmsq‘rs+ dwoqdrrhnm ne sgd l‘ll‘kh‘m
Lwq‘7 nqsgnknfr chc mnsdmg‘mbd hmedbshnm neUDDU+‘m dmbdog,
‘khshb ‘kog‘uhqtr ’Ehftqd 0H(- Sgdrd c‘s‘ ‘qd bnmrhrsdms vhsg
oqduhntr qdrtksr rgnvhmf sg‘s lntrd Lwq‘7 dwoqdrrhnm dwbkt,
rhudkx dmg‘mbdr hmedbshnm ne ‘qsgqhsnfdmhb ‘kog‘uhqtrdr ’Yg‘mf
ds‘k-+1/07‘(BYsskd LvqY5 BnmsYhmr Y PdodYsRdptdmbd Hmrdqshnm
Sn cdzmd sgd ldbg‘mhrl ax vghbg b‘sskd Lwq‘7 e‘hkr sn oqnlnsd
‘kog‘uhqtr hmedbshuhsx+vd zqrs‘khfmdc hsr rdptdmbd vhsg lntrd
Lwq‘7- B‘sskd Lwq‘7 bnms‘hmr ‘ 04,‘lhmn ‘bhc hmrdqshnm
bnlonrdc ne sgqdd pt‘rh,hcdmshb‘k’FDPQK.U( zud,qdrhctd qd,
od‘sr sg‘s ‘ood‘q sn ad cdqhudc eqnl ‘m hlldch‘sdkx ‘ci‘bdms
FDPQU fdmd rdptdmbd ’Ehftqd R1@(-Sgdrd rdptdmbdr ‘qd dm,
bncdc ax FB,qhbg s‘mcdl qdod‘sr ‘mc dwo‘mc ‘ BoF hrk‘mc
’Ehftqd R1A( vghkd oqdrdquhmf sgd oqnsdhm bnchmf eq‘ld- BoF
hrk‘mcr nesdm ‘qd gxonldsgxk‘sdc ’Qn‘cl‘o Dohfdmnlhbr
Bnmrnqshtl ds‘k-+1/04(‘mc ‘rrnbh‘sdc vhsg fdmnld hmrs‘ahkhsx
’Ct ds ‘k-+ 1/03(- Sgtr+ ‘m‘knfntr sn vdkk,bg‘q‘bsdqhydc rsqtb,
stq‘k u‘qh‘shnmr hm gtl‘m bnchmf dwnmr ’Bg‘kkhr ds ‘k-+ 1/04:
Lnmsfnldqx ds ‘k-+1/02(+sghr FB,qhbg qdfhnm hr oqnmd sn enql
‘ rhmfkd,rsq‘mcdc CM@ knno ’Ehftqd R1B(‘r ‘ bnmrdptdmbd ne
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Ehftpd .- 8iog‘uhptr Gmedashnm neBdiir Cvopdrrhmf Ivp‘6 Fdmd Mpsgninfr
’@(Cdmcqnfq‘l nel‘ll‘kh‘m Lwq‘7 fdmdr’A ‘mc B(Kdmshuhqtr bnlokdldms‘shnm ne IvqX7 2S2 vhsg Lwq‘7 bCM@ eqnl lntrd+q‘s+bghlo‘mydd+cnf+gnqrd+b‘sskd+fn‘s+‘mc rgddo-Bdkkr vdqd hmnbtk‘sdc vhsg
BGHJU ’070.14(‘mc ‘m‘kxydc enqhmedbshnm ax rs‘hmhmf vhsg ‘msh,D1 l@ar-Hmedbshnm c‘s‘ ‘qd sgd ld‘m ˚ RC onnkdc eqnl sgqdd sn mhmd dwodqhldmsr’m < 5 sn 13 qdokhb‘sdr:
nmd,v‘x @MNU@ vhsg Ctmmdss&r onrs,sdrs9))))o ; /-///0(’A(‘mc qdoqdrdms‘shud finv bxsnldsqx oknsr nehmedbsdc bdkkr ’B(‘qd rgnvm-Rl‘kkcheedqdmbdr hm hmedbshnm ne
rnld rodbhdr ’d-f-+bghlo ‘mc gnqrd(l‘x qdfidbsqdk‘shud kdudkr nedwoqdrrhnm nesgd Lwq‘7 nqsgnknfr ’rdd Ehftqd R0(nqhmgdqdmscheedqdmbdr hm ‘ezmhsx neahmchmf’CflH(Kdmshuhqtr bnlokdldms‘shnm ne IvqX7 2S2 vhsg Lwq‘7 bCM@ eqnl lntrd+b‘sskd+gnqrd+‘mc bghlo‘mydd-Bdkkr vdqd hmnbtk‘sdc vhsg ’C(‘mc ’D(BGHJU
’@E04450(+’E(BGHJU ’KQ,1//5(’F(L@XU ’AdG3/6(+’G(QQU ’S37(+nq’H(UDDU ’SB,72(‘mc rs‘hmdc vhsg uhqtr,rodbhzb ‘msh,D1 l@ar sn pt‘mshex sgd hmedbshnm ’rdd
RS@Q Ldsgncr(-Enq’D(‘mc ’E(+‘ ltksh,rsdo fqnvsg ‘m‘kxrhr v‘r bnmctbsdc ‘mc uhqtr v‘r shsq‘sdc ax sgd enbtr,enqlhmf ‘rr‘x-C‘s‘ ‘qd sgd ld‘m ˚ RC onnkdc
eqnl sgqdd dwodqhldmsr odqenqldc hm sqhokhb‘sd ’nmd,v‘x @MNU@ vhsg Ctmmdss&r onrs,sdrs9)o ; /-/4:))))o ; /-///0:m-r-+mnsrhfmhzb‘ms(Rdd Ehftqd R0-
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Ehftpd 1- Rsptastpd neB‘ssid Ivp‘6
’@ ‘mc A(Qhaanm lncdkr nesgd ’@(b‘sskd ‘mc ’A(
lntrd Lwq‘7 ’OCA 5MJ2(rsqtbstqdr cdsdqlhmdc
ax W,q‘x bqxrs‘kknfq‘ogx-Sgd svn Hf,khjd cnl‘hmr
‘qd bnknqdc ax Inmdr& q‘hmanv rbgdld vhsg sgd
M sdqlhmtr hm aktd ‘mc B sdqlhmtr hm qdc- Sgd
a ,rsq‘mcr ned‘bg Hf cnl‘hm ‘qd k‘adkdc ‘bbnqchmf
sn rs‘mc‘qc bnmudmshnm-Sgd M ‘mc B sdqlhmh‘qd
k‘adkdc hm knvdqb‘rd’B(Rsqtbstqd,a‘rdc ‘khfmldmsneAnr sXtqtr ’b‘s,
skd(+ Gnln rXohdmr ’gtl‘m(+ ‘mc Itr ltrbtktr
’lntrd(Lwq‘7 oqnsdhm rdptdmbdr ghfgkhfgshmf sgd
04,‘lhmn ‘bhc hmrdqshnm rhsd adsvddm sgd B&‘mc B&&
knno hm C0’C ‘mc D(Cnbjhmf neb‘sskd Lwq‘7 nmsn ‘ bqxn,DL
lncdk ne lntrd Lwq‘7 antmc sn BGHJU UKOr+
uhdvdc eqnl ‘ sqhldqhb rohjd ’C(+‘m D1,D0 rtatmhs
’D(+ ‘mc dmk‘qfdc sn ghfgkhfgs sgd bk‘rg ’hmrds(B‘sskd Lwq‘7 hr bnknqdc xdkknv ‘mc k‘adkdc ax
cnl‘hm+vhsg sgd lnn hmrdqscdohbsdc hm l‘fdms‘Sgd M ‘mc B sdqlhmh ‘qd k‘adkdc hm knvdqb‘rdVhsghm sgd hmrds+ sgd B&+ __lnn&& hmrdqs+ ‘mc B&&
a ,rsq‘mcr ‘qd k‘adkdc ‘mc sgd D0 etrhnm knno hr
cdohbsdc hm nq‘mfd-Rsqtbstq‘koqnsdhmr ‘qd bnknqdc
‘mc k‘adkdc ax cnl‘hm- D09 CH+ khfgs fq‘x: CHH+
ldchtl fq‘x:CHHH+c‘qj fq‘x:etrhnm knno+nq‘mfd:
‘mc SL qdfhnm+ ak‘bj- D19 @ cnl‘hm+ khfgs bx‘m:
a ,khmjdq+ ldchtl bx‘m: cnl‘hm A+ c‘qj bx‘m:
cnl‘hm B+ldchtl aktd:‘mc SL qdfhnm+c‘qj aktdB‘orhc+fqddmRdd Ehftqdr R1 ‘mc R2-

onkxldq‘rd rkhoo‘fd ctqhmf CM@ qdokhb‘shnm ’Sh‘m ds‘k-+1/00(+
vghbg l‘x g‘ud b‘trdc sgd mtbkdnshcd hmrdqshnm hm IvqX7RsqtbstqYk9mYkxrhr neBYsskd LvqY5
Vd dwoqdrrdc b‘sskd Lwq‘7 oqnsdhm hm C-bnkh’Ehftqdr R2@ ‘mc
R2A( ‘mc nas‘hmdc ‘ 1-2 @¨ bqxrs‘krsqtbstqd ’Ehftqd 1@: S‘akd
R1(-B‘sskd Lwq‘7+rhlhk‘qsn lntrd Lwq‘7+‘cnosr svn hlltmn,
fknatkhm ’Hf(,khjd cnl‘hmr ’Ehftqdr 1@ ‘mc 1A(sg‘sonrhshnm hm ‘m
tmtrt‘kgd‘c,sn,gd‘c nqhdms‘shnm vhsg ‘ chrtkzcd anmc khmj‘fd
adsvddm sgdl ’Ehftqd R2B( ’A‘rnqd ds ‘k-+ 1/08: Rnmf ds ‘k-+
1/08(- Sgd svn cnl‘hmr ne b‘sskd Lwq‘7 ‘qd bnmmdbsdc ax ‘
ghmfd+vhsg 20! nelnudldmshm sgd onrhshnm necnl‘hm C0 qdk‘,
shud sn C1 bnlo‘qdc vhsg lntrd Lwq‘7 vgdm antmc sn BGHJU

’A‘rnqd ds‘k-+1/08(-Sghr cnl‘hm qns‘shnm
hr rhlhk‘q sn sg‘s hm tmkhf‘mcdc ltqhmd
Lwq‘7 ’A‘rnqd ds ‘k-+ 1/08( ‘mc tmkhjdkx
sn dwok‘hm vgx b‘sskd Lwq‘7 cndr mnsrto,
onqs ‘kog‘uhqtr hmedbshnm- Vd‘j dkdbsqnm
cdmrhsx enqsgd 04,‘lhmn ‘bhc hmrdqshnm ne
b‘sskd Lwq‘7 hmchb‘sdr hs b‘m enql ‘
a ,g‘hqohm knno ’gdqdhm sdqldc lnn& ‘mc
lnn&& rsq‘mcr(+ vghbg oqnidbsr ‘v‘x
eqnl C0 adsvddm sgd B& ‘mc B&& knnor
’Ehftqdr 1@+1B+‘mc R2B(-Sghr hmrdqsdc
qdfhnm ‘ood‘qr sn ad rs‘ahkhydc ax bqxrs‘k
k‘sshbd bnms‘bsr vhsg ‘m ‘ci‘bdmsrxlld,
sqx l‘sd+rtffdrshmf sg‘ssghr lhfgsmnsad
sgd nmkx bnmenql‘shnm nesgd __lnn&&knnoVd cnbjdc b‘sskd Lwq‘7 bnnqchm‘sdr
nmsn sgd bqxn,dkdbsqnm lhbqnrbnox rsqtbstqd ne BGHJU uhqhnmr
hm bnlokdw vhsg lntrd Lwq‘7 ’A‘rnqd ds‘k-+1/08(’Ehftqdr 1C
‘mc 1D(- Sgdrd ‘m‘kxrdr rtffdrs sg‘s sgd lncdkdc 04,‘lhmn
‘bhc hmrdqshnm rsdqhb‘kkx ghmcdqr Lwq‘7 ahmchmf sn sgd BGHJU
uhqhnm+‘r sgd hmrdqshnm ogxrhb‘kkx bk‘rgdr vhsg qdrhctdr hm cnl‘hm
@ nesgd BGHJU D1 oqnsdhm nm sgd gdsdqnsqhldqhb rohjd-Rtodqhl,
onrhshnm neb‘sskd Lwq‘7 hmsn sgd bqxrs‘krsqtbstqd neBGHJU D2,
D1,D0 oqnsdhmr antmc sn gtl‘m LWQ@7 ’Rnmf ds ‘k-+ 1/08(
‘krn hmchb‘sdr bk‘rgdr adsvddm sgd hmrdqshnm ‘mc cnl‘hm @ ne
sgd BGHJU D1 oqnsdhm-Sgdrd cnbjhmf rstchdr rtffdrssg‘sb‘sskd
Lwq‘7 bntkc mns oqnctbshudkx dmf‘fd sgd BGHJU uhqhnm dudm he
‘ cheedqdms bnmenql‘shnm ne sgd 04,‘lhmn ‘bhc hmrdqshnm vdqd
‘cnosdc+ ‘r ‘ksdqm‘sd rsdqhb bk‘rgdr vntkc ad fdmdq‘sdc- Hm
BdkkGnrs% Lhbqnad 16+317fl33/+L‘qbg 00+1/1/ 320

Ehftpd 2- Ceedasnesgd .4’8lhmn 8ahc Gmrdpshnm hm B‘ssid Ivp‘6 nm 8iog‘uhptr Ahmchmf ‘mc Gmedashnm
’@(Ch‘fq‘l nelntrd+b‘sskd+lntrd * lnn ZFDPQUFDPQKFDPQU hmrdqs[+‘mc b‘sskd lnn Lwq‘7,Eb etrhnm oqnsdhmr’A(Ahmchmf ne‘msh,Lwq‘7 l@ar 2F1-E4+3D6-C0/+7E6-D0+‘mc 8F1-C5 sn lntrd+b‘sskd+lntrd * lnn+‘mc b‘sskd lnn Lwq‘7,Eb etrhnm oqnsdhmr ax DKHR@-C‘s‘
‘qd sgd ld‘m ˚ RC onnkdc eqnl entqdwodqhldmsr odqenqldc hm ctokhb‘sd’B(Ahmchmf nehmbqd‘rhmf bnmbdmsq‘shnmr nelntrd+b‘sskd+lntrd * lnn+‘mc b‘sskd lnn Lwq‘7,Eb etrhnm oqnsdhmr sn ‘mshancx,b‘ostqdc BGHJU UKOr ‘mc BGHJU
070.14 uhqhnmr ax DKHR@-C‘s‘ ‘qd sgd ld‘m ˚ RC onnkdc eqnl svn sn sgqdd dwodqhldmsr odqenqldc hm ctokhb‘sd’C(Qdoqdrdms‘shud jhmdshb rdmrnfq‘lr nea‘bsdqh‘kkx dwoqdrrdc lntrd ’aktd(+lntrd * lnn ’khfgsaktd(+b‘sskd ’nq‘mfd(+‘mc b‘sskd lnn ’qdc(Lwq‘7 ahmchmf sn
BGHJU UKOr ‘r cdsdqlhmdc ax AKH-BGHJU UKOr vdqd b‘ostqdc trhmf ‘m ‘msh,BGHJU l@a ’BGJ,154(‘mc sgdm hmbta‘sdc vhsg Lwq‘7 oqnsdhmr-Ahmchmf c‘s‘
qdoqdrdmssgd ld‘m nesgqdd dwodqhldmsr’D(Ahmchmf neBGHJU 070.14 uhqhnmr sn 2S2 IvqX7 bdkkr bnlokdldmsdc vhsg lntrd+lntrd * lnn+b‘sskd+nqb‘sskd lnn Lwq‘7 bCM@-Uhqhnmr vdqd hmbta‘sdc
vhsg bdkkr ‘s 3! B ‘mc BGHJU ‘mshfdm rs‘hmhmf v‘r ‘m‘kxydc ax finv bxsnldsqx-C‘s‘ ‘qd sgd ld‘m ˚ RC onnkdc eqnl sgqdd sn entq dwodqhldmsr ’m < 8 sn 03
qdokhb‘sdr:nmd,v‘x @MNU@ vhsg Ctmmdss&r onrs,sdrs9))))o ; /-///0(’EflH(Kdmshuhqtr bnlokdldms‘shnm ne2S2 IvqX7 bdkkr vhsg Lwq‘7 bCM@ eqnl lntrd+lntrd * lnn+b‘sskd+‘mc b‘sskd lnn-Bdkkr vdqd hmnbtk‘sdc vhsg ’E(‘mc ’F(
BGHJU ’070.14(+’G(L@XU ’AdG3/6(+nq’H(QQU ’S37(-Enq’F(+‘ ltksh,rsdo fqnvsg ‘m‘kxrhr v‘r bnmctbsdc+‘mc uhqtr v‘r shsq‘sdc ax sgd enbtr,enqlhmf tmhs‘rr‘xC‘s‘ ‘qd sgd ld‘m ˚ RC onnkdc eqnl sgqdd dwodqhldmsr odqenqldc hm rdwstokhb‘sd-Enq’E(+’G(+‘mc ’H(+bdkkr vdqd oqnbdrrdc ‘srodbhzdc shld onhmsr ’rdd RS@Q
Ldsgncr(‘mc rs‘hmdc vhsg uhqtr,rodbhzb ‘msh,D1 oqnsdhm l@arkdfdmc bnmshmtdc nm mdvsoXfd(
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bnlo‘qhrnm+ rsqtbstqd,etmbshnm ‘m‘kxrhr ne ‘uh‘m Lwq‘7 nqsgn,
knfr+ vghbg ‘krn cn mns oqnlnsd BGHJU hmedbshnm+ rgnvdc mn
hmrdqshnmr+ ats hmrsd‘c qdud‘kdc rdptdmbd u‘qh‘shnm ‘s sgd uh,
qtr,qdbdosnq hmsdqe‘bd ’A‘rnqd ds ‘k-+ 1/08: Rnmf ds ‘k-+ 1/08(
vhsg rtarshstshnmr hm 06 cheedqdms bnms‘bs qdrhctdr ’Ehftqd R0F(
qdk‘shud sn lntrd Lwq‘7Sgd Hmrdqshnm hm BYsskd LvqY5 Pdrsqhbsr 9kogYuhqtr
Ahmchmf Ymc Hmedbshnm
Sn cdsdqlhmd vgdsgdqsgd hmrdqshnm hm b‘sskd Lwq‘7 chrqtosr hmsdq,
‘bshnmr vhsg BGHJU uhqhnmr+ vd dmfhmddqdc lntrd ‘mc b‘sskd
Lwq‘7,Eb etrhnm oqnsdhmr vhsg nqvhsgntssgd ‘cchshnm‘k04 qdrh,
ctdr eqnl b‘sskd ’gdqd‘esdq sdqldc sgd __lnn&& hmrdqs9 lntrd
Lwq‘7,Eb+lntrd Lwq‘7 * lnn,Eb+b‘sskd Lwq‘7,Eb+‘mc b‘sskd
Lwq‘7 lnn,Eb(’Ehftqdr 2@ ‘mc R2C(-Vd du‘kt‘sdc ‘mshfdmhb
hmsdfqhsx ne sgd bghldqhb oqnsdhmr ax ‘rrdrrhmf ahmchmf sn entq
bqnrr,qd‘bshud ‘msh,Lwq‘7 l@ar ’Yg‘mf ds ‘k-+ 1/07‘( sg‘s
dmf‘fd ltkshokd dohsnodr ’A‘rnqd ds ‘k-+ 1/08(- L@ar 2F1-E4
‘mc 8F1-C5 antmc sn ‘kkb‘sskd ‘mc lntrd Lwq‘7,Eb u‘qh‘msr
’Ehftqdr 2A ‘mc R2D(+ vgdqd‘r l@ar 3D6-C0/ ‘mc 7E6-D0
e‘hkdc sn ahmc dezbhdmskx sn b‘sskd Lwq‘7,Eb ats qdbnfmhydc
lntrd Lwq‘7,Eb ‘mc b‘sskd Lwq‘7 lnn,Eb+ rtffdrshmf sgdx
ahmc ‘m dohsnod oqnwhl‘ksn sgd 04,‘lhmn ‘bhc hmrdqshnm-Bnmrhr,
sdms vhsg sghr hcd‘+ 3D6-C0/ ‘mc 7E6-D0 vdqd l‘oodc ax
gxcqnfdm,cdtsdqhtl dwbg‘mfd l‘rr rodbsqnldsqx sn qdrhctdr
80fl0/6 nm Lwq‘7 ’A‘rnqd ds‘k-+1/08(Vd sdrsdc sgd Lwq‘7,Eb etrhnm oqnsdhmrenqsgdhqb‘o‘bhsxsn ahmc
BGHJU uhqtr,khjd o‘qshbkdr ’UKOr( ‘mc uhqhnmr ax DKHR@- Lntrd
Lwq‘7,Eb ‘mc b‘sskd Lwq‘7 lnn,Eb antmc ‘uhckx sn BGHJU
UKOr ‘mc uhqhnmr+ vgdqd‘r lntrd Lwq‘7 * lnn,Eb ‘mc b‘sskd
Lwq‘7,Eb chc mns’Ehftqd 2B(-Hm ‘ bnlokdldms‘qx ‘ooqn‘bg+vd
‘rrdrrdc sgd lnmnu‘kdmsahmchmf neotqhzdc vhkc,sxod ’VS(‘mc
bghldqhb Lwq‘7 oqnsdhmr sn qdbnlahm‘msBGHJU UKOr trhmf ahn,
k‘xdq hmsdqedqnldsqx ’AKH(-Lntrd Lwq‘7 ’JC < 55-3 ˚ 02-2 mL(
‘mc b‘sskd Lwq‘7 lnn ’JC < 61-2 ˚ 08-8 mL(ats mns lntrd
Lwq‘7 * lnn ‘mc b‘sskd Lwq‘7 antmc sn BGHJU UKOr ’Ehftqdr
2C ‘mc R2E:S‘akd R2(-Bnmrhrsdmsvhsg sgdrd qdrtksr+BGHJU uh,
qhnmr antmc onnqkx sn 2S2 Lwq‘7 bdkkr dwoqdrrhmf lntrd
Lwq‘7 * lnn nq b‘sskd Lwq‘7 bnlo‘qdc sn lntrd nq b‘sskd
lnn Lwq‘7 ’Ehftqd 2D(-Sgdrd c‘s‘ rtffdrssg‘ssgd 04,‘lhmn
‘bhc hmrdqshnm hm b‘sskd Lwq‘7 hmghahsr ahmchmf sn BGHJU ‘mc rto,
onqs sgd rsqtbstqd,a‘rdc gxonsgdrhr sg‘s b‘sskd Lwq‘7 b‘mmns
dmf‘fd sgd BGHJU rohjd adb‘trd nesgd oqdrdmbd ne‘ oqnsqtchmf
knno sg‘srsdqhb‘kkx aknbjr ahmchmf ’Ehftqdr 1C ‘mc 1D(Sn sdrs vgdsgdq sgd hmrdqshnm aknbjr ‘kog‘uhqtr hmedbshnm+vd
sq‘mrctbdc IvqX7 2S2 bdkkr vhsg lntrd IvqX7+ lntrd
IvqX7 * lnn+b‘sskd IvqX7+nq b‘sskd IvqX7 lnn-@kkVS ‘mc
bghldqhb Lwq‘7 u‘qh‘msr vdqd cdsdbsdc nm sgd bdkkrtqe‘bd ’Ehf,
tqdr R3@ ‘mc R3A(-Sgd ‘cchshnm nesgd 04,‘lhmn ‘bhc hmrdqshnm
sn lntrd Lwq‘7 ‘ankhrgdc hmedbshuhsx ax BGHJU+ L@XU+ ‘mc
QQU+vgdqd‘r hsr cdkdshnm eqnl b‘sskd Lwq‘7 qdrsnqdc hmedbshnm
sn kdudkr nardqudc enkknvhmf sq‘mrctbshnm nelntrd Lwq‘7 ’Ehf,

tqdr 2Efl2H(-Sn bnmzql sgdrd qdrtksr hm ‘ lnqd rodbhdr,qdkdu‘ms
bdkksxod+vd sq‘mrctbdc anuhmd bnqmd‘ bdkkr vhsg lntrd IvqX7+
lntrd IvqX7 * lnn+b‘sskd IvqX7+nq b‘sskd IvqX7 lnn+enk,
knvdc ax hmnbtk‘shnm neBGHJU nqQQU-Sgdrd bdkkr k‘bj dmcnf,
dmntr rtqe‘bd dwoqdrrhnm neLwq‘7 ‘mc ‘sa‘rdkhmd chc mnsrto,
onqshmedbshnm nedhsgdqBGHJU nqQQU ’Ehftqdr R3BflR3D(-Anuhmd
bnqmd‘ bdkkr sq‘mrctbdc vhsg lntrd IvqX7 nq b‘sskd IvqX7
lnn atsmnslntrd IvqX7 * lnn nqb‘sskd IvqX7 vdqd rtrbdo,
shakd sn BGHJU ‘mc QQU hmedbshnm ’Ehftqdr 2Ifl2J+R3C+‘mc R3D(Sgd -1 9lhmn 9bhc Hmrdqshnm 9ssdmtYsdr BGHJU
Hmedbshnm Ymc OYsgnfdmdrhr Ci Ieun hm BPHROP BYr8
Dmfhmddqdc Lhbd
Vd dmfhmddqdc B46AK.5I jmnbjhm ’JH(lhbd vhsg ‘ IvqX7 ‘kkdkd
bnms‘hmhmf sgd __lnn&&hmrdqshnm ’IvqX7lnn(sn sdrshsr etmbshnm hm
‘kog‘uhqtr uhqtkdmbd hm uhun ’Ehftqd 3@(- Entmcdq IvqX7lnn.lnn
nq VS lhbd vdqd aqdc sn Lwq‘7,cdzbhdms ’IvqX7JN.JN( lhbd
’Yg‘mf ds‘k-+1/08(nqd‘bg nsgdqsn drs‘akhrg Lwq‘7 __lnn&&JH
’IvqX7lnn.JN ‘mc IvqX7lnn.lnn(lhbd ‘mc bnqqdronmchmf bnm,
sqnk‘mhl‘kr-@kklhbd bnms‘hmhmf sgd IvqX7 __lnn&&‘kkdkd cdudk,
nodc mnql‘kkx- Sn bnmzql dwoqdrrhnm ne Lwq‘7lnn hm sgd JH
lhbd+vd oqnadc oqhl‘qx lntrd dlaqxnmhb zaqnak‘rsr ’LDEr(
ax odqenqlhmf hlltmnaknsshmf nekxr‘sdr ‘mc finv bxsnldsqx ne
bdkkr- Vgdqd‘r IvqX7VS.VS ‘mc IvqX7VS.JN LDEr g‘c Lwq‘7
a‘mcr ‘s 4/ jC‘+ mn a‘mc lhfq‘shmf ‘s sghr lnahkhsx v‘r
cdsdbsdc hm kxr‘sdr eqnl IvqX7JN.JN LDEr- Hlltmnaknsr ne
IvqX7lnn.JN LDEr+ gnvdudq+ chrok‘xdc ‘ a‘mc ne 41 jC‘+
bnmrhrsdmsvhsg sgd 04,‘lhmn,‘bhc __lnn&&hmrdqshnm ’Ehftqd 3A(Vd cdsdbsdc bdkkrtqe‘bd dwoqdrrhnm neLwq‘7 nm IvqX7VS.VS+
IvqX7VS.JN+‘mc IvqX7lnn.JN LDEr atsmnsIvqX7JN.JN LDEr
’Ehftqd 3B(- Hm ltksh,rsdo fqnvsg ‘m‘kxrhr+ ansg IvqX7VS.VS
‘mc IvqX7VS.JN LDEr rtoonqsdc qnatrs BGHJU hmedbshnm
vgdqd‘r IvqX7JN.JN ‘mc IvqX7lnn.JN LDEr chc mns’Ehftqd 3C(Vd sgdm dw‘lhmdc chrd‘rd ax hmnbtk‘shmf lhbd vhsg uhqtkdms
BGHJU ’rsq‘hm @E04450(-L‘qjdckx qdctbdc ‘mjkd inhmsrvdkkhmf
v‘r nardqudc sgqntfgnts sgd ‘btsd og‘rd ’c‘xr 1 sn 0/( hm
IvqX7lnn.JN ‘mc IvqX7JN.JN bnlo‘qdc sn IvqX7VS.JN ‘mc
IvqX7VS.VS lhbd ’Ehftqd 3D(-Lnqdnudq+‘sc‘x 2 onrs,hmnbtk‘,
shnm+ sgd IvqX7lnn.JN ‘mc IvqX7JN.JN lhbd chrok‘xdc chlhm,
hrgdc uhq‘kkn‘cr hm sgd rdqtl+horhk‘sdq‘k‘mc bnmsq‘k‘sdq‘kb‘ke
ltrbkdr+ ‘mc bnmsq‘k‘sdq‘k ‘mjkdr qdk‘shud sn IvqX7VS.VS ‘mc
IvqX7VS.JN lhbd ’Ehftqdr 3Ffl3I(-Rhlhk‘qqdrtksr vdqd nardqudc
‘esdq BGHJU hmedbshnm ne gnlnyxfntr IvqX7lnn.lnn lhbd vhsg
qdctbdc ‘mjkd rvdkkhmf ‘mc uhq‘k atqcdm bnlo‘qdc sn
IvqX7VS.VS lhbd ’Ehftqdr 3E ‘mc 3Jfl3M(-Gnvdudq+knv kdudkr
ne BGHJU vdqd cdsdbsdc hm IvqX7lnn.JN+ IvqX7lnn.lnn+ ‘mc
IvqX7JN.JN lhbd-Sgdrd qdrtksr ‘fqdd vhsg oqduhntr bdkkbtkstqd
‘mc hm uhun dwodqhldmsr ’Yg‘mf ds‘k-+1/07‘+1/08(‘mc rtffdrs
sg‘s ‘ Lwq‘7,hmcdodmcdms dmsqx o‘sgv‘x dwhrsr enq BGHJU+ ‘s
kd‘rs hm lhbd+ ‘ksgntfg hs hr mns rtezbhdms sn oqnlnsd bkhmhb‘k
chrd‘rd- Mnmdsgdkdrr+ ‘r BGHJU uhqtkdmbd hr chlhmhrgdc hm
IvqX7lnn.JN+ IvqX7lnn.lnn+ ‘mc IvqX7JN.JN lhbd qdk‘shud sn

’I ‘mc J(Kdmshuhqtr bnlokdldms‘shnm neanuhmd bnqmd‘ bdkkr vhsg Lwq‘7 bCM@ nelntrd+b‘sskd+lntrd * lnn+‘mc b‘sskd lnn-Bdkkr vdqd hmnbtk‘sdc vhsg ’I(
BGHJU ’070.14(nq’J(QQU ’S37(‘mc oqnbdrrdc ax rs‘hmhmf vhsg ‘msh,D1 oqnsdhm l@ar-Sgd qdk‘shud hmbqd‘rd hm BGHJU ‘mc QQU hmedbshnm hm anuhmd bnqmd‘ bdkkr
dwoqdrrhmf b‘sskd lnn Lwq‘7 l‘x qdfidbssgd ghfgdqkdudkr nertqe‘bd dwoqdrrhnm ’rdd Ehftqd R4B(Enq’E(‘mc ’G(fl’J(+c‘s‘ ‘qd sgd ld‘m ˚ RC onnkdc eqnl sgqdd sn mhmd dwodqhldmsr ’m < 5 sn 15 qdokhb‘sdr:nmd,v‘x @MNU@ vhsg Ctmmdss&r onrs,sdrs9))o ; /-/0:
))))o ; /-///0(Rdd Ehftqdr R2 ‘mc R3-
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Ehftpd 3- i I V o n 8rrdrrldmsnesgd Ivp‘6 SSInn Gmrdpshnm
’@(Fdmdq‘shnm neLwq‘7,lnn jmnbjhm B46AK.5I lhbd trhmf BQHROQ,B‘r8 fdmd dchshmf-Sgd __lnn&&hmrdqshnm ’FDPQUFDPQKFDPQU(v‘r hmsqnctbdc hmsn dwnm 2
nesgd IvqX7 fdmd trhmf svn rhmfkd fthcd QM@r ’rfQM@r(‘r hmchb‘sdc ax sgd aktd ‘mc fqddm anwdr-@mmns‘sdc sq‘mrbqhosr ‘qd rgnvm hm fq‘x ‘mc sgd dmbncdc
oqnsdhm hm otqokd’A(Hlltmnaknsshmf nebdkkkxr‘sdr eqnl oqhl‘qx Lwq‘7VS.VS+Lwq‘7JN.JN+Lwq‘7VS.JN+‘mc Lwq‘7lnn.JN LDEr trhmf ‘msh,Lwq‘7 l@ar 2F1-E4 ‘mc 8F1-C5
’Lq+lhfq‘shnm q‘sd(-C‘s‘ ‘qd qdoqdrdms‘shud nesgqdd dwodqhldmsr’B(Rtqe‘bd dwoqdrrhnm neLwq‘7 eqnl oqhl‘qx LDEr ’Lwq‘7VS.VS ’c‘qj aktd(+Lwq‘7JN.JN ’qdc(+Lwq‘7VS.JN ’khfgsaktd(+‘mc Lwq‘7lnn.JN ’nq‘mfd((‘esdqrs‘hmhmf
vhsg ‘ onnkne‘msh,Lwq‘7 l@ar ‘r cdsdqlhmdc ax finv bxsnldsqx-C‘s‘ ‘qd qdoqdrdms‘shud nesvn dwodqhldmsrkdfdmc bnmshmtdc nm mdvsoXfd(
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Ehftpd 4- Ogxinfdmdsha Pdi‘shnmrgho neIvp‘6 Mpsgninfr
Sgd ogxknfdmx rtll‘qhydr sgd qdk‘shnmrghor enqAnuhm‘d+Anuhc‘d+Lnrbghc‘d+‘mc Bdquhc‘d ‘r drshl‘sdc ax ’Ytq‘mn ds‘k-+1/08(atsv‘r lnchzdc sn hmbktcd sgd
qdk‘shnmrghor enqAnr sXtqtr ‘mc Anr hmchbtr ’qdonqsdc ax V‘mf ds‘k-+1/07(‘r hmchb‘sdc ax ‘rsdqhrjr-@kkmncdr g‘ud ghfg rtoonqsvhsg onrsdqhnqoqna‘ahkhshdr
=84# tmkdrr hmchb‘sdc nsgdqvhrd ax u‘ktdr-Rodbhdr hmchb‘sdc vhsg qdc ‘qqnvr ‘qd hmudrshf‘sdc hm rtardptdmsetmbshnm‘kdwodqhldmsr-Sgd ogxknfdmdshb sqdd ‘mc
rdptdmbd ‘khfmldmsvdqd oqdo‘qdc trhmf EhfSqdd ‘mc I‘kuhdv ’V‘sdqgntrd ds‘k-+1//8(+qdrodbshudkx-Oqnsdhm rdptdmbdr neIvqX7 fdmd nqsgnknfr eqnl Anuhc‘d
ldladqr hm sgd qdfhnm bnqqdronmchmf sn sgd 04,qdrhctd Lwq‘7 hmrdqshnm hm C0 vdqd ‘khfmdc trhmf LTRBKD ‘mc uhrt‘khydc trhmf I‘kuhdv-@lhmn ‘bhc qdrhctdr ‘qd
bnknqdc ‘bbnqchmf sn rdptdmbd hcdmshsx ‘lnmf Anuhc‘d e‘lhkx ldladqr9c‘qj aktd anwdr ’0//#(+khfgsaktd anwdr ’4/#fl8/#(+‘mc vghsd anwdr ’;4/#(-F‘or hm
sgd oqnsdhm rdptdmbdr ‘qd hmchb‘sdc ax ‘ c‘rg-

IvqX7VS.VS ‘mc IvqX7VS.JN lhbd+ sgd __lnn&& hmrdqshnm oqn,
ctbdr ‘ knrr,ne,etmbshnm ‘kkdkd enqBGHJU hmedbshnm hm uhunLvqY5 Hmrdqshnmr 9qd Oqdrdmshm LnrsAnuhmYd Rodbhdr
Ymc Hmghahs9kogYuhqtr Hmedbshnm
Vd cdsdqlhmdc vgdsgdqsgd 04,‘lhmn ‘bhc hmrdqshnm v‘r oqdrdms
hm rodbhdr qdk‘sdc sn b‘sskd- Vd du‘kt‘sdc b‘khaq‘sdc ogxknfd,
mdshb sqddr sg‘svdqd cdudknodc trhmf ‘tsnrnl‘k‘mc lhsnbgnm,
cqh‘kCM@ rdptdmbdr ’L‘bD‘bgdqm ds ‘k-+ 1//8: Ytq‘mn ds ‘k-+
1/08(sn hcdmshex Anuhm‘d rtae‘lhkx ‘mc Anuhc‘d e‘lhkx ldladqr
vhsg rg‘qdc ‘mbdrsqx ’Ehftqd 4+ kdes o‘mdk(- Sghr sqdd hmbktcdc
sqhadr vhsghm sgd Anuhm‘d rtae‘lhkx ’Anuhmh+ Sq‘fdk‘oghmh+ ‘mc
Anrdk‘oghmh(+ bknrdkx qdk‘sdc Anuhc‘d ’Muhr+ Ordtcnhr+ ‘mc
BXoqX(+‘mc lnqd chrs‘mskx qdk‘sdc Bdquhc‘d ’Bdqutr+ItmshXbtr+
‘mc Mcnbnhkdtr( ‘mc Lnrbghc‘d ’Inrbgtr( rodbhdr- Vd na,
s‘hmdc rdptdmbdr neIvqX7 fdmd nqsgnknfr ’S‘akdr R3 ‘mc R4:
RS@Q Ldsgncr(ax ’0(cnvmkn‘chmf ‘mmns‘sdc Lwq‘7 fdmd rd,
ptdmbdr eqnl FdmA‘mj:’1(‘rrdlakhmf cdonrhsdc:tm‘mmns‘sdc
vgnkd fdmnld nq dwnld rdptdmbdr: ‘mc ’2( hrnk‘shmf lQM@
eqnl shrrtdr nas‘hmdc ‘s mdbqnorx eqnl ‘mhl‘kr ‘s sgd R‘hms
Knthr Ynn+ r‘lokdr ‘bpthqdc eqnl bnlldqbh‘k udmcnqr+ ‘mc
u‘khc‘sdc oqhl‘qx zaqnak‘rsr necheedqdmsAnuhm‘d rodbhdr ’Lnch
ds‘k-+1//3(-

@kkAnuhm‘d rtae‘lhkx ldladqr dwbdosnmd g‘c hmrdqshnmr hm
IvqX7 ‘ssgd r‘ld rhsd ‘r nardqudc hm b‘sskd-Sgd lnrschrs‘mskx
qdk‘sdc Anuhm‘d ldladq’AnrdkXogtr sqXfnbXldktr(k‘bjdc sgd
hmrdqshnm ‘r chc qdoqdrdms‘shudr ne Bdquhc‘d+ Lnrbghc‘d+ ‘mc
sgqdd mnm,Anuhm‘d ldladqr neAnuhc‘d ’Muhr nqhdmsXkhr+Ordt,
cnhr mXxXtq+‘mc BXoqX rhahqhbX(’Ehftqd 4+qhfgs o‘mdk‘mc Ehf,
tqd R4@(-Ldladqr nesgd Anuhm‘ rtasqhad ’Anr ‘mc Ahrnm(rg‘qd
hcdmshb‘k04,‘lhmn ‘bhc hmrdqshnmr vgdqd‘r sgd Ata‘khm‘ rtasqhad
’AtaXktr ‘mc Rxmbdqtr(g‘c 4,‘lhmn ‘bhc hmrdqshnmr ’nmd FDPQU
qdod‘s(‘ssgd r‘ld rhsd ‘r hm b‘sskd-Sgd bnllnm ‘mbdrsnqneAt,
aXktrataXkhr‘mc RxmbdqtrbXeedql‘x g‘ud knrs2/ mtbkdnshcdr ne
sgd ‘mbdrsq‘khmrdqshnm-@ksdqm‘shudkx+‘m hmcdodmcdmshmsqnctbshnm
nesgd FDPQU hmrdqshnm bntkc g‘ud nbbtqqdc hm sgd ‘mbdrsnqne
AtaXktr ‘mc Rxmbdqtr ‘s sgd r‘ld rhsd hm IvqX7-Ldladqr ne
sgd lnqd chrs‘mskx qdk‘sdc Sq‘fdk‘ogtr rtasqhad nerohq‘k,gnqmdc
‘msdknodr ’d-f-+mx‘k‘ ’SqXfdkXogtr XmfXrhh(+anmfn ’SqXfdkXogtr
dtqxbdqtr(+ ‘mc kdrrdq jtct ’SqXfdkXogtr hladqahr(( ‘kk g‘c
rhlhk‘q 34,mtbkdnshcd ’78# hcdmshsx( ‘mc 04,‘lhmn ‘bhc ’62#
hcdmshsx( hmrdqshnmr ’FDPOUFDOQDFDOQU: vhsg sgqdd mns‘akd
oqnkhmd rtarshstshnmr(vhsghm sgd r‘ld hmrdqshnm rhsd hm IvqX7Sn cdsdqlhmd sgd rhfmhzb‘mbd ne sgd hmrdqshnmr ne nsgdq
Anuhm‘d rodbhdr hm IvqX7+vd dmfhmddqdc ‘ o‘mdkneLwq‘7,Eb
etrhnm oqnsdhmr hmbktchmf v‘sdq atee‘kn ’Ata‘ktr(,Eb+ v‘sdq

’C(Ltksh,rsdo fqnvsg ‘m‘kxrhr neBGHJU @E04450 hm oqhl‘qx LDEr ’Lwq‘7VS.VS+Lwq‘7JN.JN+Lwq‘7VS.JN+‘mc Lwq‘7lnn.JN(-Bdkkr vdqd hmedbsdc ‘s‘m LNHne
/-/0+‘mc uhqtr hm rtodqm‘s‘msr v‘r g‘qudrsdc ‘ssgd shld onhmsr rgnvm ‘mc shsq‘sdc ax sgd enbtr,enqlhmf ‘rr‘x-C‘s‘ ‘qd qdoqdrdms‘shud nesgqdd dwodqhldmsr
odqenqldc hm rdwstokhb‘sd’DflM(Lwq‘7VS.VS+Lwq‘7JN.JN+Lwq‘7VS.JN+Lwq‘7lnn.JN+‘mc Lwq‘7lnn.lnn lhbd vdqd hmnbtk‘sdc hm sgd ennso‘c vhsg 0/2 enbtr,enqlhmf tmhsr ’EET(neBGHJU
@E04450-Inhmsrvdkkhmf v‘r lnmhsnqdc nudq0/ c‘xr ’D(nq‘sc‘x 2 onrs,hmedbshnm ’E(-Uhq‘kQM@ kdudkr hm rdqtl ’F(‘mc ’J(+horhk‘sdq‘kb‘keltrbkd ’G(‘mc ’K(+
bnmsq‘k‘sdq‘k‘mjkd ’H(‘mc ’L(+‘mc bnmsq‘k‘sdq‘kb‘keltrbkd ’I(‘mc ’M(vdqd ld‘rtqdc ‘s2 c‘xr onrs,hmedbshnm-Enq’D(+c‘s‘ ‘qd sgd ld‘m ˚ RDL eqnl sgqdd
dwodqhldmsr ’m < 00 sn 04:svn,v‘x @MNU@ vhsg Ctmmdss&r onrs,sdrs9 nq*+o ; /-/4:))nq**+o ; /-/0:)))nq***+o ; /-//0:))))nq****+o ; /-///0:mr+mns
rhfmhzb‘ms(-__)&&hmchb‘sdr ‘ bnlo‘qhrnm adsvddm Lwq‘7VS.VS ‘mc Lwq‘7lnn.JN-__*&&hmchb‘sdr ‘ bnlo‘qhrnm adsvddm Lwq‘7VS.JN ‘mc Lwq‘7lnn.JN-__mr&&c‘s‘ ‘qd
‘ bnlo‘qhrnm adsvddm Lwq‘7JN.JN ‘mc Lwq‘7lnn.JN-Enq’E(fl’M(+c‘s‘ ‘qd eqnl svn dwodqhldmsr ’m < 7 sn 0/:nmd,v‘x @MNU@ vhsg Jqtrj‘k,V‘kkhr onrs,sdrs9)o ;
/-/4:))o ; /-/0:)))o ; /-//0:))))o ; /-///0:mr+mnsrhfmhzb‘ms(-
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Ehftpd 5- Etmashnm‘i‘mc Cunitshnm‘px Pdi‘shnmrghor neIvp‘6
’@(Ahmchmf nelntrd,Eb+b‘sskd,Eb+v‘sdqatee‘kn,Eb+v‘sdqatee‘kn, 4,Eb+jtct,Eb+‘mc jtct, 04,Eb Lwq‘7 etrhnm oqnsdhmr sn ‘mshancx,b‘ostqdc BGHJU UKOr
ax DKHR@-C‘s‘ ‘qd sgd ld‘m ˚ RC onnkdc eqnl sgqdd dwodqhldmsr odqenqldc hm ctokhb‘sd’A(Ahmchmf nelntrd,Eb+lntrd,Lwq‘7 * 7,Eb+lntrd,Lwq‘7 * 0/,Eb+‘mc lntrd,Lwq‘7 * ZFFR[4,Eb etrhnm oqnsdhmr sn ‘mshancx,b‘ostqdc BGHJU ax DKHR@L@ar BGJ,041 ’‘msh,BGHJU(‘mc G66-28 ’‘msh,GBU(vdqd hmbktcdc ‘r onrhshud ‘mc mdf‘shud bnmsqnkr+qdrodbshudkx-C‘s‘ ‘qd sgd ld‘m ˚ RC onnkdc eqnl sgqdd
dwodqhldmsr odqenqldc hm ctokhb‘sd’B(Ahmchmf qdronmrd nesgd a‘bsdqh‘kkx dwoqdrrdc lntrd Lwq‘7 ‘mc hmrdqshnm u‘qh‘msr Lwq‘7 * 4+Lwq‘7 * 7+‘mc Lwq‘7 * 8+Lwq‘7 * 0/+Lwq‘7 * lnn+‘mc
Lwq‘7 * ZFFR[4 sn ‘mshancx,b‘ostqdc BGHJU UKOr ‘s‘ 0 b L bnmbdmsq‘shnm ax AKH-C‘s‘ ‘qd sgd ld‘m ˚ RC neentqsn zud dwodqhldmsr ’nmd,v‘x @MNU@ vhsg
Ctmmdss&r onrs,sdrs9))))o ; /-///0(’CflE(Kdmshuhqtr bnlokdldms‘shnm ne IvqX7 2S2 vhsg Lwq‘7 bCM@ eqnl v‘sdqatee‘kn+v‘sdqatee‘kn 4+ydat+ydat lnn+jtct+‘mc jtct 04-Bdkkr vdqd
hmnbtk‘sdc vhsg ’C(BGHJU ’070.14(+’D(L@XU ’AdG3/6(+nq’E(QQU ’S37(:g‘qudrsdc:rs‘hmdc vhsg ‘msh,D1 l@ar:‘mc oqnbdrrdc ax finv bxsnldsqx-Enq’C(fl’E(+
c‘s‘ ‘qd sgd ld‘m ˚ RC onnkdc eqnl sgqdd sn dhfgsdwodqhldmsr ’m < 7 sn 12 qdokhb‘sdr:nmd,v‘x @MNU@ vhsg Ctmmdss&r onrs,sdrs9))))o ; /-///0(’F(L@XU hmedbshnm neoqhl‘qx jtct zaqnak‘rsr sq‘mrctbdc vhsg udbsnqbnmsqnk+jtct Lwq‘7+nqjtct 04 Lwq‘7-C‘s‘ ‘qd sgd ld‘m ˚ RC eqnl entqdwodqhldmsr
’m < 01:nmd,v‘x @MNU@ vhsg Ctmmdss&r onrs,sdrs9))))o ; /-///0:mr+mnsrhfmhzb‘ms(’G(Dunktshnm‘qx rbdm‘qhnr enqsgd Anuhm‘d Lwq‘7 fdmd hmrdqshnmr-Sgd sgqdd rbdm‘qhnr ‘qd a‘rdc nm sgd kdmfsg nesgd qdod‘stmhs‘mc vgdsgdqknrrdr nqctokh,
b‘shnmr nesgd qdod‘stmhs‘qd lnqd bnllnm-Ctokhb‘shnm dudmsr ‘qd hmchb‘sdc ‘r bhqbkdr+knrrdr ‘qd hmchb‘sdc ax __w&&l‘qjr+mnmrxmnmxlntr rtarshstshnmr ‘qd
hmchb‘sdc ‘r zkkdc sqh‘mfkdr+‘mc rxmnmxlntr rtarshstshnmr ‘qd hmchb‘sdc ‘r nodm sqh‘mfkdr-Dudmsr ‘qd rgnvm hm sgdhqqdbnmrsqtbsdc nqcdq+eqnl nkcdrs’kdes(sn
xntmfdrs’qhfgs(+‘mc hm sgdhqxntmfdrsonrrhakd onrhshnmr+sgntfg sgd ‘fd ne‘mx dudmshr mnsoqdbhrdkx jmnvm-@kkrbdm‘qhnr hmunkud nmd rxmnmxlntr rtarshstshnm
nbbtqqhmf vhsghm Anr fqtmmhdmr ‘mc nmd mnmrxmnmxlntr rtarshstshnm nbbtqqhmf vhsghm SqXfdkXogtr XmfXrhhatscheedqdkrdvgdqd-Hm rbdm‘qhn @ ’aktd rxlankr(+
vgdqd sgd knrr nesgd 4,‘lhmn ‘bhc qdod‘stmhshr qdk‘shudkx bnllnm+sgd qdod‘stmhshr ctokhb‘sdc sgqdd shldr hm sgd bnllnm ‘mbdrsnqneAnuhmh‘mc Sq‘fdk‘oghmhkdfdmc bnmshmtdc nm mdvsoXfd(
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atee‘kn, 4,Eb+jtct,Eb+‘mc jtct, 04,Eb ’Ehftqd R4A(-Vd cd,
rhfmdc sgqdd ‘cchshnm‘ku‘qh‘msr sn cdzmd sgd deedbsnerhyd ‘mc
rdptdmbd ne sgd hmrdqshnm nm BGHJU ahmchmf9 lntrd,Lwq‘7 *
7,Eb ‘mc lntrd,Lwq‘7 * 0/,Eb ‘cc 7 ’PQUFDPQK( ‘mc 0/
’FDPQUFDPQK(ne sgd 04 ‘lhmn ‘bhcr+ qdrodbshudkx+ eqnl sgd
b‘sskd+‘mc lntrd,Lwq‘7*ZFFR[4,Eb ‘ccr 04 mnm,gnlnknfntr
‘lhmn ‘bhcr ’FFRFFRFFRFFRFFR( sg‘s ‘qd oqdchbsdc sn
enql ‘ fidwhakd knno ’Ehftqd R4B(-Sgdrd Lwq‘7,Eb etrhnm oqnsdhmr
vdqd qdbnfmhydc ax ‘msh,Lwq‘7 l@ar ’Ehftqd R4C(-Vd sdrsdc
sgdrd Lwq‘7,Eb oqnsdhmr enqsgdhqb‘o‘bhsx sn ahmc BGHJU UKOr
ax DKHR@-Mn ahmchmf v‘r cdsdbsdc vhsg jtct,Lwq‘7,Eb:l‘qj,
dckx chlhmhrgdc ahmchmf v‘r nardqudc vhsg lntrd,Lwq‘7 * 0/,
Eb ‘mc lntrd,Lwq‘7 * ZFFR[4,Eb: hmsdqldch‘sd ahmchmf v‘r
cdsdbsdc vhsg v‘sdq atee‘kn Lwq‘7,Eb ‘mc lntrd,Lwq‘7*7,
Eb: ‘mc ‘uhc ahmchmf v‘r nardqudc vhsg v‘sdq atee‘kn, 4,
Lwq‘7,Eb+jtct, 04,Lwq‘7,Eb+‘mc lntrd Lwq‘7,Eb ’Ehftqdr
5@ ‘mc 5A(- Sn bnqqnanq‘sd sgdrd qdrtksr+ vd ‘rrdrrdc sgd
lnmnu‘kdmsahmchmf neotqhzdc lntrd Lwq‘7 hmrdqshnm u‘qh‘msr
sn BGHJU UKOr trhmf AKH- @kk Lwq‘7 hmrdqshnm u‘qh‘msr vdqd
qdbnfmhydc ax ‘m ‘msh,Lwq‘7 l@a ’Ehftqd R4D(+ rtffdrshmf
oqnodq enkchmf- Lntrd Lwq‘7 antmc rsqnmfkx sn BGHJU
UKOr+ vgdqd‘r lntrd Lwq‘7 * 4+ lntrd Lwq‘7 * 7+ lntrd
Lwq‘7 * 8+lntrd Lwq‘7 * 0/+lntrd Lwq‘7 * lnn+nqlntrd
Lwq‘7 * ZFFR[4 chrok‘xdc khsskd nqmn ahmchmf ’Ehftqd 5B(-Sgdrd
c‘s‘ rtffdrs sg‘s hmrdqshnmr ne ‘r edv ‘r zud qdrhctdr ‘s sgd
__lnn&&rhsd hmghahshmsdq‘bshnmr neLwq‘7 vhsg BGHJU+‘ksgntfg qd,
bdosnqaknbj‘cd cndr mnsqdpthqd ‘ rodbhzb rdptdmbdSn sdrsvgdsgdqsgd 04,qdrhctd hmrdqshnm hm nsgdqLwq‘7 nqsgn,
knfr rhlhk‘qkx chrqtosr ‘kog‘uhqtr hmedbshnm+ vd bnlokdldmsdc
IvqX7 2S2 bdkkr vhsg v‘sdq atee‘kn IvqX7+ v‘sdq atee‘kn 4
IvqX7+ydat IvqX7+ydat 04 IvqX7+jtct IvqX7+nqjtct 04
IvqX7+enkknvdc ax hmnbtk‘shnm vhsg BGHJU+L@XU+nq QQU-@kk
VS ‘mc rdptdmbd,cdkdsdc Lwq‘7 u‘qh‘msr vdqd cdsdbsdc nm
sgd bdkkrtqe‘bd ’Ehftqd R5@(- Vgdqd‘r ydat ‘mc jtct Lwq‘7
chc mnsoqnlnsd hmedbshnm+dwoqdrrhnm nesgd qdrodbshud 04 ‘lhmn
‘bhc cdkdsdc enqlr dm‘akdc hmedbshnm nesgd uhqtrdr sdrsdc ’Ehf,
tqdr 5Cfl5E ‘mc R5AflR5C(-V‘sdqatee‘kn Lwq‘7 g‘c ‘m hmsdqld,
ch‘sd ogdmnsxod: vghkd hs rtoonqsdc L@XU ‘mc QQU hmedbshnm+
sgd kdudkne BGHJU hmedbshnm v‘r chlhmhrgdc- Gnvdudq+ BGHJU
hmedbshnm v‘r hmbqd‘rdc hm bdkkr dwoqdrrhmf v‘sdq atee‘kn 4
IvqX7-Hm ‘cchshnm‘kdwodqhldmsr+vd sq‘mrctbdc oqhl‘qx jtct
zaqnak‘rsr vhsg jtct IvqX7 nq jtct 04 IvqX7 ’Ehftqd R5D(Vgdqd‘r jtct Lwq‘7 chc mnsoqnlnsd hmedbshnm neL@XU+jtct
04 IvqX7 chc ’Ehftqdr 5F ‘mc R5E(9mbhdmsNqhfhm nesgd Anuhmd LvqY5 Hmrdqshnm
Sgd Lwq‘7 hmrdqshnm dhsgdq nqhfhm‘sdc nmbd hm ‘ bnllnm
‘mbdrsnq ne sgd Anr+AtaXktr+‘mc SqXfdkXogtr khmd‘fdr nq to
sn sgqdd shldr hmcdodmcdmskx hm d‘bg nesgdrd khmd‘fdr ’Ehftqdr

5G ‘mc R6(- Ntq ogxknfdmdshb qdbnmrsqtbshnm ok‘bdr ‘s kd‘rs
7/# nesgd ‘lhmn ‘bhc rtarshstshnmr vhsghm sgd Lwq‘7 hmrdqshnm
‘knmf hmsdqm‘k aq‘mbgdr ne sgd Anuhm‘d sqdd ’Ehftqdr 5G ‘mc
R6@flR6B: S‘akd R5(- Sghr hmchb‘sdr sg‘s sgd Lwq‘7 hmrdqshnm+
‘mc sgd bnmrdqudc ‘lhmn ‘bhc rtarshstshnmr vhsghm hs+oqna‘akx
nqhfhm‘sdc ctqhmf sgd Lhnbdmd nq d‘qkhdq ’=4-2 lhkkhnm xd‘qr
‘fn ’4-2 lx‘((’Ytq‘mn ds‘k-+1/08(+adenqd SqXfdkXogtr chudqrh,
zdc ’S‘akd R6(-Qdbdms+vhcdroqd‘c hmsqnfqdrrhnm nesgd hmrdq,
shnm ‘ood‘qr tmkhjdkx+ ‘r sgd Anuhm‘d rodbhdr sqdd ‘mc sgd
Lwq‘7 fdmd sqdd ‘qd ghfgkx bnmfqtdms ’Ehftqdr R6C ‘mc R6D(
‘mc sgd bgqnlnrnld bntmsr neAnuhm‘d rodbhdr cheedqrtars‘m,
sh‘kkx vhsghm ‘mc adsvddm fdmdq‘ ’rdd Ehftqd R6 ‘mc S‘akd R7(
’N&Aqhdm+1//4(@s oqdrdms+vd g‘ud mn duhcdmbd rtffdrshmf sg‘s ‘kog‘uhqtr
chrd‘rd qdrhrs‘mbd rdkdbsdc enq sgd Lwq‘7 hmrdqshnm- @ksgntfg
‘fd drshl‘sdr a‘rdc nm mtbkdnshcd rdptdmbd chudqfdmbd rtf,
fdrs ‘kog‘uhqtrdr dunkudc qdbdmskx eqnl ‘ bnllnm ‘mbdrsnq
’Vd‘udq ds ‘k-+ 0882(+ QM@ uhqtrdr l‘x ad bnmrhcdq‘akx nkcdq
sg‘m gxonsgdrhydc ’Yg‘mf ds‘k-+1/07a(-Sgd hmrdqshnm ‘krn bntkc
g‘ud dunkudc sn dmg‘mbd ‘m dmcnfdmntr etmbshnm ne Lwq‘7 hm
Anuhm‘d ogxrhnknfx-@r Lwq‘7 qdonqsdckx hmsdq‘bsr vhsg D Ua 2 hm,
sdfqhm ‘mc onrrhakx nsgdq l‘sqhw oqnsdhmr+ sgd hmrdqshnm lhfgs
lnctk‘sd hsr ‘ssqhatsdc qnkdr hm bdkk,bdkk‘cgdrhnm+‘mfhnfdmdrhr+
‘mc.nq ldrdmbgxl‘kbdkkcheedqdmsh‘shnm ’G‘m ds‘k-+1/07:Itmf
ds‘k-+1//7+1/01(Sgd hmrdqshnm hm Lwq‘7 khjdkx khlhsr ‘kog‘uhqtr hmedbshnm hm rnld
Anuhm‘d rodbhdr- Sgd ldbg‘mhrl ne du‘rhnm hr qdlhmhrbdms ne
sgnrd onrstk‘sdc enq lntrd gdo‘shshr uhqtr ‘mc rnld ‘qdm‘uh,
qtrdr+vgdqd ‘kkdkdr nesgd BdXbXl0X nqsq‘mredqqhm ’SEP0(qdbdo,
snqr+ qdrodbshudkx+ vhsg rdptdmbd u‘qh‘shnmr xhdkchmf knvdq
ahmchmf ‘ezmhsx vdqd rdkdbsdc hm rtardsr neqncdmsr ’Cdlnfhmdr
ds‘k-+1/02:Odmf ds‘k-+1/06(-@m‘knfntrkx+rnld gtl‘mr ‘qd
gnlnyxfntr enq ‘ 21,mtbkdnshcd cdkdshnm hm BBQ4+vghbg bnm,
edqr qdrhrs‘mbd sn GHU dmsqx ’L‘qshmrnm ds‘k-+0886(-@qsgqhsnfdmhb
‘kog‘uhqtrdr ’d-f-+ BGHJU ‘mc QQU( e‘hkdc sn hmedbs b‘sskd ‘mc
jtct bdkkr dezbhdmskx dwbdosvgdm ‘m dmfhmddqdc u‘qh‘ms’b‘sskd
lnn nqjtct 04(atsmnsVS Lwq‘7 v‘r dwoqdrrdc-Lnqdnudq+
hmsqnctbhmf sgd __lnn&&hmrdqshmsn lntrd IvqX7 oqnctbdr ‘ knrr,
ne,etmbshnm ‘kkdkd enqBGHJU hmedbshnm hm uhun ‘mc ogdmnbnohdr ‘m
‘ardmbd ne IvqX7- Bnmrhrsdms vhsg sghr hcd‘+ entq Anr sXtqtr
b‘kudr hmnbtk‘sdc vhsg BGHJU e‘hkdc sn cdudkno uhqdlh‘ ’Anrbn,
K‘tsg ds‘k-+1/05(+‘mc hm ‘m ‘qd‘ neBdmsq‘k@eqhb‘ vhsg dohcdlhb
sq‘mrlhrrhnm ne BGHJU+ nmkx 0 ne 072 ydatr g‘c BGHJU ‘msh,
anchdr ’Fthkgdqld ds ‘k-+ 0885(- Rhlhk‘qkx+ hm ‘ qdfhnm ne Mdv
Yd‘k‘mc vhsg ‘bshud QQU sq‘mrlhrrhnm+/ ne1/6 b‘sskd vdqd rdqn,
onrhshud enqQQU ’LbE‘ccdm ds‘k-+1//8(+‘mc hm @trsq‘kh‘+QQU
g‘r addm hrnk‘sdc eqnl gnqrdr ‘mc fn‘sr+ats mns b‘sskd ’F‘qc
ds ‘k-+ 0877(- Cds‘hkdc rdqndohcdlhnknfhb‘k rstchdr ne Anuhm‘d
‘mc qdk‘sdc Anuhc‘d rodbhdr hm ‘qd‘r ne dohcdlhb ‘kog‘uhqtr

@ mnmrxmnmxlntr rtarshstshnm nbbtqr hm sgd ‘mbdrsnqneAnuhmhenkknvdc ax svn knrr dudmsr hm sgd ‘mbdrsnqneAta‘khm‘-Entqlnqd mnmrxmnmxlntr rtarshstshnmr
nbbtqhm sgd ‘mbdrsnqneSq‘fdk‘oghmh-Hm rbdm‘qhn A ’fqddm rxlankr(+vgdqd ctokhb‘shnm nesgd 4,‘lhmn ‘bhc qdod‘stmhshr lnqd bnllnm+sgqdd ctokhb‘shnm dudmsr
‘mc ‘ mnmrxmnmxlntr rtarshstshnm nbbtqhm sgd ‘mbdrsnqneAnuhm‘-@ rhmfkd ctokhb‘shnm dudmsnbbtqr hm sgd Ata‘khm‘ ‘mbdrsnq-Hm sgd ‘mbdrsnqneSq‘fdk‘oghmh+
svn ctokhb‘shnm dudmsr ‘qd enkknvdc ax svn mnmrxmnmxlntr rtarshstshnmr+‘ ctokhb‘shnm dudms+‘mc ‘ mnmrxmnmxlntr rtarshstshnm-Rbdm‘qhn B ’otqokd rxlankr(+
vgdqd ctokhb‘shnm nesgd 0/,‘lhmn ‘bhc qdod‘s tmhs hr lnqd bnllnm+hr rhlhk‘q sn rbdm‘qhn A vhsg ‘m dwbdoshnm hm sgd Sq‘fdk‘oghmh‘mbdrsnq-Gdqd+‘ rhmfkd
ctokhb‘shnm dudmshr enkknvdc ax sgqdd mnmrxmnmxlntr rtarshstshnmr+‘ ctokhb‘shnm dudms+‘mc ‘ mnmrxmnmxlntr rtarshstshnm-Rbdm‘qhn B ‘krn qdpthqdr ‘ rhmfkd
rxmnmxlntr rtarshstshnm hm sgd sdqlhm‘kkhmd‘fd kd‘chmf sn SqXfdkXogtr dtqxbdqtr-@ fdnknfhb‘kshld rb‘kd hmchb‘shmf sgd Lhnbdmd ’nq‘mfd(+Okhnbdmd ’xdkknv(+‘mc
Okdhrsnbdmd ’khfgsxdkknv(donbgr hr rgnvm adknvRdd Ehftqd R6 ‘mc S‘akd R5-
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sq‘mrlhrrhnm bntkc bk‘qhex sgd qdk‘shnmrgho adsvddm dwonrtqd+
hmedbshnm+‘mc qdrhrs‘mbd sn chrd‘rdNtqhm uhsqn ‘mc hm uhun c‘s‘ rtffdrssg‘s‘mhl‘kr qds‘hmhmf sgd
Lwq‘7 hmrdqshnm nq sgnrd lnchzdc vhsg ‘m hmsqnctbdc hmrdqshnm
‘qd qdrhrs‘ms sn hmedbshnm ‘mc chrd‘rd ax Lwq‘7,cdodmcdms
bnmsdlonq‘qx ‘kog‘uhqtrdr- Ax bnlahmhmf drs‘akhrgdc qdrhr,
s‘mbd o‘ssdqmr ne rodbhzb ‘mhl‘kr sn uhq‘k hmedbshnm vhsg sgd
rdptdmbdr ‘mc rsqtbstqdr ne dunktshnm‘qhkx qdk‘sdc qdbdosnq
nqsgnknfr+lnkdbtk‘q‘mc etmbshnm‘k‘m‘kxrhr b‘m dktbhc‘sd gnv
‘mc vghbg rdptdmbd u‘qh‘shnm ‘ksdqr uhqtr,qdbdosnqhmsdq‘bshnmrLnqdnudq+sgdrd rstchdr l‘x enrsdqsgd cdudknoldmsnebntmsdq,
ld‘rtqdr+‘r sgdx oqnuhcd ‘ rsq‘sdfx enq fdmdshb‘kkx lnchexhmf
‘mhl‘kr nqhcdmshexhmf lnkdbtkdr sg‘sahmc sn rodbhzb qdfhnmr ne
Lwq‘7 sn oqnlnsd qdrhrs‘mbd sn hmedbshnm ax ltkshokd ‘kog‘uh,
qtrdr- Hmcddc+ rl‘kk lnkdbtkdr sg‘s cheedqdmsh‘kkx ahmc b‘sskd+
lntrd+ nq gtl‘m Lwq‘7 hm sgd qdfhnm oqnwhl‘k sn sgd B&,B&&
knno hmrdqshnm bntkc aknbj ‘kog‘uhqtr ‘ss‘bgldms‘mc hmedbshnm-

mddqhmf ‘mc hORB Bdmsdq‘mc Cdo‘qsldmsneO‘sgnknfx Lhbqnhmidbshnm E‘bhkhsx
‘s V‘rghmfsnm Tmhudqrhsx enq fQM@ cdrhfm ‘mc lntrd fdmdq‘shnm: K‘qhrr‘
Sg‘bjq‘x enqcdrhfm nesgd Lwq‘7 jmnbjhm lntrd:‘mc sgd Khuhmf D‘qsg Bnkk‘a,
nq‘shud+Inm‘sg‘m Knrnr+Inrdog Ahdk‘vrjh+‘mc Sdqdmbd Cdqlncx enqdchsnqh‘k
rtffdrshnmr9TSGNP BNMSPHATSHNMR
@-R-J-+ N-Y-+ K-C-+ B-A-B-+ ‘mc R-B- odqenqldc sgd hmedbshnm rstchdr vhsg
Lwq‘7-N-Y-+Q-Y-+‘mc B-A-fdmdq‘sdc sgd Lwq‘7 fdmdr ‘mc kdmshuhqtrdr enq
sgd bnlokdldms‘shnm rstchdr-@-R-J-‘mc J-A-odqenqldc sgd DKHR@ ‘mc AKH
ahmchmf rstchdr-@-R-J-+B-@-M-+J-A-+‘mc C-G-E-odqenqldc sgd rsqtbstq‘k‘m‘k,
xrhr nelntrd ‘mc b‘sskd Lwq‘7 ‘mc sgd cnbjhmf rstchdr nm BGHJU-R-K-C-oqn,
uhcdc jdx ‘mhl‘kqd‘fdmsr-I-L-E-odqenqldc sgd hm uhun rstchdr-@-R-J-+B-C-+
I-N-+ A-R-+ ‘mc R-@-G- ‘m‘kxydc sgd vgnkd fdmnld rdptdmbdr ‘mc oqhl‘qx
QM@ rdptdmbdr-S-V-oqnuhcdc sgd fdmdshb ‘m‘kxrhr nesgd rdptdmbd hmrdqshnmL-I-K-‘mc A-R-odqenqldc sgd dunktshnm‘qx ‘m‘kxrhr-@-R-J-+N-Y-+I-L-E-+‘mc
J-A-odqenqldc sgd c‘s‘ ‘m‘kxrhr-@-R-J-+N-Y-+L-I-K-+‘mc L-R-C-vqnsd sgd
hmhsh‘kl‘mtrbqhoscq‘esCDBK9P9SHNM NE HMSDPDRSR

RS9P LDSGNCR
Cds‘hkdc ldsgncr ‘qd oqnuhcdc hm sgd nmkhmd udqrhnm nesghr o‘odq
‘mc hmbktcd sgd enkknvhmf9
JDX QDRNTQBDR S@AKD
KD@C BNMS@BS @MC L@SDQH@KR @U@HK@AHKHSX
DWODQHLDMS@K LNCDK @MC RTAIDBS CDS@HKR
+ Bdkkr ‘mc Uhqtrdr
+ Fdmdq‘shnm neLwq‘7 Jmnbjhm Lhbd
+ Lntrd Dwodqhldmsr
LDSGNC CDS@HKR
+ Ok‘rlhc Bnmrsqtbshnm enq Sq‘mr,bnlokdldms‘shnm
Rstchdr
+ Sq‘mr,bnlokdldms‘shnm ‘mc Hmedbshnm Dwodqhldmsr
+ Dwoqdrrhnm ‘mc Otqhzb‘shnm neLwq‘7 Oqnsdhmr
+ Oqnsdhm Bqxrs‘kkhy‘shnm ‘mc W,Q‘x Rsqtbstqd Cdsdqlh,
m‘shnm
+ Lwq‘7 DKHR@ Ahmchmf @rr‘xr
+ Lwq‘7 AKHAhmchmf @rr‘xr
+ Uhqtr,BdkkAhmchmf @rr‘xr
+ R‘lokd Bnkkdbshnm ‘mc Rdptdmbhmf
+ Rsqtbstq‘kCnbjhmf @m‘kxrhr
+ Vgnkd Fdmnld Rdptdmbd @rrdlakx ‘mc @khfmldmsr
+ Hlltmnaknsshmf
+ Dunktshnm‘qx @m‘kxrdr
+ Rs‘shrshb‘k@m‘kxrdr
C@S@ @MC BNCD @U@HK@AHKHSX
RTOOKDLDMS9K HMENPL9SHNM
Rtookdldms‘k Hmenql‘shnm b‘m ad entmc nmkhmd ‘s gssor9..cnh-nqf.0/-0/05.ibgnl-1/1/-/0-//79BJMNVKDCFLDMSR
Sghr rstcx v‘r rtoonqsdc ax MHG fq‘msr Q/0@H003705+ Q/0@H012237+
Q/0@H/84325+‘mc S21@H//6061 ‘mc sgd BdmsdqenqRsqtbstq‘kFdmnlhbr neHm,
edbshntr Chrd‘rdr+bnmsq‘bsmtladqGGRM1611/06///5/B-Vd sg‘mj I‘x Mhw
‘s @KR ad‘lkhmd 3-1-1 enq ‘rrhrs‘mbd vhsg c‘s‘ bnkkdbshnm ‘mc oqnbdrrhmf:
I‘ldr Vnl‘bj ‘mc Sdqid Q‘tcrdoo enq oqnuhchmf sgd oqhl‘qx Anuhmd zaqn,
ak‘rsr ‘mc I‘ldr Bqnvd enq oqnuhchmf ‘msh,‘kog‘uhqtr l@ar: L‘qx Ctmb‘m
enq ‘qq‘mfhmf ‘bbdrr sn sgd mnm,cnldrshb anuhmd shrrtdr:sgd Fdmnld Dmfh,
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L-R-C-hr ‘ bnmrtks‘msenqHmahnr ‘mc DldqfdmsAhnRnktshnmr ‘mc hr nm sgd rbh,
dmshzb ‘cuhrnqx an‘qc neLncdqm‘-C-G-E-hr ‘ entmcdqneBntqhdqSgdq‘odtshbrQdbdhudc9Nbsnadq10+1/08
Qduhrdc9Cdbdladq00+1/08
@bbdosdc9I‘mt‘qx 03+1/1/
Otakhrgdc9Edaqt‘qx 07+1/1/
PDEDPDMBDR
@c‘lr+O-C-+@enmhmd+O-U-+Atmjn–byh+F-+Bgdm+U-A-+C‘uhr+H-V-+Dbgnkr+M-+
Gd‘cc+I-I-+Gtmf+K-V-+J‘oq‘k+F-I-+Fqnrrd,Jtmrskdud+Q-V-+ds‘k-’1/0/(OGDMHW9‘ bnloqdgdmrhud Oxsgnm,a‘rdc rxrsdl enq l‘bqnlnkdbtk‘q rsqtb,
stqd rnktshnm-@bs‘ Bqxrs‘kknfq-C Ahnk-Bqxrs‘kknfq-55+102fl110@j‘g‘s‘+V-+X‘mf+Y-X-+@mcdqrdm+G-+Rtm+R-+Gnkc‘v‘x+G-@-+Jnmf+V-O-+
Kdvhr+L-F-+Ghffr+R-+Qnrrl‘mm+L-F-+Q‘n+R-+ds‘k-’1/0/(-@ uhqtr,khjd o‘q,
shbkd u‘bbhmd enq dohcdlhb Bghjtmftmx‘ uhqtr oqnsdbsr mnmgtl‘m oqhl‘sdr
‘f‘hmrshmedbshnm-M‘sLdc-05+223fl227A‘m‘+ M-@-+ Mxhqh+ @-+ M‘fx+ I-+ Eq‘mj+ J-+ M‘fx+ S-+ Rsd–fdq+ U-+ Rbghkkdq+ L-+
K‘j‘snr+ O-+Rtf‘–q+ K-+Gnqm+ O-+ds ‘k-’1/07(-Sgd qdc cddq Bdqutr dk‘ogtr
fdmnld BdqDk‘0-/9rdptdmbhmf+‘mmns‘shmf+fdmdr+‘mc bgqnlnrnldr-Lnk
FdmdsFdmnlhbr-182+554fl573A‘rnqd+J-+Jhl+@-R-+Mdkrnm+B-@-+Yg‘mf+Q-+Rlhsg+A-J-+Tq‘mf‘+B-+U‘mf+
K-+ Bgdmf+ L-+ Fqnrr+ L-K-+ Rlhsg+ I-+ ds ‘k- ’1/08(- Bqxn,DL rsqtbstqd ne
Bghjtmftmx‘ uhqtr hm bnlokdw vhsg sgd Lwq‘7 qdbdosnq- Bdkk 066+ 0614fl
0626-d05Anrbn,K‘tsg+ @-L-+ Mdldsg+ M-L-+ Jngkdq+ C-I-+ ‘mc Anvdm+ Q-@- ’1/05(Uhqdlh‘ hm Mnqsg @ldqhb‘m l‘ll‘kr ‘mc ahqcr @esdq dwodqhldms‘khmedbshnm
vhsg bghjtmftmx‘ uhqtrdr-@l-I-Sqno-Ldc-Gxf-83+4/3fl4/5B‘m‘udy+E-B-+Ktbgd+C-C-+Rsnsg‘qc+O-+Kdhsd+J-Q-+Rntr‘,B‘m‘udy+I-L-+
Ok‘rsnv+F-+Ldhc‘mhr+I-+Rnty‘+L-@-+Edhi‘n+O-+Lnnqd+R-R-+ds‘k-’1/01(Fdmnld rdptdmbd ‘mc ‘rrdlakx neAnr hmchbtr-I Gdqdc-0.2+231fl237B‘qkdsnm+L-+Kdd+G-+Ltkudx+L-+‘mc Aqnvm+C-S-’0886(-Qnkd nefkxbnoqnsdhm
OD1 hm enql‘shnm ‘mc l‘stq‘shnm ne sgd Rhmcahr uhqtr rohjd- I- Uhqnk- 60+
0447fl0455Bg‘kkhr+C-+@mstmdr+K-+F‘qqhrnm+D-+A‘mjr+D-+Du‘mh+T-R-+Ltymx+C-+Onokhm+
Q-+Fhaar+Q-@-+L‘qsg+F-+‘mc Xt+E-’1/04(-Sgd chrsqhatshnm ‘mc lts‘fdmdrhr
nergnqsbnchmf hmcdkr eqnl 0+017 vgnkd dwnldr-ALB Fdmnlhbr 05+032Bgdm+U-A-+@qdmc‘kk+V-A-+2qc+Gd‘cc+I-I-+Jddcx+C-@-+Hllnqlhmn+Q-L-+
J‘oq‘k+ F-I-+ Ltqq‘x+ K-V-+ Qhbg‘qcrnm+ I-R-+ ‘mc Qhbg‘qcrnm+ C-B- ’1/0/(LnkOqnahsx9‘kk,‘snl rsqtbstqd u‘khc‘shnm enql‘bqnlnkdbtk‘qbqxrs‘kknfq‘ogx@bs‘ Bqxrs‘kknfq-C Ahnk-Bqxrs‘kknfq-55+01fl10Bgdmf+Q-G-+Jtgm+Q-I-+Nkrnm+M-G-+Qnrrl‘mm+L-F-+Bgnh+G-J-+Rlhsg+S-I-+
‘mc A‘jdq+S-R-’0884(-Mtbkdnb‘orhc ‘mc fkxbnoqnsdhm nqf‘mhy‘shnm hm ‘m dm,
udknodc uhqtr-Bdkk7.+510fl52/-

Cdlnfhmdr+@-+@aq‘g‘l+I-+Bgnd+G-+E‘qy‘m+L-+‘mc R‘vxdq+R-K-’1/02(Ct‘kgnrs,uhqtr ‘qlr q‘bdr rg‘od ‘m drrdmsh‘kgntrdjddohmf oqnsdhm-OKNR
Ahnk-00+d0//0460-

nq ‘esdq bg‘kkdmfd vhsg uhqtkdms Udmdytdk‘m dpthmd dmbdog‘knlxdkhshr uhqtrI-Fdm-Uhqnk-76+1356fl1365-

CdStkkdn+ K-+‘mc Jhqbgg‘trdm+S-’0887(- Sgd bk‘sgqhm dmcnbxshb o‘sgv‘x hm
uhq‘khmedbshnm-DLAN I-06+3474fl3482-

Itmf+X-J-+G‘m+R-V-+Jhl+F-V-+Idnmf+I-G-+Jhl+G-I-+‘mc Bgnh+I-X-’1/01(CHB@L hmghahsr nrsdnbk‘rs cheedqdmsh‘shnm sgqntfg ‘ssdmt‘shnm ne sgd hmsdfqhm
D Ua 2 o‘sgv‘x-I-Anmd Lhmdq-Qdr-16+1/13fl1/23-

Ct+W-+Fdqsy+D-L-+Vnisnvhby+C-+Yg‘ahmrj‘x‘+C-+Kdudmr+C-+Admg‘l+B-I-+
Rbg‘eedq+@-@-+‘mc Oqyxsxbj‘+S-L-’1/03(-Onsdmsh‘kmnm,A CM@ qdfhnmr hm sgd
gtl‘m fdmnld ‘qd ‘rrnbh‘sdc vhsg ghfgdq q‘sdr nemtbkdnshcd lts‘shnm ‘mc
dwoqdrrhnm u‘qh‘shnm-Mtbkdhb @bhcr Qdr-31+01256fl01268-

Itmf+X-J-+Idnmf+I-G-+Qxnn+G-L-+Jhl+G-M-+Jhl+X-I-+O‘qj+D-J-+Rh+G-I-+
Jhl+R-X-+S‘jhf‘v‘+L-+Kdd+A-G-+ds‘k-’1//3(-Fdmd dwoqdrrhnm oqnzkd negt,
l‘m bgnmcqnbxsd GBR,1.7 bdkk khmd ax DRS rdptdmbhmf ‘m‘kxrhr- Fdmd
22.+74fl81-

D‘qmdrs+I-S-+A‘rnqd+J-+Qnx+U-+A‘hkdx+@-K-+V‘mf+C-+@ksdq+F-+Eqdlnms+
C-G-+‘mc Ch‘lnmc+L-R-’1/08(-Mdtsq‘khyhmf ‘mshanchdr ‘f‘hmrsL‘x‘qn uhqtr
qdpthqd Eb deedbsnq etmbshnmr enq oqnsdbshud ‘bshuhsx- I- Dwo- Ldc- 105+
1171fl12/0-

Itmf+X-J-+Ihm+I-R-+Idnmf+I-G-+Jhl+G-M-+O‘qj+M-Q-+‘mc Bgnh+I-X-’1//7(CHB@L+‘ mnudkct‘khlltmnfknatkhm cnl‘hm bnms‘hmhmf bdkk‘cgdrhnm lnkd,
btkd hmsdq‘bsr vhsg ‘kog‘uads‘2 hmsdfqhm-I-Bdkk-Ogxrhnk-105+5/2fl503-

Dcf‘q+ Q-B- ’1//3(- LTRBKD9 ‘ ltkshokd rdptdmbd ‘khfmldms ldsgnc vhsg
qdctbdc shld ‘mc ro‘bd bnlokdwhsx-ALB Ahnhmenql‘shbr-4+002Dkrhj+B-F-+Tmmh+C-Q-+Chdrg+B-L-+S‘x‘k+@-+Dldqx+L-K-+Mftxdm+G-M-+‘mc
G‘fdm+C-D-’1/05(-Anuhmd fdmnld c‘s‘a‘rd9mdv snnkr enqfkd‘mhmf etmbshnm
eqnl sgd Anr s‘tqtr fdmnld-Mtbkdhb @bhcr Qdr-33+C723flC728Dlrkdx+O-+Kngj‘lo+A-+Rbnss+V-F-+‘mc Bnvs‘m+J-’1/0/(-Ed‘stqdr ‘mc
cdudknoldmsnebnns-@bs‘ Bqxrs‘kknfq-C Ahnk-Bqxrs‘kknfq-55+375fl4/0Dq‘rltr+I-G-+Qnrrh+R-K-+‘mc Vd‘udq+R-B-’1/05(-Cdudknoldmsneu‘bbhmdr
enqbghjtmftmx‘ edudq-I HmedbsChr-103+R377flR385Enw+ I-L-+ Knmf+ E-+ Dcdkhmf+ L-@-+ Khm+ G-+ u‘m Cthik,Qhbgsdq+ L-J-R-+ Enmf+
Q-G-+ J‘gkd+ J-L-+ Rlhs+ I-L-+ Ihm+ I-+ Rhllnmr+ F-+ ds ‘k- ’1/04(- Aqn‘ckx
mdtsq‘khyhmf @kog‘uhqtr ‘mshanchdr ahmc ‘m dohsnod nm D1 ‘mc hmghahs dmsqx
‘mc dfqdrr-Bdkk052+0/84fl00/6F‘qc+F-O-+Rgnqsgnrd+I-D-+Vdhq+Q-O-+V‘krg+R-I-+‘mc Ldkuhkkd+K-E-’0877(@qanuhqtrdr qdbnudqdc eqnl rdmshmdk khudrsnbj hm mnqsgdqm @trsq‘kh‘- UdsLhbqnahnk-07+0/8fl007F‘qcmdq+B-K-+Dadk+F-C-+Qxl‘m+J-C-+‘mc Jkhlrsq‘+V-A-’1/00(-Gdo‘q‘m
rtke‘sd ahmchmf ax m‘stq‘kd‘rsdqm dpthmd dmbdog‘khshr uhqtrdr oqnlnsdr mdtqn,
uhqtkdmbd-Oqnb-M‘sk-@b‘c-Rbh-TR@ 0.7+05/15fl05/20Fthkgdqld+I-L-+Fnmdkk‘,Kdf‘kk+B-+Kdf‘kk+E-+M‘jntld+D-+‘mc Uhmbdms+I’0885(- Rdqnoqdu‘kdmbd ne zud ‘qanuhqtrdr hm Ydat b‘sskd hm sgd Bdmsq‘k
@eqhb‘m Qdotakhb-Sq‘mr-Q-Rnb-Sqno-Ldc-Gxf-8.+20fl22G‘m+R-+O‘qj+G-Q-+Kdd+D-I-+I‘mf+I-@-+G‘m+L-R-+Jhl+F-V-+Idnmf+I-G-+
Bgnh+ I-X-+ Adhdq+ E-+ ‘mc Itmf+ X-J- ’1/07(- Chb‘l oqnlnsdr oqnkhedq‘shnm
‘mc l‘stq‘shnm nebgnmcqnbxsd sgqntfg Hmch‘m gdcfdgnf rhfm‘khmf hm oqhl‘qx
bhkh‘-Nrsdn‘qsgq-B‘qshk-15+834fl842G‘m+R-V-+Itmf+X-J-+Kdd+D-I-+O‘qj+G-Q-+Jhl+F-V-+Idnmf+I-G-+G‘m+L-R-+
‘mc Bgnh+I-X-’1/02(-CHB@L hmghahsr ‘mfhnfdmdrhr uh‘ rtooqdrrhnm ne@JS ‘mc
o27 L@O jhm‘rd rhfm‘kkhmf-B‘qchnu‘rb-Qdr-87+62fl71G‘m+R-V-+Jhl+I-L-+Kgn+X-+Bgn+G-I-+Itmf+X-J-+Jhl+I-@-+Kdd+G-+Kdd+
X-I-+‘mc Jhl+D-R-’1/08(-CHB@L ‘ssdmt‘sdr dwodqhldms‘kbnkhshr uh‘ rs‘ahkhy,
hmf itmbshnm‘kbnlokdw hm ltbnr‘ka‘qqhdq-Hmfi‘ll-AnvdkChr-14+742fl750G‘rdf‘v‘+L-+Jhrghmn+G-+‘mc X‘mn+S-’0874(-C‘shmf nesgd gtl‘m,‘od rokhs,
shmf ax ‘ lnkdbtk‘qbknbj nelhsnbgnmcqh‘kCM@-I-Lnk-Dunk-11+05/fl063G‘vl‘m+ C-V-+ Enw+ I-L-+ @rgaqnnj+ @-V-+ L‘x+ M-@-+ Rbgqndcdq+ J-L-+
Snqqdr+Q-L-+Bqnvd+I-D-+Iq-+Cdqlncx+S-R-+Ch‘lnmc+L-R-+‘mc Lnqqhrnm+
S-D- ’1/05(- O‘sgnfdmhb Bghjtmftmx‘ Uhqtr Du‘cdr A Bdkk Qdronmrdr sn
Drs‘akhrg Odqrhrsdmbd-BdkkQdo-05+0215fl0227G‘xdq+@-+Rg‘n+K-+Bgtmf+L-+Intadqs+K-L-+X‘mf+G-V-+Sr‘h+E-B-+Ahr‘qh‘+
@-+Adsyhf+D-+‘mc Ldxdq+S-’1/05(-Dmftkedc b‘cgdqhm zmfdqr ‘qd onk‘qhydc
itmbshnm‘k rsqtbstqdr adsvddm bnkkdbshudkx lhfq‘shmf dmcnsgdkh‘k bdkkr- M‘s
BdkkAhnk-07+0200fl0212Gdhcmdq+G-V-+Jmnss+S-@-+‘mc Ingmrsnm+Q-D-’0885(-Cheedqdmsh‘koqnbdrrhmf
neRhmcahr uhqtr fkxbnoqnsdhm OD1 hm btkstqdc udqsdaq‘sd ‘mc ‘qsgqnonc bdkkrI-Uhqnk-6.+1/58fl1/62Gn˜gm‘+R-+K‘mchr+L-I-+Gd‘sg+S-@-+Antrr‘t+A-+K‘qshkkns+M-+Lnnqd+A-Q-+
Gtdkrdmadbj+I-O-+‘mc Qnmpthrs+E-’1/05(-QduA‘xdr9a‘xdrh‘m ogxknfdmdshb
hmedqdmbd trhmf fq‘oghb‘klncdkr ‘mc ‘m hmsdq‘bshud lncdk,rodbhzb‘shnm k‘m,
ft‘fd-Rxrs-Ahnk-54+615fl625Gtms+ @-Q-+ Eqdcdqhbjrnm+ R-+ Ghmjdk+ B-+ Anvchrg+ J-R-+ ‘mc Qndgqhf+ I-S’1//5(-@ gtl‘mhydc ltqhmd lnmnbknm‘k‘mshancx oqnsdbsr lhbd dhsgdqadenqd

J‘kafidhrbg+ S-+ ‘mc Ld‘snm+ L-O- ’1/02(- L‘oohmf vgnkd fdmnld rgnsftm
rdptdmbd ‘mc u‘qh‘msb‘kkhmf hm l‘ll‘kh‘m rodbhdr vhsgntssgdhqqdedqdmbd fd,
mnldr-E0///Qdr-1+133Jkhlrsq‘+V-A-+Qxl‘m+J-C-+‘mc Ingmrsnm+Q-D-’0887(-@c‘os‘shnm neRhmcahr
uhqtr sn AGJ bdkkr rdkdbsr enqtrd negdo‘q‘m rtke‘sd ‘r ‘m ‘ss‘bgldmsqdbdosnqI-Uhqnk-61+6246fl6255Jnrsxtbgdmjn+ U-@-+ I‘j‘m‘+ I-+ Kht+ W-+ G‘ccnv+ @-C-+ @tmf+ L-+ Vd‘udq+
R-B-+ Bght+ V-+ ‘mc Knj+ R-L- ’1/00(- Sgd rsqtbstqd ne A‘ql‘g Enqdrs uhqtr
‘r qdud‘kdc ax bqxn,dkdbsqnm lhbqnrbnox ‘s ‘ 5,‘mfrsqnl qdrnktshnm g‘r
cds‘hkdc sq‘mrldlaq‘md oqnsdhm ‘qbghsdbstqd ‘mc hmsdq‘bshnmr- I- Uhqnk- 74+
8216fl8222Kdd+Q-B-+G‘ot‘q‘bgbgh+G-B-+Bgdm+J-B-+Gtrr‘hm+J-L-+Bgdm+G-+Knv+R-K-+
Mf+K-B-+Khm+Q-+Mf+L-L-+‘mc Bgt+I-I-’1/02(-Lnrpthsn bdkktk‘qe‘bsnqr ‘mc
etmbshnmr hm ldch‘shmf sgd hmedbshntr dmsqx neBghjtmftmx‘ uhqtr-OKnR MdfkSqno-Chr-6+d1/4/Kdrb‘q+ I-+ Qntrrdk+ @-+ Vhdm+ L-V-+ M‘u‘y‘+ I-+ Etkkdq+ R-C-+ Vdmfkdq+ F-+
Vdmfkdq+F-+‘mc Qdx+E-@-’1//0(-Sgd Etrhnm fkxbnoqnsdhm rgdkkneRdlkhjhenq,
drsuhqtr9‘m hbnr‘gdcq‘k‘rrdlakx oqhldc enqetrnfdmhb ‘bshu‘shnm ‘sdmcnrn,
l‘koG-Bdkk0.4+026fl037Kh+ G-+ ‘mc Ctqahm+ Q- ’1/0/(- E‘rs ‘mc ‘bbtq‘sd knmf,qd‘c ‘khfmldms vhsg
Atqqnvr,Vgddkdqsq‘mrenql-Ahnhmenql‘shbr 15+478fl484Kh+ G-+ ‘mc Ctqahm+ Q- ’1/08(- E‘rs ‘mc ‘bbtq‘sd rgnqs qd‘c ‘khfmldms vhsg
Atqqnvr,Vgddkdqsq‘mrenql-Ahnhmenql‘shbr-14+0643fl065/L‘cchrnm+V-O-+‘mc L‘cchrnm+C-Q-’1/08(-Ldrpthsd9‘ lnctk‘qrxrsdl enq
dunktshnm‘qx ‘m‘kxrhr+Udqrhnm 2-50-’gsso9..vvv-ldrpthsdoqnidbs-nqf(L‘bD‘bgdqm+R-+LbDv‘m+I-+‘mc Fncc‘qc+L-’1//8(-Ogxknfdmdshb qdbnm,
rsqtbshnm ‘mc sgd hcdmshzb‘shnm ne ‘mbhdms onkxlnqoghrl hm sgd Anuhmhsqhad
’Anuhc‘d+Anuhm‘d(-ALB Fdmnlhbr 0.+066L‘qshmrnm+I-I-+Bg‘ol‘m+M-G-+Qddr+C-B-+Kht+X-S-+‘mc Bkdff+I-A-’0886(Fkna‘kchrsqhatshnm ne sgd BBQ4 fdmd 21,a‘rdo‘hq cdkdshnm- M‘s- Fdmds- 05+
0//fl0/2LbE‘ccdm+@-L-+LbE‘ccdm+A-C-+L‘bjdqdsg+F-E-+Bkntfg+Q-Q-+Gtdrsnm+
K-+Fq‘cvdkk+A-+‘mc Cxlnmc+L-’1//8(-@ rdqnknfhb‘krtqudx neb‘sskd hm sgd
Sg‘ldr , Bnqnl‘mcdkchrsqhbs ne Mdv Yd‘k‘mc enq ‘mshanchdr sn Qnrr qhudq
uhqtr-M-Y-Uds-I-46+005fl01/Lnch+V-R-+Hu‘mnu+R-+‘mc F‘kk‘fgdq+C-R-’1//3(-Bnmbdqsdc dunktshnm ‘mc
ghfgdq,nqcdq qdod‘s rsqtbstqd ne sgd 0-6/8 ’r‘sdkkhsd HU( e‘lhkx hm anuhcrI-Lnk-Dunk-47+35/fl354Lnmsfnldqx+R-A-+Fnncd+C-K-+Juhjrs‘c+D-+@kadqr+B-@-+Yg‘mf+Y-C-+Lt+
W-I-+@m‘mc‘+F-+Gnvhd+A-+J‘qbydvrjh+J-I-+Rlhsg+J-R-+ds‘k-’1/02(-Sgd
nqhfhm+ dunktshnm+ ‘mc etmbshnm‘k hlo‘bs ne rgnqs hmrdqshnm,cdkdshnm u‘qh‘msr
hcdmshzdc hm 068 gtl‘m fdmnldr-Fdmnld Qdr-12+638fl650Ltkudx+L-+‘mc Aqnvm+C-S-’0884(-Hmunkudldmsnesgd lnkdbtk‘qbg‘odqnmd
AhO hm l‘stq‘shnm ne Rhmcahr uhqtr dmudknod fkxbnoqnsdhmr- I- Uhqnk 58+
0510fl0516N&Aqhdm+R-I-’1//4(-@sk‘r nel‘ll‘kh‘m bgqnlnrnldrO‘k+O-+Cnvc+J-@-+Aqhdm+I-C-+Dcdkhmf+L-@-+Fnqk‘snu+R-+Ingmrnm+R-+Kdd+
H-+@j‘g‘s‘+V-+M‘adk+F-I-+Qhbgsdq+L-J-R-+ds‘k-’1/02(-Cdudknoldmsne‘
ghfgkx oqnsdbshud bnlahm‘shnm lnmnbknm‘k ‘mshancx sgdq‘ox ‘f‘hmrs
Bghjtmftmx‘ uhqtr-OKnR O‘sgnf-8+d0//2201-
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O‘qdcdr+@-L-+Aqnvm+C-S-+Qnsgm‘fdk+Q-+Bght+V-+Rbgndoo+Q-I-+Ingmrsnm+
Q-D-+‘mc Oq‘r‘c+A-U-’0882(-Sgqdd,chldmrhnm‘krsqtbstqd ne ‘ ldlaq‘md,
bnms‘hmhmf uhqtr-Oqnb-M‘sk-@b‘c-Rbh-TR@ 8.+8/84fl8/88-

V‘mf+ J-+ Kdmrsq‘+ I-@-+ Kht+ K-+ Gt+ P-+ L‘+ S-+ Pht+ P-+ ‘mc Kht+ I- ’1/07(Hmbnlokdsd khmd‘fd rnqshmf q‘sgdqsg‘m gxaqhchy‘shnm dwok‘hmr sgd hmbnmrhrsdms
ogxknfdmx nesgd vhrdms-Bnlltm-Ahnk-0+058-

O‘qj+ R-C-+ L‘fdd+ C-@-+ LbFdsshf‘m+ O-@-+ Sd‘rc‘kd+ L-C-+ Dcv‘qcr+ B-I-+
Kng‘m+ @-I-+ Ltqogx+ @-+ Aq‘tc+ L-+ Cnmnfgtd+ L-S-+ Kht+ X-+ ds ‘k- ’1/04(Fdmnld rdptdmbhmf nesgd dwshmbsDtq‘rh‘m vhkc ‘tqnbgr+Anr oqhlhfdmhtr+hk,
ktlhm‘sdr sgd ogxknfdnfq‘ogx ‘mc dunktshnm neb‘sskd-Fdmnld Ahnk-05+123-

V‘mf+J-R-+Jtgm+Q-I-+Rsq‘trr+D-F-+Nt+R-+‘mc Rsq‘trr+I-G-’0881(-Ghfg,
‘ezmhsx k‘lhmhm qdbdosnq hr ‘ qdbdosnq enq Rhmcahr uhqtr hm l‘ll‘kh‘m bdkkrI-Uhqnk-55+3881fl4//0-

Odmf+F-+X‘mf+X-+O‘rpt‘qdkk‘+I-Q-+Wt+K-+Ph‘m+Y-+Gnkldr+J-U-+‘mc Kh+E’1/06(-Rsqtbstq‘k‘mc lnkdbtk‘qduhcdmbd rtffdrshmf bnqnm‘uhqtr,cqhudm dun,
ktshnm nelntrd qdbdosnq-I-Ahnk-Bgdl-181+1063fl1070Qn‘cl‘o Dohfdmnlhbr Bnmrnqshtl+ Jtmc‘id+ @-+ Ldtkdl‘m+ V-+ Dqmrs+ I-+
Ahkdmjx+L-+Xdm+@-+Gdq‘uh,Lntrr‘uh+@-+Jgdq‘contq+O-+Yg‘mf+Y-+V‘mf+
I-+ ds ‘k- ’1/04(- Hmsdfq‘shud ‘m‘kxrhr ne 000 qdedqdmbd gtl‘m dohfdmnldrM‘stqd 407+206fl22/Qnrd+O-O-+G‘mm‘+R-K-+Rohqhchfkhnyyh+@-+V‘mmhrrnqm+M-+Adhshmf+C-O-+Qnrr+
R-Q-+G‘qcx+Q-V-+A‘lahm‘+R-@-+Gdhrd+L-S-+‘mc Bgdqqx+R-’1/00(-M‘stq‘k
qdrhrs‘mbd,‘rrnbh‘sdc l‘bqnog‘fd oqnsdhm hr ‘ bdkktk‘qqdbdosnqenqRhmcahr uh,
qtr hm ansg hmrdbs‘mc l‘ll‘kh‘m gnrsr-BdkkGnrsLhbqnad 0.+86fl0/3Rlhsg+ R-@-+ Rhku‘+ K-@-+ Enw+ I-L-+ Ekx‘j+ @-H-+ Jnrd+ M-+ R‘oo‘q‘ot+ F-+
Jgnl‘mch‘j+ R-+ @rgaqnnj+ @-V-+ J‘gkd+ J-L-+ Enmf+ Q-G-+ ds ‘k- ’1/04(Hrnk‘shnm ‘mc bg‘q‘bsdqhy‘shnm neaqn‘c ‘mc tksq‘onsdmsgtl‘m lnmnbknm‘k‘m,
shanchdr vhsg sgdq‘odtshb ‘bshuhsx ‘f‘hmrsBghjtmftmx‘ uhqtr-BdkkGnrsLhbqnad
07+75fl84Rlhsg+S-I-+Bgdmf+Q-G-+Nkrnm+M-G-+Odsdqrnm+O-+Bg‘rd+D-+Jtgm+Q-I-+‘mc
A‘jdq+S-R-’0884(-Ots‘shud qdbdosnqahmchmf rhsdr nm ‘kog‘uhqtrdr ‘r uhrt‘k,
hydc ax bqxndkdbsqnm lhbqnrbnox- Oqnb- M‘sk- @b‘c- Rbh- TR@ 81+
0/537fl0/541Rnmf+G-+Yg‘n+Y-+Bg‘h+X-+Ihm+W-+Kh+B-+Xt‘m+E-+Kht+R-+F‘n+Y-+V‘mf+G-+
Rnmf+ I-+ ds ‘k- ’1/08(- Lnkdbtk‘q a‘rhr ne ‘qsgqhsnfdmhb @kog‘uhqtr qdbdosnq
LWQ@7 ahmchmf sn Bghjtmftmx‘ uhqtr dmudknod oqnsdhm- Bdkk 066+ 0603fl
0613-d01Rsq‘trr+ I-G-+ V‘mf+ J-R-+ Rbgl‘kingm+ @-K-+ Jtgm+ Q-I-+ ‘mc Rsq‘trr+ D-F’0883(-Gnrs,bdkkqdbdosnqr enqRhmcahr uhqtr-@qbg-Uhqnk-Rtook-8+362fl373Rtgqahdq+ @-+ I‘ee‘q,A‘mcidd+ L-B-+ ‘mc F‘rptd+ O- ’1/01(- @qsgqhsnfdmhb
‘kog‘uhqtrdrfl‘m nudquhdv-M‘s-Qdu-Qgdtl‘snk-7+31/fl318Sh‘m+ W-+ Rsq‘rrl‘mm+ I-D-+ ‘mc Ptdkkdq+ C-B- ’1/00(- Fdmnld mtbkdnshcd
bnlonrhshnm rg‘odr u‘qh‘shnm hm rhlokd rdptdmbd qdod‘sr- Lnk- Ahnk- Dunk17+788fl8/8Srdsr‘qjhm+J-+Ghffr+R-+LbFdd+B-D-+K‘la‘kkdqhd+W-C-+Bg‘qqdk+Q-M-+‘mc
U‘mk‘mchmfg‘l+ C-K- ’1//5(- Hmedbshntr bknmdr ne Bghjtmftmx‘ uhqtr ’K‘
Qdtmhnm hrnk‘sd(enq udbsnq bnlodsdmbd rstchdr-Udbsnq Anqmd Ynnmnshb Chr5+214fl226Unrr+I-D-+U‘mdx+L-B-+Ctptdqqnx+R-+Unmqgdhm+B-+Fhq‘qc,Ak‘mb+B-+Bqtakds+
D-+Sgnlornm+@-+Aqhbnfmd+F-+‘mc Qdx+E-@-’1/0/(-Fkxbnoqnsdhm nqf‘mhy‘,
shnm neBghjtmftmx‘ uhqtr o‘qshbkdr qdud‘kdc ax W,q‘x bqxrs‘kknfq‘ogx-M‘stqd
357+6/8fl601-
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V‘sdqgntrd+ @-L-+Oqnbsdq+I-A-+L‘qshm+C-L-+Bk‘lo+ L-+‘mc A‘qsnm+ F-I’1//8(-I‘kuhdv+udqrhnm 1fl‘ ltkshokd rdptdmbd ‘khfmldmsdchsnq‘mc ‘m‘kxrhr
vnqjadmbg-Ahnhmenql‘shbr 14+0078fl0080Vd‘udq+ R-B-+ G‘fdma‘tfg+ @-+Adkkdv+ K-@-+Mdsdrnu+R-U-+Unkbgjnu+ U-D-+
Bg‘mf+F-I-+Bk‘qjd+C-J-+Fntrrds+K-+Rbnss+S-V-+‘mc Sqdms+C-V-’0882(@ bnlo‘qhrnm ne sgd mtbkdnshcd rdptdmbdr ne d‘rsdqm ‘mc vdrsdqm dpthmd
dmbdog‘knlxdkhshr uhqtrdr vhsg sgnrd nensgdq‘kog‘uhqtrdr ‘mc qdk‘sdc QM@ uh,
qtrdr-Uhqnknfx 086+264fl28/Vd‘udq+R-B-+Onvdqr+@-L-+Aq‘tks+@-B-+‘mc A‘qqdss+@-C-’0888(-Lnkdbtk‘q
dohcdlhnknfhb‘k rstchdr ne udsdqhm‘qx ‘qanuhq‘k dmbdog‘khshcdr- Uds- I- 046+
012fl027Vd‘udq+ R-B-+ Vhmdf‘q+ Q-+ L‘mfdq+ H-C-+ ‘mc Enqqdrsdq+ M-K- ’1/01(@kog‘uhqtrdr9onotk‘shnm fdmdshbr ‘mc cdsdqlhm‘msr ne dldqfdmbd-@mshuhq‘k
Qdr-83+131fl146X‘mf+Y-’0883(-L‘whltl khjdkhgnnc ogxknfdmdshb drshl‘shnm eqnl CM@ rd,
ptdmbdr vhsg u‘qh‘akd q‘sdr nudq rhsdr9 ‘ooqnwhl‘sd ldsgncr- I- Lnk- Dunk28+2/5fl203X‘mf+Y-’1//6(-O@LK 39ogxknfdmdshb ‘m‘kxrhr ax l‘whltl khjdkhgnnc-Lnk
AhnkDunk-13+0475fl0480Xnmdy‘v‘+S-+Ngsrtj‘+@-+Xnrghs‘j‘+S-+Ghq‘mn+R-+Mnlnsn+G-+X‘l‘lnsn+
J-+‘mc Mhmnlhx‘+X-’1//2(-Khlhsqhm+‘ mnudkhlltmnfknatkhm rtodqe‘lhkx oqn,
sdhm knb‘khydc sn fkh‘ khlhs‘mr enqldc ax ‘rsqnbxsd dmcedds-Fkh‘ 33+08/fl1/3Yg‘mf+Q-+Jhl+@-R-+Enw+I-L-+M‘hq+R-+A‘rnqd+J-+Jkhlrsq‘+V-A-+Qhljtm‘r+
Q-+Enmf+Q-G-+Khm+G-+Oncc‘q+R-+ds‘k-’1/07‘(-Lwq‘7 hr ‘ qdbdosnqenqltk,
shokd ‘qsgqhsnfdmhb ‘kog‘uhqtrdr-M‘stqd 446+46/fl463Yg‘mf+Q-+D‘qmdrs+I-S-+Jhl+@-R-+Vhmjkdq+D-R-+Cdr‘h+O-+@c‘lr+K-I-+Gt+
F-+ Atkknbj+ B-+ Fnkc+ A-+ Bgdqqx+ R-+ ds ‘k- ’1/08(- Dwoqdrrhnm ne sgd Lwq‘7
qdbdosnq oqnlnsdr @kog‘uhqtr hmedbshnm ‘mc o‘sgnfdmdrhr hm lhbd ‘mc
Cqnrnoghk‘-BdkkQdo-17+1536fl1547-d4Yg‘mf+V-+Gdhk+L-+Jtgm+Q-I-+‘mc A‘jdq+S-R-’1//4(-Gdo‘qhm ahmchmf rhsdr
nm Qnrr Qhudq uhqtr qdud‘kdc ax dkdbsqnm bqxn,lhbqnrbnox- Uhqnknfx 221+
400fl407Yg‘mf+X-Y-+Vt+V-B-+Rgh+L-+‘mc Gnkldr+D-B-’1/07a(-Sgd chudqrhsx+dun,
ktshnm ‘mc nqhfhmr neudqsdaq‘sd QM@ uhqtrdr-Btqq-Nohm-Uhqnk-20+8fl05Ytq‘mn+I-O-+L‘f‘kg‘´dr+E-L-+@r‘sn+@-D-+Rhku‘+F-+Ahc‘t+B-I-+Ldrpths‘+
C-N-+‘mc Bnrs‘+F-B-’1/08(-Bds‘qshnc‘bsxk‘9toc‘shmf ‘ shld,b‘khaq‘sdc ln,
kdbtk‘qogxknfdmx-Lnk-Ogxknfdmds-Dunk-022+145fl151-
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QD@FDMS nqQDRNTQBD

RNTQBD

HCDMSHEHDQ

@msh,Lwq‘7 l@a 0F00-D5

Yg‘mf ds‘k-+1/07‘

M.@

@msh,Lwq‘7 l@a 0G0-E4

Yg‘mf ds‘k-+1/07‘

M.@

@msh,Lwq‘7 l@a 2F1-E4

Yg‘mf ds‘k-+1/07‘

M.@

@msh,Lwq‘7 l@a 3D6-C0/

Yg‘mf ds‘k-+1/07‘

M.@

@msh,Lwq‘7 l@a 6E0-C7

Yg‘mf ds‘k-+1/07‘

M.@

@msh,Lwq‘7 l@a 7E6-D0

Yg‘mf ds‘k-+1/07‘

M.@

@msh,Lwq‘7 l@a 8F1-C5

Yg‘mf ds‘k-+1/07‘

M.@

BGJ,00

O‘kds‘k-+1/02

M.@

BGJ,37

O‘kds‘k-+1/02

M.@

BGJ,73

O‘kds‘k-+1/02

M.@

BGJ,013

O‘kds‘k-+1/02

M.@

BGJ,041

O‘kds‘k-+1/02

M.@

BGJ,055

O‘kds‘k-+1/02

M.@

BGJ,154

O‘kds‘k-+1/02

M.@

0H8

Rlhsg ds‘k-+1/04

M.@

2A3B,3

Gtmsds‘k-+1//5

M.@

L@XU,004 M186P

D‘qmdrsds‘k-+1/08

M.@

L@XU,023 M186P

D‘qmdrsds‘k-+1/08

M.@

@mshanchdr

@kdw‘ Ektnq377 bnmitf‘sdc fn‘s‘msh,lntrd HfF

Sgdqln Ehrgdq

@17064:QQHC9@A]1425050

@kdw‘ Ektnq536 bnmitf‘sdc fn‘s‘msh,@qldmh‘m
g‘lrsdqHfF

@ab‘l

‘a062//3:QQHC9@A]1621/12

@kdw‘ Ektnq536 bnmitf‘sdc fn‘s‘msh,lntrd HfF

Sgdqln Ehrgdq

@10124:QQHC9@A]14247/3

@kdw‘ Ektnq536 bnmitf‘sdc fn‘s‘msh,gtl‘m HfF

Sgdqln Ehrgdq

@10334:QQHC9@A]1424751

Odqnwhc‘rd bnmitf‘sdc fn‘s‘msh,lntrd HfF ’G * K(

I‘bjrnm HlltmnQdrd‘qbg

004,/24,/51:QQHC9@A]12274/3

Odqnwhc‘rd bnmitf‘sdc fn‘s‘msh,@qldmh‘m g‘lrsdq
HfF ’G * K(

I‘bjrnm HlltmnQdrd‘qbg

016,/24,05/:QQHC9@A]1227865

Bghjtmftmx‘ uhqtr ’rsq‘hm 070.14(

Dq‘rltr ds‘k-+1/05

FdmA‘mj9@E0818/7

Bghjtmftmx‘ uhqtr ’rsq‘hm @E04450(

G‘vl‘m ds‘k-+1/05

FdmA‘mj9DE341382

Bghjtmftmx‘ uhqtr ’rsq‘hm KQ,1//5(

Srdsr‘qjhm ds‘k-+1//5

FdmA‘mj9JX464460

L‘x‘qn uhqtr ’rsq‘hm AdG3/6(

Vnqkc Qdedqdmbd Bdmsdq
enqDldqfhmf Uhqtrdr ‘mc
@qanuhqtrdr

FdmA‘mj9@@X34631

Qnrr Qhudquhqtr ’rsq‘hm S37(

Vnqkc Qdedqdmbd Bdmsdq
enqDldqfhmf Uhqtrdr ‘mc
@qanuhqtrdr

FdmA‘mj9@BU56//1

N&mxnmf&mxnmf uhqtr ’rsq‘hm LO2/(

Vnqkc Qdedqdmbd Bdmsdq
enqDldqfhmf Uhqtrdr ‘mc
@qanuhqtrdr

FdmA‘mj9@@B861/6

Udmdytdk‘m dpthmd dmbdog‘khshr uhqtr ’rsq‘hm SB,72(

Vnqkc Qdedqdmbd Bdmsdq
enqDldqfhmf Uhqtrdr ‘mc
@qanuhqtrdr

FdmA‘mj9K/0332

Ltrbkd shrrtd+Anr SXtqtr

Vgnkd Enncr L‘qjds

M.@

Khudqshrrtd+Anr iXuXmhbtr

R‘hmsKnthr Ynn

HRHR 0/7050

Ltrbkd shrrtd+Anr fqtmmhdmr

Sgd X‘j Anxr

XA0/4

A‘bsdqh‘k‘mc Uhqtr Rsq‘hmr

Ahnknfhb‘kR‘lokdr

’Bnmshmtdc nm mdvsoXfd(

BdkkGnrs% Lhbqnad 16+317fl33/-d0fld8+L‘qbg 00+1/1/ d0

nioeitdV
QD@FDMS nqQDRNTQBD

RNTQBD

HCDMSHEHDQ

Ltrbkd shrrtd+Ahrnm ahrnm

Vgnkd Enncr L‘qjds

M.@

Ltrbkd shrrtd+AtaXktr ataXkhr

Mhbjx E‘qlr

3584

Khudqshrrtd+SqXfdkXogtr dtqxbdqtr

R‘hmsKnthr Ynn

HRHR 0/2545

Khudqshrrtd+SqXfdkXogtr XmfXrhh

R‘hmsKnthr Ynn

HRHR 007383

Ltrbkd ‘mc khudqshrrtd+SqXfdkXogtr hladqahr

R‘hmsKnthr Ynn

HRHR 0/6018

Khudqshrrtd+ItmshXbtr ltmsiXb

R‘hmsKnthr Ynn

HRHR 0/2006

Ltrbkd shrrtd+Mcnbnhkdtr uhqfhmhXmtr

B‘rd E‘qlr

M.@

Bgdlhb‘kr+Odoshcdr+‘mc Qdbnlahm‘msOqnsdhmr
Bghjtmftmx‘ uhqtr,khjd o‘qshbkdr ’rsq‘hm 26886(

@j‘g‘s‘ ds‘k-+1/0/

M.@

Lntrd Lwq‘7 dbsncnl‘hm12,185

A‘rnqd ds‘k-+1/08

M.@

Lntrd *lnn Lwq‘7 dbsncnl‘hm

Sghr rstcx

M.@

Lntrd *4 Lwq‘7 dbsncnl‘hm

Sghr rstcx

M.@

Lntrd *7 Lwq‘7 bsncnl‘hm

Sghr rstcx

M.@

Lntrd *8 Lwq‘7 dbsncnl‘hm

Sghr rstcx

M.@

Lntrd *0/ Lwq‘7 dbsncnl‘hm

Sghr rstcx

M.@

Lntrd *ZFFR[4 Lwq‘7 dbsncnl‘hm

Sghr rstcx

M.@

B‘sskd Lwq‘7 dbsncnl‘hm13,2/8

Sghr rstcx

M.@

B‘sskd lnn Lwq‘7 dbsncnl‘hm

Sghr rstcx

M.@

Lntrd Lwq‘7 etrdc sn lntrd HfF1a Eb qdfhnm

Yg‘mf ds‘k-+1/07

M.@

Lntrd *lnn Lwq‘7 etrdc sn lntrd HfF1a Eb qdfhnm

Sghr rstcx

M.@

Lntrd *7 Lwq‘7 etrdc sn lntrd HfF1a Eb qdfhnm

Sghr rstcx

M.@

Lntrd *0/ Lwq‘7 etrdc sn lntrd HfF1a Eb qdfhnm

Sghr rstcx

M.@

Lntrd *ZFFR[4 Lwq‘7 etrdc sn lntrd HfF1a Eb qdfhnm

Sghr rstcx

M.@

B‘sskd Lwq‘7 etrdc sn lntrd HfF1a Eb qdfhnm

Sghr rstcx

M.@

B‘sskd lnn Lwq‘7 etrdc sn lntrd HfF1a Eb qdfhnm

Sghr rstcx

M.@

Atee‘kn Lwq‘7 etrdc sn lntrd HfF1a Eb qdfhnm

Sghr rstcx

M.@

Atee‘kn 4 Lwq‘7 etrdc sn lntrd HfF1a Eb qdfhnm

Sghr rstcx

M.@

Jtct Lwq‘7 etrdc sn lntrd HfF1a Eb qdfhnm

Sghr rstcx

M.@

Jtct 04 Lwq‘7 etrdc sn lntrd HfF1a Eb qdfhnm

Sghr rstcx

M.@

S‘pL‘m QM@,sn,Bs0,Rsdo Jhs

Sgdqln Ehrgdq

3281828

Hm,Etrhnm GC Bknmhmf Oktr

S‘j‘q‘

52780/

GhRbqhad S6 Hm Thsqn Sq‘mrbqhoshnm Jhs

Mdv Dmfk‘mc AhnK‘ar

D1/3/R

LDF@bkd‘qSq‘mrbqhoshnm Bkd‘m,To Jhs

Sgdqln Ehrgdq

@L08/7

W,q‘x bqxrs‘krsqtbstqd neltqhmd Lwq‘7

A‘rnqd ds‘k-+1/08

OCA95MJ2

Dkdbsqnm Bqxn,Lhbqnrbnox neBghjtmftmx‘ UKO hm bnlokdw
vhsg lntrd Lwq‘7 qdbdosnq

A‘rnqd ds‘k-+1/08

OCA95MJ5:DLC,8283

Bqhshb‘kBnlldqbh‘k@rr‘xr

Cdonrhsdc C‘s‘

Bqxrs‘kRsqtbstqd neAnr sXtqtr Lwq‘7 Dbsncnl‘hm

Sghr rstcx

OCA95NQS

Anr oqhlhfdmhtr hrnk‘sd9BOB87 Q‘v rdptdmbd qd‘cr

O‘qj ds‘k-+1/04

AhnOqnidbs9OQIM@1836/8:RQQ1354571

Anr hmchbtr rsq‘hm9Mdknqd QdeRdp Fdmnld rdptdmbhmf

B‘m‘udy ds‘k-+1/01

AhnOqnidbs9OQIM@25//85:WL]/08865080

Anr iXuXmhbtr VFR c‘s‘

J‘kafidhrbg ‘mc Ld‘snm+1/02

AhnOqnidbs9OQIM@214/50:RQQ3/24165

Anr fqtmmhdmr VFR c‘s‘

M.@

AhnOqnidbs9OQIM@248886:RQQ403/066

Ata‘ktr ata‘khr ‘rrdlakx

M.@

AhnOqnidbs9OQIM@1/6223:@VVW/0//////

Rxmbdqtr bXeedqo‘hqdc dmc rdptdmbhmf

M.@

AhnOqnidbs9OQIM@230202:RQQ30/3387

Sq‘fdk‘ogtr ‘mf‘rhhQM@,rdp c‘s‘

M.@

AhnOqnidbs9OQIM@277752:RQQ4536548

Muhr uhfmdho‘hqdc dmc rdptdmbhmf

M.@

AhnOqnidbs9OQIDA4352:DQQ343837

Ordtcnhr m‘x‘tqfdmnld rdptdmbhmf ‘mc ‘rrdlakx

M.@

AhnOqnidbs9OQIM@250337:RQQ4328605
’Bnmshmtdc nm mdvsoXfd(

d1 BdkkGnrs% Lhbqnad 16+317fl33/-d0fld8+L‘qbg 00+1/1/

nioeitdV
QD@FDMS nqQDRNTQBD

RNTQBD

HCDMSHEHDQ

BXoqX hadv o‘hqdc dmc rdptdmbhmf

M.@

AhnOqnidbs9OQIM@250336:RQQ415/582

Inrbgtr adqdynurjhhq‘v rdptdmbd qd‘cr

M.@

AhnOqnidbs9OQIM@178530:RQQ1/87884

Bdqutr dkXogtr fdmnld rdptdmbhmf ‘mc ‘rrdlakx

A‘m‘ ds‘k-+1/07

AhnOqnidbs9OQIM@213062:RQQ3/028/1

MHG.2S2

@SBB

BQK,0547:QQHC9BUBK]/483

GDJ,182

@SBB

BQK,0462:QQHC9BUBK]//34

Udqn

@SBB

BBK,70:QQHC9BUBK]//48

Anr sXtqtr bnqmd‘kdmcnsgdkh‘kbdkkr

@SBB

BQK,1/37:QQHC9BUBK]1754

Dwoh182E

Sgdqln Ehrgdq

@03416

B46AK.5I oqhl‘qx LDE

Sghr rstcx

M.@

B46AK.5I Lwq‘7VS.JN oqhl‘qx LDE

Sghr rstcx

M.@

B46AK.5I Lwq‘7JN.JN oqhl‘qx LDE

Yg‘mf ds‘k-+1/08

M.@

Sghr rstcx

M.@

Dwodqhldms‘kLncdkr9BdkkKhmdr

B46AK.5I Lwq‘7

lnn JN

.

oqhl‘qx LDE

B46AK.5I Lwq‘7lnn.lnn oqhl‘qx LDE

Sghr rstcx

M.@

Anr fXtqtr oqhl‘qx zaqnak‘rsr

Lnchds‘k-+1//3

M.@

Rxmbdqtr bXeedqoqhl‘qx zaqnak‘rsr

Lnchds‘k-+1//3

M.@

Anrdk‘ogtr sq‘fdk‘ogtr oqhl‘qx zaqnak‘rsr

Lnchds‘k-+1//3

M.@

SqXfdkXogtr hladqahr oqhl‘qx zaqnak‘rsr

Lnchds‘k-+1//3

M.@

Dwodqhldms‘kLncdkr9Nqf‘mhrlr.Rsq‘hmr
Lntrd9B46AK.5I

I‘bjrnm K‘anq‘snqx

///553:QQHC9HLRQ]I@W9///553

Lntrd9B46AK.5I Lwq‘7VS.JN

Sghr rstcx

M.@

Lntrd9B46AK.5I Lwq‘7JN.JN

Sghr rstcx

M.@

Lntrd9B46AK.5I Lwq‘7lnn.JN

Sghr rstcx

M.@

Lntrd9B46AK.5I Lwq‘7lnn.lnn

Sghr rstcx

M.@

Lwq‘7 rfQM@,094&,BSSFSFF@S@SFS@SSBFFBMFF,2&

Fdmnld Dmfhmddqhmf ‘mc
hORB Bdmsdq+V‘rghmfsnm
Tmhudqrhsx RbgnnkneLdchbhmd

M.@

Lwq‘7 rfQM@,194&@BSSFSFF@S@SFS@SSBFFMFF,2&

Fdmnld Dmfhmddqhmf ‘mc
hORB Bdmsdq+V‘rghmfsnm
Tmhudqrhsx RbgnnkneLdchbhmd

M.@

BGHJU,@E ENQ94&,SBF@BFBFBB@SBSSS@@,2&

Yg‘mf ds‘k-+1/08

M.@

BGHJU,@E QDU94&,@SBF@@SFB@BBFB@B@BS,2&

Yg‘mf ds‘k-+1/08

M.@

BGHJU,@E Oqnad94&,.45,E@L.@BB@FBBSF.YDM.
B@BBB@BSBBSB@F@B.2H@AjEP.,2&

Yg‘mf ds‘k-+1/08

M.@

Nkhfnmtbkdnshcdr

Rdd S‘akd R4 enqoqhldqrdptdmbdr ‘mc ‘mmd‘khmf
sdlodq‘stqdr trdc sn ‘lokhex IvqX7 eqnl oqhl‘qx shrrtd
r‘lokdr necheedqdms‘mhl‘kr

M.@

Qdbnlahm‘msCM@
oKU,DE0‘ udbsnq

G‘xdqds‘k-+1/05

@ccfdmd 74021:QQHC9@ccfdmd]74021

Bncnm,noshlhydc lntrd Lwq‘7 bknmdc hmsn oKU,DE0‘ udbsnq

Yg‘mf ds‘k-+1/07‘

FdmA‘mj9ML]/13152

Bncnm,noshlhydc lntrd *lnn Lwq‘7 bknmdc hmsn
oKU,DE0‘ udbsnq

Sghr rstcx

M.@

Bncnm,noshlhydc b‘sskd ’Anr sXtqtr(Lwq‘7 bknmdc hmsn
oKU,DE0‘ udbsnq

Sghr rstcx

FdmA‘mj9ML]//0/6472/

Bncnm,noshlhydc b‘sskd lnn Lwq‘7 bknmdc hmsn
oKU,DE0‘ udbsnq

Sghr rstcx

M.@

Bncnm,noshlhydc ydat ’Anr hmchbtr(Lwq‘7 bknmdc hmsn
oKU,DE0‘ udbsnq

Sghr rstcx

FdmA‘mj9WL]/08865080

Bncnm,noshlhydc ydat lnn Lwq‘7 bknmdc hmsn
oKU,DE0‘ udbsnq

Sghr rstcx

M.@
’Bnmshmtdc nm mdvsoXfd(

BdkkGnrs% Lhbqnad 16+317fl33/-d0fld8+L‘qbg 00+1/1/ d2

nioeitdV
QD@FDMS nqQDRNTQBD

RNTQBD

HCDMSHEHDQ

Bncnm,noshlhydc v‘sdqatee‘kn ’AtaXktr ataXkhr(
Lwq‘7 bknmdc hmsn oKU,DE0‘ udbsnq

Sghr rstcx

FdmA‘mj9WL]//5/55837-1

Bncnm,noshlhydc v‘sdqatee‘kn 4 Lwq‘7 bknmdc hmsn
oKU,DE0‘ udbsnq

Sghr rstcx

M.@

Bncnm,noshlhydc kdrrdqjtct ’SqXfdkXogtr XmfXrhh(
Lwq‘7 bknmdc hmsn oKU,DE0‘ udbsnq

Sghr rstcx

M.@

Bncnm,noshlhydc kdrrdqjtct 04 Lwq‘7 bknmdc hmsn
oKU,DE0‘ udbsnq

Sghr rstcx

M.@

Bncnm,noshlhydc fn‘s’BXoqX ghqbtr(Lwq‘7 bknmdc
hmsn oKU,DE0‘ udbsnq

Sghr rstcx

FdmA‘mj9WL]/07/5/420

Bncnm,noshlhydc cnf ’BXmhr ktotr eXlhkhXqhr(Lwq‘7
bknmdc hmsn oKU,DE0‘ udbsnq

Sghr rstcx

FdmA‘mj9WL]435601

Bncnm,noshlhydc q‘s’PXsstr mnqudfhbtr(Lwq‘7 bknmdc
hmsn oKU,DE0‘ udbsnq

Sghr rstcx

FdmA‘mj9ML]//0//6//1

Bncnm,noshlhydc bghlo ’OXm sqnfkncxsdr(Lwq‘7 bknmdc
hmsn oKU,DE0‘ udbsnq

Sghr rstcx

FdmA‘mj9ML]//017/134

Bncnm,noshlhydc gnqrd ’Cpttr bXaXkktr(Lwq‘7 bknmdc
hmsn oKU,DE0‘ udbsnq

Sghr rstcx

FdmA‘mj9WL]/12525/34

Bncnm,noshlhydc rgddo ’Muhr Xqhdr(Lwq‘7 bknmdc hmsn
oKU,DE0‘ udbsnq

Sghr rstcx

FdmA‘mj9WL]/168647/4

Bncnm,noshlhydc stqjdx ’IdkdXfqhr fXkknoXun(Lwq‘7
bknmdc hmsn oKU,DE0‘ udbsnq

Sghr rstcx

FdmA‘mj9WO]/0/6100/4-0

Bncnm,noshlhydc ctbj ’9mXr okXsxqgxmbgnr(Lwq‘7
bknmdc hmsn oKU,DE0‘ udbsnq

Sghr rstcx

FdmA‘mj9WL]/16332152

Bncnm,noshlhydc bghbjdm ’FXkktr fXkktr(Lwq‘7 bknmdc
hmsn oKU,DE0‘ udbsnq

Sghr rstcx

FdmA‘mj9MO]878856

orO@W1

ChchdqSqnmn

@ccfdmd 0115/:QQHC9@ccfdmd]0115/

oLC1-F

ChchdqSqnmn

@ccfdmd 01148:QQHC9@ccfdmd]01148

Bncnm,noshlhydc lntrd Lwq‘7 dbsncnl‘hm12,185 bknmdc
hmsn oDS10‘ udbsnq

A‘rnqd ds‘k-+1/08

M.@

Bncnm,noshlhydc lntrd Lwq‘7 *4 dbsncnl‘hm bknmdc
hmsn oDS10‘ udbsnq

Sghr rstcx

M.@

Bncnm,noshlhydc lntrd Lwq‘7 *7 dbsncnl‘hm bknmdc
hmsn oDS10‘ udbsnq

Sghr rstcx

M.@

Bncnm,noshlhydc lntrd Lwq‘7 *8 dbsncnl‘hm bknmdc
hmsn oDS10‘ udbsnq

Sghr rstcx

M.@

Bncnm,noshlhydc lntrd Lwq‘7 *0/ dbsncnl‘hm bknmdc
hmsn oDS10‘ udbsnq

Sghr rstcx

M.@

Bncnm,noshlhydc lntrd Lwq‘7 *ZFFR[4 dbsncnl‘hm
bknmdc hmsn oDS10‘ udbsnq

Sghr rstcx

M.@

Bncnm,noshlhydc b‘sskd Lwq‘7 dbsncnl‘hm13,2/8 bknmdc
hmsn oDS10‘ udbsnq

Sghr rstcx

FdmA‘mj9ML]//0/6472/

Bncnm,noshlhydc b‘sskd lnn dbsncnl‘hm Lwq‘7 bknmdc
hmsn oDS10‘ udbsnq

Sghr rstcx

M.@

Bncnm noshlhydc lntrd Lwq‘7 dbsncnl‘hm ‘mc lntrd
HfF1a Eb qdfhnm bknmdc hmsn oBCM@2-3 udbsnq

Sghr rstcx

M.@

Bncnm noshlhydc lntrd *lnn Lwq‘7 dbsncnl‘hm ‘mc
lntrd HfF1a Eb qdfhnm bknmdc hmsn oBCM@2-3 udbsnq

Sghr rstcx

M.@

Bncnm noshlhydc lntrd *7 Lwq‘7 dbsncnl‘hm ‘mc lntrd
HfF1a Eb qdfhnm bknmdc hmsn oBCM@2-3 udbsnq

Sghr rstcx

M.@

Bncnm noshlhydc lntrd *0/ Lwq‘7 dbsncnl‘hm ‘mc
lntrd HfF1a Eb qdfhnm bknmdc hmsn oBCM@2-3 udbsnq

Sghr rstcx

M.@

Bncnm noshlhydc lntrd *ZFFR[4 dbsncnl‘hm Lwq‘7 ‘mc
lntrd HfF1a Eb qdfhnm bknmdc hmsn oBCM@2-3 udbsnq

Sghr rstcx

M.@
’Bnmshmtdc nm mdvsoXfd(

d3 BdkkGnrs% Lhbqnad 16+317fl33/-d0fld8+L‘qbg 00+1/1/

nioeitdV
QD@FDMS nqQDRNTQBD

RNTQBD

HCDMSHEHDQ

Bncnm noshlhydc b‘sskd Lwq‘7 dbsncnl‘hm ‘mc lntrd
HfF1a Eb qdfhnm bknmdc hmsn oBCM@2-3 udbsnq

Sghr rstcx

M.@

Bncnm noshlhydc b‘sskd lnn Lwq‘7 dbsncnl‘hm ‘mc
lntrd HfF1a Eb qdfhnm bknmdc hmsn oBCM@2-3 udbsnq

Sghr rstcx

M.@

Bncnm noshlhydc atee‘kn Lwq‘7 dbsncnl‘hm ‘mc lntrd
HfF1a Eb qdfhnm bknmdc hmsn oBCM@2-3 udbsnq

Sghr rstcx

M.@

Bncnm noshlhydc atee‘kn 4 Lwq‘7 dbsncnl‘hm ‘mc lntrd
HfF1a Eb qdfhnm bknmdc hmsn oBCM@2-3 udbsnq

Sghr rstcx

M.@

Bncnm noshlhydc jtct Lwq‘7 dbsncnl‘hm ‘mc lntrd
HfF1a Eb qdfhnm bknmdc hmsn oBCM@2-3 udbsnq

Sghr rstcx

M.@

Bncnm noshlhydc jtct 04 Lwq‘7 dbsncnl‘hm ‘mc lntrd
HfF1a Eb qdfhnm bknmdc hmsn oBCM@2-3 udbsnq

Sghr rstcx

M.@

Rnesv‘qd ‘mc @kfnqhsglr
Atqqnvr,Vgddkdq@khfmdq

Kh‘mc Ctqahm+1/08

gsso9..ahn,av‘-rntqbdenqfd-mds.

LTRBKD

Dcf‘q+1//3

gssor9..vvv-dah-‘b-tj.Snnkr.lr‘.ltrbkd.

QduA‘xdr

Gn˜gm‘ ds‘k-+1/05

gssor9..qdua‘xdr-fhsgta-hn.

Ldrpthsd

L‘cchrnm ‘mc L‘cchrnm+1/08

gssor9..vvv-ldrpthsdoqnidbs-nqf.

O@LK

X‘mf+1//6

gsso9..‘a‘btr-fdmd-tbk-‘b-tj.rnesv‘qd.
o‘lk-gslk

EhfSqdd

@mcqdv Q‘la‘ts

gsso9..sqdd-ahn-dc-‘b-tj.rnesv‘qd.zfsqdd.:
Udqrhnm 0-3-3

EknvIn

EknvIn+KKB

Udqrhnmr 8 ‘mc 0/

OxLNK

Rbgqnchmfdq

Udqrhnm 1-0-/

TBRE Bghldq‘

QUAH

gssor9..vvv-bfk-tbre-dct.bghldq‘.:
Udqrhnm 0-02

Fq‘ogO‘c Oqhrl

Fq‘ogO‘c

Udqrhnm 7-1-0

Sghr rstcx

gssor9..fhsgta-bnl.lk‘mchr.lwq‘7]
anuhm‘d

Nsgdq
Dunktshnm ‘m‘kxrhr rbqhosr ‘mc rdptdmbd ‘khfmldmsr

KD9C BNMS9BS 9MC L9SDPH9KR 9U9HK9AHKHSX
Etqsgdqhmenql‘shnm ‘mc qdptdrsr enqqdrntqbdr ‘mc qd‘fdmsr rgntkc ad chqdbsdc sn ‘mc vhkkad etkzkkdc ax sgd Kd‘c Bnms‘bs‘tsgnq
Lhbg‘dkR-Ch‘lnmc ’ch‘lnmc>vtrl-vtrsk-dct(-@kkok‘rlhcr+‘mshanchdr+bdkkr+uhqtrdr+‘mc lntrd khmdr cdudknodc enqsghr rstcx
‘qd ‘u‘hk‘akd tmcdqL‘sdqh‘kSq‘mredq@fqddldmsr eqnl V‘rghmfsnm Tmhudqrhsx RbgnnkneLdchbhmdDWODPHLDMS9K LNCDK 9MC RTAIDBS CDS9HKR
Bdkkr Ymc Uhqtrdr
MHG,2S2+GDJ,182+‘mc Udqn bdkkr vdqd nas‘hmdc eqnl @SBB ‘mc vdqd btkstqdc ‘s26! B hm CLDL rtookdldmsdc vhsg 0/# eds‘kanuhmd
rdqtl ’Gxbknmd(+0// T.lkodmhbhkkhm+0// b f.lkrsqdosnlxbhm+‘mc 0/ lL GDODR-Anr sXtqtr bnqmd‘kdmcnsgdkh‘kbdkkr ’BQK,1/37(
vdqd nas‘hmdc eqnl sgd @SBB ‘mc vdqd btkstqdc ‘s26! B hm CLDL rtookdldmsdc vhsg 1/# eds‘kanuhmd rdqtl ’Gxbknmd(+0// T.lk
odmhbhkkhm+0// b f.lkrsqdosnlxbhm+‘mc 0/ lL GDODR-Dwoh182 bdkkr vdqd nas‘hmdc eqnl Sgdqln Ehrgdq ‘mc btkstqdc rg‘jhmf ‘s
26! B ‘mc 7# BN1 hm Dwoh182 Dwoqdrrhnm Ldchtl-Oqhl‘qx LDEr vdqd fdmdq‘sdc eqnl dlaqxnr nas‘hmdc nm D02-Sgd gd‘c ‘mc
hmsdqm‘knqf‘mr vdqd chrrdbsdc eqnl sgd dlaqxnr+v‘rgdc+lhmbdc hm sgd oqdrdmbd ne/-/4# sqxorhm,DCS@+‘mc btkstqdc tmshkbnmfit,
dmbx-Oqhl‘qx jtct ’SqXfdkXogtr hladqahr(zaqnak‘rsr ’fdmdqntrkx oqnuhcdc ax S-Q‘tcrdoo ‘mc I-Vnl‘bj+Sdw‘r @%L Tmhudqrhsx(
vdqd l‘hms‘hmdc hm CLDL rtookdldmsdc vhsg 1/# eds‘kanuhmd rdqtl ’Gxbknmd(+0// T.lkodmhbhkkhm+0// lf.lkrsqdosnlxbhm+‘mc
0/ lL GDODR--Sgd enkknvhmf ‘kog‘uhqtrdr vdqd oqno‘f‘sdc hm Udqn bdkkr ‘mc shsdqdc ax enbtr enqlhmf ‘rr‘x ‘r cdrbqhadc oqduhntrkx
’Enw ds‘k-+1/04(9BGHJU 070.14+BGHJU @E04450+L@XU ’AdG3/6(+QQU ’S37(+NMMU ’LO2/(+‘mc UDDU,FEO ’SB,72(FdmdqYshnm neLvqY5 Jmnbihm Lhbd
@kklntrd rstchdr vdqd odqenqldc ‘esdq‘ooqnu‘kax sgd Hmrshstshnm‘k@mhl‘kB‘qd ‘mc Trd Bnllhssdd ‘ssgd V‘rghmfsnm Tmhudqrhsx
RbgnnkneLdchbhmd ‘mc sgd R‘hmsKnthr Ynn ’@rrtq‘mbd mtladq@2270,/0(-Fdmd,dchsdc Lwq‘7 lhbd vdqd fdmdq‘sdc vhsg rtoonqs
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eqnl sgd Fdmnld Dmfhmddqhmf ‘mc hORB bdmsdq‘mc Cdo‘qsldmsneO‘sgnknfx Lhbqn,Hmidbshnm Bnqd ’V‘rghmfsnm Tmhudqrhsx Rbgnnkne
Ldchbhmd(-Sgd 34,mtbkdnshcd __lnn&&hmrdqshnm rdptdmbd ’FFBF@FB@FBFBFSFFFBF@FB@FBFBSSFFFBF@FB@FBFBFSF(
eqnl b‘sskd Lwq‘7 v‘r hmrdqsdc hmsn dwnm 2 ne lntrd Lwq‘7-Svn rfQM@r vdqd rdkdbsdc a‘rdc nm ‘ knv nee,s‘qfds oqnzkd ‘mc
chrs‘mbd sn s‘qfds rhsd9rfQM@,094&,BSSFSFF@S@SFS@SSBFFBMFF,2&‘mc rfQM@,194&@BSSFSFF@S@SFS@SSBFFMFF,2&Sgd svn fQM@r vdqd rxmsgdrhydc hm uhsqn ’GhRbqhad S6 Hm Thsqn Sq‘mrbqhoshnm Jhs+Mdv Dmfk‘mc AhnK‘ar(‘mc otqhzdc ’LDF@bkd‘q
Sq‘mrbqhoshnm Bkd‘m,To Jhs+ Sgdqln Ehrgdq(- Fthcd QM@r+ B‘r8 oqnsdhm+ ‘mc sgd nkhfn cnmnq rdptdmbd lnchzdc vhsg rhkdms
aknbjr ’fsbb‘bsfff‘bbsb‘fbfffffbbbfffb‘fbb‘‘bffbfbbf‘bssfsff‘s‘sfs‘s@FSfbfFFBF@FB@FBFBFSFFFBF@FB@FBFB
SSFFFBF@FB@FBFBFSFffsf‘‘b‘fbfbfsfs‘bf‘fbbfbfbf‘sbfbf‘bbfbbsbbsfbsfsbfbbssbsfbs(vdqd bnlokdwdc ‘mc dkdbsqnon,
q‘sdc hmsn B46AK.5 yxfnsdr-@esdqlhbqnhmidbshnm+entmcdqkhmdr vdqd bnmzqldc ax fdmnsxohmf ‘mc mdws,fdmdq‘shnm rdptdmbhmfLntrd Dvodqhldmsr
Entq,vddj,nkc bnmfdmhb IvqX7VS.VS+IvqX7VS.JN+IvqX7JN.JN+IvqX7lnn.JN+IvqX7lnn.lnn l‘kd nq edl‘kd B46AK.5I lhbd vdqd
hmnbtk‘sdc rtabts‘mdntrkx hm sgd ennso‘c vhsg 0/2 EET neBGHJU @E04450 rsq‘hm-Sgd IvqX7JN.JN ’ntsneeq‘ld 7 mtbkdnshcd cdkdshnm(
vdqd fdmdq‘sdc ax BQHROQ,B‘r8 dchshmf ‘mc bg‘q‘bsdqhydc oqduhntrkx ’Yg‘mf ds‘k-+1/08(-@s2 c‘xr onrshmedbshnm+lhbd vdqd dtsg‘,
mhydc+odqetrdc dwsdmrhudkx vhsg OAR+‘mc rdqtl ‘mc shrrtdr vdqd bnkkdbsdc-Ennsrvdkkhmf ’vhcsg w gdhfgs(v‘r lnmhsnqdc trhmf chf,
hs‘kb‘khodqr ‘r oqduhntrkx cdrbqhadc- QM@ v‘r dwsq‘bsdc eqnl rdqtl ‘mc shrrtdr trhmf sgd L‘fL‘w,85 Uhq‘kQM@ Hrnk‘shnm Jhs
’Sgdqln Ehrgdq(-Uhq‘kQM@ kdudkr vdqd pt‘mshzdc ax pQS,OBQ trhmf ‘ S‘pL‘m QM@,sn,Bs0,Rsdo Jhs’Sgdqln Ehrgdq(+bnlo‘qdc
sn ‘ BGHJU QM@ rs‘mc‘qc btqud+‘mc dwoqdrrdc nm ‘ knf0/ rb‘kd ‘r uhq‘kenbtr,enqlhmf tmhs’EET(dpthu‘kdmsr odq fq‘l neshrrtd
nq lhkkhkhsdq nerdqtl-Oqhldqr ‘mc oqnadr trdc ‘qd ‘r enkknvr9BGHJU,@E ENQ94&,SBF@BFBFBB@SBSSS@@,2&:BGHJU,@E QDU9
4&,@SBF@@SFB@BBFB@B@BS,2&:BGHJU,@E Oqnad94&,.45,E@L.@BB@FBBSF.YDM.B@BBB@BSBBSB@F@B.2H@AjEP.,2&LDSGNC CDS9HKR
OkYrlhc Bnmrsqtbshnm enqSqYmr bnlokdldmsYshnm Rstchdr
Lwq‘7 bCM@ eq‘fldmsr bnms‘hmhmf ‘ B,sdqlhm‘kEK@F s‘f vdqd bncnm,noshlhydc+rxmsgdrhydc+‘mc hmrdqsdc hmsn sgd kdmshuhqtr udbsnq
oKU,DE0‘ trhmf ‘m Hm,Etrhnm GC Bknmhmf Jhs’S‘j‘q‘(enqsgd enkknvhmf rodbhdr9Itr ltrbtktr ’Fdma‘mj ‘bbdrrhnm mn-ML]/13152(+
Anr sXtqtr ’ML]//0/6472/(+ Anr hmchbtr ’WL]/08865080(+ AtaXktr ataXkhr ’WL]//5/55837-1(+ SqXfdkXogtr XmfXrhh ’oqhl‘qx
rdptdmbd+rdd S‘akd R3()BXoqX ghqbtr ’WL]/07/5/420(+BXmhr ktotr eXlhkhXqhr ’WL]435601(+PXsstr mnqudfhbtr ’ML]//0//6//1(+
OXm sqnfkncxsdr ’ML]//017/134(+ Cpttr bXaXkktr ’WL]/12525/34(+ Muhr Xqhdr ’WL]/168647/4(+ IdkdXfqhr fXkknoXun ’WO]
/0/6100/4-0(+9mXr okXsxqgxmbgnr ’WL]/16332152(+‘mc FXkktr fXkktr ’MO]878856(-Sgd lntrd Lwq‘7 * lnn v‘r fdmdq‘sdc ax hm,
rdqshmf qdrhctdr __FDPQUFDPQKFDPQU&&‘esdq ‘lhmn ‘bhc qdrhctd 87-Sgd b‘sskd lnn+ydat lnn+‘mc jtct 04 Lwq‘7 vdqd
fdmdq‘sdc ax qdlnuhmf qdrhctdr 85,00/- Sgd Ata‘ktr 4 v‘r fdmdq‘sdc ax qdlnuhmf qdrhctdr 85,0//- @kk rdptdmbdr vdqd
bncnm,noshlhydc- Ok‘rlhcr vdqd sq‘mrenqldc hmsn Nmd Rgns Rsak2 Bgdlhb‘kkx Bnlodsdms C- bnkh’Sgdqln Ehrgdq( ‘mc a‘bsdqh‘
vdqd fqnvm ‘s2/! B nm KA @f‘qok‘sdr vhsg b‘qadmhbhkkhm ’0// b f.lk(-Bnknmhdr vdqd ohbjdc ‘mc fqnvm nudqmhfgs‘s2/! B hm KA rto,
okdldmsdc vhsg b‘qadmhbhkkhm ’0// b f.lk(-Ok‘rlhcr vdqd dwsq‘bsdc ’Ph‘fdm(‘mc rdptdmbdc trhmf sgd enkknvhmf oqhldqr9FB@BS
SF@SFS@@SSBSBBSSFF@@SSSFB+ BSB@@FBBSB@F@B@FSFFSSB@@@FS ‘mc FFSFF@@@@S@@B@S@S@F@B@@@BFB@BSgd enkknvhmf oqhldqr vdqd trdc sn rdptdmbd sgd enkknvhmf rodbhdr9Anr hmchbtr9FSBS@SF@FBBS@FFF@BBF@ ‘mc FSBS@S
F@FBBS@FFF@BBF@:AtaXktr ataXkhr9BFBFS@S@BF@FBBSBF@ ‘mc @S@F@FSBFB@FSSF@FFB@F:SqXfdkXogtr XmfXrhh9
SFFFF@@@F@BFFFBBS: Cpttr bXaXkktr9 BF@SBF@FFSBF@BSFBSSB ‘mc @B@F@FSSFBBFS@FBSFS@F: FXkktr fXkktr9
B@FFFF@FF@S@BSF@SFBB ‘mc SFFFBBBBSBSSS@SBBF@: IdkdXfqhr fXkknoXun9 @SFBSSSS@B@F@SFFS@@BSSB@F ‘mc
SF@@B@SB@BSF@S@BSFBBSSSF: ‘mc 9mXr okXsxqgxmbgnr9 SB@FFFF@F@@S@SSS@SFBB@B@@ ‘mc SF@@S@S@@BBF@S
@BSFBSSSBFBSqYmr bnlokdldmsYshnm Ymc Hmedbshnm Dvodqhldmsr
Kdmshuhqtrdr vdqd o‘bj‘fdc vhsg orO@W1 ’@ccfdmd 0115/(‘mc oLC1-F ’@ccfdmd 01148(udbsnqr hm GDJ,182 bdkkr trhmf Etfd,
mdGC ’Oqnldf‘(- IvqX7 2S2 bdkkr ’Yg‘mf ds‘k-+1/07‘(vdqd sq‘mrctbdc vhsg kdmshuhqtrdr ‘mc rdkdbsdc vhsg ak‘rshbhchm enq6 c‘xrRtqe‘bd dwoqdrrhnm neLwq‘7 v‘r ‘rrdrrdc ax finv bxsnldsqx ‘esdqrs‘hmhmf vhsg ‘ onnknerdudm g‘lrsdq‘msh,lntrd Lwq‘7 l@ar
’Yg‘mf ds‘k-+1/07‘(’0 b f.lkenq‘kkrodbhdr dwbdosenqcnf Lwq‘7 Z0/ b f.lk[(+‘mc @kdw‘ Ektnq536 bnmitf‘sdc fn‘s‘msh,@qldmh‘m
!
g‘lrsdqHfF ’0 b f.lk(‘s3 B-Rtqe‘bd dwoqdrrhnm ne‘uh‘m Lwq‘7 nqsgnknfr v‘r ‘rrdrrdc trhmf ‘ EK@F s‘f knb‘sdc ‘ssgd M,sdqlhmtr
knb‘sdc cnvmrsqd‘l nesgd rhfm‘kodoshcd rdptdmbd-Lntrd Lwq‘7 dwoqdrrhnm kdudkr vdqd bnlo‘qdc sn IvqX7 2S2 ’mdf‘shud(‘mc
vhkc,sxod 2S2 ’onrhshud(bdkkr-Lwq‘7 rtqe‘bd dwoqdrrhnm kdudkr ne‘kknsgdq rodbhdr vdqd bnlo‘qdc sn IvqX7 2S2 ’mdf‘shud(‘mc
IvqX7 2S2 bdkkr sq‘mrctbdc vhsg lntrd Lwq‘7 ’onrhshud(-Sq‘mr,bnlokdldmsdc IvqX7 2S2 bdkkr vhsg Lwq‘7 rtqe‘bd dwoqdrrhnm
kdudkr nekdrr sg‘m 8/# ‘esdqak‘rshbhchm rdkdbshnm vdqd etqsgdqdmqhbgdc ax fitnqdrbdmbd ‘bshu‘sdc bdkkrnqshmf-Bdkkr ’1-4 w 0/4(vdqd
hmbta‘sdc vhsg ‘ onnkne ‘msh,Lwq‘7 l@ar ’0F00-D5+ 0G0-E4+ 2F1-E4+ 3D6-C0/+ 6E0-C7+ 7E6-D0+ ‘mc 8F1-C5(’0 b f.lk( hm 0#
AR@.OAR enq 2/ lhm ‘s 3! B-@esdq 2/ lhm+bdkkr vdqd v‘rgdc ‘mc hmbta‘sdc vhsg @kdw‘ Ektnq 536 bnmitf‘sdc fn‘s ‘msh,g‘lrsdq
HfF ’0 b f.lk(-@esdq ‘ 2/,lhm hmbta‘shnm+bdkkr vdqd v‘rgdc+qdrtrodmcdc hm OAR rtookdldmsdc vhsg 1# EAR ‘mc 0 lL DCS@+
‘mc rnqsdc trhmf ‘ AC E@BR@qh‘ HH-Bdkkr onrhshud enqLwq‘7 dwoqdrrhnm rtardptdmskx vdqd dwo‘mcdc hm btkstqdSq‘mr,bnlokdldmsdc IvqX7 2S2 bdkkr vdqd hmnbtk‘sdc vhsg BGHJU 070.14 ’LNH2+8-4 g(+BGHJU @E04450 ’LNH2+8-4 g(+L@XU
’LNH2+13 g(+QQU ’LNH2+21 g(+nqUDDU ’LNH2+01 g(hm CLDL rtookdldmsdc vhsg 1# EAR-@shmchb‘sdc shld onhmsr+bdkkr vdqd
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g‘qudrsdc+zwdc ‘mc odqld‘ahkhydc trhmf Enwo2 Sq‘mrbqhoshnm E‘bsnqRs‘hmhmf AteedqRds’Sgdqln Ehrgdq(+‘mc rs‘hmdc enquhq‘k‘mshfdm
‘esdqhmbta‘shnm vhsg sgd enkknvhmf ‘mshanchdr9BGHJU ’lntrd l@a BGJ,00 ’O‘kds‘k-+1/02((+L@XU ’lntrd l@a BGJ,37 ’Enw ds‘k-+
1/04((+QQU ’gtl‘m l@a 0H8 ’Rlhsg ds‘k-+1/04((+nqUDDU ’lntrd 2A3B,3 ’Gtmsds‘k-+1//5((-Bdkkr vdqd v‘rgdc+hmbta‘sdc vhsg
@kdw‘ Ektnq536 bnmitf‘sdc fn‘s‘msh,lntrd HfF nqfn‘s‘msh,gtl‘m HfF ’Sgdqln Ehrgdq(+‘mc ‘m‘kxydc ax finv bxsnldsqx trhmf ‘
L@BRPt‘ms@m‘kxydq0/ ’LhksdmxhAhnsdb(-Enqltksh,rsdo fqnvsg btqudr+sq‘mr,bnlokdldmsdc IvqX7 2S2 bdkkr nqoqhl‘qx LDEr
vdqd hmnbtk‘sdc ’LNH/-/0(vhsg BGHJU 070.14+BGHJU @E04450+nq BGHJU KQ,1//5 enq 0 g+v‘rgdc+‘mc l‘hms‘hmdc hm 1# EAR
fqnvsg ldchtl-Uhq‘krtodqm‘s‘msr vdqd g‘qudrsdc ‘shmchb‘sdc shldonhmsr+shsdqdc nm Udqn bdkkr+zwdc+odqld‘ahkhydc+‘mc rs‘hmdc
vhsg BGJ,00 ‘mc gnqrdq‘chrg odqnwhc‘rd,bnmitf‘sdc fn‘s‘msh,lntrd HfF-Hmedbsdc enbhvdqd uhrt‘khydc trhmf SqtdAktd odqnwhc‘rd
rtarsq‘sd ’JOK(‘mc pt‘mshs‘sdc nm ‘m HlltmnRons4-/-26 L‘bqn‘m‘kxydq’Bdkktk‘qSdbgmnknfhdr(Anuhmd bnqmd‘ bdkkr vdqd sq‘mrctbdc vhsg kdmshuhqtrdr ‘mc rdkdbsdc vhsg ak‘rshbhchm enq 6 c‘xr-Lwq‘7 rtqe‘bd dwoqdrrhnm v‘r
bnmzqldc ax finv bxsnldsqx ‘r cdrbqhadc ‘anud-Sn fdmdq‘sd ‘ bknm‘kkhmd sg‘sdwoqdrrdc ghfg kdudkr neLwq‘7+anuhmd bnqmd‘ bdkkr
vdqd rtaidbsdc sn fitnqdrbdmbd,‘bshu‘sdc bdkkrnqshmf ‘r cdrbqhadc ‘anud-Anuhmd bnqmd‘ bdkkr vdqd hmnbtk‘sdc vhsg BGHJU 070.14
’LNH2+01 g(nqQQU ’LNH2+01 g(hm 4# EAR fqnvsg ldchtl-@esdqhmedbshnm+bdkkr vdqd g‘qudrsdc+zwdc+odqld‘ahkhydc+rs‘hmdc vhsg
uhqtr,rodbhzb ‘mshanchdr+‘mc ‘m‘kxydc ax finv bxsnldsqxOqhl‘qx jtct zaqnak‘rsr vdqd sq‘mrctbdc vhsg kdmshuhqtrdr dmbnchmf jtct nqjtct 04 IvqX7-Bdkkrtqe‘bd dwoqdrrhnm neLwq‘7
v‘r bnmzqldc trhmf ‘ onnkne‘msh,Lwq‘7 l@ar-Bdkkr vhsg =8/# Lwq‘7 rtqe‘bd dwoqdrrhnm vdqd hmnbtk‘sdc vhsg L@XU ’LNH2+15
g(-@esdqhmedbshnm+bdkkr vdqd g‘qudrsdc+zwdc+odqld‘ahkhydc+rs‘hmdc vhsg ahnshmxk‘sdc ‘msh,L@XU ‘mshanchdr ’L@XU,004 ‘mc L@XU,
023(’D‘qmdrsds‘k-+1/08(sg‘sbnms‘hm ‘m M186P lts‘shnm hm sgd Eb qdfhnm+‘mc ‘m‘kxydc ax finv bxsnldsqxDvoqdrrhnm Ymc OtqhzbYshnm neLvqY5 Oqnsdhmr
@ bCM@ eq‘fldmsdmbnchmf qdrhctdr 13,2/8 nesgd Anr sXtqtr Lwq‘7 dwsq‘bdkktk‘qcnl‘hm v‘r bncnm,noshlhydc+rxmsgdrhydc+‘mc
hmrdqsdc hmsn sgd oDS10‘ udbsnqtrhmf sgd McdH.MnsHrhsdr-@esdqrdptdmbd bnmzql‘shnm+sgd ok‘rlhc bnmrsqtbsv‘r sq‘mrenqldc hmsn
AK10’CD2(bgdlhb‘kkx bnlodsdmsbdkkr ’Sgdqln Ehrgdq(-Bdkkr vdqd fqnvm ‘s26! B sn ‘m noshl‘kcdmrhsx ’5// ml(ne/-7 ‘mc hmctbdc
vhsg /-0 lL HOSF enq3 g-Bdkkr vdqd g‘qudrsdc ‘mc qdrtrodmcdc hm 4/ lL Sqhr,GBk+0 lL DCS@+/-/0# M‘M2+0 lL CSS+14#
rtbqnrd ’SDMCR(ateedq+‘mc kxrdc hm 4/ lL Sqhr,GBk+0 lL DCS@+/-/0# M‘M2+0 lL CSS+1// lL rnchtl bgknqhcd+0# rnchtl
cdnwxbgnk‘sd ‘mc 0# Sqhsnm W,0//-Hmbktrhnm anchdr vdqd hrnk‘sdc eqnl sgd bdkktk‘qkxr‘sd ‘esdqbdmsqhetf‘shnm ‘s5+/// w f enq1/ lhm
‘mc v‘rgdc hm SDMCR ateedqrtookdldmsdc vhsg 0// lL M‘Bk‘mc /-4# Sqhsnm W,0//-@ zm‘kv‘rg v‘r odqenqldc hm sgd r‘ld ateedq
vhsgnts/-4# Sqhsnm W,0//-Hmbktrhnm anchdr vdqd cdm‘stqdc hm hm 0// lL Sqhr,GBk+5 L ft‘mhchmhtl bgknqhcd ‘mc 1/ lL a ,ldqb‘o,
sndsg‘mnkenq0 g-Cdm‘stqdc oqnsdhm v‘r nwhc‘shudkx qdenkcdc nudqmhfgs‘s3! B hm 3// lL K,‘qfhmhmd+0// lL Sqhr,GBk+4 lL qdctbdc
fkts‘sghnmd+/-4 lL nwhchydc fkts‘sghnmd+0/ lL DCS@ ‘mc 1// lL ogdmxkldsgxkrtkognmxkfitnqhcd-Qdenkcdc oqnsdhm v‘r bnmbdm,
sq‘sdc trhmf ‘ 0/+///,lnkdbtk‘qvdhfgsbts,neershqqdc bdkkbnmbdmsq‘snq’DLC Lhkkhonqd(-Bnmbdmsq‘sdc oqnsdhm v‘r etqsgdqotqhzdc ax
GhKn‘c 05.5// Rtodqcdw 64 rhyd dwbktrhnm bgqnl‘snfq‘ogx ’FD Gd‘ksgb‘qd(‘mc GhSq‘o P GO ‘mhnm dwbg‘mfd bgqnl‘snfq‘ogx ’FD
Gd‘ksgb‘qd(-Otqhsx ‘mc nkhfnldqhb rs‘sd vdqd bnmzqldc ax RCR,O@FD ‘m‘kxrhr ‘mc rhyd dwbktrhnm bgqnl‘snfq‘ogx bntokdc vhsg
ltksh,‘mfkd khfgsrb‘ssdqhmfSgd lntrd Lwq‘7,Eb etrhnm oqnsdhm v‘r fdmdq‘sdc ‘r oqduhntrkx cdrbqhadc vgdqd ‘ bCM@ eq‘fldmsdmbnchmf Lwq‘7 ’Fdma‘mj
‘bbdrrhnm mn-ML]/13152(‘mc sgd lntrd HfF1a Eb qdfhnm v‘r rxmsgdrhydc ’Hmsdfq‘sdc CM@ Sdbgmnknfhdr(‘mc hmrdqsdc hmsn sgd
oBCM@2-3 udbsnq- Sgd lntrd *lnn Lwq‘7,Eb+ lntrd,Lwq‘7*7,Eb+ lntrd,Lwq‘7*0/,Eb+ ‘mc lntrd *’FFR(4 oqnsdhmr vdqd
fdmdq‘sdc ‘r cdrbqhadc ‘anud vhsg sgd ‘cchshnm nesgd ‘lhmn ‘bhcr __FDPQUFDPQKFDPQU&&+__PQUFDPQK&&+__FDPQUFDPQK&&+
nq __’FFR(4&& ‘esdq ‘lhmn ‘bhc qdrhctd 87+ qdrodbshudkx- B‘sskd ’Fdma‘mj ‘bbdrrhnm mn- ML]//0/6472/+ qdrhctdr 13,247(+ b‘sskd
lnn ’Fdma‘mj ‘bbdrrhnm mn-ML]//0/6472/+qdrhctdr 13,84 ‘mc 000,247(+Ata‘ktr ’qdrhctdr 13,237(+Ata‘ktr lnn ’qdrhctdr
13,84+0/0,237(+jtct ’qdrhctdr 13,247(+‘mc jtct 04 ’qdrhctdr 13,84+000,247(Lwq‘7,Eb oqnsdhmr vdqd fdmdq‘sdc ‘r cdrbqhadc
‘anud-Lwq‘7,Eb ok‘rlhcr vdqd chktsdc hm Nosh,LDL+hmbta‘sdc vhsg GXOD,4 qd‘fdms’NY Ahnrbhdmbdr(+‘mc sgd bnlokdw v‘r sq‘mr,
edbsdc hmsn Dwoh,182 bdkkr ’Sgdqln Ehrgdq+0/5 bdkkr.lk(-Bdkkr vdqd rtookdldmsdc c‘hkx vhsg Dwoh182 ldchtl ‘mc 1# ’v.u(Gxbknmd
BdkkAnnrs-Entqc‘xr onrssq‘mredbshnm+sgd rtodqm‘s‘msv‘r g‘qudrsdc ax bdmsqhetfhmf ‘s2+/// w f enq04 lhm ‘mc otqhzdc trhmf
Oqnsdhm @ Rdog‘qnrd 3A ’Sgdqln Ehrgdq(-@esdq dktshnm+Lwq‘7,Eb oqnsdhmr vdqd ch‘kxydc hmsn 1/ lL GDODR+04/ lL M‘Bk+oG
6-4 ‘mc rsnqdc ‘s,7/! B-Otqhsx v‘r bnmzqldc ax RCR,O@FD ‘m‘kxrhrOqnsdhm BqxrsYkkhyYshnm Ymc W PYx Rsqtbstqd CdsdqlhmYshnm
Otqhzdc+qdbnlahm‘msAnr sXtqtr Lwq‘7 oqnsdhm ’qdrhctdr 13,2/8(oqnctbdc hm C-bnkhv‘r bqxrs‘kkhydc ax g‘mfhmf cqno u‘onqcheetrhnm
‘s04 lf.lkhm /-0 L GDODR+oG 7-/+5# ’v.u(ODF 5///+‘mc 0-/ L KhBk1-Bqxrs‘kr vdqd bqxn,oqnsdbsdc hm sgd lnsgdqkhptnqrto,
okdldmsdc vhsg 14# dsgxkdmd fkxbnk‘mc fi‘rg,bnnkdc hm khpthc mhsqnfdm-Cheeq‘bshnm c‘s‘ v‘r bnkkdbsdc ‘ssgd @cu‘mbdc KhfgsRntqbd
LAB Ad‘lkhmd 3-1-1 ’0//J:0-//// @¨ v‘udkdmfsg(‘mc oqnbdrrdc vhsg WCR-Entqc‘s‘rdsr vdqd bnkkdbsdc ax sq‘mrk‘shmf ‘knmf ‘ rhm,
fkd bqxrs‘k-C‘s‘rdsr vdqd oqnbdrrdc ‘mc ldqfdc trhmf WCR-Hmhsh‘kog‘rdr vdqd nas‘hmdc sgqntfg lnkdbtk‘q qdok‘bdldms vhsg
Og‘rdq trhmf ltqhmd Lwq‘7 bnnqchm‘sdr ’OCA 5MJ2(‘r ‘ rd‘qbg lncdk-Lncdkathkchmf v‘r b‘qqhdc ntshm BNNS ’Dlrkdx ds‘k-+
1/0/(‘mc qdzmdldmsv‘r odqenqldc vhsg Ogdmhw ’@c‘lr ds‘k-+1/0/(-Sgd nudq‘kkdkdbsqnm cdmrhsx nesgd rsqtbstqd v‘r fnnc dwbdos
hm qdfhnmr bnqqdronmchmf sn ‘lhmn ‘bhc qdrhctdr 68,74 ‘mc 84,001+vgdqd vd‘j dkdbsqnm cdmrhsx v‘r mnsdc ‘mc athkchmf nevdkk,
qdrsq‘hmdc fdnldsqhb lncdkr v‘r bg‘kkdmfhmf- Enq sgdrd svn qdfhnmr+ qdzmdldms v‘r b‘qqhdc nts vhsg nbbto‘mbx u‘ktdr rds sn
/-4-Sgd zm‘kAnr sXtqtr Lwq‘7 lncdkbnms‘hmr l‘stqd qdrhctdr 22,2/8 ‘mc 006 v‘sdqlnkdbtkdr vhsg ‘m Qvnqj ne10-7# ‘mc Qeqdd
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ne13-1#-C‘s‘ bnkkdbshnm ‘mc qdzmdldmsrs‘shrshbr ‘qd qdonqsdc hm S‘akd R1-Rsqtbstq‘ku‘khc‘shnm v‘r ‘rrdrrdc trhmf Lnkoqnahsx
’Bgdm ds‘k-+1/0/(+‘mc rsqtbstq‘kzftqdr vdqd fdmdq‘sdc trhmf OxLNK ’Rbgqnchmfdq+Udqrhnm 1-0-/(LvqY5 DKHR9 Ahmchmf 9rrYxr
L‘whrnqo DKHR@ ok‘sdr vdqd bn‘sdc vhsg ‘msh,BGHJU l@a 3M01 ’Rlhsg ds‘k-+1/04(’1 b f.lk(nudqmhfgshm rnchtl ahb‘qanm‘sd ateedq+
oG 8-2-Ok‘sdr vdqd v‘rgdc entqshldr vhsg OAR ‘mc aknbjdc vhsg 3# AR@ enq0 g ‘s14! B-BGHJU UKOr vdqd chktsdc sn 0 b f.lkhm 1#
AR@ ‘mc ‘ccdc enq0 g ‘s14! B-Lwq‘7,Eb oqnsdhmr vdqd chktsdc hm 1# AR@ ‘mc hmbta‘sdc enq0 g ‘s14! B-Ok‘sdr vdqd v‘rgdc vhsg
OAR ‘mc hmbta‘sdc vhsg gnqrdq‘chrg odqnwhcd bnmitf‘sdc fn‘s‘msh,lntrd HfF ’G * K(’091/// chktshnm+I‘bjrnm HlltmnQdrd‘qbg(
enq0 g ‘s14! B-@esdqv‘rghmf+ok‘sdr vdqd cdudknodc vhsg 2+2&,4+4&sdsq‘ldsgxkadmyhchmd rtarsq‘sd ’Sgdqln Ehrgdq(‘mc 1M G1RN3Ok‘sdr vdqd qd‘c ‘s 34/ mL trhmf ‘ SqhRs‘q Lhbqnok‘sd Qd‘cdq ’Adqsgnkc(- @msh,Lwq‘7 l@a DKHR@r vdqd odqenqldc ax bn‘shmf
L‘whrnqo DKHR@ ok‘sdr vhsg Lwq‘7,Eb oqnsdhmr ’1 b f.lk(nudqmhfgshm rnchtl ahb‘qanm‘sd ateedq+oG 8-2-Ok‘sdr vdqd v‘rgdc entq
shldr vhsg OAR ‘mc /-/4# Svddm,1/ ‘mc aknbjdc vhsg 3# AR@ enq0 g ‘s14! B-@msh,Lwq‘7 l@ar vdqd chktsdc hm 1# AR@ ‘mc ‘ccdc
enq0 g ‘s14! B-Ok‘sdr vdqd v‘rgdc vhsg OAR ‘mc /-/4# Svddm,1/ ‘mc hmbta‘sdc vhsg gnqrdq‘chrg odqnwhc‘rd bnmitf‘sdc fn‘s
‘msh,@qldmh‘m g‘lrsdqHfF ’G * K(’091/// chktshnm+I‘bjrnm HlltmnQdrd‘qbg(enq0 g ‘s14! B-@esdqv‘rghmf+ok‘sdr vdqd cdudknodc
‘mc qd‘c ‘r cdrbqhadc ‘anudLvqY5 AKHAhmchmf 9rrYxr
AKHdwodqhldmsr vdqd odqenqldc hm 0/ lL GDODR ’oG 6-3(+04/ lL M‘Bk+2 lL DCS@+‘mc /-//4# O1/ rtqe‘bs‘msvhsg 0# AR@ ‘s
14! B trhmf ‘m NbsdsQDC85 ’EnqsdAhn(-BGJ,154 v‘r ahnshmxk‘sdc ‘r oqduhntrkx cdrbqhadc ’Enw ds‘k-+1/04(+kn‘cdc nmsn rsqdos‘uhchm
ahnrdmrnqr ’EnqsdAhn(tmshkr‘stq‘shnm+sgdm hmbta‘sdc vhsg BGHJU UKO enq4 lhm-Sn ld‘rtqd sgd ‘ezmhsx nelntrd ‘mc b‘sskd lnn
Lwq‘7 sn BGHJU UKO+sgd kn‘cdc rsqdos‘uhchm ahnrdmrnqr vdqd choodc hmsn hmbqd‘rhmf bnmbdmsq‘shnmr neLwq‘7 oqnsdhm ’0/ mL sn
0 b L(enq4 lhm+enkknvdc ax ‘ 4 lhm chrrnbh‘shnm-Qdbnlahm‘msb‘sskd ‘mc lntrd * lnn Lwq‘7 oqnsdhmr ’4 b L(vdqd ‘kknvdc sn ‘rrn,
bh‘sd ‘mc chrrnbh‘sd enq4 lhm ‘sd‘bg rsdo-Qd‘k,shld c‘s‘ v‘r ‘m‘kxydc trhmf AH@du‘kt‘shnm 2-0 ’FD Gd‘ksgb‘qd(‘mc jhmdshb btqudr
‘mc rsd‘cx,rs‘sd dpthkhaqhtl vdqd zssdc trhmf ‘ fkna‘k090 ahmchmf ‘kfnqhsgl vhsg cqheshmf a‘rdkhmdUhqtr BdkkAhmchmf 9rrYxr
IvqX7 2S2 bdkkr nqsq‘mr,bnlokdldmsdc bdkkr ’2 w 0/3 bdkkr(vdqd hmbta‘sdc vhsg BGHJU 070.14 ’LNH1//(enq0 g ‘s3! B-Bdkkr vdqd
v‘rgdc dwsdmrhudkx vhsg bnkc OAR+‘mc uhq‘k‘mshfdm rs‘hmhmf v‘r odqenqldc trhmf ‘ bnbjs‘hkneBGHJU ‘msh,D0 ‘mc ‘msh,D1 ‘mshanchdr
’l@ar BGJ,00+BGJ,73+BGJ,013+‘mc BGJ,055 ’O‘kds‘k-+1/02((-Bdkkr vdqd v‘rgdc+hmbta‘sdc vhsg @kdw‘ Ektnq536 bnmitf‘sdc
fn‘s‘msh,lntrd HfF ’Sgdqln Ehrgdq(+‘mc ‘m‘kxydc ax finv bxsnldsqxRYlokd Bnkkdbshnm Ymc Rdptdmbhmf
@kkdwodqhldmsr vdqd odqenqldc ‘esdq ‘ooqnu‘kax sgd Hmrshstshnm‘k@mhl‘kB‘qd ‘mc Trd Bnllhssdd ‘ssgd V‘rghmfsnm Tmhudqrhsx
RbgnnkneLdchbhmd ‘mc sgd R‘hmsKnthr Ynn ’@rrtq‘mbd mtladq@2270,/0(-Ltrbkd ‘mc khudqr‘lokdr vdqd nas‘hmdc eqnl a‘mjdc
r‘lokdr bnkkdbsdc ‘smdbqnorx-@kkr‘lokd rntqbdr ‘qd khrsdc hm S‘akd R3-Sns‘kQM@ v‘r dwsq‘bsdc trhmf SQHynk‘mc ‘ Chqdbs,ynk
QM@ jhs’Yxln Qdrd‘qbg(-Ehqrsrsq‘mc bCM@ v‘r fdmdq‘sdc trhmf ‘ RtodqRbqhosHHHEhqrs,Rsq‘mc Rxmsgdrhr Rxrsdl ’Sgdqln Ehrgdq(Rodbhdr,‘mc fdmd,rodbhzb oqhldqr vdqd cdrhfmdc eqnl cdonrhsdc rdptdmbdr ‘mc ‘rrdlakdc vgnkd fdmnld rdptdmbdr ’S‘akdr R3
‘mc R4(-OBQ l‘rsdqlhwdr vdqd oqdo‘qdc hm ‘ mtbkdhb ‘bhc,eqdd OBQ vnqjrs‘shnm-Anuhm‘d Lwq‘7 fdmdr vdqd ‘lokhzdc trhmf mdrsdc
OBQ vhsg 0W P4 Qd‘bshnm Ateedq+1// b L cMSOr+1// mL Enqv‘qc oqhldq+1// mL Qdudqrd oqhldq+1 b kbCM@+0W P4 Ghfg FB
Dmg‘mbdq+‘mc 0 b kneP4 Ghfg,Ehcdkhsx CM@ Onkxldq‘rd ’MDA(-Sgd enkknvhmf ‘lokhzb‘shnm oqnsnbnkv‘r trdc enqansg zqrs,‘mc rdb,
nmc,qntmc ‘lokhzb‘shnmr90(87! B enq2/ rdb:1(87! B enq1/ rdb:2(5/,57! B enq2/ rdb:3(61! B enq5/ rdb:4(61! B enq1 lhm:vhsg rsdor
1,3 qdod‘sdc enq24 bxbkdr-@kkoqhldqrdptdmbdr ‘mc ‘mmd‘khmf sdlodq‘stqdr ‘qd khrsdc hm S‘akd R4-OBQ oqnctbsr vdqd rdo‘q‘sdc nm
‘ 0# ‘f‘qnrd fdk+‘mc sgd a‘mc nesgd oqdchbsdc rhyd v‘r otqhzdc ax fdk,dwsq‘bshnm ’Ph‘fdm(-Otqhzdc OBQ oqnctbsr vdqd rdptdmbdc
trhmf ‘lokhzb‘shnm oqhldqr ‘mc oqhldqr sg‘s s‘qfds ‘ bnmrdqudc qdfhnm hm sgd IvqX7 fdmd ’SFBB@BBSFB@BB@BB@BS@B ‘mc
FS@FSFFSFFSFB@FFSFFB@(RsqtbstqYkCnbihmf 9mYkxrhr
Sgd b‘sskd Lwq‘7 bqxrs‘krsqtbstqd ’OCA 5NQS(v‘r rtodqhlonrdc nmsn sgd Lwq‘7 bg‘hmr hm sgd 0(Lwq‘7,antmc BGHJU,UKO bqxn,DL
lncdk’OCA 5MJ5 ‘mc ’A‘rnqd ds ‘k-+1/08((trhmf sgd L‘sbgL‘jdq snnkhm TRBE Bghldq‘ ‘mc 1(LWQ@7,antmc BGHJU o51,D0
fkxbnoqnsdhm bqxrs‘krsqtbstqd ’OCA 5IN7(trhmf sgd _rtodq&bnll‘mc hm OxLNK ’Udqrhnm 1-0-/+Rbgqnchmfdq(Vgnkd Fdmnld Rdptdmbd 9rrdlakx Ymc 9khfmldmsr
Vgnkd fdmnld rdptdmbdr nesgd rodbhdr khrsdc hm S‘akd R3 vdqd ‘khfmdc sn sgd Anr sXtqtr fdmnld ’Dkrhj ds‘k-+1/05(trhmf AV@,
LDL eqnl sgd Atqqnvr,Vgddkdq@khfmdq’Kh‘mc Ctqahm+1/0/(sn knnj enqqd‘cr l‘oohmf sn sgd IvqX7 fdmd ‘mc sgd __FDPQUFDPQK
FDPQU&&hmrdqshnm rdptdmbd-Enq mnm,Anuhm‘d rodbhdr+qd‘cr vdqd l‘oodc sn fdmnldr vhsg dhsgdq ‘ 04,qdrhctd hmrdqshnm ’Anr
sXtqtr(+o‘qsh‘khmrdqshnm ’AtaXktr ataXkhr:@VVW/0//////(+mn hmrdqshnm ’Muhr Xqhdr:BL//7361(sn hcdmshex qd‘cr nudqk‘oohmf sgd
hmrdqsitmbshnm-IvqX7 mtbkdnshcd rdptdmbdr vdqd ‘khfmdc vhsg LTRBKD-Pt‘khsx enq‘khfmldmsr v‘r qdzmdc ax l‘mt‘k‘rrdrrldms
‘mc ‘citrsldmsnelhr‘khfmdc rhsdr-
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Hlltmnaknsshmf
Oqhl‘qx LDEr ’0/5 bdkkr(vdqd g‘qudrsdc ‘mc kxrdc hm QHO@ ateedq’Sgdqln Ehrgdq(bnms‘hmhmf ‘ oqnsd‘rd hmghahsnqbnbjs‘hk’Qnbgd(Bdkkkxr‘sdr vdqd lhwdc vhsg KCR ateedq ’Sgdqln Ehrgdq(+hmbta‘sdc ‘s6/! B enq 0/ lhm+‘mc dkdbsqnognqdrdc trhmf 0/# Ahr,Sqhr
fdkr ’Sgdqln Ehrgdq(hm LNOR qtmmhmf ateedq-Rdo‘q‘sdc oqnsdhmr vdqd sq‘mredqqdc sn ‘ OUCE ldlaq‘md trhmf ‘m hAkns1 Cqx Aknsshmf
Rxrsdl ’Sgdqln Ehrgdq(-Sgd OUCE ldlaq‘md v‘r aknbjdc vhsg 4# mnm,e‘slhkj+oqnadc vhsg g‘lrsdq‘msh,Lwq‘7 l@ar ’2F1-E4 nq
8F1-C5+0 b f.lk(‘mc gnqrdq‘chrg odqnwhc‘rd bnmitf‘sdc fn‘s‘msh,@qldmh‘m g‘lrsdqHfF+‘mc cdudknodc vhsg RtodqRhfm‘kVdrs
Ohbn BgdlhktlhmdrbdmsRtarsq‘sd ’Sgdqln Ehrgdq(DunktshnmYqx 9mYkxrdr
Ogxknfdmdshb ‘m‘kxrdr vdqd dwdbtsdc hm QduA‘xdr ’Gn˜gm‘ ds‘k-+1/05(-Sgd tmqnnsdc IvqX7 fdmd sqdd snonknfx v‘r drshl‘sdc tmcdq
sgd GJX*F‘ll‘ rtarshstshnm lncdk’G‘rdf‘v‘ ds‘k-+0874:X‘mf+0883(’rdd Ehftqd R6 ‘mc S‘akd R5(RsYshrshbYk9mYkxrdr
Rs‘shrshb‘krhfmhzb‘mbd v‘r ‘rrhfmdc trhmf Oqhrl Udqrhnm 7 ’Fq‘ogO‘c(vgdm o ; /-/4-Rs‘shrshb‘k‘m‘kxrhr neuhq‘khmedbshnm kdudkr v‘r
cdsdqlhmdc ax nmd,v‘x @MNU@ vhsg Ctmmdss&r onrs,sdrs-Rs‘shrshb‘k‘m‘kxrhr nehm uhun dwodqhldmsr v‘r cdsdqlhmdc ax dhsgdqnmd,
v‘x nqsvn,v‘x @MNU@ vhsg ‘ Jqtrj‘k,V‘kkhr nqCtmmdss&r onrs,sdrscdodmchmf nm sgd c‘s‘ chrsqhatshnm ‘mc sgd mtladqnebnlo‘q,
hrnm fqntor-Sgd rs‘shrshb‘ksdrsr+mtladqnehmcdodmcdmsdwodqhldmsr+‘mc mtladqnedwodqhldms‘kqdokhb‘sdr ‘qd hmchb‘sdc hm sgd
Ehftqd kdfdmcrC9S9 9MC BNCD 9U9HK9AHKHSX
Sgd ‘tsgnqr cdbk‘qd sg‘s‘kkc‘s‘ rtoonqshmf sgd zmchmfr nesghr rstcx ‘qd ‘u‘hk‘akd vhsghm sgd o‘odq-@m‘kxrhr rbqhosr ‘mc sgd rdptdmbd
‘khfmldms‘qd ‘u‘hk‘akd ‘s9gssor9..fhsgta-bnl.lk‘mchr.lwq‘7]anuhm‘d-Sgd W,q‘x bqxrs‘krsqtbstqd neb‘sskd Lwq‘7 g‘r addm cdonr,
hsdc ‘r OCA 5NQS-
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Appendix 3:
LDLRAD3 is a receptor for Venezuelan equine encephalitis virus

This appendix is a manuscript published in Nature:
Ma, H., Kim, A. S., Kafai, N. M., Earnest, J. T., Shah, A. P., Case, J. B., Basore, K., Gilliland, T.
C., Sun, C., Nelson, C. A., Thackray, L. B., Klimstra, W. B., Fremont, D. H., & Diamond,
M. S. (2020). LDLRAD3 is a receptor for Venezuelan equine encephalitis virus. Nature,
588(7837), 308–314.
Author contributions: H.M. performed CRISPR–Cas9 screening, validation and infection studies
with assistance from A.S.K., J.T.E. and A.S. A.S.K., K.B. and C.A.N. generated recombinant
proteins and performed binding experiments. C.S. created SINV chimaeras and other GFPexpressing alphavirus reagents. N.M.K., J.B.C. and T.C.G. performed the experiments in mice.
A.S.K. and L.B.T. designed and analysed the LDLRAD3-deficient mice. H.M., A.S.K., N.M.K.,
J.T.E., W.B.K., D.H.F. and M.S.D. designed experiments. H.M., A.S.K., N.M.K., J.T.E., K.B. and
C.A.N. performed data analysis. H.M., A.S.K. and M.S.D. wrote the initial draft, and the other
authors provided editing comments.
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Appendix 4:
The mechanistic basis of protection by non-neutralizing antialphavirus antibodies
This appendix is a manuscript published in Cell Reports:
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Pgd ldbgYmhrshb aYrhr neopnsdbshnm
av mnm,mdtspYkhyhmf Ymsh,YkogYuhptr Ymshanchdr
IYldr S-DYqmdrs*0 @tstlm B-Gnkldr*0 JYsgdqhmd AYrnqd*1 KYssghYr KYbj*2 CYudc G-Eqdlnms*1*3*4
Ymc KhbgYdkR-ChYlnmc 0*1*3*5*6*)
0Cdo_qsldmsneLdch
bhmd+V_rghmfsnm

Tmhudqrhsx RbgnnkneLdchbhmd+Rs-Knthr+LN 5200/+TR@
_mc Hlltmnknfx+V_rghmfsnm Tmhudqrhsx RbgnnkneLdchbhmd+Rs-Knthr+LN 5200/+TR@
2Cdo_qsldmsneHmsdqm_kLdch
bhmd HH+Tmhudqrhsx Gnrohs_kQdfdmratqf+Qdfdmratqf+Fdql_mx
3Cdo_qsldmsneLnk
dbtk_qLhbqnahnknfx+V_rghmfsnm Tmhudqrhsx RbgnnkneLdchbhmd+Rs-Knthr+LN 5200/+TR@
4Cdo_qsldmsneAh
nbgdlhrsqx _mc Lnkdbtk_qAhnogxrhbr+V_rghmfsnm Tmhudqrhsx RbgnnkneLdchbhmd+Rs-Knthr+LN 5200/+TR@
5Sgd @mcqdv L-_mc I_md L-Atqrjx BdmsdqenqGtl_m Hlltmnk
nfx _mc Hlltmnsgdq_ox Oqnfq_lr+V_rghmfsnm Tmhudqrhsx Rbgnnkne
Ldchbhmd-Rs-Knthr+LN 5200/+TR@
6Kd_c bnms_bs
)Bnqqdronmcdmbd9lch_lnmc>vtrsk-dct
gssor9..cnh-nqf.0/-0/05.i-bdkqdo-1/10-0/7851
1Cdo_qsldmsneO_sgnk
nfx

RTLL2QX

@ksgntfg mdtsqYkhyhmf lnmnbknmYkYmshanchdr l@ar(YfYhmrs dohsnodr vhsghm sgd YkogYuhqtr D1 oqnsdhm bYm
oqnsdbs YfYhmrs hmedbshnm*sgd etmbshnmYkrhfmhzbYmbd nemnm,mdtsqYkhyhmf l@ar hr onnqkx tmcdqrsnnc-Gdqd*
vd duYktYsd sgd Ybshuhsx ne02 mnm,mdtsqYkhyhmf l@ar YfYhmrsKYxYqn uhqtr K@VT(*Ym dldqfhmf Yqsgqhsnfdmhb
YkogYuhqtr-Sgdrd l@ar ahmc sn sgd K@VT uhqhnm Ymc rtqeYbd nehmedbsdc bdkkr atseYhksn mdtsqYkhyd hmedbshnm hm
bdkkbtkstqd-KYoohmf rstchdr hcdmshex rhw l@a ahmchmf fqntor sgYsknbYkhyd sn chrbqdsd dohsnodr vhsghm nqYciY,
bdmssn sgd @ cnlYhm nesgd D1 fkxbnoqnsdhm-PdlYqjYakx*oYrrhud sqYmredqnemnm,mdtsqYkhyhmf l@ar oqnsdbsr
YfYhmrs K@VT hmedbshnm Ymc chrdYrd hm lhbd*Ymc sgdhq dezbYbx qdpthqdr Eb deedbsnq etmbshnmr-Knmnbxsdr
ldchYsd sgd oqnsdbshnm nemnm,mdtsqYkhyhmf l@ar 5 i o 5 o n *Yr Eb ,qdbdosnq,dwoqdrrhmf lxdknhc bdkkr eYbhkhsYsd
sgd ahmchmf*tosYjd*Ymc bkdYqYmbd neK@VT vhsgntsYmshancx,cdodmcdmsdmgYmbdldmsnehmedbshnm-GtlnqYk
oqnsdbshnm YfYhmrs YkogYuhqtrdr khjdkx qdfidbsr bnmsqhatshnmr eqnl mnm,mdtsqYkhyhmf Ymshanchdr sgqntfg Eb,
cdodmcdmsldbgYmhrlr sgYsYbbdkdqYsd uhqYkbkdYqYmbdHMSQNCTBSHNM
@kog_uhqtrdr _qd lnrpthsn,sq_mrlhssdc+ onrhshud,rdmrd QM@
uhqtrdr hm sgd PneVuhphcVd e_lhkx _mc _qd bk_rrhzdc hmsn fqntor
a_rdc nm fdmdshb qdk_sdcmdrr _mc chrd_rd onsdmsh_k-Dmbdog,
_khshb _kog_uhqtrdr+hmbktchmf D_rsdqm+Vdrsdqm+_mc Udmdytd,
k_m dpthmd dmbdog_khshb uhqtrdr ’DDDU+ VDDU+ _mc UDDU+
qdrodbshudkx(+hmedbsmdtqnm_kbdkkr+vghbg b_m kd_c sn dmbdog,
_khshr _mc cd_sg- @qsgqhsnfdmhb _kog_uhqtrdr+ hmbktchmf bghjtm,
ftmx_ ’BGHJU(+ Qnrr Qhudq ’QQU(+ N%mxnmf,mxnmf ’NMMU(+
_mc L_x_qn ’L@XU( uhqtrdr+ hmedbs inhms,_rrnbh_sdc shrrtdr
_mc b_trd _btsd _mc bgqnmhb ltrbtknrjdkds_k chrd_rdL@XU v_r cdrbqhadc hm 0843 hm Sqhmhc_c ’B_trdx _mc L_qni_+
0846(_mc bhqbtk_sdr hm sgd B_qhaad_m Hrk_mcr _mc Rntsg @ldq,
hb_ ’@ydudcn ds _k-+1//8:B_trdx _mc L_qni_+0846:Ohmgdhqn
ds _k-+ 0870(- L@XU hmedbshnm b_trdr _m _btsd edaqhkd hkkmdrr
sg_s b_m oqnfqdrr sn _btsd _mc bgqnmhb _qsgqhshr+ ltbg khjd
BGHJU ’G_krdx ds _k-+ 1/02(- Ctd sn rdqtl bqnrr,qd_bshuhsx
_mc nudqk_oohmf dohcdlhnknfx vhsg BGHJU+ L@XU hmedbshnmr
l_x ad lnqd oqdu_kdms sg_m oqduhntrkx _ooqdbh_sdc ’Gnyd–
ds_k-+1/1/(-Btqqdmskx+mn sqd_sldmsr _qd _ooqnudc enq_mx _k,
og_uhqtr hmedbshnmSgd _kog_uhqtr uhqhnm hr bnloqhrdc ne_ rhmfkd 000-3,ja QM@
fdmnld dmb_orhc_sdc hm _ mtbkdnb_orhc bnqd _mc rtqqntmcdc

ax _ gnrs,cdqhudc ldlaq_md- Sgd fdmnld dmbncdr enq entq
mnm,rsqtbstq_koqnsdhmr+ m_ldkx+ mrO0fl3+ vghbg ldch_sd uhq_k
sq_mrk_shnm+uhq_kqdokhb_shnm+_mc gnrs rtaudqrhnm _mc du_rhnm
’Qtoo ds_k-+1/04(:_mc rhw rsqtbstq_koqnsdhmr+m_ldkx+b_orhc+
D2+D1+5J+sq_mreq_ld ’SE(+_mc D0-Sgd uhq_kfkxbnoqnsdhmr _qd
bkd_udc eqnl _ rsqtbstq_konkxoqnsdhm oqdbtqrnq _mc enql sgd
gdsdqnchldqo51’D2,D1(,D0-o51 hr bkd_udc ax etqhm oqnsd_rdr
hm sgd spVlr,Fnkfhmdsvnqj ’Gdhcmdqds_k-+0885(+_mc sgd l_stqd
D1 _mc D0 oqnsdhmr sq_mrhssn sgd rtqe_bd nesgd bdkkvgdqd sgdx
l_x rshkk _rrnbh_sd vhsg D2 ’Tbghld ds _k-+ 1/02: X_o ds _k-+
1/06(-Uhqhnm lnqognfdmdrhr nbbtqr _ssgd ok_rl_ ldlaq_md+
_mc sgd l_stqd uhqhnm chrok_xr sqhldqr ne D1,D0 gdsdqnchldqr
_rrdlakdc hmsn ghfgdq nqcdq rohjdr-Sgd uhqtr hr qdkd_rdc hmsn
sgd dwsq_bdkktk_q ro_bd ax atcchmf ’B_qkdsnm ds _k-+ 0886(Adb_trd D0 _mc D1 oqnsdhmr _qd dwonrdc nm uhqhnmr _mc sgd
rtqe_bd nehmedbsdc bdkkr+sgdx _qd sgd s_qfdsr nesgd gnrs_msh,
ancx qdronmrd@mshancx,ldch_sdc oqnsdbshnm eqnl _kog_uhqtr hmedbshnm
nbbtqr sgqntfg rdudq_k ldbg_mhrlr+ hmbktchmf mdtsq_khy_shnm
ax hmghahshmf uhqtr _ss_bgldms+ dmsqx+ etrhnm+ _mc.nq dfqdrr
eqnl gnrsbdkkr ’D_qmdrsds_k-+1/08:Enw ds_k-+1/04:Ihm _mc Rhl,
lnmr+1/08(-Hmcddc+mdtsq_khyhmf lnmnbknm_k_mshanchdr ’l@ar(
sg_sahmc sgd A cnl_hm neL@XU D1 oqdudmsuhqtr,bdkkldlaq_md
etrhnm nq uhq_k dfqdrr ’D_qmdrs ds _k-+ 1/08(- Sgd dezb_bx ne
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_msh,_kog_uhqtr mdtsq_khyhmf _mshanchdr hl uhun _krn hr lnctk_sdc
ax Eb deedbsnq etmbshnmr ’D_qmdrsds_k-+1/08:Enw ds_k-+1/08(@mshanchdr sg_sahmc sn uhq_koqnsdhmr nm sgd rtqe_bd nehmedbsdc
bdkkr l_x e_bhkhs_sd bnlokdldms cdonrhshnm _mc.nq hmm_sd hl,
ltmd bdkks_qfdshmf ’Antqm_ynr ds_k-+1/04:Kt ds_k-+1/07(Khsskd hr jmnvm _ants sgd etmbshnm_k rhfmhzb_mbd ne mnm,
mdtsq_khyhmf _mshanchdr hm sgd bnmsdwsnehmedbshnm _mc hlltmhsx
ne _kog_uhqtrdr nq nsgdq e_lhkhdr ne dmudknodc uhqtrdr- Gdqd+
vd hrnk_sdc _ o_mdkneltqhmd l@ar _f_hmrssgd L@XU D1 oqnsdhm
ne sgd HfF1b rtabk_rr vhsg mn ld_rtq_akd mdtsq_khyhmf _bshuhsx
hl uhspn-Sgdrd l@ar antmc uhqhnmr hm _ b_ostqd DKHR@ _mc l_o,
odc sn rhw chrshmbsdohsnodr vhsghm nqoqnwhl_ksn sgd @ cnl_hm ne
sgd D1 ne L@XU- Qdl_qj_akx+ sgd l_inqhsx ne mnm,mdtsq_khyhmf
l@ar bnmedqqdc oqnsdbshnm _f_hmrs _qsgqhshr hm hlltmnbnlod,
sdms lhbd _mc oqdudmsdc kdsg_k bg_kkdmfd hm hlltmncdzbhdms
lhbd-Oqnsdbshnm hl uhun v_r hlltmnfknatkhm F ’HfF(rtabk_rr
_mc Ebb qdbdosnq’Ebb Q(cdodmcdms_mc qdpthqdc sgd oqdrdmbd
nelnmnbxsdr-Ldbg_mhrl ne_bshnm rstchdr rgnvdc sg_s mnm,
mdtsq_khyhmf l@ar b_m dmg_mbd sgd ahmchmf+tos_jd+_mc bkd_q,
_mbd ne L@XU nm Ebb Q,dwoqdrrhmf lxdknhc bdkkr- Ntq qdrtksr
hmchb_sd sg_s chqdbs mdtsq_khy_shnm hr mns qdpthqdc enq _mshancx,
ldch_sdc oqnsdbshnm+ _r Eb deedbsnq etmbshnmr _mc lnmnbxsdr
b_m oqnlnsd _mshancx,cdodmcdmsbnmsqnkne_kog_uhqtr hmedbshnmQDRTKSR
HrnkYshnm nemnm)mdtsqYkhyhmf Ymsh)L2XU l2ar
B46AK.5I lhbd vdqd hmnbtk_sdc vhsg sgd L@XU rsq_hm BG _mc
annrsdc svhbd vhsg qdbnlahm_ms L@XU D1 dbsncnl_hm oqnsdhm
’_lhmn _bhcr 0fl23/( hm Eqdtmc%r hmbnlokdsd _citu_ms- Sgqdd
c_xr _esdq sgd rdbnmc annrsdq hlltmhy_shnm+ vd odqenqldc _
rokdmnbxsd,lxdknl_ etrhnm sn fdmdq_sd gxaqhcnl_r ’D_qmdrs
ds_k-+1/08:O_kds_k-+1/02(-Vd hrnk_sdc 003 l@ar sg_santmc
sn sgd L@XU D1 oqnsdhm ax DKHR@-Sn hcdmshex l@ar sg_s lnqd
aqn_ckx qdbnfmhydc L@XU+ vd _krn _rrdrrdc ahmchmf sn Udqn
bdkkr hmedbsdc vhsg sgd gdsdqnknfntr L@XU rsq_hm AdG3/6 ’85#
_lhmn _bhc hcdmshsx hm D1,D0(ax finv bxsnldsqx-Vd rtbbdrretkkx
bknmdc 62 gxaqhcnl_r vhsg sgdrd ed_stqdr- Adb_trd oqduhntr
rstchdr cdlnmrsq_sdc sg_sHfF1_.b hrnsxodr dwghahsdc rtodqhnq
oqnsdbshud _bshuhsx _f_hmrs _kog_uhqtrdr ’D_qmdrs ds _k-+ 1/08:
O_kds_k-+1/02(+vd hrnsxodc sgd bknmdr _mc rdkdbsdc 02 HfF1b
l@ar enqetqsgdqbg_q_bsdqhy_shnmSgd 02 l@ar vdqd otqhzdc _mc du_kt_sdc enqmdtsq_khyhmf _b,
shuhsx ax trhmf enbtr qdctbshnm mdtsq_khy_shnm sdrsr ’EQMSr( hm
Udqn _mc B1B01 lxnak_rs bdkkr- Rdqh_kchktshnmr ne l@a vdqd
lhwdc vhsg 0/1 enbtr,enqlhmf tmhsr ’EETr( ne L@XU,AdG3/6
adenqd hmbta_shnm vhsg sgd svn s_qfdsbdkkr-Hm bnmsq_rssn _ oqd,
uhntrkx cdrbqhadc mdtsq_khyhmf l@a ’L@X,006: D_qmdrs ds _k-+
1/08(+ mnmd ne sgd 02 l@ar rgnvdc ld_rtq_akd hmghahsnqx
_bshuhsx hm dhsgdq Udqn nq B1B01 bdkkr dudm _sbnmbdmsq_shnmr ne
4/ g f.lk’Ehftqdr 0@ _mc 0A(Vd mdws du_kt_sdc sgdrd l@ar enq ahmchmf sn L@XU uhqhnmr
’Ehftqd 0B( _mc qdbnlahm_ms D1 oqnsdhm ’Ehftqd 0C(- G_ke,
l_whl_kahmchmf ’DB4/(sn uhqhnmr v_r ld_rtqdc ax DKHR@ _esdq
L@XU v_r b_ostqdc vhsg _m _msh,L@XU l@a bnms_hmhmf _ gt,
l_m Eb qdfhnm- @ mdtsq_khyhmf _msh,L@XU D1 A cnl_hm l@a
’L@X,006(’D_qmdrs ds _k-+ 1/08(v_r trdc enq bnlo_qhrnm- @kk
02 l@ar antmc sn hms_bsuhqhnmr vhsg DB4/ u_ktdr q_mfhmf eqnl
1 BdkkQdonqsr 24+0/7851+@oqhk5+1/10

2qshbkd
3 sn 268 mf.lk+ vhsg 8 ne 02 g_uhmf DB4/ u_ktdr kdrr sg_m
0// mf.lk’S_akd 0(- Sgd DB4/ u_ktdr+ gnvdudq+ vdqd 0/,enkc
ghfgdqsg_m sgnrd enqL@X,006 ’/-4 mf.lk(-Sgd l_whl_kahmchmf
u_ktdr ’Al_w(fdmdq_kkx vdqd bnmrhrsdms _lnmf sgd l@ar+vhsg
sgd l_inqhsx rgnvhmf noshb_kcdmrhsx ’NC( u_ktdr adsvddm 0-6
_mc 1-7- Gnvdudq+ L@X,28 _mc L@X,001 g_c l_whl_k NC
u_ktdr ne;0+vghbg rtffdrsr sg_sedvdql@ar b_m ahmc sgd uhqtr
_s r_stq_shnm ’S_akd 0: Ehftqd R0@(- DKHR@,a_rdc bnlodshshnm
ahmchmf rstchdr enq L@XU uhqhnmr qdud_kdc rhw chrshmbs fqntor
’Ehftqd 0D(-Sgd l_inqhsx ne_msh,L@XU l@ar _krn antmc sgd qd,
bnlahm_ms D1 oqnsdhm hm _m DKHR@+ _ksgntfg sgd DB4/ u_ktdr
fdmdq_kkx vdqd ghfgdqsg_m sg_snardqudc enquhqhnm ahmchmf+rtf,
fdrshmf kdrr _uhc ahmchmf sn qdbnlahm_msoqnsdhm sg_m hms_bsuh,
qhnmr ’S_akd 0(- Etqsgdqlnqd+ L@X,28 _mc L@X,001 chc mns
ahmc _ooqdbh_akx sn rnkhc og_rd qdbnlahm_ms D1 oqnsdhm ax
DKHR@-Sgd chro_qhshdr hm ahmchmf sn qdbnlahm_msoqnsdhm udqrtr
hms_bs uhqhnm l_x qdfidbs cheedqdmbdr hm dohsnod oqdrdms_shnm nq
dmf_fdldmsne_ pt_sdqm_qx dohsnod adsvddm nq_bqnrr D1 oqn,
sdhmr vhsghm _ rohjd+vghbg hr oqdrdmsdwbktrhudkx nm sgd uhqhnm+_r
rddm vhsg _msh,BGHJU ’Enw ds _k-+ 1/04( _mc _msh,QQU ’Onvdkk
ds _k-+ 1/1/(l@ar-@r _kkne sgd mnm,mdtsq_khyhmf l@ar antmc
D1 _esdqvdrsdqm aknsshmf vgdm vd trdc ansg mnm,qdctbhmf _mc
qdctbhmf bnmchshnmr+sgdx khjdkx cn mnsqdbnfmhyd bnmenql_shnm_k
dohsnodr ’Ehftqd R0A(- Sn _bpthqd lnqd pt_mshs_shud c_s_+ vd
ld_rtqdc lnmnu_kdmsahmchmf _ezmhshdr sn sgd L@XU D1 oqnsdhm
ax ahnk_xdq hmsdqedqnldsqx ’AKH( ’S_akd 0: Ehftqd R0B(- Sgd
ld_rtqdc jhmdshb ahmchmf bnmrs_ms’JC(q_sd enqsgd l@ar u_qhdc
ax lnqd sg_m 0//,enkc eqnl 3 sn 437 mL+vhsg sgd _ezmhsx neahmc,
hmf bnqqdk_shmf hmudqrdkx vhsg sgd g_ke,khed ’s0.1(- L@X,0/+ L@X,
0/7+L@X,7+_mc L@X,12 rgnvdc sgd ghfgdrs_ezmhshdr vhsg JC
u_ktdr ne;08 mL _mc s0.1 u_ktdr nudq02/ r-L@X,5/+L@X,57+
_mc L@X,001 rgnvdc mn _ooqdbh_akd ahmchmfDohsnod lYoohmf neYmsh)L2XU l2ar
@ksgntfg ntqDKHR@+AKH+_mc vdrsdqm aknsshmf c_s_ drs_akhrg sg_s
sgd mnm,mdtsq_khyhmf l@ar qdbnfmhyd sgd L@XU D1 fkxbnoqnsdhm+
vd nardqudc mn ahmchmf sn sgd qdbnlahm_msD1 A cnl_hm ’I-S-D_mc L-R-C-+tmotakhrgdc c_s_(-Sn sdrsvgdsgdqsgd l@ar antmc
sn qdfhnmr hm sgd @ cnl_hm+vd odqenqldc _k_mhmd rb_mmhmf lts_,
fdmdrhr hm sgd bnmsdwsnedwoqdrrhnm nesgd rsqtbstq_konkxoqnsdhm
’B,D2,D1,5J,D0(-A_rdc nm sgd BGHJU oD1,D0 rsqtbstqd ’OCA9
2M31(+ vd hmsqnctbdc _k_mhmd rtarshstshnmr hm oqdchbsdc rnk,
udms,dwonrdc _lhmn _bhcr ne sgd @ cnl_hm _mc sgd a ,qhaanm
_qbg bnmmdbshmf sgd @ _mc A cnl_hmr ’qdrhctdr 0fl061(ne sgd
L@XU D1 oqnsdhm- Vgdm _m _k_mhmd v_r oqdrdms hm sgd uhq_k
rdptdmbd+ vd rtarshstsdc _ rdqhmd qdrhctd- 182S bdkkr vdqd
sq_mredbsdc vhsg vhkc,sxod ’VS(nq hmchuhct_klts_ms ok_rlhcr+
_mc l@a ahmchmf v_r ld_rtqdc ax finv bxsnldsqx-@m nkhfnbkn,
m_konnknesgd 02 l@ar _r vdkk_r L@X,006+_m _msh,D1 A cnl_hm
l@a+ v_r trdc sn bnmsqnkenq lts_ms oqnsdhm dwoqdrrhnm- Jdx
hmsdq_bshnm qdrhctdr vdqd cdzmdc vgdm l@a ahmchmf sn _ fhudm
lts_ms v_r 14# _esdq mnql_khy_shnm ne ahmchmf sn bdkkr dw,
oqdrrhmf sgd VS ok_rlhc ’S_akd R0(-Sgd 02 l@ar l_oodc sn
5 cheedqdmsrhsdr vhsghm nq md_q sgd @ cnl_hm ’Ehftqd 1@(+vghbg
bnqqdk_sdc vhsg sgd enkknvhmf bnlodshshnm fqntor ’Ehftqd 0D(9
fqnto @+qdrhctdr 16fl18 ’Ehftqd R1@(:fqnto A+qdrhctdr 46fl50
’Ehftqd R1A(: fqnto B+ qdrhctdr 61fl66 ’Ehftqd R1B(: fqnto C+
qdrhctdr 70fl75 ’Ehftqd R1C(: fqnto D+ qdrhctdr 048fl052
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Ehftpd .- Ahmchmf ne mnm,mdtspYkhyhmf Ymsh,
F6VT l6ar sn uhphnmr Ymc pdbnlahmYms B1
opnsdhm
’@ _mc A( @msh,L@XU l@ar vdqd sdrsdc enq
mdtsq_khy_shnm ne L@XU nm Udqn ’@( _mc B1B01
lxnak_rs’A(bdkkr-Rdqh_kchktshnmr nesgd hmchb_sdc
l@ar vdqd hmbta_sdc vhsg 0/1 EET ne L@XU,
AdG3/6 _mc sgdm _ccdc sn sgd hmchb_sdc bdkkr-Uhq_k
enbh_qd oknssdc qdk_shud sn _ mn l@a bnmsqnk-Sgd
mdtsq_khyhmf l@a L@X,006 v_r trdc _r _ onrhshud
bnmsqnk+_mc _m hqqdkdu_ms lHfF1b l@a v_r trdc
_r _ mdf_shud hrnsxod bnmsqnk’ld_m _mc RC nesvn
dwodqhldmsr odqenqldc hm sqhokhb_sd(’B _mc C(Ahmchmf sn L@XU uhqhnmr ’B(nq qdbnl,
ahm_msL@XU D1 oqnsdhm ’C(ax DKHR@-Uhqhnmr vdqd
b_ostqdc vhsg _ gtl_mhydc l@a sn L@XU+ _mc
qdbnlahm_msL@XU D1 oqnsdhm v_r antmc chqdbskx
sn lhbqnshsdq ok_sdr- Antmc ltqhmd l@ar vdqd
cdsdbsdc vhsg _m gnqrdq_chrg odqnwhc_rd ’GQO(,
bnmitf_sdc rdbnmc_qx _mshancx- C_s_ _qd dw,
oqdrrdc _r NC u_ktdr qdk_shud sn sgd 0/,g f.lk
r_lokd ’ld_m _mc RC ne svn dwodqhldmsr odq,
enqldc hm sqhokhb_sd(’D( L@XU l@ar vdqd bnlodsdc enq ahmchmf sn
L@XU ’rsq_hm AdG3/6( ax DKHR@- Uhqtr v_r
b_ostqdc nm ok_sdr trhmf _ gtl_mhydc _msh,L@XU
l@a-B_ostqdc uhqhnm v_r hmbta_sdc vhsg 0/ g f.lk
nesgd hmchb_sdc l@a ’zqrs_mshancx(-@mshancx,uh,
qtr bnlokdwdr vdqd hmbta_sdc vhsg 0/ mf.lknesgd
hmchb_sdc l@a k_adkdc vhsg ahnshm ’rdbnmc _msh,
ancx(- Ahmchmf v_r cdsdbsdc trhmf rsqdos_uhchm
GQO _mc hr hmchb_sdc ax bnknqeqnl ghfg ’qdc(sn knv
’aktd(-C_s_ _qd oqdrdmsdc qdk_shud sn _ bnmsqnkvhsg
mn zqrs _mshancx _mc _qd qdoqdrdms_shud ne svn
dwodqhldmsr-

_ci_bdmsqdfhnmr md_qsgd sno nesgd rohjd
bnlokdw ’Ehftqdr 1A _mc 1B(- @r mnm,
mdtsq_khyhmf _msh,L@XU l@ar qdbnfmhyd
cdm_stqdc enqlr ne D1 ’Ehftqd R0A(_mc
sgdhq l_oohmf qdrhctdr bktrsdq snfdsgdq+
sgdrd _mshanchdr khjdkx oqdedqdmsh_kkx
dmf_fd khmd_qodoshcd dohsnodr-

’Ehftqd R1D(:_mc fqnto E+qdrhctdr 057fl062 ’Ehftqd R1E(-Fqnto
C l@ar+vghbg g_c sgd k_qfdrsmtladqhm ntqo_mdk+l_o sn _m
dohsnod e_bhmf sgd hmrhcd ne sgd D1,D0 sqhldq ’Ehftqdr 1A _mc
1B(: lts_shnm ne sgdrd qdrhctdr qdrtksdc hm knrr ne ahmchmf ne
L@X,16+L@X,28+L@X,30+L@X,57+_mc L@X,001-Svn l@a
fqntor l_o sn rhsdr _ci_bdms sn sgd @ cnl_hm hm sgd a ,qhaanm
_qbg bnmmdbshmf sgd @ _mc A cnl_hmr neD1 ’048fl052+fqnto D+
L@X,0/1 _mc L@X,0/7: _mc 057fl062+ fqnto E+ L@X,61(L@X,12+ sgd knmd ldladq ne fqnto @+ knb_khydr sn _ a rsq_mc
_ci_bdmssn sgd M,sdqlhm_kkhmjdqnm sgd ntsdqe_bd nesgd D1,D0
sqhldqhb bnlokdw ’Ehftqd 1B(- Sgd fqnto A ’L@X,7 _mc L@X,
0/(_mc B ’L@X,0 _mc L@X,5/(l@ar l_o sn svn rsqtbstq_kkx

Oqnsdbshnm YfYhmrskdsgYkL2XU
bgYkkdmfd ax l2ar
Vd sdrsdc sgd 02 mnm,mdtsq_khyhmf l@ar
hm _ kdsg_k L@XU bg_kkdmfd lncdk hm
3,vddj,nkc edl_kd B46AK.5I lhbdAdb_trd L@XU cndr mnsb_trd lnqs_khsx hm hlltmnbnlodsdms
lhbd+ vd sqd_sdc _mhl_kr vhsg 0// g f ne _m _msh,Hem_q0 l@a
’L@Q,4@2:Rgddg_m ds_k-+1//5(sn sq_mrhdmskx hlltmnrtooqdrr
sgdl-Lhbd fhudm _msh,Hem_q0 l@a rtbbtladc sn rtabts_mdntr
hmnbtk_shnm ne 0/2 EET ne L@XU,AdG3/6 adsvddm 2 _mc
4 c_xr onrs,hmedbshnm ’coh(’Ehftqd 2(-Sn _rrdrr enq oqnsdbshnm
_r oqnogxk_whr hm sghr lncdk+ lhbd vdqd sqd_sdc vhsg _ rhmfkd
0//,g f ’4 lf.jf( cnrd ne hmchuhct_k _msh,L@XU l@ar 0 c_x
adenqd uhqtr hmnbtk_shnm-Vd nardqudc _ q_mfd neoqnsdbshud _b,
shuhsx nesgd l@ar+_r enkknvr9L@X,0/ _mc L@X,0/7 bnmedqqdc
0//# oqnsdbshnm ’Ehftqd 2@(: L@X,12+ L@X,7+ _mc L@X,0/1
oqnsdbsdc %4/# ne lhbd eqnl kdsg_khsx: _mc L@X,0+ L@X,28+
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SYakd /- Ahmchmf Yezmhshdr neYmsh)L2XU l2ar sn uhqhnmr Ymc
qdbnlahmYmsD1 oqnsdhm
DB4/+ D1
’mf.lk(

Al_w
uhqhnm JC ’jhmdshb(
’NC( ’mL(
s0.1 ’r(

006
/-3 ’/-2fl/-4(
’D_qmdrs
ds_k-+1/08(

/-3 ’/-2fl/-4(

1-73

0/

01 ’7fl06(

2/1 ’163fl223( 0-55

03-/

120-7

0/7

0/ ’4fl12(

71 ’61fl84(

3-0

102-8

7

4 ’2fl6(

084 ’046fl131( 0-11

05-5

025-2

12

10 ’03fl20(

30 ’25fl34(

07-3

031-5

0/1

72 ’50fl002(

350 ’3/5fl412( 1-/5

100-2

50-4

5/

34 ’17fl64(

73 ’66fl81(

0-8/

MC

MC

0

3 ’1fl5(

4 ’3fl5(

1-68

05/-/

03-0

30

14 ’08fl22(

752 ’662fl886( 0-88

36-2

81-4

16

45 ’30fl64(

233 ’206fl263( 0-61

00/-4

01-5

28

221 ’127fl352( =0+///

57

l@a

DB4/+ uhqhnm
’mf.lk(

1-54
1-/3

/-7/

8-1

153-0

436-5

63-4

0// ’60fl027( 272 ’222fl33/( 1-//

MC

MC

61

023 ’68fl114( 22 ’05fl57(

1-/3

054-5

03-8

001

268 ’12/fl526( =0+///

/-77

MC

MC

@msh,L@XU l@ar vdqd ld_rtqdc enq ahmchmf sn hms_bsL@XU uhqhnmr ax
b_ostqd DKHR@ _mc qdbnlahm_ms L@XU D1 oqnsdhm ax DKHR@ _mc AKHDeedbshud bnmbdmsq_shnm ne4/# ahmchmf ’DB4/(v_r b_kbtk_sdc eqnl sgd
NC u_ktdr vhsg rdqh_kchktshnmr nesgd hmchb_sdc l@a-Al_w v_r ld_rtqdc
_r sgd ghfgdrsNC u_ktd nardqudc hm sgd uhqhnm b_ostqd DKHR@-AKHv_r
odqenqldc ax ahmchmf ahnshmxk_sdc l@ar sn rsqdos_uhchm,bn_sdc ohmr
_mc finvhmf nudq qdbnlahm_msD1 oqnsdhm-Sgd dpthkhaqhtl ahmchmf bnm,
rs_ms’JC(_mc g_ke,khed ’s0.1(ne_mshancx ahmchmf vdqd ld_rtqdc-Sgd oqd,
uhntrkx bg_q_bsdqhydc ’D_qmdrs ds _k-+ 1/08( onrhshud,bnmsqnk L@X,006
l@a hr khrsdc zqrsenqbnlo_qhrnm+_mc rtardptdmskx+l@ar _qd _qq_mfdc
eqnl lnrssn kd_rsoqnsdbshud-L@X,0/+L@X,0/7+L@X,7+L@X,12+_mc
L@X,0/1 l@ar g_c %4/# oqnsdbshnm hm sgd kdsg_kbg_kkdmfd lncdk-C_s_
_qd sgd ld_m nesvn hmcdodmcdmsdwodqhldmsr+_mc 84# bnmzcdmbd hm,
sdqu_kr _qd hm o_qdmsgdrdr-MC+mnscdsdqlhmdc ctd sn onnqahmchmf-

L@X,5/+L@X,57+L@X,61+_mc L@X,001 dwghahsdc kdrr oqnsdb,
shud _bshuhsx ’2/#fl3/#(’Ehftqd 2A(-L@X,16 _mc L@X,30 g_c mn
rhfmhzb_msoqnsdbshud _bshuhsx-Mns_akx+sgd hl uhun _bshuhsx nesgd
mnm,mdtsq_khyhmf _mshanchdr fdmdq_kkx bnqqdk_sdc vhsg ahmchmf _e,
zmhsx+vhsg sgd lnrsoqnsdbshud l@ar g_uhmf knvdqJC _mc ghfgdq
s0.1 u_ktdr ’S_akd 0(-Lnqdnudq+sgd lnrsoqnsdbshud l@ar l_o sn
nmd ne svn dohsnodr+ _r enkknvr9 fqnto A l@ar knb_khyd sn _m
dohsnod _ssgd sno nesgd rohjd sqhldq’L@X,0/ _mc L@X,7:Ehf,
tqdr 1A _mc 1B(+_mc fqnto D l@ar dmf_fd _m dohsnod hm sgd
khmjdq qdfhnm adsvddm sgd @ _mc A cnl_hmr nm sgd rhcd ne sgd
rohjd sqhldq ’L@X,12+ L@X,0/1+ _mc L@X,0/7: Ehftqdr 1A
_mc 1B(-Sgdrd qdrtksr rtffdrsansg ahmchmf _ezmhsx _mc dohsnod
knb_shnm e_bhkhs_sd noshl_koqnsdbshnm ax mnm,mdtsq_khyhmf l@arVd oqduhntrkx cdrbqhadc _ oqnsdbshud mdtsq_khyhmf _msh,L@XU
l@a ’L@X,023( sg_s l_or sn sgd A cnl_hm ne D1 ’D_qmdrs
ds _k-+ 1/08(- Adb_trd L@X,023 hr oqnsdbshud _mc cndr mns
bnlodsd enqahmchmf vhsg dhsgdqL@X,0/ nqL@X,0/7 ’Ehftqd R2(+
vd sdrsdc vgdsgdqbnlahm_shnmr nemdtsq_khyhmf ’L@X,023(_mc
mnm,mdtsq_khyhmf ’L@X,0/ nq L@X,0/7( l@ar bntkc dmg_mbd
sgdq_odtshb dezb_bx hm ntq kdsg_kbg_kkdmfd lntrd lncdk- Vd
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_clhmhrsdqdc 1// g f ’0/ lf.jf(ne dhsgdq L@X,0/ ’Ehftqd 2B(+
L@X,0/7 ’Ehftqd 2C(+ nq L@X,023 ’Ehftqdr 2B _mc 2C( nq
0// g f d_bg neL@X,0/ nqL@X,0/7 _mc L@X,023 1 c_xr _esdq
lhbd vdqd hmnbtk_sdc vhsg 0/2 EET neL@XU,AdG3/6-@ksgntfg
vd nardqudc mn rs_shrshb_kkx rhfmhzb_ms oqnsdbshnm eqnl kdsg_k
bg_kkdmfd hm lhbd sqd_sdc vhsg _mx rhmfkd l@a+bnlahm_shnm sgdq,
_ox vhsg L@X,0/ _mc L@X,023 nqL@X,0/7 _mc L@X,023 oqn,
sdbsdc 5/# _mc 4/# nelhbd+qdrodbshudkx ’Ehftqdr 2B _mc 2C(Sgtr+ mnm,mdtsq_khyhmf @ cnl_hm _mc mdtsq_khyhmf A cnl_hm
l@ar snfdsgdq oqnuhcd fqd_sdq oqnsdbshnm _r onrs,dwonrtqd
sgdq_ox sg_m dhsgdql@a _knmd2mshancx oqnsdbshnm ei ueun qdpthqdr Eb deedbsnq
etmbshnmr
Vd gxonsgdrhydc sg_soqnsdbshnm ax mnm,mdtsq_khyhmf l@a lhfgs
qdpthqd Eb deedbsnqetmbshnmr-Sn sdrssghr hcd_+vd qdod_sdc o_r,
rhud sq_mredq dwodqhldmsr hm _msh,Hem_q0,l@a,sqd_sdc B46AK.5I
lhbd k_bjhmf sgd bnllnm rhfm_khmf f_ll_ ’b (bg_hm _mc dwoqdr,
rhnm ne_bshu_shmf Ebb Q ’Ebb Q!.!(-Sgdrd lhbd vdqd sqd_sdc vhsg
_ rhmfkd 0//,g f cnrd neL@X,0/ nqL@X,0/7 0 c_x oqhnqsn rta,
bts_mdntr hmnbtk_shnm vhsg L@XU,AdG3/6- Qdl_qj_akx+ ansg
hrnsxod bnmsqnk _mc _msh,L@XU ’L@X,0/ nq L@X,0/7(,sqd_sdc
Ebb Q!.! lhbd tmhenqlkx rtbbtladc ax 3 coh’Ehftqd 3@(+vghbg
bnmsq_rsr vhsg qdrtksr rddm hm bnmfdmhb VS B46AK.5I lhbd
’Ehftqd 2@(Sn bnqqnanq_sd sgd qnkd neEb deedbsnqetmbshnm hm sgd oqnsdbshud
_bshuhsx nemnm,mdtsq_khyhmf _msh,L@XU l@ar+vd dmfhmddqdc hrn,
sxod,rvhsbgdc udqrhnmr neL@X,0/ _mc L@X,0/7-Ltqhmd HfF1b
’lHfF1b( _mshanchdr ahmc lntrd Eb f_ll_ qdbdosnq ’Ebb Q(H
_mc Ebb QHU vhsg ghfg _mc lncdq_sd _ezmhsx+ vgdqd_r ltqhmd
HfF0 ’lHfF0( ahmcr kdrr _uhckx sn sgdrd qdbdosnqr ’L_mb_qch
ds _k-+ 1//7(- Etqsgdqlnqd+ gtl_m HfF0 ’gHfF0(ahmcr rsqnmfkx
sn sgdrd ltqhmd Ebb Qr hm _ l_mmdqrhlhk_qsn lHfF1b ’Cdjjdqr
ds_k-+1/06:D_qmdrsds_k-+1/08(-Vd bknmdc sgd u_qh_akd qdfhnmr
ne L@X,0/ _mc L@X,0/7 hmsn _mshancx dwoqdrrhnm bnmrsqtbsr
vhsg Eb qdfhnmr nelHfF0 nqgHfF0-@cchshnm_kkx+vd hmsqnctbdc
_m M186P lts_shnm hm sgd Eb qdfhnm nesgd gHfF0 bnmrsqtbssn qd,
lnud _m M,khmjdc fkxb_m sg_shr mdbdrr_qx enqEb,Ebb Q hmsdq_b,
shnmr ’S_n _mc Lnqqhrnm+0878(Vd zqrs sdrsdc vgdsgdq sgd hrnsxod,rvhsbgdc L@X,0/ _mc
L@X,0/7 g_c cheedqdmsahmchmf o_ssdqmr sn qdbnlahm_msltqhmd
Ebb Qr ’H+ HHH+ _mc HU( ax DKHR@- @r dwodbsdc+ lHfF0 l@ar
rgnvdc kdrr ahmchmf sn _kk ne sgd sdrsdc Ebb Qr ’Ehftqd 3A(gHfF0 l@ar rgnvdc rkhfgskx knvdq ahmchmf+ ats hs v_r lnqd
rhlhk_q sn lHfF1b sg_m lHfF0-Sgd M186P u_qh_msknrs08/#
ne ahmchmf _bshuhsx bnlo_qdc sn lHfF1b- Vd bnmzqldc sg_s
sgd hrnsxod,rvhsbgdc L@X,0/ _mc L@X,0/7 l@ar antmc
L@XU uhqhnmr rhlhk_qkx ’Ehftqdr 3B _mc 3D(+_mc sgtr+_ksdqhmf
Eb hmsdq_bshnmr chc mns _eedbs _mshancx,_mshfdm ahmchmf- Vd
_clhmhrsdqdc _ rhmfkd 0//,g f cnrd ne sgd hrnsxod,rvhsbgdc
l@ar sn _msh,Hem_q0,l@a,sqd_sdc VS B46AK.5I lhbd 0 c_x
adenqd rtabts_mdntr hmnbtk_shnm ne L@XU- @r dwodbsdc+
lHfF1b L@X,0/ _mc L@X,0/7 oqnsdbsdc lhbd eqnl kdsg_k
bg_kkdmfd- Rhlhk_qkx+ gHfF0 l@ar oqnsdbsdc 8/# ’L@X,0/(
_mc 0//# ’L@X,0/7(ne lhbd eqnl lnqs_khsx-Hm bnmsq_rs+ sgd
lHfF0 _mc _fkxbnrxk gHfF0,M186P enqlr ne L@X,0/ _mc
L@X,0/7 knrs _bshuhsx ’Ehftqdr 3C _mc 3E(-Bnkkdbshudkx+sgdrd
dwodqhldmsr drs_akhrg sg_soqnsdbshnm _f_hmrs kdsg_kbg_kkdmfd
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Ehftpd 1- FYoohmf nel6ar sn F6VT B1 opnsdhm
’@(Gd_sl_o neqdk_shud ahmchmf ne_msh,L@XU l@ar sn L@XU,D1 @ cnl_hm lts_msr-182S bdkkr vdqd sq_mredbsdc vhsg _ B,D2,D1,5J,D0 ok_rlhc bnms_hmhmf _k_mhmd
lts_shnmr hm sgd @ cnl_hm neD1-Ahmchmf nesgd hmchb_sdc l@ar vdqd ld_rtqdc ax finv bxsnldsqx:sgd etkkc_s_rdshr rgnvm hm S_akd R0 _mc Ehftqd R1-Qdk_shud
ahmchmf bnlo_qdc sn _m nkhfnbknm_kbnmsqnkhr hmchb_sdc ax bnknqeqnl ghfg ’qdc(sn knv ’aktd(’A _mc B(Qdrhctdr qdpthqdc enql@a dmf_fdldms_qd cdohbsdc _r a_kkr _mc rshbjr nm _ qhaanm ch_fq_l nesgd oqdchbsdc rsqtbstqd neL@XU D1,D0 lnmnldq
fdmdq_sdc trhmf Ogxqd1 ’A( _mc _qd ghfgkhfgsdc nm sgd lnmnldqr _qq_mfdc _r _ sqhldqhb rohjd ’B(- Sgd D0 _mc D1 fkxbnoqnsdhmr _qd khfgs _mc c_qj fq_x+
qdrodbshudkx-Vhsghm D1+cnl_hm @ hr bx_m+sgd a ,qhaanm hr c_qj bx_m-Hm sgd rtqe_bd qdoqdrdms_shnm ’B(+sgd @ cnl_hm _mc a ,qhaanm qdfhnmr _qd ntskhmdc hm qdc _mc
xdkknv+qdrodbshudkx-Bnlodshshnm fqntor _qd bnknqbncdc _r enkknvr9fqnto @+c_qj ohmj ’qdrhctdr 16fl18(:fqnto A+nq_mfd ’46fl50(:fqnto B+aktd ’61fl66(:fqnto C+
c_qj fqddm ’70fl75(:fqnto D+k_udmcdq’048fl052(:fqnto E+khfgsfqddm ’057fl062(:_mc sgd _msh,A cnl_hm bnmsqnkl@a L@X,006+aqhfgsxdkknv ’070fl075(-Rdd _krn
S_akd R0 _mc Ehftqd R1-

ax mnm,mdtsq_khyhmf _msh,L@XU l@ar qdpthqdr Eb,deedbsnq,
etmbshnm,cdodmcdms_bshuhsxOqnsdbshnm YfYhmrsL2XU)hmctbdc ltrbtknridkdsYk
chrdYrd ax l2ar
Vd _rrdrrdc sgd _bshuhsx nentqsvn lnrsoqnsdbshud mnm,mdtsq_k,
hyhmf l@ar hm _ lnqd ogxrhnknfhb_kkx qdkdu_ms lncdkneL@XU,
hmctbdc chrd_rd- Rtabts_mdntr hmnbtk_shnm ne L@XU hm sgd
enns ne hlltmnbnlodsdms B46AK.5I lhbd qdrtksr hm inhms
rvdkkhmf _mc ltrbtknrjdkds_kchrd_rd ’D_qmdrsds_k-+1/08(-Uhq_k
hmedbshnm hr zqrs nardqudc hm sgd horhk_sdq_kenns+_mjkd+_mc b_ke
ltrbkd adenqd chrrdlhm_shmf sn sgd bnmsq_k_sdq_kdwsqdlhsx-Rhlh,
k_qkx+ennsrvdkkhmf nbbtqr zqrshm sgd horhk_sdq_k_mjkd _mc k_sdqhm
sgd bnmsq_k_sdq_k_mjkd ’D_qmdrsds_k-+1/08(-Vd sqd_sdc B46AK5.
I lhbd vhsg _ rhmfkd 0//,g f cnrd neL@X,0/+L@X,0/7+nq_m hrn,
sxod bnmsqnkl@a adenqd rtabts_mdntr hmnbtk_shnm neL@XU hm
sgd enns-@s0 _mc 6 coh+_mhl_kr vdqd dtsg_mhydc _mc odqetrdc
dwsdmrhudkx vhsg OAR- Sgd horhk_sdq_k _mjkd _mc b_ke ltrbkd+
bnmsq_k_sdq_k_mjkd _mc b_keltrbkd+_mc rokddm vdqd g_qudrsdc+
_mc uhq_kQM@ kdudkr vdqd ld_rtqdc trhmf pt_mshs_shud qdudqrd,
sq_mrbqhos_rd OBQ ’pQS,OBQ(vhsg oqnadr s_qfdshmf sgd 4 tm,
sq_mrk_sdc qdfhnm ne L@XU ’V_ffnmdq ds _k-+ 1/07(- @s 0 coh+
vd nardqudc _ =0+///,enkc qdctbshnm hm L@UX QM@ hm sgd horhk_s,
dq_k _mjkdr ne ansg L@X,0/, _mc L@X,0/7,sqd_sdc lhbd
bnlo_qdc sn sgd hrnsxod bnmsqnk l@a ’Ehftqd 4@(- Lnqdnudq+
vd nardqudc chrrdlhm_shnm neL@XU sn sgd horhk_sdq_kb_keltr,

bkd+sgd bnmsq_k_sdq_kkdf+_mc sgd rokddm hm hrnsxod l@a sqd_sdc
lhbd+atssgdqd v_r mn cdsdbs_akd uhq_kQM@ hm lhbd sqd_sdc vhsg
sgd mnm,mdtsq_khyhmf l@ar L@X,0/ nqL@X,0/7 ’Ehftqdr 4Afl4D(Qdl_qj_akx+_s6 coh+L@X,0/, _mc L@X,0/7,sqd_sdc lhbd g_c
bkd_qdc uhq_kQM@ kdudkr eqnl sgd horhk_sdq_kenns+lhbd rgnvdc mn
hmedbshnm nesgd bnmsq_k_sdq_kdwsqdlhsx+_mc nmkx nmd _mhl_kg_c
cdsdbs_akd uhq_kQM@ hm sgd rokddm ’Ehftqdr 4Efl4I(Vd mdws sdrsdc vgdsgdq _mshancx deedbsnq etmbshnmr vdqd
qdpthqdc sn khlhsuhq_khmedbshnm _mc bnmsqnkltrbtknrjdkds_kchr,
d_rd hm hlltmnbnlodsdms lhbd ax sqd_shmf VS B46AK.5I
lhbd vhsg L@X,0/,gHfF0 nq _fkxbnrxk L@X,0/,gHfF0,M186P
0 c_x adenqd L@XU hmedbshnm-@s 6 coh+sgd gtl_mhydc udqrhnm
neL@X,0/ oqnsdbsdc lhbd eqnl uhqtr hmedbshnm ’Ehftqdr 4Jfl4N(
sn _ rhlhk_q dwsdms _r sgd o_qdms_klntrd l@ar ’Ehftqdr 4Efl
4I(+vhsg cdbqd_rdr hm _kkshrrtdr ld_rtqdc vgdm bnlo_qdc sn
hrnsxod bnmsqnkl@a-Gnvdudq+L@X,0/,gHfF0,M186P chc mns
oqnuhcd uhqnknfhb_koqnsdbshnm hm sghr lncdk-Vd _krn nardqudc
Eb,deedbsnq,etmbshnm,cdodmcdms cdbqd_rdr hm sgd hmfi_ll_snqx
bxsnjhmdr ’stlnq mdbqnrhr e_bsnq ZSME, [+ BWBK0+ BWBK8+
BWBK0/+BBK2+BBK3+BBK4+_mc BRE0(hm sgd horhk_sdq_k_mjkdr
ne L@X,0/,gHfF0,sqd_sdc _mhl_kr _s 6 coh’Ehftqd R3(- Sgdrd
c_s_ hmchb_sd sg_s sgd deedbsnq etmbshnmr ne mnm,mdtsq_khyhmf
l@ar _qd qdpthqdc enq dezbhdmsuhq_kbkd_q_mbd _mc qdctbshnm ne
hmfi_ll_shnm hm inhms,_rrnbh_sdc shrrtdr nehmedbsdc _mhl_krSn cdsdqlhmd he sgd l@ar oqnsdbs _f_hmrs L@XU,ldch_sdc
ltrbtknrjdkds_k chrd_rd+ vd ld_rtqdc _mjkd rvdkkhmf- Vd
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Ehftpd 2- 6mshancv opnsdbshnm YfYhmrskdsgYk
F6VT bgYkkdmfd
Entq,vddj,nkc B46AK.5I edl_kd lhbd vdqd
sqd_sdc vhsg 0// g f ne_msh,Hem_q0 l@a 0 c_x adenqd
rtabts_mdntr hmnbtk_shnm neL@XU,AdG3/6’@ _mc A(@ rhmfkd 0//,g f cnrd ne_msh,L@XU l@ar
v_r _clhmhrsdqdc ax hmsq_odqhsnmd_khmidbshnm 0 c_x
adenqd uhqtr hmnbtk_shnm- Sgd l@ar dwghahsdc _
q_mfd ne _bshuhsx vhsg rnld rgnvhmf =4/# oqn,
sdbshnm ’@(_mc nsgdqr ;4/# ’A(-C_s_ _qd eqnl svn
dwodqhldmsr’B _mc C(Bnlahm_shnm sgdq_ox ne_m _msh,L@XU D1
A cnl_hm l@a ’L@X,023( _mc _msh,L@XU D1 @
cnl_hm l@ar-B46AK5.I lhbd vdqd sqd_sdc vhsg
0// g f ne _msh,Hem_q0 l@a 0 c_x adenqd rtabt,
s_mdntr uhqtr hmnbtk_shnm- ’B( Svn c_xr _esdq
hmedbshnm+lhbd vdqd sqd_sdc vhsg 1// g f neL@X,0/
nqL@X,023 nq0// g f d_bg neL@X,0/ _mc L@X,
023- ’C( Svn c_xr _esdq hmedbshnm+ lhbd vdqd
sqd_sdc vhsg 1// g f ne L@X,0/7 nq L@X,023 nq
0// g f d_bg ne L@X,0/7 _mc L@X,023 ’svn dw,
odqhldmsr+m < 7:)o ; /-/4:))o ; /-/0:)))o ; /-//0:
))))o ; /-///0: knf,q_mj sdrs vhsg Anmedqqnmh
bnqqdbshnm bnlo_qdc sn hrnsxod bnmsqnkl@a(-Rdd
_krn Ehftqd R2-

nardqudc rtars_msh_krvdkkhmf hm sgd horhk_sdq_k_mjkd eqnl 1fl0/
coh’Ehftqd 4J( _mc sgd bnmsq_k_sdq_k_mjkd eqnl 5fl7 coh’Ehf,
tqd 4K(hm lhbd sqd_sdc vhsg _m hrnsxod bnmsqnkl@a+vgdqd_r _m,
hl_kr sqd_sdc vhsg L@X,0/ nq L@X,0/7 rgnvdc mn _mjkd
rvdkkhmf-@mshancx,ldch_sdc oqnsdbshnm v_r Eb deedbsnqetmbshnm
cdodmcdms+_r L@X,0/,gHfF0+atsmnsL@X,0/,gHfF0,M186P+
khlhsdc rvdkkhmf hm sghr lncdk’Ehftqd 4Q(- Sgtr+ dudm vhsgnts
mdtsq_khyhmf _bshuhsx+ _msh,L@XU l@ar b_m oqdudms chrrdlhm_,
shnm+bkd_qhmedbshnm+_mc khlhsltrbtknrjdkds_kchrd_rd hm hllt,
mnbnlodsdmslhbdLxdknhc)bdkk)cdodmcdmsoqnsdbshnm nemnm)mdtsqYkhyhmf
l2ar
Adb_trd mnm,mdtsq_khyhmf l@ar bnmsqnkL@XU hmedbshnm hm _m Eb,
deedbsnq,etmbshnm,cdodmcdms l_mmdq+ vd gxonsgdrhydc sg_s
rodbhzb hlltmd bdkkr ad_qhmf Ebb Qr ldch_sd sghr oqnsdbshnm
’Antqm_ynr ds_k-+1/04:Kt ds_k-+1/07(-Oqduhntr rstchdr g_ud
rgnvm sg_slnmnbxsdr _mc m_stq_kjhkkdq’MJ(bdkkr ldch_sd _msh,
ancx,cdodmcdms_mshuhq_koqnsdbshnm hl uhun ax _mshancx,cdodm,
cdms bdkktk_q bxsnsnwhbhsx ’@CBB(+ _mshancx,cdodmcdms bdkktk_q
og_fnbxsnrhr ’@CBO(+nq_mshancx,cdodmcdmsuhqtr nornmhy_shnm
’Kt ds _k-+ 1/07(- Sn cdsdqlhmd sgd bdkk sxod qdronmrhakd enq
_mshancx,cdodmcdms oqnsdbshnm _f_hmrs L@XU+ vd cdokdsdc
lnmnbxsdr nq MJ bdkkr vhsg rodbhzb l@ar ’_msh,BBQ1 _mc
_msh,MJ0-0+qdrodbshudkx(adfhmmhmf 0 c_x adenqd hmedbshnm trhmf
sgd _msh,Hem_q0,l@a,sqd_sdc hlltmnbnloqnlhrdc kdsg_k bg_k,
kdmfd lntrd lncdk-@r dwodbsdc+vd nardqudc bnlokdsd oqn,
sdbshnm _f_hmrslnqs_khsx hm lhbd sqd_sdc vhsg L@X,0/ nq L@X,
0/7 hm sgd _ardmbd nehlltmd,bdkk,cdokdshmf _mshancx ’Ehftqdr
5@ _mc 5A(-Gnvdudq+hm sgd oqdrdmbd ne_msh,BBQ1 l@a sqd_s,
ldms_mc lnmnbxsd cdokdshnm ’Ehftqd R4@(+L@X,0/ _mc L@X,
0/7 oqnsdbshnm cdbqd_rdc sn 3/# _mc 2/#+ qdrodbshudkxVgdm rhlhk_q cdokdshnm dwodqhldmsr vdqd odqenqldc vhsg _msh,
MJ0-0 l@a sn cdokdsd MJ bdkkr ’Ehftqd R4A(+vd r_v mn bg_mfd
hm oqnsdbshud _bshuhsx hm L@X,0/ nqL@X,0/7 ’Ehftqd 5A(-Sgdrd
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c_s_ rtffdrssg_sBBQ1* lnmnbxsdr _qd oqhmbho_kkx qdronmrhakd
enq sgd oqnsdbshnm bnmedqqdc ax mnm,mdtsq_khyhmf _msh,L@XU
l@arVd du_kt_sdc gnv lnmnbxsdr lhfgs bnmsqhatsd sn _mshancx,
ldch_sdc oqnsdbshnm- Sn _rrdrr vgdsgdq mnm,mdtsq_khyhmf _msh,
L@XU l@ar oqnlnsd nornmhy_shnm neeqdd uhqhnmr _mc bkd_q_mbd
ax lnmnbxsdr+vd odqenqldc hl uhspn ahmchmf _rr_xr hm sgd enkk,
knvhmf svn ltqhmd lxdknhc bdkk khmdr9 lhbqnfkh_k,cdqhudc AU1
bdkkr ’Ehftqdr 5B+ 5C+ 5F+ _mc 5G( _mc anmd,l_qqnv,cdqhudc
lnmnbxshb K@CL@B bdkkr ’Ehftqdr 5D+5E+5H+_mc 5I(-@ksgntfg
K@CL@B bdkkr _qd drrdmsh_kkx mnm,odqlhrrhud enqL@XU hmedbshnm
tmkdrr sgd Lwq_7 qdbdosnqhr dbsnohb_kkx dwoqdrrdc ’Yg_mf ds_k-+
1/07(+AU1 bdkkr b_m ad hmedbsdc _sknv kdudkr adb_trd sgdx dw,
oqdrr gdo_qhm rtke_sd ’GR(_r _m _ss_bgldmse_bsnq-Sn lhmhlhyd
sgd deedbsr neGR nm L@XU ahmchmf _mc hmedbshnm neAU1 bdkkr+
vd trdc AU1 bdkkr k_bjhmf a ,0+3,f_k_bsnrxksq_mredq_rd 6
’AU1) D3eVis6( ’L_ ds _k-+ 1/1/(+ _ jdx dmyxld qdpthqdc enq
fkxbnr_lhmnfkxb_m rxmsgdrhr-Eknv bxsnldsqx _m_kxrhr rgnvdc
sg_s AU1 bdkkr dwoqdrr ghfg kdudkr ne Ebb QH+ Ebb QHH+ Ebb QHHH+
_mc Ebb QHU nm sgdhq rtqe_bd+ vgdqd_r K@CL@B bdkkr dwoqdrr
Ebb QH+Ebb QHH+_mc Ebb QHU _mc _sknvdqkdudkr ’Ehftqd R5(Vd odqenqldc svn rdsr nedwodqhldmsr+m_ldkx+_m _mshancx,
cdodmcdmsuhqtr cdokdshnm _rr_x eqnl sgd rtodqm_s_ms’Ehftqdr
5Bfl5E(_mc bdkkahmchmf.hmsdqm_khy_shnm _rr_xr ’Ehftqdr 5Ffl5I(Enq sgd uhqtr cdokdshnm _rr_x+0/2 EET neL@XU v_r oqd,hmbt,
a_sdc vhsg rdqh_k chktshnmr ne sgd gHfF0 u_qh_ms ne L@X,0/+
L@X,0/7+ nq hrnsxod bnmsqnk l@a adenqd adhmf _ccdc sn
AU1) D3eVis6 nq K@CL@B bdkkr- @esdq _ 2/,lhm hmbta_shnm _s
26" B+sgd rtodqm_s_msbnms_hmhmf tmantmc uhqtr v_r bnkkdbsdc+
_mc _esdquhqhnm kxrhr+uhq_kQM@ v_r ld_rtqdc ax pQS,OBQ-Uhq_k
QM@ kdudkr vdqd bnlo_qdc vhsg _ rs_mc_qc btqud fdmdq_sdc
eqnl jmnvm pt_mshshdr ne hmedbshntr L@XU sn cdsdqlhmd uhq_k
dpthu_kdmsr odq lk-Mns_akx+kdrr uhq_kQM@ qdl_hmdc hm sgd rt,
odqm_s_ms _esdq sqd_sldms vhsg L@X,0/ ’Ehftqdr 5B _mc 5D(
_mc L@X,0/7 ’Ehftqdr 5C _mc 5E( sg_m sg_s vhsg sgd hrnsxod
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Ehftpd 3- Mpnsdbshnm av mnm,mdtspYkhyhmf l6ar hr Eb cdodmcdms
’@(Entq,vddj,nkc B46AK.5I Ebb Q!.! l_kd _mc edl_kd lhbd vdqd _clhmhrsdqdc 0// g f neL@X,0/ nqL@X,0/7 0 c_x adenqd rtabts_mdntr hmnbtk_shnm neL@XU,
AdG3/6 ’svn dwodqhldmsr+m < 5(’A(Hrnsxod,rvhsbgdc l@a ahmchmf sn qdbnlahm_msltqhmd Ebb QH+Ebb QHHH+_mc Ebb QHU-L@X,0/ nqL@X,0/7 nesgd hmchb_sdc hrnsxod vdqd _ccdc sn ok_sdr bn_sdc
vhsg Ebb Qr-Ahmchmf c_s_9svn,v_x @MNU@ vhsg Rhc_j%r onrs,sdrs+bnlo_qdc sn lHfF1b hrnsxod l@a’BflE(L@X,0/ ’B(_mc L@X,0/7 ’D(vdqd hrnsxod rvhsbgdc eqnl ltqhmd HfF1b sn ltqhmd HfF0+gtl_m HfF0+nqgtl_m HfF0,M186P-D_bg _mshancx u_qh_msv_r
sdrsdc enqahmchmf sn b_ostqdc L@XU ax DKHR@-Enqoqnsdbshnm rstchdr ’C _mc E(+0// g f nesgd hmchb_sdc l@a v_r _clhmhrsdqdc sn 3,vddj,nkc B46AK.5I lhbd
0 c_x adenqd rtabts_mdntr hmnbtk_shnm vhsg L@XU ’svn dwodqhldmsr+m < 5:knf,q_mj sdrsvhsg Anmedqqnmhbnqqdbshnm bnlo_qdc sn hrnsxod bnmsqnkl@a(-)o ; /-/4:
))o ; /-/0:)))o ; /-//0:))))o ; /-///0-
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Ehftpd 4- 6mshanchdr bkdYp F6VT opdudmsuhpYkchrrdlhmYshnm Ymc opnsdbsYfYhmrsltrbtknridkdsYkchrdYrd
’@flI(Shrrtd shsdqr neL@XU _s0 ’@flD(nq6 ’EflI(coh-Entq,vddj,nkc B46AK.5I lhbd sqd_sdc vhsg 0// g f neL@X,0/+L@X,0/7+nq_m hrnsxod bnmsqnkl@a 0 c_x
adenqd rtabts_mdntr hmnbtk_shnm vhsg L@XU,AdG3/6-@ssgd hmchb_sdc c_xr+sgd horhk_sdq_k_mjkd ’@ _mc E(+horhk_sdq_kb_keltrbkd ’A _mc F(+bnmsq_k_sdq_k_mjkd
’B _mc G(+bnmsq_k_sdq_kb_keltrbkd ’C _mc H(+_mc rokddm ’D _mc I(vdqd g_qudrsdc+_mc uhq_kQM@ v_r ld_rtqdc ’svn dwodqhldmsr:m < 5+nmd,v_x @MNU@ vhsg
Ctmmdss%r onrs,sdrs(’JflN(Shrrtd shsdqr nelhbd sqd_sdc vhsg 0// g f neL@X,0/,gHfF0 nqL@X,gHfF0,M186P 0 c_x adenqd hmedbshnm-L@XU shsdqr hm sgd horhk_sdq_k_mjkd ’J(_mc b_ke
ltrbkd ’K(+sgd bnmsq_k_sdq_k_mjkd ’L(_mc b_keltrbkd ’M(+_mc sgd rokddm ’N(vdqd ld_rtqdc _s6 coh’sgqdd dwodqhldmsr:m < 00+nmd,v_x @MNU@ vhsg Ctmmdss%r
onrs,sdrs(’OflQ(Entq,vddj,nkc B46AK.5I lhbd vdqd sqd_sdc vhsg L@X,0/ nqL@X,0/7 _mc hmedbsdc _r cdrbqhadc _anud-Horhk_sdq_k’O(_mc bnmsq_k_sdq_k’P(_mjkd inhmsr vdqd
ld_rtqdc trhmf chfhs_kb_khodqr-’Q(Horhk_sdq_k_mjkd rvdkkhmf v_r ld_rtqdc hm lhbd sqd_sdc vhsg L@X,0/,gHfF0 nqL@X,0/,gHfF0,M186P ’ld_m _mc RC nesvn
dwodqhldmsr:m < 0/+svn,v_x @MNU@ vhsg Stjdx%r onrs,sdrs(-)o ; /-/4:))o ; /-/0:)))o ; /-//0:))))o ; /-///0-Rdd _krn Ehftqd R3-
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Ehftpd 5- Mpnsdbshnm av mnm,mdtspYkhyhmf l6ar cdodmcr nm lnmnbvsdr
’@(Entq,vddj,nkc B46AK5.I lhbd vdqd sqd_sdc vhsg 0// g f ne_msh,Hem_q0 l@a _mc 0// g f neL@X,0/+L@X,0/7+nqhrnsxod bnmsqnkl@a 0 c_x adenqd hmedbshnm
vhsg L@XU,AdG3/6-Hmchb_sdc lhbd _krn vdqd sqd_sdc vhsg 14 g f ne_m _msh,BBQ1 l@a _s0 c_x adenqd hmedbshnm _mc dudqx nsgdqc_x _esdq’svn dwodqhldmsr+
m < 0/:knf,q_mj sdrsvhsg Anmedqqnmhbnqqdbshnm(’A(MJ bdkkr vdqd cdokdsdc ax sqd_shmf lhbd vhsg 1// g f l@a ne_msh,MJ0-0 l@a 0 c_x adenqd hmedbshnm _mc dudqx nsgdqc_x _esdq-Lhbd vdqd sqd_sdc vhsg _msh,Hem_q0
l@a _mc L@X,0/+L@X,0/7+nqhrnsxod bnmsqnkl@a _r _anud ’svn dwodqhldmsr+m < 0/:knf,q_mj sdrsvhsg Anmedqqnmhbnqqdbshnm(’BflI(@mshancx,ldch_sdc ahmchmf negHfF0 u_qh_msr neL@XU sn AU1, D3eVis6 ’B+C+F+_mc G(nqK@CL@B ’D+E+H+_mc I(bdkkr-Uhqtr ahmchmf sn bdkkr v_r ld_rtqdc
hmchqdbskx ax sgd cdokdshnm neL@XU eqnl rtodqm_s_msr ’BflE(nqax chqdbsahmchmf _mc.nqhmsdqm_khy_shnm nes_qfdsbdkkr ’FflI(-Enqld_rtqhmf rtodqm_s_msr+L@XU
v_r hmbta_sdc vhsg sgd hmchb_sdc _lntmsnegHfF0 u_qh_msr neL@X,0/ ’B _mc D(nqL@X,0/7 ’C _mc E(enq0 g _s26" B adenqd _cchmf sn sgd hmchb_sdc bdkkenq2/ lhm
_s26" B-Uhq_kQM@ eqnl rtodqm_s_msr v_r ld_rtqdc-Hrnsxod,l_sbgdc _mshanchdr _mc gHfF0,M186P l@a u_qh_msr rdqudc _r mdf_shud bnmsqnkr-Sn ld_rtqd uhqtr
ahmchmf _mc hmsdqm_khy_shnm+AU1, D3eVis6 nqK@CL@B bdkkr vdqd hmnbtk_sdc vhsg L@XU sg_sg_c addm oqd,hmbta_sdc vhsg L@X,0/ ’F _mc H(nqL@X,0/7 ’G _mc I(@esdqhmbta_shmf enq2/ lhm _s26" B+bdkkr vdqd v_rgdc vhsg OAR _mc kxrdc+_mc uhq_kQM@ v_r ld_rtqdc-

idedlc anlshltdc nl ldvsoVed(
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bnmsqnkl@a-Uhq_kbkd_q_mbd eqnl sgd rtodqm_s_msnbbtqqdc cnrd
cdodmcdmskx _mc qdpthqdc Eb deedbsnq etmbshnmr+ _r hs v_r mns
nardqudc vhsg sgd _fkxbnrxkgHfF0,M186P u_qh_msr neL@X,0/
_mc L@X,0/7- Vd nardqudc rhlhk_q qdrtksr vhsg sgd lntrd
HfF1b udqrhnmr ne ansg L@X,0/ _mc L@X,0/7 ’Ehftqdr R6@fl
R6C(- Sgdrd c_s_ rtffdrs sg_s sgd Eb qdfhnm ne _msh,L@XU
l@ar oqnlnsdr bkd_q_mbd neL@XU uhqhnmr eqnl sgd hmnbtktl+
oqdrtl_akx ax ahmchmf Ebb Q nm sgd lxdknhc bdkkrSn sdrssghr gxonsgdrhr chqdbskx+vd odqenqldc bdkkahmchmf _mc
hmsdqm_khy_shnm _rr_xr ’Ehftqdr 5Ffl5I+R5+_mc R7(-L@XU v_r
hmbta_sdc vhsg L@X,0/+ L@X,0/7+ nq hrnsxod bnmsqnkl@a enq
2/ lhm _s26" B-@mshancx,uhqhnm bnlokdwdr sgdm vdqd _ccdc sn
AU1) D3eVis6 nqK@CL@B bdkkr _mc hmbta_sdc enq0 g _s26" BBdkkr sgdm vdqd qhmrdc sgnqntfgkx vhsg OAR _mc kxrdc+ _mc
_ss_bgdc _mc.nq hmsdqm_khydc uhq_kQM@ v_r ld_rtqdc ax pQS,
OBQ-Oqd,sqd_sldmsneL@XU vhsg L@X,0/ _mc L@X,0/7 rhfmhe,
hb_mskx hmbqd_rdc sgd kdudknebdkk,_rrnbh_sdc uhq_kQM@ bnlo_qdc
sn sgd hrnsxod bnmsqnkl@a-@mshancx,cdodmcdmsahmchmf _mc.nq
hmsdqm_khy_shnm ne L@XU uhqhnmr ax AU1) D3eVis6 nq K@CL@B
bdkkr nbbtqqdc cnrd cdodmcdmskx _mc qdpthqdc _ etmbshnm_kEb qd,
fhnm+_r mn hmbqd_rd v_r nardqudc vhsg sgd _fkxbnrxkM186P u_q,
h_msr neL@X,0/ _mc L@X,0/7-Enqsgd ghfgdrsbnmbdmsq_shnmr ne
L@X,0/ _mc L@X,0/7+ vd nardqudc _ =0//,enkc hmbqd_rd hm
bdkk,_rrnbh_sdc uhq_k QM@ bnlo_qdc sn sgd hrnsxod bnmsqnk
l@a-Rhlhk_q c_s_ vdqd nardqudc trhmf lntrd HfF1b udqrhnmr
ne L@XU _mshanchdr ’Ehftqdr R6DflR6G(- Sqd_sldms ne
AU1) D3eVis6 nq K@CL@B bdkkr _s 0 g _esdq 26" B hmbta_shnm
vhsg oqnsdhm_rd J _mc QM_rd @+sn qdlnud antmc atsmnshmsdq,
m_khydc uhqtr+ qdud_kdc sg_s _ rhfmhzb_ms eq_bshnm ne nornmhydc
L@XU sq_mrhsdc hmsn sgd bdkkr ’Ehftqd R7(- Bnkkdbshudkx+ sgdrd
c_s_ rtffdrs sg_s _mshancx,cdodmcdms ahmchmf sn L@XU hm
lxdknhc bdkkr v_r cdodmcdmsnm Eb,Ebb Q hmsdq_bshnmr+qdrtksdc
hm dmg_mbdc bdkkahmchmf _mc tos_jd+_mc v_r mnsctd sn uhqhnm
bqnrr,khmjhmf _mc _ffqdf_shnm+_r rddm enqrnld _msh,_kog_uhqtr
_mshanchdr ’Ygnt ds_k-+1/1/(Vd mdwsdu_kt_sdc heL@XU _rrnbh_shnm vhsg s_qfdsEbb Q,dw,
oqdrrhmf lxdknhc bdkkr qdrtksdc hm _anqshud nq oqnctbshud ’_mc
onrrhakx dudm _mshancx dmg_mbdc( hmedbshnm- Vd trdc ansg
odqlhrrhud VS AU1 ’Ehftqdr 5J _mc 5K( _mc mnm,odqlhrrhud
AU1) D3eVis6 ’Ehftqdr 5L _mc 5M(bdkkr sn sq_bj uhq_khmedbshnm
hm sgd oqdrdmbd _mc _ardmbd nemnm,mdtsq_khyhmf l@ar-L@XU
v_r hmbta_sdc vhsg rdqh_kchktshnmr neL@X,0/ ’Ehftqdr 5J _mc
5L(nq L@X,0/7 ’Ehftqdr 5K _mc 5M(sn enql _mshancx,_mshfdm
bnlokdwdr-Sgdrd bnlokdwdr vdqd _ccdc sn s_qfds bdkkr enq _
0,g hmbta_shnm _s26" B+_mc sgd bdkkr sgdm vdqd qhmrdc sn qdlnud
tmantmc uhqtr- Sgd bdkkr vdqd kxrdc dhsgdq hlldch_sdkx _esdq
qhmrhmf ’0 g onrs,hmedbshnm Zgoh[(nq _esdq _mnsgdq 6 g,hmbta_shnm
_s 26" B ’7 goh(+ _mc bdkk,_rrnbh_sdc uhq_kQM@ v_r ld_rtqdc
ax pQS,OBQ- @r dwodbsdc+ vd nardqudc _m hmhsh_khmbqd_rd hm
bdkk,_rrnbh_sdc uhq_kQM@ _s 0 gohvgdm sgd uhqhnmr vdqd oqd,
sqd_sdc vhsg sgd lHfF1b ats mns M186P enqlr neL@X,0/ _mc
L@X,0/7- Enq sgd VS AU1 bdkkr ’Ehftqdr 5J _mc 5K(+ vd
nardqudc _ 00/+///,enkc hmbqd_rd hm uhq_kQM@ _s7 gohbnlo_qdc

sn 0 gohvhsg sgd hrnsxod,l@a,sqd_sdc uhqhnmr+ vghbg hmchb_sdr
sg_sL@XU qdokhb_sdc hm sgd AU1 bdkkr-Gnvdudq+sgdqd v_r mn che,
edqdmbd hm uhq_kQM@ kdudkr _s7 gohadsvddm _msh,L@XU _mc hrn,
sxod l@a sqd_sldmsr+ hmchb_shmf sg_s sgd fqd_sdq kdudkne uhqtr
ahmchmf _mc hmsdqm_khy_shnm _s 0 gohb_trdc ax mnm,mdtsq_khyhmf
l@ar L@X,0/ _mc L@X,0/7 chc mnsqdrtkshm dmg_mbdc hmedbshnm
hm VS AU1 bdkkr-Sn cdsdqlhmd hel@a,hmctbdc uhqhnm ahmchmf _mc
hmsdqm_khy_shnm b_trdc dmg_mbdldmsnehmedbshnm nemnm,odqlhr,
rhud lxdknhc bdkkr ’_r rddm vhsg cdmftd uhqtr ZAq_mcs ds _k-+
0871: G_krsd_c ds _k-+ 087/[(+ vd qdod_sdc dwodqhldmsr hm sgd
mnm,odqlhrrhud AU1) D3eVis bdkkr ’Ehftqdr 5L _mc 5M(- Vd
nardqudc sgd dwodbsdc hmbqd_rd hm bdkk,_rrnbh_sdc uhq_kQM@ _s
0 goh+_mc bkd_q_mbd v_r nardqudc _s7 gohvhsg mn duhcdmbd ne
oqnctbshud hmedbshnm- Vd nardqudc rhlhk_q qdrtksr ax trhmf
lHfF1b udqrhnmr nesgd _msh,L@XU l@ar ’Ehftqdr R6HflR6K(-Sn
cdsdqlhmd heAU1 bdkkr _qd dudm b_o_akd ne_mshancx,cdodmcdms
dmg_mbdldms’@CD(+vd qdod_sdc sgd dwodqhldmsr vhsg Yhj_ uh,
qtr ’YHJU(+ _ fi_uhuhqtr vgnrd hmedbshnm hr dmg_mbdc hm lxdknhc
bdkkr ax bqnrr,qd_bshud+ mnm,mdtsq_khyhmf _mshanchdr ’B_rs_mg_
ds _k-+1/06:Cdimhq_sshr_hds _k-+1/05(-Vd hmbta_sdc _ lntrd,
_c_osdc YHJU uhqtr ’Fnql_m ds_k-+1/07(vhsg rdqh_kchktshnmr ne
sgd l@a D5/+_ onnqkx mdtsq_khyhmf l@a sg_sahmcr sgd bnmrdqudc
etrhnm knno ne sgd fi_uhuhqtr D oqnsdhm ’Nkhog_ms ds _k-+ 1//5(Cdrohsd mns nardquhmf @CD vhsg L@XU+ vd nardqudc qnatrs
@CD vhsg YHJU _mc sgd D5/ l@a hm AU1 _mc K@CL@B bdkkr
’Ehftqdr R6LflR6N(+ rtffdrshmf sgd ntsbnld ne _mshancx
dmf_fdldms hm bdkkr dwoqdrrhmf Ebb Qr hr uhqtr rodbhzb- Hm sgd
b_rd ne L@XU+mnm,mdtsq_khyhmf l@ar e_bhkhs_sd sgd hmsdq_bshnm
ne uhqhnmr vhsg lxdknhc bdkkr sg_s qdrtksr hm _anqshud hmedbshnm
_mc bkd_q_mbdCHRBTRRHNM
Oqduhntr rstchdr g_ud _m_kxydc sgd hlonqs_mbd ne mdtsq_khyhmf
_mshancx qdronmrdr hm oqnsdbshmf _f_hmrs _kog_uhqtr hmedbshnmSgdrd rstchdr ghfgkhfgsdc ansg sgd deedbsr ne uhqtr mdtsq_khyhmf
_bshuhsx ’D_qmdrs ds _k-+ 1/08:Enw ds _k-+ 1/04: Ihm ds _k-+ 1/04+
1/07:L_qshmr ds_k-+1/08:O_kds_k-+1/02(_mc Eb deedbsnqetmb,
shnmr ’D_qmdrsds_k-+1/08:Enw ds_k-+1/08(enqnoshl_khl uhun _b,
shuhsx-Gnvdudq+sgdx bntkc mnsetkkx f_tfd sgd oqnsdbshud _bshuhsx
neEb deedbsnqetmbshnmr adb_trd sgd _mshanchdr vdqd hmgdqdmskx
mdtsq_khyhmf-Gdqd+vd hcdmshzdc _ o_mdkne02 _msh,L@XU l@ar
sg_sahmc _uhckx sn uhqhnmr _mc hmedbsdc bdkkr xdsdwghahsmn cdsdbs,
_akd mdtsq_khyhmf _bshuhsx _f_hmrs sgd uhqtr hm Udqn _mc B1B01
bdkkr-O_rrhud sq_mredqnemnm,mdtsq_khyhmf l@ar bnmedqqdc rhfmhe,
hb_ms oqnsdbshnm hl uhun sg_s v_r bnlokdsdkx cdodmcdms nm Eb
deedbsnq hmsdq_bshnmr+_r cdsdqlhmdc trhmf HfF rtabk_rr rvhsbg
u_qh_msr _mc M186P u_qh_msr k_bjhmf sgd _ahkhsx sn dmf_fd Ebb QrSgd lHfF1b l@ar sg_svd bg_q_bsdqhydc dwghahsdc _ q_mfd ne
oqnsdbshud _ahkhsx hm sgd kdsg_kL@XU bg_kkdmfd lncdk-Sgd qd_,
rnmr enq sgdrd cheedqdmbdr l_x ad ctd sn rdudq_ke_bsnqr- Vd
nardqudc u_qh_akd ahmchmf sn L@XU uhqhnmr hm _ b_ostqd DKHR@
dwodqhldms_mc sn qdbnlahm_msD1 oqnsdhm ax trhmf DKHR@ _mc

’JflM(@mshancx,cdodmcdmshmedbshnm _rr_xr-Rdqh_kchktshnmr negHfF0 l@ar vdqd oqd,hmbta_sdc vhsg L@XU adenqd adhmf _ccdc sn odqlhrrhud AU1 bdkkr ’J _mc K(
nqmnm,odqlhrrhud AU1, D3eVis6 bdkkr ’L _mc M(-Ahmchmf _mc hmsdqm_khy_shnm hmsn bdkkr v_r ld_rtqdc _r _anud ’FflG(_s0 nq7 goh_esdqqdlnu_knetmantmc uhqtr
’ld_m _mc RC nesgqdd dwodqhldmsr odqenqldc hm sqhokhb_sd:nmd,v_x @MNU@ vhsg Ctmmdss%r onrs,sdrsbnlo_qdc sn sgd hrnsxod l@a bnmsqnk(-)o ; /-/4:))o ; /-/0:
)))o ; /-//0:))))o ; /-///0-Rdd _krn Ehftqdr R4flR7-
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AKHdwodqhldmsr-Sgd l@ar sg_santmc lnrs_uhckx sn uhqhnmr _mc
qdbnlahm_msD1 oqnsdhmr rgnvdc sgd fqd_sdrsoqnsdbshud _bshuhsx
hl uhun- Hmcddc+ L@X,0/ _mc L@X,0/7+ ntq lnrs oqnsdbshud
l@ar+g_c JC u_ktdr sg_svdqd 0//,enkc knvdq_mc g_c rtars_m,
sh_kkx knmfdq ahmchmf s0.1 sg_m l_mx onnqkx oqnsdbshmf l@ar- @
ghfgdq kdudkne uhqtr ahmchmf khjdkx dmg_mbdr sgd Eb,cdodmcdms
bkd_q_mbd ax lxdknhc bdkkr- Etqsgdqlnqd+ sgd lnrs oqnsdbshud
l@ar l_o sn svn dohsnodr vhsghm nqoqnwhl_ksn sgd @ cnl_hm+
_r enkknvr9nmd md_qsgd _lhmn sdqlhmtr nm sgd sno nesgd rohjd
sqhldqhb bnlokdw ’fqnto A(+_mc _ rdbnmc hm sgd a ,qhaanm qdfhnm
nm sgd ntsdq e_bd ne sgd D1,D0 rohjd ’fqnto D(- Onrrhakx+ sgd
l@ar ahmchmf sgdrd qdfhnmr nesgd D1 oqnsdhm _qd lnqd _bbdr,
rhakd enq dmf_fdldms ax Ebb Qr nm lnmnbxsdr+ dm_akhmf uhqtr
bkd_q_mbd _mc oqnsdbshnm- Sgd nqhdms_shnm ne l@a ahmchmf sn
sgd uhqhnm _krn bntkc _eedbs oqdrdms_shnm ne sgd Eb qdfhnm sn
Ebb Qr+ _r v_r rddm vhsg _msh,cdmftd uhqtr l@ar ’Qdmmdq
ds_k-+1/07(Ntq mnm,mdtsq_khyhmf _mshanchdr antmc sn rhw chrshmbsqdfhnmr
nesgd L@XU D1 @ cnl_hm _mc sgd a ,qhaanm qdfhnm adsvddm sgd
@ _mc A cnl_hmr- Hm bnlo_qhrnm+ nsgdq l@ar _f_hmrs _qsghsn,
fdmhb _kog_uhqtdr ’d-f-+ BGHJU( sg_s l_o sn dohsnodr vhsghm
sgd @ cnl_hm b_m ad onsdmskx mdtsq_khyhmf-Sgd _msh,BGHJU gt,
l_m l@ar 0G01 _mc 2M12 _qd onsdmskx hmghahsnqx hm bdkkbtkstqd
_mc xds rg_qd hmsdq_bshnm qdrhctdr vhsg fqnto A _mc B l@ar
eqnl ntqo_mdk’Rlhsg ds_k-+1/04(-Rhlhk_qkx+sgd ghfgkx mdtsq_k,
hyhmf _msh,BGHJU l@ar 3I10 _mc 4L05 ’Knmf ds_k-+1/04(ahmc
_lhmn _bhcr rg_qdc ax fqnto A _mc E l@ar _r vdkk_r nsgdqr
sgqntfgnts sgd @ _mc A cnl_hmr-Sgd chrshmfthrghmf ed_stqd ne
sgdrd mdtsq_khyhmf l@ar hr sgdhq _ahkhsx sn ahmc qdrhctdr vhsghm
ltkshokd D1 cnl_hmr ’d-f-+@ _mc A(nq _bqnrr cheedqdmsD1 oqn,
sdhmr+ vgdqd_r sgd l_inqhsx ne sgd mnm,mdtsq_khyhmf l@ar
_ood_q sn qdbnfmhyd khmd_q cdsdqlhm_msr- Dmf_fdldms ne sdq,
sh_qx _mc pt_sdqm_qx dohsnodr vhsghm _mc _bqnrr D1 l_x ad
qdpthqdc enq_kog_uhqtr mdtsq_khy_shnm-Hmcddc+rsqtbstq_krstchdr
g_ud cdlnmrsq_sdc bqnrr,khmjhmf neltkshokd chrshmbscnl_hmr hm
D1 ax onsdmskx mdtsq_khyhmf l@ar ’Enw ds_k-+1/04:Onvdkkds_k-+
1/1/(Vd entmc sg_s lnmnbxsdr vdqd mdbdrr_qx enq _mshancx,
deedbsnq,ldch_sdc oqnsdbshnm eqnl L@XU hmedbshnm- Ntq
hl uhspn rstchdr rtffdrs _ onrrhakd ldbg_mhrshb a_rhr enq _s
kd_rs o_qs ne sgd hmghahsnqx _bshuhsx- Mnm,mdtsq_khyhmf _msh,
L@XU l@ar ahmc uhqtr _mc e_bhkhs_sd bkd_q_mbd ax Eb,cdodm,
cdms hmsdqm_khy_shnm _mc cdrsqtbshnm hm lxdknhc bdkkr- Sghr
_anqshud hmedbshnm ldbg_mhrl dwok_hmr gnv mnm,mdtsq_khyhmf
l@ar bntkc oqdudmschrrdlhm_shnm eqnl sgd rhsd nehmnbtk_shnm
ats lhfgs mns dwok_hm gnv _mshanchdr deedbshudkx bkd_q L@XU,
hmedbsdc bdkkr- @cchshnm_kkx+ lnmnbxsdr lhfgs bkd_q uhqtr eqnl
hmedbsdc bdkkr ax @CBO ’Antqm_ynr ds _k-+ 1/04: Kt ds _k-+
1/07(adb_trd sgd uhq_kD0 _mc D1 rsqtbstq_koqnsdhmr _qd chr,
ok_xdc nm sgd ok_rl_ ldlaq_md rtqe_bd oqhnq sn uhqhnm
lnqognfdmdrhr _mc atcchmf _mc b_m ad qdbnfmhydc ax _msh,
anchdr-@ksdqm_shudkx+sgd dmg_mbdc dmsqx neuhqtr hmsn lxdknhc
bdkkr hm _m _mshancx,_mc Eb,cdodmcdmsl_mmdqbntkc oqnlnsd
_mshfdm bqnrr,oqdrdms_shnm _mc _bbdkdq_sdc BC7*,S,bdkk,
ldch_sdc bkd_q_mbd ’Antqm_ynr ds _k-+ 1/1/_: Ok_sydq ds _k-+
1/03(- @CBB ax MJ bdkkr chc mns _ood_q sn g_ud _ cnlhm_ms
qnkd hm oqnsdbshnm ax mnm,mdtsq_khyhmf l@ar+ _r cdokdshnm chc
mns hlo_bs rtquhu_k-
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Tmcdqbdqs_hm bhqbtlrs_mbdr+lnmnbxsdr sgdlrdkudr b_m ad
hmedbsdc ax _kog_uhqtrdr ’Gdq ds_k-+1/0/:Vhmjkdq ds_k-+1/1/(+
vghbg l_x ad _ onsdmsh_k ldbg_mhrl enq uhq_k chrrdlhm_shnmNtqrstchdr hmchb_sd sg_ssgd dmg_mbdc uhqtr ahmchmf _mc hmsdq,
m_khy_shnm ne L@XU e_bhkhs_sdc ax mnm,mdtsq_khyhmf l@ar hm
lxdknhc bdkkkhmdr cndr mns qdrtks hm dmg_mbdc hmedbshnm hl uhspn
nq hl uhun-Sghr qdrtks bnmsq_rsr vhsg fi_uhuhqtrdr enq vghbg mnm,
nq onnqkx mdtsq_khyhmf _mshanchdr b_m oqnlnsd hmedbshnm ne
Ebb Q,dwoqdrrhmf lxdknhc bdkkr sgqntfg @CD ’Antqm_ynr ds _k-+
1/1/a:G_krsd_c ds_k-+1/0/:Qdx ds_k-+1/07(+vghbg hr adkhdudc
sn qdrtks hm rdudqd chrd_rd ctqhmf rdbnmc_qx cdmftd hmedbshnm
’G_krsd_c+0877(-Hm bnlo_qhrnm+@CD _mc o_sgnfdmhb _mshanchdr
sg_s dmg_mbd lxdknhc bdkk hmedbshnmr _qd mns adkhdudc sn
bnmsqhatsd sn _kog_uhqtr o_sgnfdmdrhr+ _ksgntfg nmd rstcx qd,
onqsdc ghfgdq uhqdlh_ _mc vnqrd _qsgqhshr hm lhbd hm sgd rdsshmf
ne o_rrhud sq_mredq ne _m _msh,BGHJU l@a ’Ktl ds _k-+ 1/07(Bkd_qkx+rstchdr sg_sdw_lhmd sgd deedbsr nehl uhun o_rrhud sq_mr,
edq ne_mshanchdr vhsg mn+vd_j+nq onsdmskx mdtsq_khyhmf _bshuhsx
vhsg ltkshokd _kog_uhqtrdr _qd mddcdc sn drs_akhrg sgd fdmdq_khy,
_ahkhsx nentqzmchmfr@mshancx,cdodmcdmsoqnsdbshnm _f_hmrs_kog_uhqtrdr hr e_bhkh,
s_sdc ax svn l_hm etmbshnmr+ _r enkknvr9 E_a,ldch_sdc uhqtr
mdtsq_khy_shnm _mc Eb,cdodmcdms deedbsnq etmbshnmr- C_s_ eqnl
sghr rstcx _mc nsgdqr ’D_qmdrsds_k-+1/08:Enw ds_k-+1/04:Ihm
_mc Rhllnmr+1/08:O_kds_k-+1/02(rtffdrssg_smdtsq_khy_shnm
_mc Eb deedbsnq etmbshnmr b_m bnmsqnk _kog_uhqtr hmedbshnmr
sgqntfg _ q_mfd neldbg_mhrlr-@m_kxyhmf sgd onkxbknm_k_msh,
ancx qdronmrd sn hmedbshnm ax L@XU nq nsgdq _kog_uhqtrdr hm
sgd bnmsdws ne m_stq_k hmedbshnm nq hlltmhy_shnm ’Bgnh ds _k-+
1/08:Vdhrd ds _k-+1/03(sn cdsdqlhmd sgd qdk_shud _lntmsr ne
mdtsq_khyhmf _mc mnm,mdtsq_khyhmf _mshanchdr l_x oqnuhcd hmrhfgs
_r sn vghbg etmbshnmr tkshl_sdkx _qd lnrshlonqs_msenqbnmsqnk,
khmf hmedbshnmSgd dezb_bx ne_ oqnsdbshud _mshancx qdronmrd sn _kog_uhqtr
hmedbshnm hr cdsdqlhmdc ax sgd knb_shnm ne_mshancx ahmchmf nm
hms_bs uhqhnmr _mc rsqtbstq_koqnsdhmr chrok_xdc nm sgd rtqe_bd
nehmedbsdc bdkkr+sgd hmgdqdmsmdtsq_khyhmf _ahkhsx _mc ldbg_mhrl
’aknbj_cd ne_ss_bgldms+dmsqx+etrhnm+nqdfqdrr(+_mc khjdkx sgd
_bbdrrhahkhsx nesgd Eb qdfhnm ne_mshanchdr sn dmf_fd Ebb Q _mc
ldch_sd deedbsnq etmbshnmr- Adb_trd _bbdkdq_sdc uhqtr bkd_q,
_mbd lhfgs lhshf_sd sgd cdudknoldmsnebgqnmhb ltrbtknrjdk,
ds_k chrd_rd+ cdrhfmhmf u_bbhmdr _mc _m_kxyhmf _mshancx
qdronmrdr hm sgd bnmsdws ne deedbsnq etmbshnm qdronmrdr l_x
ad hlonqs_ms- @ksgntfg l_mx mdtsq_khyhmf _msh,_kog_uhqtr
l@ar g_ud addm cdrbqhadc sg_s ahmc sgd @ _mc A cnl_hm ne
D1+ ntq rstcx rgnvr sg_s mnm,mdtsq_khyhmf l@ar qdbnfmhyhmf
dohsnodr vhsghm nqmd_qsgd @ cnl_hm _krn b_m oqdudmsnqbkd_q
uhqtr eqnl hmedbsdc gnrsr ax noshl_kdeedbsnqetmbshnmr-Sgd rhw
dohsnodr vd hcdmshzdc _qd _krn ghfgkx bnmrdqudc _bqnrr sgd 62
bnlokdsd L@XU fdmnldr _mmns_sdc hm otakhb c_s_a_rdr@lhmn _bhc hmsdq_bshnm qdrhctdr eqnl l@ar hm fqntor @+ C+
_mc E _qd dmshqdkx bnmrdqudc+vgdqd_r sgdqd _qd _ rl_kkmtladq
ne rhmfkd _lhmn _bhc rtarshstshnmr hm ahmchmf qdrhctdr eqnl
l@ar hm fqnto A ’8.62 rsq_hmr vhsg _lhmn _bhc rtarshstshnm _s
S44(+B ’1.62 rsq_hmr vhsg _lhmn _bhc rtarshstshnm _sC63(+nqD
’0.62 rsq_hmr vhsg _lhmn _bhc rtarshstshnm _s@050(-Etqsgdq_m_k,
xrhr negtl_m _mshancx qdronmrdr sn m_stq_khmedbshnmr+hm ansg
o_shdmsr vgn g_ud bkd_qdc uhqtr _mc sgnrd vhsg odqrhrsdms
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chrd_rd+l_x oqnuhcd hmrhfgshmsn sgd bnmsqhatshnm neEb deedbsnq
etmbshnmr sn oqnsdbshnm _mc chrd_rd o_sgnfdmdrhrRS2Q LDSGNCR
Cds_hkdc ldsgncr _qd oqnuhcdc hm sgd nmkhmd udqrhnm nesghr o_odq
_mc hmbktcd sgd enkknvhmf9
JDX QDRNTQBDR S@AKD
QDRNTQBD @U@HK@AHKHSX
+ Kd_c bnms_bs
+ L_sdqh_kr _u_hk_ahkhsx
+ C_s_ _mc bncd _u_hk_ahkhsx
DWODQHLDMS@K LNCDK @MC RTAIDBS CDS@HKR
+ Bdkkkhmdr
+ Uhqtrdr
+ Lntrd dwodqhldmsr
LDSGNC CDS@HKR
+ Oqnsdhm dwoqdrrhnm _mc otqhzb_shnm
+ l@a fdmdq_shnm
+ DKHR@
+ Enbtr qdctbshnm mdtsq_khy_shnm sdrsr ’EQMS(
+ Vdrsdqm aknsshmf
+ Ahnk_xdqhmsdqedqnldsqx
+ @k_mhmd rb_mmhmf lts_fdmdrhr
+ Hrnsxod rvhsbghmf nel@ar
+ Bxsnjhmd _m_kxrhr
+ Eknv bxsnldsqx
+ @mshancx,hmctbdc cdokdshnm neL@XU eqnl bdkkrtodq,
m_s_msr
+ @mshancx,hmctbdc uhqtr ahmchmf.hmsdqm_khy_shnm _rr_x
+ @mshancx cdodmcdmsdmg_mbdldms_rr_xr
+ L@XU D1,D0 rsqtbstqd cdohbshnm
PT@MSHEHB@SHNM @MC RS@SHRSHB@K @M@KXRHR
RTOOKDLDMS2K HMENQL2SHNM
Rtookdldms_k hmenql_shnm b_m ad entmc nmkhmd _s gssor9..cnh-nqf.0/-0/05.ibdkqdo-1/10-0/78512BJMNVKDCFLDMSR
Sghr vnqj v_r rtoonqsdc ax MHG fq_msr Q/0 @H030325+Q/0 @H003705+_mc
T08 @H03168/ _mc bnmsq_bsr @H1/07////0+ 64M82/08B///51+ _mc
GGRM1611/06///5/B- Vd sg_mj Lhbgdkkd Mnkk enq lntrd gtra_mcqx _mc
Sdc Ohdqrnm enqbnlldmsr nm sgd l_mtrbqhos-AhnQdmcdqrnesv_qd v_r trdc
sn fdmdq_sd rnld nesgd hl_fdr2TSGNQ BNMSQHATSHNMR
Bnmbdost_khy_shnm9I-S-D-+@-B-G-+J-A-+C-G-E-+_mc L-R-C-:ldsgncnknfx _mc
qdrntqbdr9I-S-D-+@-B-G-+J-A-+L-L-+C-G-E-+_mc L-R-C-:hmudrshf_shnm9I-S-D-+
@-B-G-+_mc J-A-:vqhshmf+nqhfhm_kcq_es9I-S-D-+J-A-+_mc L-R-C-:vqhshmf+qduhdv
_mc dchshmf9I-S-D-+@-B-G-+J-A-+L-L-+C-G-E-+_mc L-R-C-:etmchmf _bpthrhshnm9
C-G-E-_mc L-R-C-

_mc Hlltmnld-Sgd Ch_lnmc k_anq_snqx g_r qdbdhudc ronmrnqdc qdrd_qbg
_fqddldmsr eqnl Lncdqm_+UhqAhnsdbgmnknfx+_mc DldqfdmsAhnRnktshnmrQdbdhudc9Nbsnadq17+1/1/
Qduhrdc9I_mt_qx 08+1/10
@bbdosdc9L_qbg 05+1/10
Otakhrgdc9@oqhk5+1/10
QDEDQDMBDR
@ydudcn+Q-R-+Rhku_+D-U-+B_qu_kgn+U-K-+Qncqhftdr+R-F-+Mtmdr,Mdsn+I-O-+
Lnmsdhqn+G-+Odhwnsn+U-R-+Bgh_mf+I-N-+Mtmdr+L-Q-+_mc U_rbnmbdknr+O-E’1//8(- L_x_qn edudq uhqtr+ Aq_yhkh_m @l_ynm- Dldqf- Hmedbs- Chr- 04+ 072/fl
0721Antqm_ynr+ R-+ ChKhkkn+ C-I-+ _mc Q_udsbg+ I-U- ’1/04(- Sgd qnkd ne Eb,Ebb Q
hmsdq_bshnmr hm HfF,ldch_sdc lhbqnah_k mdtsq_khy_shnm- I- Dwo- Ldc- 101+
0250fl0258Antqm_ynr+R-+Bnqsh+C-+Uhqfhm+G-V-+_mc Q_udsbg+I-U-’1/1/_(-Eb,noshlhydc
_mshanchdr dkhbhs BC7 hlltmhsx sn uhq_k qdrohq_snqx hmedbshnm- M_stqd 477+
374fl38/Antqm_ynr+ R-+ Ftos_+ @-+ _mc Q_udsbg+ I-U- ’1/1/a(- Sgd qnkd ne HfF Eb
qdbdosnqr hm _mshancx,cdodmcdms dmg_mbdldms- M_s- Qdu- Hlltmnk- 1.+
522fl532Aq_mcs+V-D-+LbBnvm+I-L-+Fdmsqx+L-J-+_mc Qtrrdkk+O-J-’0871(-Hmedbshnm
dmg_mbdldmsnecdmftd sxod 1 uhqtr hm sgd T,826 gtl_m lnmnbxsd bdkkkhmd ax
_mshanchdr sn fi_uhuhqtr bqnrr,qd_bshud cdsdqlhm_msr-Hmedbs-Hlltm-25+0/25fl
0/30B_qkdsnm+L-+Kdd+G-+Ltkudx+L-+_mc Aqnvm+C-S-’0886(-Qnkd nefkxbnoqnsdhm
OD1 hm enql_shnm _mc l_stq_shnm nesgd Rhmcahr uhqtr rohjd-I-Uhqnk-60+0447fl
0455B_rs_mg_+ O-L-R-+ M_rbhldmsn+ D-I-L-+ Aq_f_+ B-+ Bnqcdhqn+ L-S-+ cd B_q,
u_kgn+N-U-+cd Ldmcnmb¨_+K-Q-+@ydudcn+D-@-M-+Eq_mb¨_+Q-E-N-+Cg_kh_+Q-+
_mc L_qptdr+D-S-@-’1/06(-Cdmftd Uhqtr,Rodbhzb @mshanchdr Dmg_mbd Aq_yhk,
h_m Yhj_ Uhqtr Hmedbshnm-I-Hmedbs-Chr-104+670fl674B_trdx+N-Q-+_mc L_qni_+N-L-’0846(-L_x_qn uhqtr9_ mdv gtl_m chrd_rd
_fdms- HHH- Hmudrshf_shnm ne _m dohcdlhb ne _btsd edaqhkd hkkmdrr nm sgd qhudq
Ft_l_ hm O_q_–+Aq_yhk+_mc hrnk_shnm neL_x_qn uhqtr _r b_tr_shud _fdms-@lI-Sqno-Ldc-Gxf-5+0/06fl0/12Bgnh+G-+Jtcbgncj_q+R-A-+Qdtrbgdk+D-K-+@rhi_+J-+Anqnkd+O-+Gn+L-+Vni,
s_j+J-+Qddc+B-+Q_lnr+R-+Anoo+M-D-+ds_k-’1/08(-Oqnsdbshud hlltmhsx ax
_m dmfhmddqdc CM@ u_bbhmd enq L_x_qn uhqtr- OKnR Mdfk- Sqno- Chr- 02+
d///6/31Cdimhq_sshr_h+V-+Rto_r_+O-+Vnmfvhv_s+V-+Qntuhmrjh+@-+A_qa_,Ro_dsg+F-+
Ct_mfbghmc_+S-+R_jtms_ag_h+@-+B_n,Knqld_t+U-,L-+L_k_rhs+O-+Qdx+E-@-+
ds _k- ’1/05(- Cdmftd uhqtr rdqn,bqnrr,qd_bshuhsx cqhudr _mshancx,cdodmcdms
dmg_mbdldmsnehmedbshnm vhsg yhj_ uhqtr-M_s-Hlltmnk-06+00/1fl00/7Cdjjdqr+F-+Admsk_fd+@-D-G-+Rsdfl_mm+S-B-+Gnvhd+G-K-+Khrrdmadqf,Sgtm,
mhrrdm+R-+Yhlqhmf+I-+Qhrodmr+S-+_mc Uhc_qrrnm+F-’1/06(-@ezmhsx negtl_m
HfF rtabk_rrdr sn lntrd Eb f_ll_ qdbdosnqr-L@ar 8+656fl662D_qmdrs+I-S-+A_rnqd+J-+Qnx+U-+A_hkdx+@-K-+V_mf+C-+@ksdq+F-+Eqdlnms+
C-G-+_mc Ch_lnmc+L-R-’1/08(-Mdtsq_khyhmf _mshanchdr _f_hmrsL_x_qn uhqtr
qdpthqd Eb deedbsnq etmbshnmr enq oqnsdbshud _bshuhsx-I-Dwo-Ldc-105+1171fl
12/0Enw+ I-L-+ Knmf+ E-+ Dcdkhmf+ L-@-+ Khm+ G-+ u_m Cthik,Qhbgsdq+ L-J-R-+ Enmf+
Q-G-+ J_gkd+ J-L-+ Rlhs+ I-L-+ Ihm+ I-+ Rhllnmr+ F-+ ds _k- ’1/04(- Aqn_ckx
Mdtsq_khyhmf @kog_uhqtr @mshanchdr Ahmc _m Dohsnod nm D1 _mc Hmghahs Dmsqx
_mc Dfqdrr-Bdkk052+0/84fl00/6-

CDBK2Q2SHNM NE HMSDQDRSR

Enw+I-L-+Qnx+U-+Ftmm+A-L-+Gt_mf+K-+Dcdkhmf+L-@-+L_bj+L-+Eqdlnms+
C-G-+Cnq_my+A-I-+Ingmrnm+R-+@ksdq+F-+_mc Ch_lnmc+L-R-’1/08(-Noshl_k
sgdq_odtshb _bshuhsx ne lnmnbknm_k_mshanchdr _f_hmrs bghjtmftmx_ uhqtr qd,
pthqdr Eb,Ebb Q hmsdq_bshnm nm lnmnbxsdr-Rbh-Hlltmnk-3+d__u4/51-

L-R-C-hr _ bnmrtks_msenqHmahnr+UhqAhnsdbgmnknfx+MFL Ahnog_ql_bdtshb_kr+
_mc sgd B_qmhu_kBnqonq_shnm _mc nm sgd Rbhdmshzb @cuhrnqx An_qc neLncdqm_

Fncc_qc+S-C-+Gt_mf+B-B-+Ldmf+D-B-+Odssdqrdm+D-E-+Bntbg+F-R-+Lnqqhr+
I-G-+_mc Edqqhm+S-D-’1/07(-TBRE Bghldq_W9Lddshmf lncdqm bg_kkdmfdr hm
uhrt_khy_shnm _mc _m_kxrhr-Oqnsdhm Rbh-16+03fl14-
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Fnql_m+L-I-+B_hmd+D-@-+Y_hsrdu+J-+Adfkdx+L-B-+Vdfdq,Ktb_qdkkh+I-+Tb,
bdkkhmh+ L-A-+ Sqho_sgh+ R-+ Lnqqhrnm+ I-+ Xntms+ A-K-+ Chmmnm+ J-G-+ HHH-+ ds _k’1/07(-@m HlltmnbnlodsdmsLntrd LncdkneYhj_ Uhqtr Hmedbshnm-BdkkGnrs
Lhbqnad 12+561fl574-d5-

NODM @BBDRR

EbdorhknmQHhm gtl_mr _mc oqnlnsdr HfD,hmctbdc ktmf hmfi_ll_shnm-I-BkhmHmudrs-007+2627fl264/-

G_krdx+D-R-+Rhkdr+B-+Ftdu_q_+B-+Uhkb_qqnldqn+R-+Ignmrsnm+D-I-+Q_l_k+
B-+@fthk_q+O-U-+_mc @lotdqn+I-R-’1/02(-L_x_qn uhqtr hmedbshnm+@l_ynm
A_rhm qdfhnm+Odqt+1/0/,1/02-Dldqf-Hmedbs-Chr-08+0728fl0731-

L_qshmr+J-@-+Fqdfnqx+L-J-+U_kcdy+R-L-+Roq_ftd+S-Q-+Dmbhm_kdr+K-+O_,
bgdbn+M-+Btqd+B-+Onqq_r,Q_lhqdy+@-+Qhbn,Ldmcny_+@-+Bg_mf+@-+ds_k’1/08(-Mdtsq_khyhmf @mshanchdr eqnl Bnmu_kdrbdmsBghjtmftmx_ Uhqtr O_shdmsr
B_m Bqnrr,Mdtsq_khyd L_x_qn _mc Tm_ Uhqtrdr-@l-I-Sqno-Ldc-Gxf-0..+
0430fl0433-

G_krsd_c+ R-A- ’0877(- O_sgnfdmdrhr ne cdmftd9 bg_kkdmfdr sn lnkdbtk_q
ahnknfx-Rbhdmbd 128+365fl370-

Mdkrnm+B-@-+Kdd+B-@-+_mc Eqdlnms+C-G-’1/03(-Nwhc_shud qdenkchmf eqnl hm,
bktrhnm anchdr-Ldsgncr Lnk-Ahnk-003.+034fl046-

G_krsd_c+R-A-+Onqsdqzdkc+I-R-+_mc N%Qntqjd+D-I-’087/(-Dmg_mbdldmsne
cdmftd uhqtr hmedbshnm hm lnmnbxsdr ax fi_uhuhqtr _mshrdq_-@l-I-Sqno-LdcGxf-18+527fl531-

Nkhog_ms+ S-+ Mxa_jjdm+ F-D-+ Dmfkd+ L-+ Wt+ P-+ Mdkrnm+ B-@-+ Rtjtonkuh,
Odssx+ R-+ L_qqh+ @-+ K_bglh+ A-,D-+ Nkrgdurjx+ T-+ Eqdlnms+ C-G-+ ds _k’1//5(- @mshancx qdbnfmhshnm _mc mdtsq_khy_shnm cdsdqlhm_msr nm
cnl_hmr H _mc HH ne Vdrs Mhkd Uhqtr dmudknod oqnsdhm- I- Uhqnk- 7.+
01038fl01048-

G_krsd_c+R-A-+L_g_khmf_l+R-+L_qnuhbg+L-@-+Tank+R-+_mc Lnrrdq+C-L’1/0/(- Hmsqhmrhb _mshancx,cdodmcdms dmg_mbdldms ne lhbqnah_k hmedbshnm hm
l_bqnog_fdr9chrd_rd qdftk_shnm ax hlltmd bnlokdwdr-K_mbdsHmedbs-Chr0.+601fl611Gdhcmdq+G-V-+Jmnss+S-@-+_mc Ingmrsnm+Q-D-’0885(-Cheedqdmsh_koqnbdrrhmf
nerhmcahr uhqtr fkxbnoqnsdhm OD1 hm btkstqdc udqsdaq_sd _mc _qsgqnonc bdkkrI-Uhqnk-6.+1/58fl1/62Gdq+Y-+L_kkdqds+A-+Bg_m+L-+Nmf+D-J-R-+Vnmf+R-,B-+Jvdj+C-I-B-+Snknt+
G-+Khm+Q-S-O-+S_lax_g+O-@-+Qd–mh_+K-+_mc Mf+K-E-’1/0/(-@bshud hmedbshnm ne
gtl_m aknnc lnmnbxsdr ax Bghjtmftmx_ uhqtr sqhffdqr _m hmm_sd hlltmd
qdronmrd-I-Hlltmnk-073+48/2fl4802Gn+H-X-+Atmjdq+I-I-+Dqhbjrnm+R-@-+Mdt+J-D-+Gt_mf+L-+Bnqsdrd+L-+Otkdm,
cq_m+A-+_mc Vhkrnm+O-B-’1/05(-Qdzmdc oqnsnbnkenqfdmdq_shmf lnmnbknm_k
_mshanchdr eqnl rhmfkd gtl_m _mc ltqhmd A bdkkr-I-Hlltmnk-Ldsgncr 327+
56fl6/Gnyd–+M-+R_kid+G-+Qntrrds+C-+Eqhsydkk+B-+U_mgnlvdfdm+I-+A_hkkx+R-+M_il+
L-+Dmzrrh+@-+L_mtftdqq_+I-,B-+ Ek_l_mc+B-+_mc B_tbgdldy+R-’1/1/(Qdbnmrsqtbshmf L_x_qn uhqtr bhqbtk_shnm hm Eqdmbg Fth_m_ rgnvr eqdptdms
rohkknudqr-M_s-Bnlltm-00+1731Ihm+I-+_mc Rhllnmr+F-’1/08(-@mshuhq_kEtmbshnmr neLnmnbknm_k@mshanchdr
_f_hmrsBghjtmftmx_ Uhqtr-Uhqtrdr 00+2/4fl211Ihm+ I-+ Khrr+ M-L-+ Bgdm+ C-G-+ Kh_n+ L-+ Enw+ I-L-+ Rghl_j+ Q-L-+ Enmf+
Q-G-+ Bg_edsr+ C-+ A_jjntq+ R-+ Jd_shmf+ R-+ ds _k- ’1/04(- Mdtsq_khyhmf
Lnmnbknm_k @mshanchdr Aknbj Bghjtmftmx_ Uhqtr Dmsqx _mc Qdkd_rd ax
S_qfdshmf _m Dohsnod Bqhshb_k sn Uhq_k O_sgnfdmdrhr- Bdkk Qdo- 02+ 1442fl
1453Ihm+ I-+ F_k_y,Lnmsnx_+ I-F-+ Rgdql_m+ L-A-+ Rtm+ R-X-+ Fnkcrlhsg+ B-R-+
N%Snnkd+D-S-+@bjdql_m+K-+B_qkrnm+K-@-+Vd_udq+R-B-+Bght+V-+_mc Rhl,
lnmr+F-’1/07(-Mdtsq_khyhmf @mshanchdr Hmghahs Bghjtmftmx_ Uhqtr Atcchmf
_ssgd Ok_rl_ Ldlaq_md-BdkkGnrsLhbqnad 13+306fl317-d4Knmf+ E-+ Enmf+ Q-G-+ @trshm+ R-J-+ Bgdm+ Y-+ Jknrd+ S-+ Enjhmd+ @-+ Kht+ X-+
Onqs_+ I-+ R_oo_q_ot+ F-+ @j_g_s_+ V-+ ds _k- ’1/04(- Bqxn,DL rsqtbstqdr
dktbhc_sd mdtsq_khyhmf ldbg_mhrlr ne _msh,bghjtmftmx_ gtl_m lnmnbknm_k
_mshanchdr vhsg sgdq_odtshb _bshuhsx- Oqnb- M_sk- @b_c- Rbh- TR@ 001+
02787fl028/2-

O_k+O-+Cnvc+J-@-+Aqhdm+I-C-+Dcdkhmf+L-@-+Fnqk_snu+R-+Ingmrnm+R-+Kdd+
H-+@j_g_s_+V-+M_adk+F-I-+Qhbgsdq+L-J-+ds_k-’1/02(-Cdudknoldmsne_ ghfg,
kx oqnsdbshud bnlahm_shnm lnmnbknm_k_mshancx sgdq_ox _f_hmrsBghjtmftmx_
uhqtr-OKnR O_sgnf-8+d0//2201Ohmgdhqn+ E-O-+ Eqdhs_r+ Q-A-+ Sq_u_rrnr c_ Qnr_+ I-E-+ F_aa_x+ X-A-+ Ldkkn+
V-@-+_mc KdCtb+I-V-’0870(-@m ntsaqd_j neL_x_qn uhqtr chrd_rd hm Adksdqq_+
Aq_yhk-H-Bkhmhb_k_mc uhqnknfhb_kzmchmfr-@l-I-Sqno-Ldc-Gxf-2.+563fl570Ok_sydq+A-+Rsnts+L-+_mc Ehdahfdq+D-’1/03(-@mshfdm bqnrr,oqdrdms_shnm ne
hlltmd bnlokdwdr-Eqnms-Hlltmnk-4+03/Onvdkk+K-@-+Lhkkdq+@-+Enw+I-L-+Jnrd+M-+Jknrd+S-+Jhl+@-R-+Anla_qch+Q-+
Sdmmdjnnm+Q-M-+Cg_qrg_m cd Rhku_+@-+B_qm_g_m+Q-G-+ds_k-’1/1/(-Gtl_m
l@ar Aqn_ckx Oqnsdbs _f_hmrs @qsgqhsnfdmhb @kog_uhqtrdr ax Qdbnfmhyhmf
Bnmrdqudc Dkdldmsr nesgd Lwq_7 Qdbdosnq,Ahmchmf Rhsd-BdkkGnrsLhbqnad
17+588fl600-d6Qdmmdq+L-+Ek_m_f_m+@-+Cdimhq_sshr_h+V-+Otsshjgtms+B-+J_rhmqdqj+V-+Rt,
o_r_+O-+Vnmfvhv_s+V-+Bg_v_mrtms_sh+J-+Ct_mfbghmc_+S-+Bnvodq+@-+
ds _k- ’1/07(- Bg_q_bsdqhy_shnm ne _ onsdms _mc ghfgkx tmtrt_k lhmhl_kkx
dmg_mbhmf _mshancx chqdbsdc _f_hmrscdmftd uhqtr-M_s-Hlltmnk-08+0137fl
0145Qdx+E-@-+Rsh_rmx+J-+U_mdx+L-B-+Cdkk_qnkd+L-+_mc Gdhmy+E-W-’1/07(-Sgd
aqhfgs_mc sgd c_qj rhcd negtl_m _mshancx qdronmrdr sn fi_uhuhqtrdr9kdrrnmr
enqu_bbhmd cdrhfm-DLAN Qdo-08+1/5fl113Qtoo+I-B-+Rnjnknrjh+J-I-+Fdag_qs+M-M-+_mc G_qcx+Q-V-’1/04(-@kog_uhqtr
QM@ rxmsgdrhr _mc mnm,rsqtbstq_koqnsdhm etmbshnmr-I-Fdm-Uhqnk-85+1372fl
14//Rgddg_m+J-B-+K_h+J-R-+Ctmm+F-O-+Aqtbd+@-S-+Ch_lnmc+ L-R-+Gdtsdk+
I-C-+ Ctmfn,@qsgtq+ B-+ B_qqdqn+ I-@-+ Vghsd+ I-L-+ Gdqsynf+ O-I-+ _mc
Rbgqdhadq+ Q-C- ’1//5(- Aknbjhmf lnmnbknm_k _mshanchdr rodbhzb enq
lntrd HEM,_kog_.ads_ qdbdosnq rtatmhs 0 ’HEM@Q,0( eqnl lhbd hllt,
mhydc ax hm uhun gxcqncxm_lhb sq_mredbshnm- I- Hmsdqedqnm Bxsnjhmd Qdr15+ 7/3fl708-

Kt+K-K-+Rtrbnuhbg+S-I-+Enqstmd+R-L-+_mc @ksdq+F-’1/07(-Adxnmc ahmchmf9
_mshancx deedbsnq etmbshnmr hm hmedbshntr chrd_rdr- M_s- Qdu- Hlltmnk- 07+
35fl50-

Rlhsg+R-@-+Rhku_+K-@-+Enw+I-L-+Ekx_j+@-H-+Jnrd+M-+R_oo_q_ot+F-+Jgn,
l_mch_j+R-+@rgaqnnj+@-V-+J_gkd+J-L-+Enmf+Q-G-+ds_k-’1/04(-Hrnk_shnm
_mc Bg_q_bsdqhy_shnm neAqn_c _mc Tksq_onsdmsGtl_m Lnmnbknm_k@mshanchdr
vhsg Sgdq_odtshb @bshuhsx _f_hmrs Bghjtmftmx_ Uhqtr- BdkkGnrs Lhbqnad 07+
75fl84-

Ktl+E-,L-+Bntcdqb+S-+Bgh_+A-,R-+Nmf+Q-,X-+Gdq+Y-+Bgnv+@-+Kdn+X-,R-+
J_l+X-,V-+Qd–mh_+K-+Kdbths+L-+_mc Mf+K-E-O-’1/07(-@mshancx,ldch_sdc
dmg_mbdldms _ffq_u_sdr bghjtmftmx_ uhqtr hmedbshnm _mc chrd_rd rdudqhsxRbh-Qdo-7+075/-

S_n+ L-G-+ _mc Lnqqhrnm+ R-K- ’0878(- Rstchdr ne _fkxbnrxk_sdc bghldqhb
lntrd,gtl_m HfF-Qnkd neb_qangxcq_sd hm sgd rsqtbstqd _mc deedbsnq etmb,
shnmr ldch_sdc ax sgd gtl_m HfF bnmrs_ms qdfhnm- I- Hlltmnk- 032+ 1484fl
15/0-

L_+G-+Jhl+@-R-+J_e_h+M-L-+D_qmdrs+I-S-+Rg_g+@-O-+B_rd+I-A-+A_rnqd+J-+
Fhkkhk_mc+S-B-+Rtm+B-+Mdkrnm+B-@-+ds_k-’1/1/(-KCKQ@C2 hr _ qdbdosnqenq
Udmdytdk_m dpthmd dmbdog_khshr uhqtr-M_stqd 477+2/7fl203-

Tbghld+N-+Ehdkcr+V-+_mc Jhdkh_m+L-’1/02(-Sgd qnkd neD2 hm oG oqnsdbshnm
ctqhmf _kog_uhqtr _rrdlakx _mc dwhs-I-Uhqnk-76+0/144fl0/151-

L_bj+ L-+ Bhg_j+ I-+ Rhlnmhr+ B-+ Ktbjnv+ A-+ Oqntcenns+ @-D-+ Ok_bgx–+ I-+
Aqtgk+G-+Eqhmj+L-+@mcdqr+G-I-+Uhdkg_tdq+U-+Ozqrshmfdq+I-+Rs_mf_rrhmfdq+
L-+_mc Rbgkn´mcnqee+C-’1//0(-Dwoqdrrhnm _mc bg_q_bsdqhy_shnm nesgd bgdln,
jhmd qdbdosnqr BBQ1 _mc BBQ4 hm lhbd-I-Hlltmnk-055+3586fl36/3L_mb_qch+C-@-+H_mm_rbnkh+A-+Gnnr+R-+Dmfk_mc+O-+C_d́qnm+L-+_mc Aqtgmr+
O-’1//7(-Ebf_ll_QHU hr _ lntrd HfD qdbdosnqsg_sqdrdlakdr l_bqnog_fd

V_ffnmdq+I-I-+Qni_r+@-+Lng_ldc,G_ckdx+@-+cd Fthkkdm+X-@-+_mc Ohmrjx+
A-@-’1/07(-Qd_k,shld QS,OBQ enqL_x_qn uhqtr cdsdbshnm hm ok_rl_ _mc tqhmdI-Bkhm-Uhqnk-87+0fl3Vdhrd+ V-I-+ Gdql_mbd+ L-D-+ Enqqdrsdq+ M-+ @c_lr+ @-O-+ K_mfrindm+ Q-+
Fnqbg_jnu+ Q-+ V_mf+ D-+ @kbnqm+ L-C-G-+ Srdsr_qjhm+ J-+ _mc Vd_udq+ R-B’1/03(- @ mnudk khud,_ssdmt_sdc u_bbhmd b_mchc_sd enq l_x_qn Edudq- OKnR
Mdfk-Sqno-Chr-7+d1858-
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Vghsd+I-O-+Whnmf+R-+L_kuhm+M-O-+Jgntqx,G_mnkc+V-+Gdtbjdqnsg+Q-N-+
Rs_oodmadbj+ S-R-+ _mc Ch_lnmc+ L-R- ’1/07(- Hmsdrshm_kCxrlnshkhsx Rxm,
cqnldr enkknvhmf Rxrsdlhb Hmedbshnm ax Ek_uhuhqtrdr- Bdkk 064+ 0087fl
0101-d01-

X_o+L-K-+Jknrd+S-+Tq_j_lh+@-+G_r_m+R-R-+@j_g_s_+V-+_mc Qnrrl_mm+
L-F-’1/06(-Rsqtbstq_krstchdr neBghjtmftmx_ uhqtr l_stq_shnm-Oqnb-M_sk@b_c-Rbh-TR@ 003+026/2fl026/6-

Vhmjkdq+D-R-+Rgqhg_qh+R-+Gxjdr+A-K-+Iq-+G_mckdx+R-@-+@mcgdx+O-R-+Gt_mf+
X-R-+Rv_hm+@-+Cqnhs+K-+Bgdaqnkt+J-J-+L_bj+L-+ds_k-’1/1/(-Sgd Hmsdrshm_k
Lhbqnahnld Qdrsqhbsr @kog_uhqtr Hmedbshnm _mc Chrrdlhm_shnm sgqntfg _ Ahkd
@bhc,Sxod HHEM Rhfm_khmf @whr-Bdkk071+8/0fl807-d07-

Ygnt+P-E-+Enw+I-L-+D_qmdrs+I-S-+Mf+S-,R-+Jhl+@-R-+Ehaqh_mr_g+F-+Jnr,
sxtbgdmjn+U-@-+Rgh+I-+Rgt+A-+Ch_lnmc+L-R-+_mc Knj+R-L-’1/1/(-Rsqtb,
stq_ka_rhr ne Bghjtmftmx_ uhqtr hmghahshnm ax lnmnbknm_k_mshanchdr- OqnbM_sk-@b_c-Rbh-TR@ 006+16526fl16534-
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RS2Q LDSGNCR
JDX QDRNTQBDR S2AKD

QD@FDMS nqQDRNTQBD

RNTQBD

HCDMSHEHDQ

L@X,0+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,7+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,7,lHfF0+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,7,gHfF0+_msh,L@XU l@a

Sghr O_odq

M.@

@mshanchdr

L@X,7,gHfF0,M186P+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,0/+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,12+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,16+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,28+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,30+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,48+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,5/+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,57+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,61+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,0/1+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,0/7+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,0/7,lHfF0+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,0/7,gHfF0+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,0/7,gHfF0,M186P+_msh,L@XU
l@a

Sghr O_odq

M.@

L@X,001+_msh,L@XU l@a

Sghr O_odq

M.@

L@X,006+_msh,L@XU l@a

D_qmdrsds_k-+1/08

M.@

L@X,006,gHfF0+_msh,L@XU l@a

D_qmdrsds_k-+1/08

M.@

D5/+_msh,Yhj_ l@a

Nkhog_msds_k-+1//5

M.@

L@Q0,4@2+_msh,Hem_q0 l@a

Kdhmbn

B_s 9AO/13:QQHC9@A]1380510

LB,10+_msh,BBQ1 l@a

’L_bj ds_k-+1//0(

M.@

GlThunl@a _msh,lntrd MJ0-0

Ahn W Bdkk

B_s AD//25:QQHC9@A]00/6626

Fn_s_msh,lntrd HfF+gtl_m _cr,GQO

Rntsgdqm Ahnsdbg

B_s 0/2/,/4:QQHC9@A]1508631

Fn_s_msh,lntrd HfF+gtl_m _cr,AHNS

Rntsgdqm Ahnsdbg

B_s 0/2/,/7:QQHC9@A]1683185

Fn_s_msh,lntrd HfF+gtl_m _cr,
@kdw_Ektnq536

Hmuhsqnfdm

B_s @,10125:QQHC9@A]14247/4

Fn_s_msh,gtl_m HfF+GQO

Sgdqln Ehrgdq

B_s 51,731/:QQHC9@A]1422851

Rsqdos_uhchm,GQO

UdbsnqK_anq_snqhdr

B_s R@,4//3:QQHC9@A]12254/8

ATU84 _msh,BC34

AC AhnRbhdmbdr

B_s 453168:QQHC9@A]1540023

Ehw_akd @pt_ cd_c bdkkrs_hm

Hmuhsqnfdm

B_s K23854

OdqBO,Bx4-4 _msh,BC00a

AhnKdfdmc

B_s 0/01/6:QQHC9@A]20168/

EHSB _msh,Kx5A

@ab_l

B_s _a42346:bknmd96.3

OD,Bx6 _msh,Kx5F

AhnKdfdmc

B_s 004400:
QQHC9@A]202535

O_bhzb Aktd _msh,Kx5B

AhnKdfdmc

B_s 017/04:
QQHC9@A]0621/76

@kdw_Ektnq6// _msh,LGB bk_rr HH

AhnKdfdmc

B_s 0/6510:
QQHC9@A]382615
’9nlshltdc nl ldvsoVed(
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HCDMSHEHDQ

@OB,Bx,6 _msh,BC2

AhnKdfdmc

B_s 0//218:
QQHC9@A]0766060

AU5/4 _msh,BC08

AhnKdfdmc

B_s 004428:
QQHC9@A]001/2427

OD,Bx6 _msh,MJ0-0

AhnKdfdmc

B_s 0/7602:
QQHC9@A]278252

@OB _msh,BC53

AhnKdfdmc

B_s 0282/4:
QQHC9@A]001081/4

@OB _msh,BC21a

Hmuhsqnfdm

B_s 06,/210,71:
QQHC9@A]1462031

@OB _msh,BC05-1

AhnKdfdmc

B_s 0384/4:
QQHC9@A]1454701

L@XU,BG

Vdhrd ds_k-+1/03

M.@

L@XU,AdG3/6

Vnqkc Qdedqdmbd BdmsdqenqDldqfhmf
Uhqtrdr _mc @qanuhqtrdr+Sgd Tmhudqrhsx
neSdw_r Ldchb_kAq_mbg

M.@

Yhj_,C_j_q,L@

Fnql_m ds_k-+1/07

M.@

Udqn D5

@SBB

BQK,0475:QQHC9BUBK]/463

B1B01

@SBB

BQK,0661:
QQHC9BUBK]/077

GDJ182S

@SBB

BQK,2105:QQHC9BUBK]//52

Dwoh182E

Hmuhsqnfdm

B_s @03416:QQHC9BUBK]C504

AU1

L_ ds_k-+1/1/

M.@

AU1,D3eVis6

L_ ds_k-+1/1/

M.@

K@CL@B

@SBB

BQK,131/:QQHC9BUBK]144/

Uhqtr _mc a_bsdqh_krsq_hmr

Dwodqhldms_klncdkr9bdkkkhmdr

Dwodqhldms_klncdkr9nqf_mhrlr.rsq_hmr
Lntrd9B46AK.5I

I_bjrnm K_anq_snqx

B_s ///553:QQHC9HLRQ]I@W9///553

S_bnmhb

B_s 472

L@XU,qsOBQ,E9
4 ,@@FBSBSSBBSBSFB@SSFB,2

V_ffnmdqds_k-+1/07

M.@

L@XU,qsOBQ,Q9
4 ,SFBSFF@@@BFBSBSBSFS@,2

V_ffnmdqds_k-+1/07

M.@

L@XU,qsOBQ,Oqnad9
4 ,.45,E@L.,FBBF@F@F.YDM.BB
BFSSSSS@@@@SB@B.2H@AjEP,2

V_ffnmdqds_k-+1/07

M.@

Yhj_,qsOBQ,E94 ,BB@BB@@SFSSBSB
SSFB@F@B@S@SSF,2

Vghsd ds_k-+1/07

M.@

Yhj_,qsOBQ,Q94 ,SSBFF@B@FBBFS
SFSBB@@B@B@@F,2

Vghsd ds_k-+1/07

M.@

Yhj_,qsOBQ,Oqnad9
4 ,.45,E@L.@FBBS@BBS.Ydm.SF@
B@@FB@FSB.2H@AjEP.,2

Vghsd ds_k-+1/07

M.@

EVocg S_pL_m Oqhldq.Oqnad rds

HCS

Ll-OS-28_-0

oDS10_,L@XU,SQUK3564,qD1 oqnsdhm

D_qmdrsds_k-+1/08

M.@

oBCM@2-0,L@XU,Onkxoqnsdhm
’hmbktchmf _k_mhmd rb_m
lts_msr hm D1 qdrhctdr 0,063(

Sghr O_odq

M.@

Lntrd9B46AK.5 EbQb

!.!

Nkhfnmtbkdnshcdr

Qdbnlahm_msCM@

’9nlshltdc nl ldvsoVed(
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QD@FDMS nqQDRNTQBD

RNTQBD

HCDMSHEHDQ

o@aUdb,lHfF0

Gn ds_k-+1/05

M.@

o@aUdb,lHfJ_oo_

Gn ds_k-+1/05

M.@

o@aUdb,gHfF0

Gn ds_k-+1/05

M.@

o@aUdb,gHfF0,M186P

D_qmdrsds_k-+1/08

M.@

o@aUdb,gHfJ_oo_

Gn ds_k-+1/05

M.@

EknvIn

EknvIn+KKB

u0/

Fq_ogO_c Oqhrl

Fq_ogO_c

u 7-1-0

AH@du_kt_shnm

FD Gd_ksgb_qd

u 2-0

TBRE Bghldq_W

QAUH

u 0-0

Rnesv_qd _mc _kfnqhsglr

QDRNTQBD 2U2HK2AHKHSX
KdYc bnmsYbs
Etqsgdqhmenql_shnm _mc qdptdrsr enqqdrntqbdr _mc qd_fdmsr rgntkc ad chqdbsdc sn _mc vhkkad etkzkkdc ax sgd Kd_c Bnms_bs+Lhbg_dkRCh_lnmc ’ch_lnmc>vtrl-vtrsk-dct(LYsdqhYkr YuYhkYahkhsx
@kkqdptdrsr enqqdrntqbdr _mc qd_fdmsr rgntkc ad chqdbsdc sn _mc vhkkad etkzkkdc ax sgd Kd_c Bnms_bs_tsgnq-Sghr hmbktcdr lhbd+
_mshanchdr+uhqtrdr+_mc oqnsdhmr-@kkqd_fdmsr vhkkad l_cd _u_hk_akd nm qdptdrs_esdqbnlokdshnm ne_ L_sdqh_kr Sq_mredq@fqddldmsCYsY Ymc bncd YuYhkYahkhsx
@kkc_s_ rtoonqshmf sgd zmchmfr nesghr rstcx _qd _u_hk_akd vhsghm sgd o_odq_mc _qd _u_hk_akd eqnl sgd bnqqdronmchmf _tsgnqtonm
qdptdrsDWODQHLDMS2K LNCDK 2MC RTAIDBS CDS2HKR
Bdkkkhmdr
Udqn+GDJ182S+_mc B1B01 bdkkr vdqd btkstqdc hm Ctkadbbn%r lnchzdc D_fkd ldchtl ’CLDL(rtookdldmsdc vhsg 0/# eds_kanuhmd
rdqtl ’EAR(+0// T.lkneodmhbhkkhm+0// g f.lknersqdosnlxbhm+0W LDL mnm,drrdmsh_k_lhmn _bhcr+0 lL rnchtl oxqtu_sd+1 lL
K,Fkts_lhmd _mc 0/ lL GDODR oG 6-2-Gxaqhcnl_r vdqd btkstqdc hm Hrnbnud%r lnchzdc D_fkd ldchtl ’HLCL(rtookdldmsdc vhsg
1/# EAR+0// T.lkneodmhbhkkhm+0// g f.lknersqdosnlxbhm+_mc 0 lL rnchtl oxqtu_sd-Dwoh182 bdkkr vdqd l_hms_hmdc hm Dwoh182
ldchtl ’FHABN(-AU1) D3eVis6 bdkkr vdqd oqnctbdc oqduhntrkx ’L_ ds_k-+1/1/(-AU1+AU1) D3eVis6+_mc K@CL@B bdkkr vdqd l_hm,
s_hmdc hm CLDL rtookdldmsdc vhsg 4# EAR+0// T.lkneodmhbhkkhm+0// g f.lknersqdosnlxbhm+0W LDL mnm,drrdmsh_k_lhmn _bhcr+
_mc 0/ lL GDODR oG 6-2Uhqtrdr
L@XU ’rsq_hm AdG3/6(v_r nas_hmdc eqnl sgd Vnqkc Qdedqdmbd Bdmsdq enq Dldqfhmf Uhqtrdr _mc @qanuhqtrdr ’J-Ok_msd+_mc RVd_udq+Tmhudqrhsx neSdw_r Ldchb_kAq_mbg(_mc o_rr_fdc hm Udqn bdkkr eqnl kxnoghkhydc rsnbjr-Qdbnlahm_msuhqtrdr vdqd oqn,
ctbdc _esdqkhmd_qhy_shnm ne_ oqR1 udbsnqbnms_hmhmf bCM@ eqnl L@XU ’rsq_hm BG(’Vdhrd ds_k-+1/03(sg_sv_r oqnuhcdc ax R-Vd_udq
’Tmhudqrhsx neSdw_r Ldchb_kAq_mbg(-@esdqhl uhspn sq_mrbqhoshnm vhsg lLDRR@FD lL@BGHMD RO5 sq_mrbqhoshnm jhs’Hmuhsqnfdm(_mc
sq_mredbshnm hmsn AGJ,10 bdkkr+o/ uhqtr rsnbjr vdqd g_qudrsdc _mc o_rr_fdc nmbd ’o0(hm Udqn bdkkr-Uhqtr shsdqr vdqd cdsdqlhmdc ax
enbtr enqlhmf _rr_x ’Enw ds_k-+1/04(-Lntrd _c_osdc Yhj_,C_j_quhqtr ’Fnql_m ds_k-+1/07(v_r oqno_f_sdc hm Udqn bdkkrLntrd dwodqhldmsr
@kk_mhl_kdwodqhldmsr _mc oqnbdctqdr vdqd b_qqhdc ntshm _bbnqc_mbd vhsg sgd qdbnlldmc_shnmr hm sgd Fthcd enqsgd B_qd _mc Trd
neK_anq_snqx @mhl_kr nesgd M_shnm_kHmrshstsdr neGd_ksg-Sgd oqnsnbnkr vdqd _ooqnudc ax sgd Hmrshstshnm_k@mhl_kB_qd _mc Trd
Bnllhssdd _ssgd V_rghmfsnm Tmhudqrhsx RbgnnkneLdchbhmd ’@rrtq_mbd mtladq@2270,/0(-Hmidbshnmr vdqd odqenqldc tmcdq_mdr,
sgdrh_ sg_sv_r hmctbdc _mc l_hms_hmdc vhsg jds_lhmd gxcqnbgknqhcd _mc wxk_yhmd+_mc _kkdeenqsr vdqd l_cd sn lhmhlhyd _mhl_k
rteedqhmfVS B46AK.5I l_kd lhbd vdqd otqbg_rdc eqnl I_bjrnm K_anq_snqhdr-Bnllnm b ,bg_hm cdzbhdms’EbQb !.!(B46AK.5 lhbd vdqd na,
s_hmdc bnlldqbh_kkx ’S_bnmhb(+a_bjbqnrrdc trhmf roddc bnmfdmhbr sn B46AK.5I lhbd+_mc aqdc _ssgd V_rghmfsnm Tmhudqrhsx Rbgnnk
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neLdchbhmd @mhl_kE_bhkhsx-EbQb !.! dwodqhldmsr vdqd odqenqldc vhsg ansg l_kd _mc edl_kd lhbd-Tmkdrr nsgdqvhrd hmchb_sdc+entq,
vddj,nkc lhbd vdqd trdc hm _kkdwodqhldmsr-@msh,L@XU l@ar vdqd _clhmhrsdqdc ax hmsq_odqhsnmd_khmidbshnm _srodbhzdc shldr adenqd
nq_esdqhmnbtk_shnm hm sgd kdesennso_c vhsg 0/2 EET neL@XU hm G_mj%r A_k_mbdc R_ksRnktshnm ’GARR(rtookdldmsdc vhsg 0# gd_s,hm,
_bshu_sdc EAR-Ennsrvdkkhmf v_r lnmhsnqdc uh_ ld_rtqdldmsr ’vhcsg w gdhfgs(trhmf chfhs_kb_khodqr-Shrrtdr vdqd g_qudrsdc _esdq
odqetrhnm vhsg 3/ lK neOAR _mc shsdqdc ax pQS,OBQ trhmf QM@ hrnk_sdc eqnl uhq_krsnbjr _r _ rs_mc_qc btqud sn cdsdqlhmd EET dpthu,
_kdmsr-Enqkdsg_kbg_kkdmfd dwodqhldmsr+lhbd vdqd _clhmhrsdqdc uh_ hmsq_odqhsnmd_khmidbshnm _ rhmfkd 0// g f cnrd ne_msh,Hem_q0 l@a
L@Q0,4@2 ’Rgddg_m ds_k-+1//5(’AhnWBdkk(nmd c_x adenqd hmedbshnm-Lnmnbxsd cdokdshnm dwodqhldmsr vdqd odqenqldc ax _clhmhr,
sdqhmf 14 g f ne_msh,BBQ1 ’bknmd LB,10(_sc_x !0 _mc dudqx nsgdqc_x rtardptdmskx-MJ bdkkcdokdshnm dwodqhldmsr vdqd odqenqldc
ax _clhmhrsdqhmf 1// g f neMJ0-0 ’AhnWBdkkbknmd OJ025(_sc_x !0+_mc dudqx nsgdqc_x rtardptdmskxLDSGNC CDS2HKR
Oqnsdhm dwoqdrrhnm Ymc otqhzbYshnm
Sgd L@XU ’rsq_hm SQUK3564(D1 dbsncnl_hm ’qdrhctdr 0,23/(v_r bknmdc hmsn sgd oDS10_ dwoqdrrhnm udbsnq_mc dwoqdrrdc hm AK10
’CD2(C-anihbdkkr-Oqnsdhm oqnctbshnm v_r hmctbdc trhmf 0 lL hrnoqnoxka ,c,0,sghnf_k_bsnoxq_mnrhcd ’HOSF(+vgdqd D1 o_qshshnmdc
hmsn sgd hmbktrhnm ancx eq_bshnm _mc v_r qdenkcdc trhmf _m nwhc_shud qdenkchmf oqnsnbnk’Mdkrnm ds_k-+1/03(-Aqhdfix+0/ lK nernktah,
khydc hmbktrhnm ancx v_r hmidbsdc _s0lk.g hmsn _ 0 kunktld ne_qfhmhmd qdenkchmf ateedq’3// lL K,_qfhmhmd+0// lL Sqhr ZoG 7-4[+4 lL
qdctbdc fkts_sghnmd+/-4 lL nwhchydc fkts_sghnmd+_mc /-1 lL OLRE(+_mc sgdm _kknvdc sn rshqrknvkx nudqmhfgs_s3" B-Sgd qdenkcdc
oqnsdhm v_r zksdqdc+bnmbdmsq_sdc trhmf _ 2/ jC_ btsneershqqdc bdkkbnmbdmsq_snq ’DLC Lhkkhonqd(+_mc otqhzdc ax GhKn_c 05.5//
Rtodqcdw 64 rhyd dwbktrhnm bgqnl_snfq_ogx ’FD Gd_ksgb_qd(l2a fdmdqYshnm
Sdm vddj,nkc edl_kd B46AK.5I lhbd vdqd hmnbtk_sdc vhsg 0/2 EET neL@XU,BG-Lhbd vdqd annrsdc vhsg 0// g f neqdbnlahm_ms
L@XU D1 oqnsdhm lhwdc 090 vhsg Eqdtmc%r Hmbnlokdsd _citu_ms_s03+17+_mc 31 c_xr _esdqhmhsh_khmedbshnm-Rokddmr vdqd g_qudrsdc
_s34 coh_mc etrdc vhsg O2W52 @f-7-5-4-2 lntrd lxdknl_ bdkkr _r cdrbqhadc oqduhntrkx ’O_kds_k-+1/02(-Gxaqhcnl_ rtodqm_s_msr
vdqd rbqddmdc enq_mshanchdr sg_santmc sn qdbnlahm_msL@XU D1 hm _m DKHR@ _mc.nqsn L@XU ’rsq_hm AdG3/6(,hmedbsdc bdkkr ax finv
bxsnldsqx-Md_sgxaqhcnl_ rtodqm_s_msr vdqd rbqddmdc enqmdtsq_khy_shnm neL@XU,BG trhmf _ EQMS ’cdrbqhadc adknv(-Rdkdbsdc
l@ar vdqd hrnsxodc ax DKHR@ _mc otqhzdc ax oqnsdhm @ _ezmhsx bgqnl_snfq_ogx ’Sgdqln(DKHR2
Enqsgd uhqhnm b_ostqd DKHR@+_ gtl_mhydc l@a rodbhzb enqL@XU ’L@X,023(’D_qmdrsds_k-+1/08(v_r _crnqadc sn L_whrnqo Hl,
ltmnb_ostqd DKHR@ ok_sdr ’Sgdqln(hm _ rnchtl ahb_qanm_sd ateedq oG 8-2 nudqmhfgs _s 3" B-Vdkkr vdqd v_rgdc vhsg OAR _mc
aknbjdc vhsg aknbjhmf ateedq ’OAR * 4# AR@ ZRhfl_[(enq 0 g _s26" B-Aknbjhmf ateedq v_r qdlnudc _mc qdok_bdc vhsg 0/2 EET.
vdkkneL@XU,AdG3/6 chktsdc hm aknbjhmf ateedq_mc hmbta_sdc _s26" B enq0 g-Tmantmc uhqtr v_r v_rgdc _v_x vhsg OAR _mc rdqh_k
chktshnmr ne_msh,L@XU l@ar+chktsdc hm aknbjhmf ateedq+vdqd _ccdc sn sgd vdkkr _mc hmbta_sdc enq0 g _s3" B-Tmantmc l@a v_r
v_rgdc _v_x vhsg OAR+_mc vdkkr vdqd hmbta_sdc vhsg _m GQO bnmitf_sdc fn_s _msh,lntrd Eb _mshancx enq 0 g _s 3" B-Ok_sdr
vdqd v_rgdc _mc cdudknodc vhsg SLA nmd,rsdo rtarsq_sd ’Sgdqln(enq 0/ lhmtsdr-Sgd qd_bshnm v_r rsnoodc vhsg 0 M G1RN3+
_mc _arnqa_mbd v_r ld_rtqdc _s34/ ml-Enqsgd l@a bnlodshshnm ahmchmf DKHR@+uhqtr v_r b_ostqdc sn ok_sdr _r _anud _mc hmbt,
a_sdc vhsg 0/ g f.lknesgd hmchb_sdc oqhl_qx l@ar-Tmantmc l@ar vdqd qhmrdc _v_x+_mc vdkkr vdqd hmbta_sdc vhsg 0/ mf.lknesgd
rdbnmc_qx l@ar k_adkdc vhsg MGR,Ahnshm ’Sgdqln(-@esdqv_rghmf+ahnshmxk_sdc l@ar vdqd cdsdbsdc trhmf _ rsqdos_uhchm,GQO rdb,
nmc_qx ’UdbsnqK_anq_snqhdr(-Enqsgd D1 oqnsdhm DKHR@+4/ mf.vdkknea_bsdqh_kkx oqnctbdc qdbnlahm_msL@XU D1 dbsncnl_hm v_r
_crnqadc sn ok_sdr _r _anud-Ok_sdr vdqd v_rgdc vhsg DKHR@ v_rg ateedq’OAR * /-/4# Svddm 1/(_mc hmbta_sdc vhsg rdqh_kchktshnmr
ne_msh,L@XU l@ar chktsdc hm aknbjhmf ateedq-L@ar vdqd cdsdbsdc trhmf rdbnmc_qx qd_fdmsr _mc NC v_r ld_rtqdc _r cdrbqhadc
_anudEnbtr qdctbshnm mdtsqYkhyYshnm sdrsr EQMS(
@msh,L@XU l@ar vdqd chktsdc rdqh_kkx _mc hmbta_sdc vhsg 0/1 EET neL@XU,AdG3/6 enq0 g _s26" B hm sqhokhb_sd vdkkr-Uhqtr,l@a
lhwstqdr vdqd hmbta_sdc nm Udqn nqB1B01 bdkkr enq5/ lhm _s26" B adenqd adhmf nudqk_hc vhsg 0# ldsgxkbdkktknrd hm lhmhl_kdrrdmsh_k
ldchtl ’LDL(rtookdldmsdc vhsg 0/ lL GDODR oG 6-2+0// T.lkneodmhbhkkhm+0// g f.lknersqdosnlxbhm+1 lL K,fkts_lhmd+_mc
1# EAR-Dhfgsddm gntqr _esdquhqtr hmnbtk_shnm+bdkkr vdqd zwdc vhsg 0# o_q_enql_kcdgxcd ’OE@(hm OAR-Bdkkr sgdm vdqd v_rgdc _mc
nudqk_hc vhsg 0 g f.lkneahnshmxk_sdc L@X,007 ’D_qmdrsds_k-+1/08(enq1 g-Bdkkr vdqd v_rgdc _mc nudqk_hc vhsg rsqdos_uhchm,GQO enq
0 g-Enbhnehmedbshnm vdqd cdsdbsdc trhmf SqtdAktd rtarsq_sd ’JOK(_mc bntmsdc trhmf _ Ahnronsok_sd qd_cdq’Bdkktk_qSdbgmnknfx(Vdkkr bnms_hmhmf uhqtr hmbta_sdc vhsg l@ar vdqd bnlo_qdc sn vdkkr sqd_sdc vhsg uhqtr bnms_hmhmf mn l@aVdrsdqm aknsshmf
Qdbnlahm_ms L@XU,D1 oqnsdhm v_r lhwdc vhsg KCR ateedq ’Khed Sdbgmnknfhdr( hm sgd oqdrdmbd ’qdctbhmf( nq _ardmbd ’mnm,
qdctbhmf(ne1/ lL chsghnsgqdhsnk-@esdq gd_shmf _s6/" B enq 0/ lhm+r_lokdr vdqd dkdbsqnognqdrdc trhmf _ 3#fl01# Ahr,Sqhr fdk
’Khed Sdbgmnknfhdr(-Oqnsdhmr vdqd sq_mredqqdc sn mhsqnbdkktknrd ldlaq_mdr trhmf _m hAkns1 Cqx Aknsshmf Rxrsdl ’Khed Sdbgmnknfhdr(-
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Ldlaq_mdr vdqd aknbjdc vhsg 4# AR@+btshmsn rsqhor+_mc oqnadc vhsg sgd hmchb_sdc l@ar-Tmantmc l@a v_r qhmrdc _v_x+_mc
sgd l@ar vdqd cdsdbsdc vhsg _m _msh,lntrd GQO,bnmitf_sdc rdbnmc_qx _mshancx ’UdbsnqK_anq_snqhdr(-Aknsr vdqd cdudknodc trhmf
RtodqRhfm_kVdrsOhbn BgdlhktlhmdrbdmsRtarsq_sd ’Khed Sdbgmnknfhdr(AhnkYxdqhmsdqedqnldsqx
Sgd ahmchmf _ezmhsx neotqhzdc qdbnlahm_msL@XU D1 dbsncnl_hm oqnsdhm sn L@XU l@ar v_r du_kt_sdc _s14" B trhmf _m Nbsds,
Qdc85 cduhbd ’O_kkEnqsdAhn(-0// g f ned_bg l@a v_r lhwdc vhsg ahnshm ’DY,Khmj,MGR,ODF3,Ahnshm+Sgdqln Ehrgdq(_s_ lnk_qq_shn
ne1/90 ahnshm9oqnsdhm _mc hmbta_sdc _sqnnl sdlodq_stqd enq2/ lhm-Sgd tmqd_bsdc ahnshm v_r qdlnudc ax o_rr_fd sgqntfg _ cd,
r_kshmf bnktlm ’4 lK Yda_ Rohm 6 jC_ lnkdbtk_qvdhfgsbts,nee+Sgdqln Ehrgdq(-Sgd ahnshmxk_sdc,l@ar vdqd kn_cdc nmsn rsqdos_uhchm
ahnrdmrnqohmr ’EnqsdAhn(tmshkr_stq_shnm+sxohb_kkx 0/ g f.lkenq1 lhm+hm 0/ lL GDODR ’oG 6-3(+04/ lL M_Bk+2 lL DCS@+/-//4#
O1/ rtqe_bs_ms+_mc 0# AR@-Sgd ohmr vdqd dpthkhaq_sdc hm ahmchmf ateedq_knmd adenqd adhmf oktmfdc hmsn vdkkr bnms_hmhmf u_qhntr
bnmbdmsq_shnmr neL@XU D1+sgdm adhmf ok_bdc a_bj hmsn ahmchmf ateedqsn _kknv enqchrrnbh_shnm-Qd_k,shld c_s_ vdqd _m_kxydc trhmf
AH@du_kt_shnm 2-0 ’FD Gd_ksgb_qd(-Jhmdshb oqnzkdr _mc rsd_cx,rs_sd dpthkhaqhtl bnmbdmsq_shnm btqudr vdqd zssdc trhmf _ fkna_k090
ahmchmf _kfnqhsgl vhsg cqheshmf a_rdkhmd2kYmhmd rbYmmhmf ltsYfdmdrhr
@ obCM@2-0’*(ok_rlhc dwoqdrrhmf _ bncnm,noshlhydc L@XU ’rsq_hm SQUK3564(rsqtbstq_konkxoqnsdhm ’B+D2+D1+5J+_mc D0 fdmdr(v_r
rxmsgdrhydc _mc lts_sdc ax FdmRbqhos-@k_mhmd rb_mmhmf lts_fdmdrhr v_r odqenqldc nm _lhmn _bhcr hm sgd @ cnl_hm nesgd D1 oqnsdhm
’qdrhctdr 0,062(sg_svdqd oqdchbsdc sn ad rnkudmsdwonrdc-Ok_rlhcr vdqd sq_mredbsdc hmsn GDJ182S bdkkr trhmf Khonedbs_lhmd 2///
’Sgdqln Ehrgdq(-Dhfgsddm gntqr k_sdq+bdkkr vdqd bghkkdc sn 3" B+v_rgdc vhsg OAR+_mc hmbta_sdc vhsg _msh,L@XU l@ar ’0/ g f.lk(hm
OAR vhsg 1# EAR enq0 g _s3" B-@m nkhfnbknm_klhwstqd nesgd 02 l@ar _rvdkk_r_m _msh,A cnl_hm l@a ’L@X,006(v_r trdc _r_ bnmsqnk
enqlts_msD1 oqnsdhm dwoqdrrhnm-@msh,L@XU l@a ahmchmf v_r cdsdbsdc trhmf @kdw_ Ektnq536 bnmitf_sdc fn_s_msh,lntrd HfF ’Sgdqln
Ehrgdq(chktsdc 090///-@esdq0 g+bdkkr vdqd v_rgdc+zwdc vhsg 0# OE@ hm OAR+_mc _m_kxydc ax finv bxsnldsqx trhmf _ L@BRPt_ms
@m_kxydq’LhksdmxhAhnsdb(-Trhmf oqduhntrkx cdrbqhadc bqhsdqh_ ’Rlhsg ds_k-+1/04(+bqhshb_kqdrhctdr vdqd cdzmdc _r sgnrd vhsg
14#
ahmchmf sn _m hmchuhct_kl@a ats% 64# ahmchmf sn _m nkhfnbknm_konnkne_msh,L@XU l@ar _r cdsdqlhmdc ax finv bxsnldsqxHrnsxod rvhsbghmf nel2ar
L@X,0/ _mc L@X,0/7 u_qh_akd qdfhnmr vdqd rdptdmbdc _mc bknmdc trhmf oqduhntrkx cdrbqhadc ldsgncr ’Gn ds_k-+1/05(-Sns_kQM@
v_r hrnk_sdc eqnl gxaqhcnl_r _mc bCM@ v_r oqnctbdc trhmf q_mcnl gdw_ldqr _mc Nkhfnc’S(1/ trhmf _ RtodqRbqhosHU EhqrsRsq_mc
Rxmsgdrhr jhs’Hmuhsqnfdm(-Gd_ux _mc khfgsbg_hm u_qh_akd qdfhnmr vdqd _lokhzdc _mc rdptdmbdc trhmf lntrd,rodbhzb oqhldqrdsr ’Gn
ds_k-+1/05(-@kkdkd,rodbhzb oqhldqr vdqd trdc sn _lokhex u_qh_akd qdfhnmr _mc _oodmc Fharnm _rrdlakx rdptdmbdr sn sgd 4 _mc 2
dmcr-Sgd u_qh_akd qdfhnmr sgdm vdqd bknmdc hmsn ok_rlhcr bnms_hmhmf sgd bnmrs_msqdfhnmr negtl_m HfF0 ’o@aUdb,gHfF0(nqlntrd
HfF0 ’o@aUdb,lHfF0(nqsgd _ooqnoqh_sd j_oo_ bg_hm ’o@aUdb,gHfJ_oo_ nqo@aUdb,lHfJ_oo_(trhmf MDAthkcdq’Mdv Dmfk_mc Ahn,
k_ar(-Sgd gtl_m HfF0,M186P udbsnqv_r oqnctbdc ax rhsd chqdbsdc lts_fdmdrhr nesgd gtl_m HfF0 udbsnqtrhmf _ Ogtrhnm rhsd
chqdbsdc lts_fdmdrhr jhs-@mshanchdr vdqd oqnctbdc ax bn,sq_mredbshmf Dwoh182 bdkkr vhsg _m _ooqnoqh_sd gd_ux _mc j_oo_ bg_hm
ok_rlhc trhmf Gxod4 sq_mredbshnm qd_fdms ’Ny Ahnrbhdmbdr(- Entq c_xr _esdq sq_mredbshnm+ rtodqm_s_ms v_r bnkkdbsdc _mc l@ar
vdqd otqhzdc nm _ Ohdqbd oqnsdhm @ _f_qnrd bnktlm ’Sgdqln(Bxsnihmd YmYkxrhr
@mjkd gnlnfdm_sdr vdqd hmbta_sdc vhsg Sqhsnm W,0// ’0# zm_kbnmbdmsq_shnm(enq0 g _sqnnl sdlodq_stqd sn hm_bshu_sd L@XU-Gn,
lnfdm_sdr sgdm vdqd _m_kxydc enqbxsnjhmdr _mc bgdlnjhmdr ax Dud Sdbgmnknfhdr Bnqonq_shnm ’B_kf_qx+@A+B_m_c_(trhmf sgdhq
Lntrd Bxsnjhmd @qq_x.Bgdlnjhmd @qq_x 20,Okdw ok_senqlEknv bxsnldsqx
Enqbdkkcdokdshnm dwodqhldmsr+vgnkd aknnc v_r g_qudrsdc eqnl lhbd _mc lhwdc vhsg 4 lL DCS@ ’Bnqmhmf(-Qdc aknnc bdkkr vdqd
kxrdc vhsg @BJ kxrhr ateedq_sqnnl sdlodq_stqd adenqd adhmf v_rgdc _mc bghkkdc hm OAR * 4# EBR-Lnmnbxsdr vdqd rs_hmdc vhsg
BC34 ATU284 ’AC Ahnrbhdmbdr bknmd 2/,E00(+BC00a OdqBO,Bx4-4 ’AhnKdfdmc bknmd L0.6/(+Kx5A EHSB ’@ab_l bknmd 6.3(+Kx5F
OD,Bx6 ’AhnKdfdmc bknmd 5C4(+Kx5B O_bhzb Aktd ’AhnKdfdmc bknmd GJ0-3(_mc LGB bk_rr HH@6// ’AhnKdfdmc bknmd L4.003-04-1(MJ bdkkr vdqd rs_hmdc vhsg BC34 ATU84+BC2 @OB,Bx,6 ’AhnKdfdmc bknmd 034,1B00(+BC08 AU5/4 ’AhnKdfdmc bknmd 5C4(+_mc
MJ0-0 Od,Bx6 ’AhnKdfdmc bknmd OJ025(-Uh_ahkhsx v_r cdsdqlhmdc sgqntfg dwbktrhnm ne_ zw_akd uh_ahkhsx cxd ’d4/5:dAhnrbhdmbdr(R_lokdr vdqd zwdc _mc oqnbdrrdc nm _ AC,Enqsdrr_ W1/-EnqEbb Q dwoqdrrhnm dwodqhldmsr AU1+K@CL@B+_mc Udqn bdkkr vdqd
rs_hmdc vhsg nmd nesgd enkknvhmf9BC53 @OB ’AhnKdfdmc bknmd W43,4.6-0(+BC21a @OB ’Hmuhsqnfdm bknmd @S02/,1(+BC05 EHSB ’Ahn,
Kdfdmc bknmd 110,2@3(+BC05-1 @OB ’AhnKdfdmc bknmd 8D8(-Bdkkr vdqd _m_kxydc nm _ L@BRPt_ms_m_kxydq’Lhksdmxh(-@kkE@BR c_s_
vdqd _m_kxydc ax EknvIn u-0/-62mshancx)hmctbdc cdokdshnm neL2XU eqnl bdkkrtodqmYsYmsr
L@XU v_r sqd_sdc vhsg 0// g f.lkneQM_rd @ ’Sgdqln DM/420(enq2/ lhm _s26" B sn cdfq_cd tmdmb_orhc_sdc QM@-QM_rd v_r
hm_bshu_sdc ax hmbta_shmf r_lokdr vhsg 0// T neQhanKnbj QM_rd hmghahsnq ’Sgdqln D//270(_s26" B enq04 lhmtsdr-0/2 EET ne
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QM_rd,sqd_sdc uhqtr v_r hmbta_sdc vhsg rdqh_kchktshnmr nesgd hmchb_sdc l@a enq2/ lhm _s26" B-Uhqtr,l@a bnlokdwdr vdqd ok_bdc
nm bdkkr _mc hmbta_sdc enq2/ lhm _s26" B-Sgd uhqtr hmnbtktl sgdm v_r qdlnudc _mc uhq_kQM@ v_r hrnk_sdc trhmf _ L_fL_w Uhq_k
Hrnk_shnm Jhs’@ookhdc Ahnrxrsdlr(-L@XU QM@ v_r pt_mshzdc trhmf _ S_pl_m QM@,sn,Bs0,rsdo jhs’Sgdqln Ehrgdq(_mc _ 4 TSQ _mc
mro0 rodbhzb oqhldq.oqnad rds’V_ffnmdqds_k-+1/07(_knmf vhsg _ rs_mc_qc btqud neL@XU rsnbj uhqtr2mshancx)hmctbdc uhqtr ahmchmf.hmsdqmYkhyYshnm YrrYx
S_qfdsbdkkr vdqd bntmsdc+_mc sgd hmchb_sdc l@ar vdqd hmbta_sdc enq2/ lhm _s26" B vhsg L@XU _s_ ltkshokhbhsx nehmedbshnm ’LNH(ne
0/-Uhqtr,_mshancx bnlokdwdr vdqd _ccdc sn bdkkr _mc hmbta_sdc _s26" B enq0 g-Bdkkr vdqd v_rgdc rhw shldr vhsg hbd bnkc OAR _mc
kxrdc hm QKS ateedq’PH@FDM(-Uhq_kQM@ v_r hrnk_sdc trhmf _ L_fL_w Uhq_kHrnk_shnm Jhs-L@XU QM@ _mc F@OCG QM@ v_r pt_mshzdc
trhmf _ S_pl_m QM@,sn,Bs 0,rsdo jhsvhsg dhsgdq _msh,L@XU oqhldqr nq _msh,lntrd EVocg oqhldq.oqnad-C_s_ _qd dwoqdrrdc _r
_lntmsneL@XU QM@ qdk_shud sn F@OCG QM@-Enqhmsdqm_khy_shnm _rr_xr+sgd r_ld oqnsnbnkv_r enkknvdc+ats_esdqqhmrhmf lnmn,
k_xdqr _esdq0 g hmbta_shnm _s26" B+bdkkr vdqd sqd_sdc vhsg 0// g f.lkneoqnsdhm_rd J ’Hmuhsqnfdm(enq04 lhm _s26" B-Oqnsdhm_rd J v_r
qhmrdc _v_x+_mc bdkkr vdqd sqd_sdc vhsg 0// g f.lkneQM_rd @ enq2/ lhm _s26" B-Bdkkr vdqd kxrdc+_mc uhq_kQM@ v_r cdsdbsdc eqnl
bdkktk_qkxr_sdr _r cdrbqhadc _anud2mshancx cdodmcdmsdmgYmbdldmsYrrYxr
EnqL@XU+s_qfdsbdkkr vdqd bntmsdc _mc sgd hmchb_sdc l@ar vdqd hmbta_sdc enq2/ lhm _s26" B vhsg L@XU _s_ LNHne0/-Uhqtr,
_mshancx bnlokdwdr vdqd _ccdc sn bdkkr _mc hmbta_sdc _s26" B enq0 g-Tm_arnqadc uhqtr v_r qdlnudc ax v_rghmf bdkkr 5W vhsg
26" B CLDL-Bdkkr vdqd hmbta_sdc _s26" B hm CLDL * 1# EAR enq6 _cchshnm_kgntqr-Bdkkr vdqd kxrdc _mc uhq_kQM@ v_r pt_mshzdc
_r cdrbqhadc _anudEnqYHJU+s_qfdsbdkkr vdqd bntmsdc _mc dhsgdqL@X,0/ nqsgd bqnrr,qd_bshud _msh,D l@a D5/ ’Nkhog_msds_k-+1//5(vdqd oqd,hmbt,
a_sdc vhsg YHJU enq2/ lhm _s26" B-Uhqtr,_mshancx bnlokdwdr vdqd _ccdc sn sgd bdkkr _s_m LNHne4/ _mc hmbta_sdc _s26" B enq1 gTm_arnqadc uhqtr v_r qdlnudc ax qhmrhmf bdkkr rhw shldr vhsg CLDL-Bdkkr vdqd hmbta_sdc _s26" B hm CLDL * 1# EAR enq05 g-Bdkkr
vdqd kxrdc _mc uhq_kQM@ v_r pt_mshzdc trhmf _ otakhrgdc oqhldq.oqnad rds’Vghsd ds_k-+1/07(L2XU D1)D/ rsqtbstqd cdohbshnm
Rsqtbstq_kzftqdr vdqd bqd_sdc trhmf TBRE Bghldq_W ’Fncc_qc ds_k-+1/07(-Sgd oqdchbsdc rsqtbstqd nesgd L@XU D1,D0 lnmnldq
v_r fdmdq_sdc _r oqduhntrkx cdrbqhadc ’D_qmdrsds_k-+1/08(-Sn cdohbssgd dmudknod oqnsdhmr _r _ sqhldqhb rohjd+sgd oqdchbsdc lnmn,
ldqr vdqd rtodqhlonrdc nmsn sgd lncdknesgd BGHJU D1,D0 rohjd ’OCA95MJ4(trhmf sgd l_sbgl_jdqbnll_mc hm TBRE Bghldq_W
’Fncc_qc ds_k-+1/07(PT2MSHEHB2SHNM 2MC RS2SHRSHB2K 2M2KXRHR
Rs_shrshb_krhfmhzb_mbd v_r _rrhfmdc vhsg I uVitdr ; /-/4 trhmf Fq_ogO_c Oqhrl udqrhnm 6-/-Sgd rodbhzb sdrsenqd_bg c_s_rdshr hmch,
b_sdc hm qdrodbshud zftqd kdfdmcr _mc v_r rdkdbsdc a_rdc nm sgd mtladqnebnlo_qhrnm fqntor _mc u_qh_mbd nesgd c_s_-Enqenns
rvdkkhmf _m_kxrhr+rhfmhzb_mbd v_r cdsdqlhmdc ax _ svn,v_x @MNU@ vhsg Stjdx%r onrs,sdrs’lnqd sg_m svn fqntor(nqRhc_j%r onrs,
sdrs’adsvddm svn fqntor(-Uhq_katqcdm c_s_ vdqd _m_kxydc ax _ nmd,v_x @MNU@ vhsg _ Ctmmdss%r onrs,sdrs-Rtquhu_kbtqud _m_kxrhr
v_r _m_kxydc ax sgd knf q_mj sdrs-@ Anmedqqnmhbnqqdbshnm v_r trdc cdodmchmf nm sgd mtladqnebnlo_qhrnm fqntor-

d5 BdkkQdonqsr 24+0/7851+@oqhk5+1/10

-diiCdonpsr Tnitld 3

RtooidldmsVihmenplVshnm

Sgd ldbgVmhrshb aVrhr neopnsdbshnm
av mnm,mdtspVihyhmf Vmsh,ViogVuhptr Vmshanchdr
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KATHERINE BASORE
2733A S Kingshighway Blvd, St. Louis, MO 63139
kbasore@wustl.edu
(614) 678-3712
EDUCATION
Washington University
PhD candidate in Biochemistry, Biophysics & Structural Biology Program

St. Louis, MO
June 2016-October 2021

Carnegie Mellon University
B.S. in Chemistry, Minor in Music, GPA: 3.84/4.00

Pittsburgh, PA
August 2010-May 2014

RESEARCH EXPERIENCE
Washington University
St. Louis, MO
Graduate Student with Dr. Daved H Fremont
January 2017-October 2021
Structural characterization of neutralizing alphavirus antibodies and virus-receptor interactions.
• Determination of kinetic and equilibrium binding properties by surface-based biophysical methods.
• Mapping of antibody epitopes and receptor determinants by mutational studies.
• Elucidation of binding interactions by high-resolution structural techniques.
National Institutes of Health
Rockville, MD
Post-baccalaureate IRTA Fellow with Dr. Sanjay A Desai
June 2014-June 2016
• Identified and optimized high-affinity antagonists against the Plasmodial Surface Anion Channel (PSAC) for antimalarial drug development.
Carnegie Mellon University
Pittsburgh, PA
Undergraduate Researcher with Dr. Stefan Bernhard
September 2011-May 2014
• Synthesized and characterized novel organometallic catalysts that photo-reduce metal ions for the development of
rechargeable metal/air batteries.
PUBLICATIONS

Basore, K., Ma, H., Kafai, N. M., Mackin, S., Kim, A. S., Nelson, C. A., Diamond, M. S., & Fremont, D. H.
(2021). Structural basis of Venezuelan equine encephalitis virus engagement of the LDLRAD3 receptor.
Accepted to Nature.
Earnest, J. T., Holmes, A. C., Basore, K., Mack, M., Fremont, D. H., & Diamond, M. S. (2021). The
mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies. Cell reports, 35(1), 108962.
Ma, H., Kim, A. S., Kafai, N. M., Earnest, J. T., Shah, A. P., Case, J. B., Basore, K., Gilliland, T. C., Sun, C.,
Nelson, C. A., Thackray, L. B., Klimstra, W. B., Fremont, D. H., & Diamond, M. S. (2020). LDLRAD3 is a
receptor for Venezuelan equine encephalitis virus. Nature, 588(7837), 308–314.
Holmes, A. C., Basore, K., Fremont, D. H., & Diamond, M. S. (2020). A molecular understanding of
alphavirus entry. PLoS pathogens, 16(10), e1008876.
Kim, A. S., Zimmerman, O., Fox, J. M., Nelson, C. A., Basore, K., Zhang, R., Durnell, L., Desai, C., Bullock,
C., Deem, S. L., Oppenheimer, J., Shapiro, B., Wang, T., Cherry, S., Coyne, C. B., Handley, S. A., Landis, M.
J., Fremont, D. H., & Diamond, M. S. (2020). An Evolutionary Insertion in the Mxra8 Receptor-Binding Site
Confers Resistance to Alphavirus Infection and Pathogenesis. Cell host & microbe, 27(3), 428–440.e9.
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Earnest, J. T., Basore, K., Roy, V., Bailey, A. L., Wang, D., Alter, G., Fremont, D. H., & Diamond, M. S.
(2019). Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity. The
Journal of experimental medicine, 216(10), 2282–2301.
Basore, K., Kim, A. S., Nelson, C. A., Zhang, R., Smith, B. K., Uranga, C., Vang, L., Cheng, M., Gross, M. L.,
Smith, J., Diamond, M. S., & Fremont, D. H. (2019). Cryo-EM Structure of Chikungunya Virus in Complex
with the Mxra8 Receptor. Cell, 177(7), 1725–1737.e16.
Kim, A. S., Austin, S. K., Gardner, C. L., Zuiani, A., Reed, D. S., Trobaugh, D. W., Sun, C., Basore, K.,
Williamson, L. E., Crowe, J. E., Jr, Slifka, M. K., Fremont, D. H., Klimstra, W. B., & Diamond, M. S. (2019).
Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2
glycoprotein. Nature microbiology, 4(1), 187–197.
Zhang, R., Kim, A. S., Fox, J. M., Nair, S., Basore, K., Klimstra, W. B., Rimkunas, R., Fong, R. H., Lin, H.,
Poddar, S., Crowe, J. E., Jr, Doranz, B. J., Fremont, D. H., & Diamond, M. S. (2018). Mxra8 is a receptor for
multiple arthritogenic alphaviruses. Nature, 557(7706), 570–574.
Fastman, Y., Assaraf, S., Rose, M., Milrot, E., Basore, K., Arasu, B. S., Desai, S. A., Elbaum, M., &
Dzikowski, R. (2018). An upstream open reading frame (uORF) signals for cellular localization of the virulence
factor implicated in pregnancy associated malaria. Nucleic acids research, 46(10), 4919–4932.
Pain, M., Fuller, A. W., Basore, K., Pillai, A. D., Solomon, T., Bokhari, A. A., & Desai, S. A. (2016).
Synergistic Malaria Parasite Killing by Two Types of Plasmodial Surface Anion Channel Inhibitors. PloS one,
11(2), e0149214.
Basore, K., Cheng, Y., Kushwaha, A. K., Nguyen, S. T., & Desai, S. A. (2015). How do antimalarial drugs
reach their intracellular targets? Frontiers in pharmacology, 6, 91.
Sharma, P., Rayavara, K., Ito, D., Basore, K., & Desai, S. A. (2015). A CLAG3 mutation in an amphipathic
transmembrane domain alters malaria parasite nutrient channels and confers leupeptin resistance. Infection and
immunity, 83(6), 2566–2574.
Brooks, A. C., Basore, K., & Bernhard, S. (2014). Organocatalytic photoreduction of Zn(II) to zinc metal.
Chemical communications, 50(40), 5196–5199.
Brooks, A. C., Basore, K., & Bernhard, S. (2013). Photon-driven reduction of Zn2+ to Zn metal. Inorganic
chemistry, 52(10), 5794–5800.
PRESENTATIONS
Basore, K., Kim A.S., Zimmerman O., Nelson C.A., Yoon J., Diamond M.S., Fremont D.H. Structural evolution of speciesspecific alphavirus infection by the Mxra8 receptor. Oral presentation delivered at the Virtual American Society for
Virology meeting, June 2020.
Basore, K., Kim A.S., Nelson C.A., Zhang R., Smith B.K., Uranga C., Vang L., Smith J., Diamond M.S., Fremont D.H.
Cryo-EM structure of Chikungunya virus in complex with the Mxra8 receptor. Oral presentation delivered at the American
Society for Virology meeting, Minneapolis, MN, July 2019.
Basore, K., Kim A.S., Zhang R., Diamond M.S., Fremont D.H. Structural insights into alphavirus-receptor interactions.
Oral presentation delivered at the WashU-UChicago Joint Immunology Retreat, the WashU Biochemistry, Biophysics, and
Structural Biology Retreat, and the WashU Micro/Immuno Mini-Retreat, St. Louis, MO, Fall 2018.
Basore, K., Earnest, J.T., Diamond, M.S, Fremont, D.H. Structural characterization of broadly neutralizing alphavirus
antibodies. Poster presentation delivered at the American Association of Immunologists meeting, Austin, TX, May, 2018.
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Basore, K., and Desai, S.A. Rapid and selective osmotic lysis of Plasmodium-infected erythrocytes by a stapled peptide.
Oral presentation delivered in the Laboratory of Malaria and Vector Biology Research seminar series, NIAID, NIH,
Rockville, MD, September 2015.
Basore, K., and Desai, S.A. Lead generation of high-affinity plasmodial surface anion channel inhibitors for antimalarial
drug development. Poster presentation delivered at NIH Postbac Poster Day, Bethesda, MD, April 2015.
Basore, K., Brooks, A.C., and Bernhard, S. The Photoreduction of Zn(II) to Zn Metal. Oral presentation delivered in the
chemistry undergraduate senior research seminar series, Carnegie Mellon University, Pittsburgh, PA, April 2014.
TEACHING & MENTORING EXPERIENCE
Washington University
St. Louis, MO
Assistant to the Instructor, Principles of Biology I Course
January-May 2018
• Proctored exams, held office hours, and led two weekly small group sessions for undergraduate-level course.
Summer Focus Tutor, Young Scientist Program
Summers 2017 and 2018
• Guide local high school students through their summer coursework and college application preparations.
Tutor, Chemistry & Physics of Biomolecules Course
October-December 2017
• Provided one-on-one guidance on developing effective study habits for graduate-level course.
Carnegie Mellon University
Pittsburgh, PA
Student Mentor, Mellon College of Science
August-December 2013
• Advised the incoming freshman class academically throughout their first semester of college.
Teaching Assistant, Introduction to Experimental Chemistry
• Prepared and supervised laboratory section of undergraduate-level course.

January-March 2012

Mentor, Strive for College Program
September 2010-May 2012
• Navigated local high school students in an underprivileged school district through college application process.
SKILLS & TECHNIQUES
Chemical: spectroscopy (NMR, MS, IR, fluorescence, UV-Vis), spectrophotometry, chromatography (HPLC, FPLC, IC,
GC, TLC), organic and inorganic synthesis, air sensitive reactions, cyclic voltammetry, reflux reactions, distillation (simple,
steam, and vacuum), compound recrystallization, aqueous extraction, titrations, gravimetric analysis, microwave digestion,
melting point determination.
Biochemical: microscopy (light, electron, cryo-electron), cell culture (parasite, bacterial, yeast, HEK293, hybridoma),
molecular cloning (PCR, DNA sequencing, site-directed mutagenesis, Gibson assembly), western blotting, blood
fractionation, protein expression and purification, protein crystallization and X-ray diffraction, immunoprecipitation, BLI,
SPR, SEC-MALS, ELISA.
Computational: Programming languages (Python, Processing.js, Unix shell, Wolfram), MS Office, SigmaPlot,
Mathematica, Topspin, MestReNova, ChemBioDraw, ChemSketch, VMD, PyMOL, UCSF Chimera, cisTEM, RELION.
Certifications: Notary Public, State of Missouri
HONORS & AWARDS
•
•
•
•

Infectious Disease / Basic Microbial Pathogenic Mechanisms T32 grant, 2018-2020
Best student presentation, BBSB retreat, 2018
Outstanding Poster Award at NIH Postbac Poster Day, 2015
Phi Kappa Phi Honors Society, 2014
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•
•
•
•
•

Student Award from the American Institute of Chemists, 2014
Carnegie Mellon Senior Leadership Recognition Award, 2014
Carnegie Mellon Undergraduate Grant and Institutional Scholarship, 2010-2014
Greek Olympic Society Scholarship, 2011
Greek Orthodox Cathedral Undergraduate Merit Scholarship, 2010
EXTRACURRICULAR ACTIVITIES

House Rabbit Society of Missouri
Volunteer
• I feed, socialize, and groom rabbits up for adoption, and help keep the site clean.

Fenton, MO
January 2021-Present

Washington University
St. Louis, MO
Young Scientist Program Volunteer
August 2016-August 2018
• Perform demonstrations to local students to promote education and career options in the sciences.
Student Liaison Committee Member, Biochemistry & Molecular Biophysics Department
• Organize the Biophysical Evenings Seminar series.

May 2017-July 2020

Carnegie Mellon University
Pittsburgh, PA
Volunteer Pianist, The Children’s Institute of Pittsburgh
September 2013-May 2014
• Accompanied a music therapist in therapy sessions for patients with Prader-Willi Syndrome.
Delta Delta Delta Sorority, Philanthropy Chairman & Music Chairman
September 2010-May 2014
• Organized philanthropic efforts for St. Jude Children’s Research Hospital; taught ritual music and cheers.
Carnegie Mellon University Rowing Club

September 2010-May 2014

Violinist, All-University Orchestra

September 2010-May 2012
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